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Abstract
This thesis details three different projects.
The first project describes the synthesis of tritium-labelled 
Dickerson's DNA dodecamer, 5'-CGCGAATTCGCG-3', using phosphite triester 
chemistry. Coupling of the or A& 2'-deoxyadenosine nucleosides was
optimized with only five molar equivalents when using a novel manual 
apparatus. Tritiated 2’-deoxyadenosine phosphoramidites were prepared from 
halogenated precursors by catalytic reduction with tritium gas. The NMR 
spectra of the nucleosides and nucleotides were assigned.
The second project describes bovine pancreatic phospholipase Az 
inhibition as studied by NMR spectroscopy. An unsaturated amide substrate 
analogue inhibitor was synthesized and site-specifically tritium-labelled by 
the reduction of an alkene double bond in the inhibitor using tritium gas 
and Wilkinson's homogeneous catalyst. The chosen reduction method was
identified from a range of deuteriation procedures conducted on a model 
system.
The third and final project describes the structure of
chromone-2-carboxylates as studied by NMR spectroscopic and X-ray 
crystallographic methods. Brominated sodium cromoglycate was synthesized for 
use as a substrate for tritium labelling. Its structure and that of its 
precursor were determined by X-ray crystallographic, iR-lR NMR NOE
difference and NMR spectroscopic analyses. The structure arrived at 
differs from that previously published.
An 170 NMR spectroscopic investigation of carboxylate derivatised 
chromone-2-carboxylates in a range of solvents was also undertaken. iR, 
and 170 NMR assignments are given. Oxygen-17 enrichment was achieved by 
acid-catalysed exchange or acyl chloride hydrolysis with [i7o]water. 
Acid-catalysis gave the product with the endocyclic %-pyrone oxygen 
selectively enriched. Isotopic enrichment allowed the acquisition of high 
quality i?o NMR spectroscopic data of molecules under experimental 
conditions which were untenable at natural oxygen-17 abundance.
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1. General Introduction
The first chapter of this thesis describes the synthesis and 
site-specific tritium labelling at both A5 and A6 positions of the 
self-complimentary DNA oligonucleotide, Dickerson's dodecamer, at high 
specific radioactivity.
The Dickerson 12-mer showing the position of the adenine base residues
The position and specificity of tritium labelling was elucidated by 
and 3H NMR spectroscopic analyses. The oligonucleotide will be applied in 
future NMR investigations of macromolecular hydration.
The constituent purines; 2'-deoxyadenosine and 2'-deoxyguanosine and 
pyrimidines; 2'-deoxycytidine and thymidine have the following numbering 
schemes :
PURINES
2'-Deoxyadenos ine 2'-Deoxyguanos ine
NH
OH
H
PYRIMIDINES
2'-Deoxycytidine Thymidine
oNH
3 N ^
HO
OH
CHHN
OH
The numbering of oligonucleotide polymers begins at the free 5'-OH end 
of the polymer, by convention, and the polymer is written 5' -— 3'. The 
synthesis proceeds in the opposite direction, 3' — 4 5'. The arrangement 
for Dickerson's dodecamer would be:
5' C^G-C-G-A-A-T-T-C-G-C— G 3'
1 2 3 4 5 6 7 8 9 10 11 12
The chapter begins with literature reviews of all the relevant topics: 
The structure of the Dickerson DNA 12-mer and reports of NMR assignment 
and hydration; the various routes to [2-3R] and [S-^ H] labelled adenines; 
the assignment of the 2 and 8 position protons and tritons in their 
respective and NMR spectra and the complication caused by substitution 
at the 6-amino function of the adenine purine ring; the chemistry of the 
derivatizations of nucleosides necessary for the chemical synthesis of DNA 
molecules; the manipulation of these substituted nucleosides to achieve the 
synthesis of DNA oligonucleotides and, lastly, reports of manual apparatus 
used in DNA syntheses.
The experimental section describes the synthesis of the halogenated 
precursors used, along with direct exchange labelling, to give the labelled 
nucleosides; their characterization and IH/^H NMR assignments and 
derivatizations for DNA synthesis. The use of a manual DNA apparatus to
synthesise tritium-labelled Dickerson DNA 12-mer is described and the
results of these along with the resultant NMR data are represented as a
series of tables and figures. Other diagrammatic data are presented as 
appendices.
A discussion and appraisal of the results obtained concludes this 
chapter.
1.1 Abbreviations
The following abbreviations have been used in this report. They are 
listed approximately alphabetically.
A Adenosine
Ac Acetyl (CH3CO-)
AMP Adenosine monophosphate
ATP Adenosine triphosphate
B Base (ie. purine or pyrimidine)
2BrdA 2-Brorao-2'-deoxyadenos ine
BBrdA 8-Bromo-2'-deoxyadenos ine
SBrN^BzdA 8-Brorao-N^-benzoyl-2'-deoxyadenosine
BPTI Bovine pancreatic trypsin inhibitor
Bz Benzoyl (PhCO-)
BzCl Benzoyl chloride
2C1A 2-Chloroadenosine
2CldA 2-Chloro-2'-deoxyadenosine
CED 3'-0-[(2-Cyanoethy1),(N,N-di i sopropyl)]phosphoramidi te
2ClN&BzdA 2-Chloro-N6-Benzoyl-2'-deoxyadenosine
COSY Correlated spectroscopy (2D)
CPG Controlled pore glass
dA 2'-Deoxyadenos ine
DCA Dichloroacetic acid
dC 2'-Deoxycytidine
dG 2'-Deoxyguanos ine
dT (2'-Deoxy)Thymidine
DIPEA Diisopropylethylamine
DMA Dimethylacetamide
DMAP 4-(N,N-dimethylamino)pyridine
DMF Dimethylformamide
DMSO Dimethylsulphoxide
DMTrCl 4,4'-Dimethoxytrityl chloride
DMTr 4,4'-Dimethoxytr i tyl
DNA 2'~Deoxynucleic acid
2FA 2-Fluoroadenos ine
2FdA 2-Fluoro-2'-deoxyadenosine
HPLC High pressure liquid chromatography
mCPBA Meta-chloroperoxybenzoic acid
MMTr 4-Monomethoxytrityl
NMR Nuclear magnetic resonance
NOESY 2D nuclear Overhauser enhancement spectroscopy
N^BzdA N^-Benzoyl-2'-deoxyadenosine
NTLF National Tritium Labeling Facility
PE Polyethene
PP Polypropene
psi Pounds per square inch
PTFE Polytetrafluoroethene
py Pyridine
RP Reversed phase
Tc Correlation time
Tm Mixing time
TBDMS Tert-Butyldimethylsilyl
TCA Trichloroacetic acid
TEA Triethylamine
TEAAc Triethylammonium acetate
THF Tetrahydrofuràn
TLC Thin layer chromatography
TMSCl Trimethylsilyl chloride
Toi Toluyl (p-CHaPhCO-)
Tr Trityl (-CPha)
2. LITERATURE REVIEWS
2. LITERATURE REVIEWS
2.1 The Dickerson Dodecamer
The so-called Dickerson dodecamer is a synthetic DNA 12-mer of primary 
sequence, 5'-CGCGAATTCGCG-3'^ . This oligonucleotide is self-complimentary 
-able to form duplexes with itself- and has been extensively studied by a 
myriad of techniques^, principally X-ray crystallograpyi and NMR
spectroscopy2-8.
The continued interest in this oligonucleotide stems from studies of
the range of structures a DNA strand can adopt in solution under different
conditions. The Dickerson 12-mer conforms to just over one complete turn of 
the classical Watson-Crick right-handed duplex of B-DNA, a long slender 
conformation in which the heterocyclic bases are perpendicular to the helix 
axis*'9. This form dominates at high hydration levels (>80%)8.
The GAATTC sequence in the middle of the 12-mer is known to be an EcoRI 
restriction endonuclease recognition site.
2.2 NMR Assignment and X-Ray CrystalloKranhv
The prerequisite of a study of solution hydration of a biological 
macromolecule is that complete iH NMR assignments are available and that the 
structure of the macromolecule is known at high resolutionio. The latter 
requirement is usually fulfilled by X-ray crystallography although NMR 
methods are increasingly used for this task. These needs are satisfied for 
the Dickerson 12-meri'7.
From this basis, unambiguous assignments of NOE's between protons of 
the DNA molecule and hydration water molecules can be obtained^®.
The X-ray crystal structure of the Dickerson 12-mer* shows a
right-handed B-DNA conformation with a 19° bend in the helix axis thought to
be induced by intermolecular hydrogen bonding in the crystal. The problems 
with X-ray data are that DNA molecules are highly flexible resulting in the 
resolution of the diffraction obtained from crystals sometimes being too low 
to define the backbone of the duplex, let alone the hydration water
molecules^.
It is known that the same DNA sequence can crystallise into a number of 
space groups dependent on the variability of crystallization conditions. 
Apart from the inherent flexibilty of the molecule, packing forces may 
strongly affect the intrinsic structure of the molecule and of the 
surrounding hydrating water molecules, throwing into question its similarity 
to solution structure*.
X-ray data identifies a spine of hydration along the minor groove of 
the Dickerson 12-mer in the B-DNA form*. The static X-ray structure, 
however, reveals nothing of the dynamicism of the hydrogen bonding network 
nor differentiates between different types of water molecular hydration.
The sequential method of *H NMR signal assignment is generally 
applicable to all right-handed double-stranded helices?. The method?•** 
consists of identifying groups of signals by 2D COSY which are then
spatially connected by NOESY. Intense NOESY cross peaks arise from the
following protons being close throughspace:
(1) (base)n - (base)„y-l Eg. A6(H8) - T7(H6)
(2) (base)n ” (Hl')n-i Eg. H8 purinen - (HI'« + HI'n-0
(3) (base)n - (H2")n-i Eg. H8 purinen - (H2")n-l
The éxchangable imino (NH) protons and the non-exchangable base 
(aromatic) protons resonate between 11-13ppra, all other protons being upfield 
from this. As the HI' and H2" chemical shifts are well separated from the 
aromatic peaks, three sets of cross peaks appear in isolated regions of the 
NOESY spectrum which simplifies interpretation.
The two-fold symmetry of the Dickerson 12-mer results in the signals 
from both strands of the duplex being coincident, thereby halving the 
observed signals compared to a non-symmetrical duplex?.
Hare et al? found that the two adenine H8 protons of the Dickerson
12-mer are coincident at 8.09 ppm in DzO at pH 7.0. The adenine H2 protons 
could not be directly assigned because they are spatially segregated from 
other non-exchangable protons in DzO although an NOE was observed between
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the H2 protons of the consecutive adenine bases at positions 5 and 6.
It is observed that all signals from the Dickerson 12-mer are resolved 
from the water chemical shift at 10^ C*2.
For NMR samples (typical volume, SOOul) containing less than about 0.5 
- Ipnole of the Dickerson 12-mer at low ionic strength, the phenomenon of 
self-association occurs. A single strand of the DNA oligonucleotide forms an 
intramolecular hydrogen bound complex between the self-complimentary 
sequences at both ends of the strand, creating the hair-pin structure*3:
5' 3'
C~”GI IG"“**CI Îr\fA T Hairpin loopw
2.3 Significance of Hydration in Biological Processes
Hydration of biological macromolecules in solution is pivotal in 
defining their structure, how they respond to transitions and interactions 
due to changes to the environment of the biomolecule. Hence, hydration can 
be critical for the function of the biomolecule** and DNA recognition by 
proteins and drugs may be influenced by the presence of strongly 
hydrogen-bound water.
Unlike globular proteins, nucleic acids do not have a clearly defined 
internal tertiary structure so that almost all atoms may interact with the 
solvent. Hydration of DNA is influenced by the DNA sequence, the size of the 
major and minor grooves and the overall conformation of the nucleic acid*.
2.4 Experimental Data for Rvdration
The investigation of biomolecule hydration can be studied by high 
resolution X-ray diffraction although, in recent years, a much greater range
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of structural and dynamical information has been demonstrated by NMR
methods 10-12, 14-17,
2.4.1 X-Rav Methods
For the Dickerson 12-mer, in the B-DNA configuration, a spine of 
hydration*»* is observed in X-ray crystal structures. It consists of an 
ordered water network in the centre of the minor groove and double ribbons 
at the ends of the minor groove*.
The width of the groove is believed to be more important than the
sequence in determining the architecture of the hydration water around it*.
2.4.2 NMR Methods
The problem of performing *H NMR in water (a low percentage of DzO is
used for the frequency lock) solution is the very high concentration of
solvent protons. This gives rise to an intense solvent signal which presents 
dynamic range problems**»*?. Hence, the solvent signal must be suppressed 
without destroying the magnetization necessary to participate in the cross 
relaxation (ie. the NOE cross peak).
In the primary hydration sphere for DNA there are about 20 waters per 
nucleotide*. A very recent computational study by Osman et al calculated 
that the A-T pair in the Dickerson 12-mer is solvated by an average of 20.45 
molecules of water2.
The first report of the observation of individual hydration water 
molecules and characterization of their binding sites was made in 1989 by 
Wuthrich and Otting** for the globular protein, BPTI. Their results gave a 
residence time for hydration water as approximately 0.3ns at 36^ 0.
The data of Wemmer and K u b in e c *2 show negative NOE cross peaks from 
water to the H2 protons of A5 and A6 (amongst other DNA protons) in the A-T 
rich segment of the spine of hydration in the minor groove of the Dickerson 
12-mer. The sign of the NOE indicates a lifetime for the water molecules to 
be of the order of several nanoseconds, a relatively long time!
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2.5 Use of Heteronuclear Spin-1/2 Isotopes in DNA NMR Experiments
The DNA 6-mer CGTACG has been synthesized with the dA residue enriched 
with nitrogen-15 at the 1- and 6-positions*8 . The NMR-active, spin 1/2 
nitrogen-15 labels function as structural monitors that were used to monitor 
and charaterize helix-to-coil transitions and proved to be sensitive 
reporters of hydrogen bond interactions.
Similarly, O&MeG with N* and N^ *^ N-labels has been used to probe the 
mis-pair O^ MeG.’T solution structure by *^ N NMR in a DNA 12-mer**.
Tritium (hydrogen-3) possesses many well-known profitable features 20 
that have been used to good effect for biomolecular NMR2*“26;
(1) Tritium has the highest sensitivity to NMR detection
(2) Zero background
(3) All the data and techniques applicable to *H NMR (ID or 2D) are 
directly transferrable.
(4) Tritium labelling chemistry is well developed
With the validation of 3r in SH-*H 2D NOE experiments^?, the use of 
NMR in studying biomolecular hydration may be a valuable approach.
2.6 The Route to the F2-3H1Oligonucleotide Synthon
This section provides a cursory glance at some of the reactions 
employed in the routes to 2CldA and 2BrdA (see SCHEME 1) and subsequently to 
the fully protected tritiated reagent prepared for application in DNA 
oligomeric synthesis. The synthesis had already been followed to compound 
(6) (see SCHEME 1); this review decribes the routes to all subsequent 
compounds in the scheme.
2.7 Biological Activity of 2-Halonucleosides
Many structurally modified nucleosides are useful in anti-viral and 
cancer t r e a t m e n t s 2 8. it has emerged^*')* that 2-substituted adenosines and 
2'-deoxyadenosines display potent effects. Those of 2-haloadenosine and 
2-halo-2’-deoxyadenosine are illustrated in TABLE 1.
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TABT.E 1 : Biological Activity of 2-Halonucleosides
Compound Biological Activity Reference
2FA/ 2FdA Potent tumor inhibitors 31,32,33
2C1A/ 2BrA Blood platelet aggregation 
inhibitor
Potent effects on blood 
pressure and cardiovascular 
system
Enzyme inhibitors
29,31,32,33
2CldA/ Tumor cell growth inhibitor 31,30,34,35
2BrdA (leukemia)
The halogen in the 2-position prevents enzymatic deamination by 
adenosine d e a m i n a s e ) 3.35 but allows phosphorylation by adenosine 
kinase33,35, enabling the analogue to become incorporated in DNA thereby 
blocking DNA synthesis which leads to its cytotoxic effect.
Because of this biological activity, considerable synthetic effort has 
been expended in preparing 2-halonucleosides36. 3 0 ,3 7 ,3 5 ,38,39.40,32,34,41,42 
thus making these 2-halogenated nucleosides the obvious choice as precursors 
to site-specifically tritium-labelled DNA oligonucleotides.
2.8 2-Position Halogénation (Compound (711
The route to the 2,6-dichloronucleoside (7), employing 2-amino 
diazotization in a non-aqueous medium was adapted from the procedure 
described by Rob i n s )2 for adenosine. This method of halogénation at the 
2-position in nucleosides has also been utilised by Nair for iodination)? 
and Jaiswal for b r o m ination*3 of adenosine analogues and is similar to the 
more fimiliar Sandmeyer reaction of benzene chemistry.
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2.9 é-Dehalogenoammonolysis f Compound f8))
As TABLE 2 shows, the reaction conditions for 6-halogenoammonolysis 
vary widely for, essentially, the same reaction.
TART.E 2: 2.6-DihaloPurine Anmonolvsis
Yield
X
Solvent N H 3
Source
Temp. Reaction
Length/hrs
Reference
- MeOH NH3 gas sat'd 
at 0®C
100 17 44
56 MeOH NH3 gas sat'd 
at 5"’C
R.T. 1 week 29
60 MeOH NH3 gas sat'd 
at 5°C
R.T. 1 week 29
84 MeOH NH3 gas sat'd 
at O'C
(a)R.T 
(b)30-40
(a)overnight 
(b) 3
45
76.5 - Liq. NH3 R.T. 26 31
71 MeOH NH3 gas sat'd 
at 0 %
100 5 34
93 Eton NH3 gas sat'd 
at -10 °G
(a)-lO
(b) 25
(a) 10
(b) 23
37
94 MeOH NH3 gas sat'd 
at 0°C
60 32 35
54 iPrOH NH3 gas at 
R.T.
R.T. 2.5 46
Substrate
X=C I
AcO
AcO OAc X = Br
.6)
AcO-yOv^
AcO OAc
A o O - y O O
AcO
OTol &
TolO
' -N
AcOxlAcO OAc
T o lO -y O v J
OTol.60
AcO
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All involve heating to high temperatures (up to 100“C) for lengthy 
periods of time or even longer ( up to 1 week!) at room temperature. As the 
nucleophilic base, ammonia, is used in excess for these reactions, it is 
essential that the solvents and reaction conditions are completely anhydrous 
in order to eliminate base mediated depurination. Depurination is the lysis 
of the sugarCl'“baseN9 bond.
These reaction methodologies reported (TABLE 2) are inconvenient due to 
their length and the high pressures involved (ie. ammonia gas at high 
temperatures). Also, all the methods in the literature37,44,29,45,3i.34,35 
give the 2',3',5'- or 3',5'-deprotected products which are more hydrophilic 
than lipophilic increasing the experimental difficulty of conventional 
chromatographic purification of these 2-halonucleosides.
2.10 N^-Benzoylation (Compounds (91 and flOl)
The protection of the free amino (-NH2) groups on the heterocyclic 
rings of dA,dC and dG is a necessary precautionary step against unwanted DNA
oligomeric chain extension at these sites*?. The most common protecting
group is the amide moiety with benzoylation being most popular for dA.
The classical procedure of Khorana et a l *8 remains a primary route to 
N^BzdA's. This indirect "peracylation-deacylation" route is a consequence of 
the inability to selectively acylate the 6-NH2 in the presence of the 
3',5'-0H's of dA, yet it is possible to selectively deacvlate the
peracylated intermediate to give the N&-monoacylated product. This method is 
widely used by other workers in the a r e a * o **9,5 0 . They report the use of 
between 4*8 and 10*0 equivalents of benzoyl chloride to effect 
per-benzoylation in an anhydrous pyridine medium over two hours to give a 
quantitative yield of the per-benzoylated nucleoside*8.
The site of aroylation has been a point of contention with the
suggestion that the reactive endocyclic position may react with p-toluyl 
chloride to give ,N0-diToldA5 3:
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p-TolCl
py
HO
Tol
Toi
HO
NH,Co
OH
The m  NMR study of Anzai et and the confirmatory data of Lyon et
al54 showed no resolution of NMR signals thereby concluding that the site of 
purine ring acylation was solely the N^-position.
Sodium hydroxide is used as a base^O'^s to give the N^-monobenzoylated 
product in pyridine/ alcohol solvent mixtures (65-70% yield).
A further discussion of the role of N&-protecting groups appears in 
section 2.21.
2.11 Reductive 2-Dechlorination (Compound(ID)
Listed in TABLE 3 are examples of catalytic reductive 2-dechlorination 
of 2-chloropurines and 2-chloro-2'-deoxyadenosines, including a
2-bromoadenosine for comparison.
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TABLE 3: Catalytic Dechlorination of 2-Cbloro-2 ' -deoxyadenosines
Isotope Position Solvent Tine Sp.Act. Ref.Cat/SubSubstrate Catalyst
(Ci/mmol)(hrs.)LabelledRatio Source
NH,
N.A,Pd/C
HO
17:1 0.5 N.A.20% Pd/C 393:2
H20:28% NH4OH
Water N.A.5% Pd/C 2.5OH
(45 psi) pH 8.0Q"'HO
NH,
C2,C8
BzNH
30% Pd/C C2.C8 DMFHO
(1 atm) (1:3)OH
PdO pH 8.6C2 43,52
(1 atm) (90%) phosphateOHOH
buffer
N.A. = Not Applicable
All the examples make use of palladium catalysts. With the N^-position 
underivatized, all the literature sources describe the use of basified (and 
bufferedSZ) aqueous solvents. The use of protic solvents in catalytic 
hydrogen isotope labelling is unusual in that the labile protium from the
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solvent may act as a source of isotope dilution in the labelling experiment. 
This is not the case for 2-BrATP (see TABLE 3). Thus, it is probable that 
for 2-BrATP52, where H8 labelling is minimal, catalytic exchange at this 
position is very effectively back-exchanged into the basified aqueous 
solvent. Debromination occurs at the catalyst surface with adsorbed T2 gas 
to give [2-3H]ATP. Back-exchange of 3H2 (T2) is ineffective because of its 
greatly reduced kinetic acidity^s. These points coupled with the finer 
details of Jaiswal's experimental p r o c e d u r e ^ 3,52  ^ in part, explains the 
reason for almost exclusive and near-quantitative H2 tritium labelling of 
the purine ring in ATP.
Tritium-labelled adenosines and 2'-deoxyadenosines have been used in 
the biological sciences for metabolism studiesS*, isolation of receptors&o 
and to fulfil a need for a cytokinin of high specific radioactivity^i for 
further research.
2.12 DMTr Reaction (Compound (1211
The temporary protection*? of the 5'-OH group of the ribofuranosyl 
sugar is effected as the 4,4'-dimethoxytrityl ether. The synthetic procedure 
for this reaction has altered little since its inception by Khorana et al&* 
and has been described in detail by numerous workers*o,4 8,50. dMAP is used 
nowadays to activate the triarylchioromethane reactant^S:
Cl'TrCl +  (CH3) N - ^ ^ N  ^  (CH3)N-
B B
(CH3)N-^^-Tr + ^
O H  Ô H
HCl + py ----- > pyH+Cl- (py is the solvent)
The alkylation is highly selective for the 5'-OH primary alcohol in the 
presence of the secondary 2'-OH and/or 3'-OH alcohols. It is observed^s that 
the reaction of DMTrCl with secondary alcohols is very slow (ca. 14 hrs.) 
and requires a higher temperature (40-45 *C), presumably due to a steric
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effect. The resultant triarylmethylether is acid labile with the ease of 
cleavage increasing with the nature and number of electron-donating groups 
on the benzene rings. The effect of p-OMe groups has been investigated by 
Lund&6 and observed by Khorana*®• .
A further discussion of 5'-OH protecting groups appears in section
2.20.
2.13 Phosnhitvlation (Compound (131)
The most important and complex derivative that is necessary for DNA 
oligonucleotide synthesis is the 3'-phosphite triester. This has been 
referred to as the "oligonucleotide synthon"®?.
Phosphite reagents are highly reactive and it took several years to 
hone the physical properties of the chlorophosphoramidite reagent®® and the 
nucleoside phosphoramidite product®^.?o. The nature of the alkyl groups on 
the amino substituent emerged as the crucial factor for good stability.
The chlorophosphoramidite has now standardised upon the 
diisopropylamino function as it can be easily synthesized in high yield 
(78%?®) at very high purity (>98%?®) as determined by ®*P NMR spectroscopy.
Cl
P ARO^ R = C H3 or [CH^pN
The compound is less volatile and, thus, very much less likely to 
hydrolyse?!'?2 to the corresponding H-phosphonate?®»?* with atmospheric 
moisture than its dimethylamino predecessor.
Cl
. H P  ---- >^ RO ...V  Y
The chlorophosphoramidites have been fully characterized by Sinha et
al?5.
Highly localised acidity arising from a too rapid reaction in the 
condensation to form the nucleoside phosphoramidite can lead to a low
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reaction yield due to side-product formation.
B
DMTrO-n yOVfOH
r
HCl + N-\ r
DMTrO—w O 'vV  'ÎR0-'
S id e -D ro d u c ts  i 
B
H 0 - \  yO
OCEDA
DMTrO
OCED
-V NH* Cl
r
?CEDO—^Ovy
OCED
B
”TR O - P - H&
HCl
B
DMTrO-^Oy^
01R O -PIO
DMTrO
Sinha et al75 report that the 3',3'-dimer (C) represents 3% of the 
product from the reaction and Beaucage^3 gives a value of 5% to side-product 
(E). It is essential to quench the excess chlorophosphoramidite before the 
aqueous work-up to limit the amount of (E):
CH3O
-> p /L + TEA.H*Cr
ÇI
RO^'^'-n C ^  ♦ CH,OH
y
TEA
RO^' '"Ny
The nucleoside phosphoramidite can easily be synthesized in high yield 
and purity70.75 to give a highly reactive reagent of good stability for DNA 
s y n t h e s i s 7 0 , 7 1 . 7 6 ,  po isolate the phosphoramidite in reasonable purity, many 
workers precipitate the phosphoramidite in a l k a n e s ^ 7 , 7 0 , 7 7 .  Such
experimental procedures tend to be inefficient at the micromolar reaction 
scale of radiosynthesis and were not used.
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The scope for impurities is wide (see above) and they are all capable 
of curtailing the stepwise monomer coupling yield in DNA polymer synthesis. 
A corollary of the higher stability of the diisopropylaminophosphoramidite 
is that it does not degrade on silica. Apart from being able to monitor the 
course of the phosphoramidite reaction by TLC74.75,77, TLC can further be 
used as a very sensitive analytical technique for quality contrôlas in 
phosphoramidite purity checking. The EtOAciCHzClziTEA (9:9:2) solvent system 
is the most popular?8,77. This reveals two diastereoisomers due to partial 
resolution of the stereoisomers created by the asymmetric phosphorus centre.
T C A G
"nil
1 = I IH.O — • -
3 =
H u e U o il( l« *3 *p h e ip h o ttn ild l|t
2 () ( ) (J ()
2 = CH,0— jj— H 4 =  UnknaM»
Flash chromatographic purification of the phosphoramidite^7,78,70,77 ig 
seen as an essential requisite of high yields in DNA oligomeric synthesis as 
sideproducts and impurities, if not removed, will diminish yields via DNA 
synthesis reagent depleting secondary reactions.
A further discussion of 3'-OH groups appears in section 2.23.
2.14 8-Bromo-2'-deoxvadenosine Syntheses
The use of 8-halopurine intermediates is an attractive route to 
site-specifically tritium-labelled purine nucleosides as 8BrdA can be 
directly synthesized via a one-step reaction from the corresponding 
nucleoside, in contrast to the considerable synthetic effort that is 
necessary to arrive at 2-halopurines.
B e a m a n a n d  Holmes et al79 were the first to report the compound but 
due to the methodology employed and the low solubility of the
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3 5 '-diacetate protected dA starting material in organic solvents, the 
yields were low (49%). Ikehara and co-workers^o tried a dioxane/water 
mixture as solvent but the yield was disappointing (42%). After a sustained 
effort, Ikehara8o-82 described the use of a pH 4 sodium acetate buffer and 
bromine water. This simple procedure gave 8BrdA from dA in reasonable yield 
(74.5%82). This route is now the method of choice for this useful 
electrophilic intermediate®3-85. Guy et al86 were able to fine tune the 
conditions to further improve the yield to 88%. The method of Ikehara 
incorporating the improvements of Guy were used by this author to synthesise 
8BrdA.
As the N^-benzoyl protected dA is a requisite of the phosphite triester 
phosphoramidite route to DNA oligomers, it was necessary to protect the 
6-NH2 function before the reductive debromination reaction yielding the 
tritiated intermediate. The "transient" protection route of Ti et al^s is 
the simplest and quickest route to N^BzdA in moderate yield (55%7 .S4) as the 
3',5'-bis(trimethylsilyl)- protected intermediate*? is formed selectively 
and efficiently in the presence of the 6-NH2 function and its isolation is 
unnecessary leaving an easy hydrolytic step to give the required product. 
This procedure has been adapted for 8BrdA by Singh et al®^»^* and this was 
followed by the author.
Maeda et al®* have described the synthesis of [8-2H]dA via the Dz gas 
reductive debromination of 8-BrdA in an acidic medium (1:1 Ac0H:H20).
2.15 Purine-H8 Exchange
The study of H8-purine acidity is the subject of interest in the 
biological sciences because of its' part in the DNA structure. As a 
consequence, the topic of H8-purine hydrogen isotope exchange labelling has 
been well covered in the literature. The experimental routes to directly 
labelled purine rings falls roughly into two sections: Metal-catalyzed and 
Non-catalyzed.
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2.15.1 (A) Metal-Catalyzed Exchange
Platinum black (Adams' catalyst**) appears to have been used 
exclusively for deuterium and tritium exchange labelling of purines. This 
work is summarised in TABLE 4:
TABLE 4: Purine Rinx Ccmpounds Labelled Bv 
Adams' Catalyst Exchange with Hydrogen Isotope Sources
Substrate Sub/Cat Isotope Temp. Time Sp. Act. Ref.
Ratio Source (*C) Hrs. (Ci/mmole)
6:1 T2O 100 20 0.44 90
^OH
-
(>100 Ci) 
T2O - - 0.14 91
dA
(
3:5
PdO/BaSOi)
T2 
(25 Ci)
R.T. 3.5 17 57
A 6:1 D2O 100 40 N.A. 92
dA 1:2-10 D2O 80 or 
100
50-
120
N.A. 93
N.A. = Not Applicable
As the work of Letham and co-worker** illustrates (see TABLE 4), even 
using a large excess of tritiated water (presumably of a low specific 
radioactivity), gives a low specific radioactivity for the purine product 
and this is reflected in the result of Summons et al*i. The high catalytic 
activity of the platinum black of Adams' catalyst** results in labelling of 
both the 2 and 8-positions of the purine ring.
A thorough investigation of Adams' catalyzed exchange of dA (amongst 
other purines) was reported by Kinoshita et al*3 who found, by mass 
spectrometric analysis of the exchange product, that optimised H2/H8
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labelling occurred for a catalyst:substrate ratio of 1.7:1 at 8 0 for 68 
hours. This gave 81 mole% dideuteriation. At a lower catalyst loading, Maeda 
and c o - w orker *2 report 100% H2/H8 dideuteriation under the conditions given 
in TABLE 4. They prepared [2-2H]dA by backexchanging the 2h8 by reflux in 
water for one hour.
2.15.2 (B) Non-Catalvsed Exchange
Of greater biological interest is the lability of H8 in water at 
various pH values, thus mimicking its reactivity in biological systems.
Adenosine was boiled in 12-18 Ci/mmole [3H]water at pH 7 for 5.5 hours 
claiming to give [8-SH]A of similar specific radioacivity**. Summons et al*i 
used the same procedure to label zeatin. Maeda et al®* used a 7:3 (v/v) 
D20:dmso 0.2M phosphate buffer at pH 7 to form [8-2H]dA from dA by heating 
at 81*C. They reported a rate of 5.4x10-5 s"i for deuteriation, in 
qualitative agreement with the value of 6 .3x 10"5 g-i reported by Jones et 
al5 8 for the detritiation of [8-3R]A in water at 85%. Further evidence for 
H8 lability was noted by Shelton and co-worker** who stated that [8-3H]A was 
completely back-exchanged in a 0.35M NaOH (pH = 13.5) solution at 37*C over 
18 hours, pH-Rate profiles constructed by Maeda et al®® and Jones et al*5 
show a rate acceleration at pH 12-13. In both cases, reaction mechanisms 
were presented to support the results. By comparing the kinetic results for 
adenine and adenosine, Jones et al5* concluded that the N*-ribofuranosyl 
sugar had an electron withdrawing effect on the purine ring. Also, these 
workers state that the kinetic acidity of H8 is approximately 2000 times 
that of H2.
2.16 Adenosine Aromatic NMR Assignments
IH NMR data of the aromatic protons in adenosine and 2'-deoxyadenosine 
are scarce. Mostly, just the ribofuranosyl sugar chemical shifts are 
reported for nucleosides.
TABLE 5 lists some data reported for purine aromatic H^ NMR chemical 
shifts.
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TABLE 5: Purine Nucleoside Ar(Maatic NMR Chemical Shifts
Compound H2 H8 Solvent Reference
A 8.20 8.60 CDCI3 96
B 8.20 8,42 CDCI3 97
C 8.16 - de-DMSO 98
C 7.37 - de-DMSG 86
D 8.15 8.35 CDCI3 99
HNBz
MMTrO
P OAc
NBz,
V
CI.C
B
NH,
t b d m s o
OTBDMS
HO-i yO
The iR NMR signal assignments for the purine ring hydrogens of the 
and 2-substituted adenosines used in this work are given in TABLE 7 and 
APPENDIX 1.
2.17 Frequency Selective Homonuclear Proton NMR nOe Difference Snectroscopv
If two protons are situated relatively close to one another
throughspace (ca. <0.4 nm) - they are not necessarily connected via
throughbond J-coupling - then upon irradiation of one of the pair of
protons, a signal enhancement will be observed for the second of the two
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protons which increases with irradiation timeis?. This is the basis of all 
nOe experiments.
The difference m e t h o d i s e , 1 5 9  i g  the most sensitive and rigorous of 
experiments by which nOe's may be detected and spatial and structural 
information d e d u c e d i ^ o .I 6 i . This methodology extends from the fact that 
nOe's are easier to detect by the subtraction of one spectrum or FID from 
another, resulting in the so-called difference spectrum in which unaffected
signals disappear leaving only the enhancement itself and the saturated
r e s o n a n c e i 6 2 , i 6 3 .  Indeed, it is possible to observe nOe's of only 1% using 
this p r o c e d u r e ! 59. NOe's can be measured from "both ends" of the system 
giving convincing evidence of the close proximity of the affected groups. In 
the first spectrum a signal is saturated, using gated decoupling, whilst in 
the second spectrum irradiation is performed away from any signals.
Subtraction of the second spectrum from the first spectrum gives the 
difference spectrum that uncovers any nOe's.
However, the nOe difference method does have certain d r a w b a c k s !58j
(II Subtraction Errors 
For the experiment to be successful the utmost performance of the NMR 
spectrometer is necessary. To eliminate the unaffected signals entirely, the 
two spectra must coincide exactly, with the signals being at the same
absolute frequencies. Any inequality in the position of the NMR signals in 
the two spectra results in a residual signal having dispersive characterise;
Subtract
(1-2)
Hence, the frequency generator of the instrument must be stable to 
within narrow limits throughout the course of the experiment.
(Ill Temperature
Temperature fluctuations during the experiment are perhaps the major
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cause of poor results and failure. The chemical shifts of molecules usually 
show a temperature dependence which may affect resonances of interest
directly or move them indirectly via a shift in the frequency of the lock
signal. Hence, isothermal conditions are a prerequisite for the experiment.
fllll The Solvent Used
The quality of the results and the ease of the experiment is highly
dependent on the solvent chosen. Acetone (and ordinary organic solvents
generally) is one of the best NMR solvents due to its low viscosity. This 
causes its deuterium resonance to be very sharp giving an excellent 
spectrometer lock signal. Conversely, water is one of the worst NMR 
solvents. It has extensive intermolecular hydrogen bond structure resulting 
in a high viscosity. Its douterons, D+, are exchanging giving a broad signal 
which is pH, solute and also highly temperature dependent.
2.18 DNA Synthesis: Introduction
DNA is an organic phosphate macromolecule that represents genetic code. 
Its existence was discovered in 1944 and its function was delineated nine 
years later in 1953100. Since that time, it has been realised that the 
synthesis of short oligonucleotides for physico-chemical investigations and 
longer gene fragments in biological studies is highly desirableioi,i02.
To satisfy this need, chemists have sought to isolate a viable 
synthetic method. This involves the precise manipulation of a whole set of 
different functional groups using compatible protecting groups, some 
temporarily, some permanently protected throughout the synthesis^o.ioz. As 
an example of the rate of progress, Alvarado-Urbina et al wrote in 1981loi, 
"only a highly trained and skilled chemist could produce a single 12-unit 
sequence in less than three months". Today, this task would take a half-day.
2.19 Solid-Ffaase Support DNA Synthesis
The concept of solid-phase support syntheses for biopolymers was 
initiated by Merrifieldios for which he received the Nobel prize for
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Chemistry in 1984. The principle of the solid-phase method is generally 
applicable throughout synthetic chemistry wherever there is a need to 
assemble linear p o l y m e r s i .
Although the first reported preparation of a dinucleotide was a 
solution synthesisio?, the overwhelming advantages of the solid-phase 
support approach were soon r e c o g n i z e d ^ ^ ,71,77,loi,1 0 2 .106. These include:
(1) Large excesses of solution reagents may be used to force 
reactions to completion ensuring high yielding monomer 
additions.
(2) Purification of reaction intermediates is limited to simple 
filtration and washing leaving the propagating chain attached 
to the solid-phase support. Solution syntheses require the 
inefficient and laborious purification of each reaction 
intermediate resulting from each monomer addition.
(3) Much quicker syntheses.
(4) As the yields are high, the reaction scale can be kept low 
which makes the use of excess reagents economical.
(5) The synthetic strategy is simple, requiring only the use of 
mixing, filtering and washing techniques. This makes the 
applicability of biopolymer synthesis more widespread.
A wide range of materials have been investigated^oi»^ 02,108 as 
solid-phase supports. Following the lead of MerrifieldiO), 
polystyrene-basedios and other organici08,iio polymers were considered but 
were found to be unsatisfactory due to the following properties:
(1) Excessive swelling on contact with organic solvents^.
(2) Slow diffusion of solution reagents and wash solvents in the 
polymer resulting in inefficient mass transfer and poor yields.
(3) Irreversible adsorption of reagents onto the polymer.
(4) Chemical and mechanical degradation upon exposure to solvents 
and reagentsu*.
Consequently, the use of silica was explored*12**13 and refined,
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terminating in the now widely used controlled pore glass?*'*** (CPG) silica. 
CFG is a pure silicate glass (particle size 120-177 jam) which has been 
treated to give a macroporous structure with pores of uniform size?? (500A 
or lOOOA). Its advantages over polymers include*?.* * *.* * 5 ;
(1) It is rigid and does not swell allowing more efficient mass 
transfer of reagents and faster diffusion of solvents through 
the matrix.
(2) Inert and insoluble to any and all combinations of reagents 
and solvents.
(3) Good mechanical properties.
(4) Easy to derivatise reproducibly with the initial nucleoside.
The link between the solid-phase support and the nucleoside must be 
stable to all the reaction conditions yet must be simply and quickly cleaved 
to afford the oligonucleotide product at the end of the synthesis.
The link is synthesized from a 2'-deoxynucleoside-3'-0-succinate- 
p-nitrophenyl ester condensation with an alkylamine derivatised
CPG??'*01,102,116;
DMTrO- 1  .O
OEt - p ,
DMTrO— 1 ,0
V / .O -O -S i
The base labile succinate ester of the 3'-OH fulfills this requirement 
for CPG. Using the propylamine link gives maximum coupling yields of only 
95-96% whereas longer linkages result in >98% coupling efficiencies, the 
consequence of a steric effect??.
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DMTrO
This method of derivatization gives a convenient loading of 20-30 ^ o l  
per g r a m * 0 2 . 1 1 1 . 1 1 6 , 1 0 8 , 7 7  for the initial nucleoside as determined by the 
visible spectrophotometric assay of the products of acidic detritylation. 
S o n v e a u x * 0 8  gives a wide-ranging account of the subject.
The first reported synthesis of DNA on a silica support was in 1980**5.
2.20 Wash Solvent
The ideal wash solvent must conform to several properties that are 
necessary for use in DNA syntheses. It must be an organic, dipolar aprotic 
solvent that has a low viscosity, yet has a relatively high boiling point so 
that solvent evaporation and concomitant aerial moisture condensation is not 
a problem. This eliminates solvents like dichloromethane. It must also be 
chemically inert towards the various functionalities of the growing 
nucleotide chain and solution reagents, nor promote side-reactions. For 
example, pyridine promotes the N3-methylation of dT from methyl-protected 
phosphite/phosphate triester intermediates. Moreover, another useful 
property is a high dielectric constant to support the ionic character of the 
coupling reaction.
Acetonitrile fits these requirements well. As a bonus, it is easily 
dried (CaH2) and can be kept anhydrous with molecular sieves without the 
need for stabilizers (eg. THF). A water concentration of 200ppm will 
hydrolyse one half of a phoshoramidite solution. It is usual practice to 
have a water contamination of the solvent of less than 50ppm to keep 
hydrolysis, as a phosphoramidite wasting mechanism, at 10% or less**?.
2.21 5*-Tritvl Ethers
Triphenylmethyl (trityl) ethers are invariably used as 5'-OH protecting
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groups, since their introduction by Khorana et al in 1962*8,64.
The trityl function must be cleaved as part of the DNA synthetic cycle 
to reveal the 5'-OH for coupling**8. The deprotection is facile under acidic 
conditions * 82,108.u 9 which is the best compromise as a base labile group 
would also induce hydrolysis of the 3 '-succinate linkage that holds the 
oligonucleotide to the solid-phase support*88. Brdnsted (DCA, TCA) and Lewis 
(ZnBrz) acids are used for deprotection.
The highly acidic carboxylic acid, TCA (pKa = 0.7?*) in
dichloromethane*? (3% w/v) or nitromethane affords very rapid and
quantitative detritylation??**88. However, the purine nucleosides, 
especially N^BzdA, are prone to depurination under these acidic 
conditions*82,106.108,119. jt is fortunate that the period of exposure is 
short (60-90 seconds??) and that purine nucleosides detritylate quicker than 
their pyrimidine counterparts??. Furthermore, substitution of the phenyl 
rings of the trityl function by methoxyl groups enhances the rate of
detritylation*8,*8,64,i08. it was found that the parent triphenylmethyl
group was too stable to acidic detritylation, giving an unacceptable level 
of depurination. Conversely, the tris(p-methoxy)triphenylmethyl group was
found to be too labile, its synthesis and purity being problematic*88. its 
rate of the acid-induced cleavage is 286 times that of the parent groups5. 
The best compromise was found for the DMTr group.
The use of the Lewis acid, ZnBrz does not result in the risk of 
depurinations. However, it is not favoured due to the very long reaction 
time that is necessary (ca. 30 minutes*?).
The intense orange colour*88.118 (A«ax«498nm,£ = 7 .2x10*)5?.i18,120,121 
of the DMTr carbocation side-product lends it to ancillary functions, such
as: solid-phase support loading calculations*?»*28, stepwise and overall
yield calculations*?»*28 and trouble-shooting of synthetic or apparatus 
abnormalities*18,120,122.
The visible spectrophotometric assay involves collection of the 
cleaved DMTr cation with acetonitrile washings at each chain extension,
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dilution with O.IOM p-toluenesulphonic acid in acetonitrile*?•*20.122 and 
spectrophotometric analysis. The first reading for the support-bound 
nucleoside gives the loading of nucleoside on the solid-support material. 
Sometimes, this first value is low due to spontaneous detritylation during 
storage of the CPG*20. The data collected is reliable only if the capping 
procedure is efficient so that the quantity of DMTr cation released is 
directly proportional to the chemical yield of the coupling reaction 
immediately preceding the detritylation??.
The use of structurally different triarylraethyl ethers, giving cations 
of different colour for each type of nucleoside has been advocated??**23 but 
their use is not widespread.
The CPG column must be completely washed clean of the TCA acid reagent 
before going on to the coupling reaction as residual acid can induce 
solution-borne oligonucleotides to form that then are able to couple to the 
support-bound oligomer to give longer sequences than desired***.
2.22 N5-Protecting Grouns
The exocyclic amino functions of dA, dC and dG (dT does not have an 
amino group) are universally derivatized to achieve two goals*00 :
(1)Prevention of side reactions*? (eg. phosphitylation) occurring at the 
amino group and (2) Perhaps more importantly, the derivatized nucleosides 
have greatly increased solubility in organic solvents*thereby increasing 
their ease of use in DNA syntheses.
The amino protecting groups introduced by Khorana et al in 1963*8 are 
still favoured, no doubt because of their widespread commercial availabilty. 
These are the benzoyl group used for dA and dC and the isobutyroyl group for 
dG.
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HNBz
o ô  ( D
I/O n IHO
OH ÔH 6 h
dC dA dG
However, a number of problems exist when using these groups. These 
relate to deprotection (A) and depurination (B):
2.22.1 (A1 Deprotection
The acyl protecting groups above require lengthy and harsh conditions 
to effect hydrolysis to release the free amino groups. These severe 
hydrolytic conditions reduces the yield of the oligonucleotide and may 
completely destroy a novel oligonucleotide incorporating non-natural 
internucleotide linkages (eg. thioates)*?.
2.22.2 (B) Denurination
The chemical stability of dA is profoundly altered by the protection of 
the exocyclic 6-amino function. In acidic conditions (eg. detritylation), 
N^-acylated dA's protonate primarily at N?, a highly unstable species that 
readily depurinatesiOB. a Cl' carbocation intermediate exists at the rate 
determining step of the depurination mechanism*o*. As a direct consequence, 
dA residues at the ends of the oligonucleotide chain face a greater risk of 
depurination than the same residue that is flanked by 5',3'-phosphates in 
the middle of the chain^^'ioS'iiB.
In recognition of these problems, a large amount of research effort has 
been expended to design more labile exocyclic amino protecting groups which 
increase the resistance to depurination*?. The dialkylformadineioo,in and 
di-n-butylaminomethylene groups of Matteuccii24 are of note, the 
dimethylformadine recently becoming commercially available*?. Also, 
phenoxyacetylBG is of interest since it only requires 15 minutes at 55*C to 
deprotect, compared with a minimum of five hours for the benzoyl group. The 
p-t-butyl derivative has been very recently commercialised*25. These
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commercial examples are shown below. 
&
OH OH
A full list of alternative N^dA protecting groups is given by 
Sonveaux^o®.
2.23 3'-Protection/ Activation/ Coupling
The central part of any DNA synthesis is the formation of the 
internucleotide phosphate linkage. There are basically three main groups of 
precursor used: Phosphates, phosphites and H-phosphonates*7,loo.
Although requiring a greater synthetic effort*?, the phosphite approach 
is f a v o u red^26,127 because of its high reactivity and rapidity??**?•loo,i15, 
The trivalent phosphorus of the phosphite triester has two dissociable 
groups100;
Persistent Protecting Grouns
The methoxyl group was the initial choice as a persistent protecting 
group for a phosphite triester bond. Its deprotection requires a separate 
reaction from the other persistent protecting groupsi28. if this 
deprotection was not quantitative, N^— méthylation of dT occurs under the 
basic conditions of the second deprotection reactionio®*iii»i29. These 
difficulties led to the choice of the 2-cyanoethyl group as a superior 
alternative*?'?5'128,130. This approach consolidated the deprotection 
strategy to just one post-synthesis deprotection reaction^®»i®°*m »i^i.
Temporary ProteAng Groups
The second of the two dissociable groups on the trivalent phosphite 
reagent is an alkylamine?^. The use of the branched alkyl isopropyl group 
led to a stable, high purity reagent?®*?2.
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A c t iv a t io n
A weak acid is used as a co-reactant in the acetonitrile-borne 
reaction. Tetrazole (pKa = 4.8132) is the reagent of choice77,106,ui as it 
can be readily purified by sublimation and does not suffer from the 
hygroscopic problem associated with amine hydrochloridesiii.
The dialkylamine of the phosphoramidite is transformed into an 
excellent leaving group upon protonation of the nitrogen atom77.108,iis,133;
aB i
O
and may be substituted to form the tetrazolide?o. Attack of the 
nucleophilic primary 5'-OH of the support-bound nucleotide gives the monomer 
addition adduct.
A®' aBz
o
p ^
B ------------------ ^ N C - ^ . ^ 0
OCPG
OCPG
Obviously, any exogeneous nucleophiles will compete with the
support-bound 5'-OH for the adivated phosphoramidite. Prior washing of the
support with anhydrous acetonitrile is therefore essential. Phosphoramidite 
chemistry is extremely sensitive to moisture and o x y g e n ^ 7 ,77,loo,134 and is 
best conducted under an atmosphere of argon gas*?. Argon's high density and 
low oxygen contamination makes it preferable to nitrogen gas*?'ii8.
Phosphora miditesi21 are applied as O.IM solutions in acetonitrile, 
10-30 molar e q u i v a l e n t s ? ^ ,77,106 being typically used per coupling.
Tetrazole is applied as a 0.511 solution (almost saturated) in acetonitrile 
and up to 300-400 molar equivalents are usedio*. The excess of tetrazole 
ensures complete activation of the expensive phosphoramidite reagent whose
36
own excess in turn assures that the reaction is almost
qua n titative!06,108.118.
The older and much slower phosphorylation schemes required protection 
of the QG-position of dG r e s i d u e s * ® » ! 0 6 . i 0 8 , 1 3 5 - 1 3 8  because phosphorylation 
can occur at this position as well as the 5'-OH chain end, especially under 
basic c o n d i t i o n s !2 0 , The p-nitrophenylethyl protecting group is u s e d ! 3 9 , i 4 0 .  
The QG position is also prone to phosphitylation although this risk is low 
if the reaction time is kept short, as is the case (ca, 2  m i n u t e s ) los.iis.
2.24 Canning
"Capping" refers to the blocking of the 5'-OH functions of the
oligonucleotides that failed to couple with the phosphoramidite nucleoside
monomer. The cap is usually the acetyl moiety, giving 5'-acetate esters.
The two reagents (see FIGURE 1) are mixed in situ to give the
acetylating reactant. Previously DMAP was used as a catalyst but since the
"reaction mixture darkens and deterioates rapidly"??, 1-methylimidazole has 
been substituted*?. Normally, a stepwise coupling yield of 98% or more is 
possible leaving less than 2% of the oligonucleotide as failure sequences 
with unreacted 5'-OH's that must be efficiently capped. A typical reaction
time is two m i n u t e s ? ? •! ® G . 
HO-i ® O B
OR OR
Capping is extremely important to circumvent possible problems. Capping 
ensures that the failure sequences are an even distribution of chain 
lengths. If capping were not used, the majority of failure sequences would 
have one less base than the desired product. Hence, capping helps to 
simplify the purification of the product*?»!®g. Capping deprives the 5'-OH's 
of previously unreacted failure sequences from consuming the phosphoramidite 
reagent meant for the desired sequence oligonucleotide. Thus, capping helps 
to maintain the efficiency of subsequent coupling reactions??. Capping
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ensures that the quantity of DMTr cation collected directly reflects the 
efficiency of the last coupling of the desired oligonucleotide only, thus 
securing the integrity of the DMTr analysis technique??.
2.25 Oxidation
The forfeit for the phosphite triester over the phosphate ester and 
H-phosphonate synthetic routes is the need to oxidise the newly formed 
phosphite triester linkage, which is highly reactiveioo, unstable and 
suspectible to acid or base cleavage, to the stable pentavalent phosphate 
triesteriiB.
Organic reagents in anhydrous solvents have been tried (mCPBA*!*) and 
have been found to be unsatisfactory. Iodine is used as a mild oxidant in a 
basic (2,6-dimethyIpyridine) THF solution with water as the oxygen donor. 
This reaction has been used to label the phosphate ester with oxygen 
(17Q132) and sulphur (32S, 35si4i) isotopes.
Pon et ali40 have detailed the mechanism of Piii to pv oxidation by 
iodine:
E OR-, I*O -P -O R ' 
OH _
OR 
R"0/ "'OR'
«■ H ,0
OR
r"o - p - o r ' ♦ N'H* r
This reaction occurs very rapidly, being complete in 10 seconds*i*, 
although a 30 second reaction time is usually used as a "safety'^ factor in 
routine work**8 '**9.
The oxidation reaction immediately follows capping in order to 
eliminate the possibility of traces of water (from the oxidising reagent) 
causing acetic acid to form from the acetic anhydride capping reagent. This 
order of the reactions would expose the growing oligonucleotide to 
deleterious conditions.
Liberal washings with acetonitrile solvent and drying with argon gas is
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necessary to expel the iodine/water reagent??'***.
2.26 The Experiment
Early coupling strategies mimicked nature using phosphate (PV)
precursors. However, this proved to be unfavourable as, for example, the
phosphate diester method required several hours to several days to conduct 
couplings***. This low reactivity meant that these methods were prone to 
various damaging side reactions, thereby lowering the overall yield 
considerably*42. The phosphite triester method achieves more rapid and more 
complete coupling***•*2* with the combination of CPG solid-phase support and 
phosphoramidite chemistry being the present best approach to DNA
synthesis***. Cycle times for one monomer addition are typically 10-15 
minutes??,**9,122,143.
Of the four conceivable reaction scenarios, the 3'— >5' direction, with 
the activated phosphite on 3'-OH of the solution reagent reacting with 5'-OH 
of the support-bound oligonucleotide is the one used almost 
exclusively4?.108'122. This direction makes use of the more reactive primary 
5'-OH47.*o*. Nature uses the reverse 5'■— > 3' direction based on
5'-triphosphates4? which has been used in some early syntheses4S,*44,
A chemical yield of, say, 90% is usually considered excellent for any 
synthesis but the coupling yield in oligonucleotide DNA synthesis has a 
dramatic effect on the overall yield4?,*oi due to the linear nature of the 
synthesis. Coupling yields of less than 98% are totally unacceptable4?. 
Commercial automated DNA synthesizers are able to deliver mean coupling 
efficiencies of 98-99%4?,*20, The effect of coupling yields on the overall 
yield of product is shown below. Overall post-purification yields of 10-30% 
are typical.
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Complete genes consist of nucleotides hundreds of bases long. To 
achieve the synthesis of such large biomolecules, a combination of chemical 
methods to synthesize gene fragments and enzymatic methods to bond them 
together are necessary*oo,i45.
Very large scale syntheses (physico-chemical studies require 10's of 
mg's of material) and the use of valuable modified nucleosides has led to 
the desire to minimise reagent consumption while maintaining high yields. 
Increasing the solution reagent concentration and moderate increases in 
reaction times within an extremely anhydrous environment**? has meant that 
the use of . 2-4 molar equivalents is possible**?, about 10% of the usual 
amount used.
Brown4 ? gives useful formulae for the calculation of molecular weight 
and UV absorbance extinction coefficients of oligonucleotides.
2.27 Manual DNA Synthesizers
The evolution of DNA synthesizers has paralleled the development of 
phosphorus/phosphite coupling reagents. Today's sophisticated automated 
synthesizers share a common ancestry in the simple manual DNA synthesizers. 
To quote Brown*?, "The assembly of an oligonucleotide has always been a 
laborious and demanding task as the multitude of chemical reactions and 
washes involved are extremely sensitve to moisture..."
Manual synthesizers began with the humble t e s t - t u b e *?»*2* in which
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reagent solutions were added.to the solid-phase support and centrifuged 
before décantation. Next came the use of sintered glass filter
f u n n e l / c o l u m n s ? 5 , 7 7 , 102,109,145,146 in which a solution reagent was added to
the solid-phase support at the filter and then removed by vacuum filtration. 
Finally there are the syringe-type apparatus*•**3»**?•**® where the 
solid-phase support material is retained in the barrel of the syringe by the 
addition of a filter and reagents drawn up and expelled by manipulation of 
the syringe piston***. Manual synthesizers are most useful for the 
production of short (15-20-mers) oligonucleotides**3. The results of DNA 
syntheses using syringe and filter column type apparatus are shown in TABLE 
6 with the results obtained here for comparison.
TAWJB 6; Hemults of DMA Syntheses Usinr Apparatiia
rType of Apparatus Syringe Syringe Filter Col. Filter Col. Filter Col.
Author Tanaka Seliger Sinha Schott Culf
N-ner (overall B-ner* 5-ner3 8-ner® 5-ner** 12-ner*2
yield) (61%)2 (9.5%)* 
13-ner5 
(9.4%)&
(63%)
10-ner^
(55%)
13-ner*® 
(45%)
(56%)*2
Stepwise 94% 55%.82%? 92% 95-97% 94*3
Yield
Cycle Tine 13 22 45-55 10 15
(nins.)
No. Equivs. - - 25-30 15 10-12
Coupling
No. Equivs. - - 70-75 37 40-50
Tetrazole
1. T6CAGGTT, 6 Minutes coupling tine with 2'-deoxynucleoside-S'-nethoxyphosphorochoridites.
2. 31% after purification by preparative TLC.
3. GCTAG with 2'-deoxynucleosi<le“3'-(nethoxy-N,N-dinethylanino)phosphoranidites.
4. After purification by HPLC.
5. AATTCTAGCTGCA with 2'-deoxynucleoside-3'-(nethoxy-N,N-dimethylanino)phosphoranidites.
6. After purification by HPLC.
7. Synthesis of 13-ner employed solid-phase support drying with argon gas.
8. GGGATCCC with 2'-deoxynucleoside-3'-(methoxy-N,N-dimethylanino)phosphoranidites.
9. GGGATATCCC with 2'-deoxynucleoside-3'-(nethoxy-N-norpholino)phosphoranidites.
10. TCA6TTGCAGTAG with 2'-deoxynucleoside-3'-(nethoxy-N,N-di isopropyl)phosphoranidi tes.
11. ttttt with 2'-deoxynucleoside-3'-(nethoxy-N,N-di isopropyl)phosphoranidi tes.
12. CGCGAATTCGCG using 2'-deoxynucleoside-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoranidites.
13. Use of 4 equivalents for the coupling of dA^.
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2.27.1 Svringe-Tvpe Apparatus
Syringe apparatus have been described by PIess, Tanaka and Seliger.
Tanaka**9 modified a glass syringe by placing a 2mm porous 
polypropylene filter inside the barrel of the syringe close to the Luer 
fitting to retain the 140 junole/g dT derivatized silica solid-phase support. 
Solution reagents were exposed to the support by drawing up and depressing 
the syringe piston.
Seliger**® states that the frequent motion of the piston causes the 
formation of debris from the support material due to mechanical disruptions 
leading to filter clogging and attendant difficulties. A modified apparatus 
was used consisting of two connecting polypropylene syringes illustrated 
below;
adaptai
m t r  suooorl '
- ' • i1 . 1 1 . 1 .1
poly e pport
S Y R  I N G E  A S Y R I N G E  B
Syringe A is the reaction chamber. It is equipped with two tightly 
fitting ceramic filters containing the 92 pmole/g polymer support. Solution 
reagents are introduced via a needle at the syringe A Luer fitting by 
manipulating the remote syringe B. Seliger demonstrated a significant yield 
increase by using argon gas as a drying and air exclusion agent.
2.27.2 Filter Columns
This type of apparatus is much more common?®•??»*®2,109,i45,146, it 
typically comprises a sintered glass filter glass column secured to a 
Buchner-type flask connected to a vacuum source??«*09, usually a water 
aspirator! The top of the column is sealed with a serum cap equipped with a
pressure-venting needle?®•??»*02.109. a detailed description of such a
synthesizer is provided by Atkinson and Smith??. The apparatus of Ito et 
al109 is illustrated below;
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A hybrid of the two types of apparatus is that described by Schott 
The apparatus centres on the use of commercially available CPG-filled 
columns (for use in automatic DNA synthesizers). The female Luer fittings of 
the columns at both ends of the column accommodate a needle (via an adaptor) 
and a 500^1 syringe. The syringe is used to introduce and expel solution 
reagents into and from the column. Schott conducted test reactions to 
optimise the duration of coupling and capping reactions, stating that the 
most important factor is the efficient mixing of reagents. The use of the 
commercial columns (available in l^ole and lO^ole) avoids losses incurred 
due to transfer of the support material.
2.28 Denrotection
At the end of the synthesis the oligonucleotide chains are still 
attached to the solid-phase support and have acetyl functions blocking the 
5'-ends of failure sequences, the persistent 2-cyanoethyl phosphate ester 
protecting groups and the isobutyroyl and benzoyl amide protecting groups of 
dG, dC and dA respectively. All these groups must be removed to release the 
DNA strand. It is advantageous to be able to cleave all the different 
protecting groups in a single chemical procedureioz. Indeed, the choice and 
combination of the numerous protecting groups has this in mind.
It is essential to first remove the persistent protecting group of the 
phosphate triester by a selective reaction that avoids DNA strand scission 
to yield the anionic phosphate diester that is resistant to further 
nucleophilic attackio*. In this way, random oligonucleotide chain cleavages
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are impossible. As an example, the now defunct methyl phosphate ester 
protecting group is removed by triethylammonium thiophenoxide before the 
hydrolytic cleavage of the remaining protecting groups. The methyl group has 
been succeeded by the 2-cyanoethyl function.
The selection of the 2-cyanoethyl function as a phosphate ester 
protecting group is able to satisfy all the necessary requirements:
(1) It is rapidly cleaved under the uniform aqueous ammonolytic 
conditions, preventing chain scission^os.iao,
(2) Theyô-elimination (E2) mechanisra^s.96,I3i.150 ensures that the 
phosphorus centre is not directly attacked, avoiding any structural 
consequences150.
(3) The side-product of acrylonitrile^^i is prone to polymerisation 
necessitating filtration before chromatographic purification.
The two step ammonium hydroxide procedure introduced by Narang et al in 
1980149 is the most common deprotection strategy. This entails placing the 
oligonucleotide bearing solid-phase support in concentrated ammonium
hydroxide solution for one or two hours at room 
temperature47.75,77,118,i20,143,146,149, This effects 3'-succinate
hydrolysis77'i20, severing the oligonucleotide from the solid-phase support 
and partial hydrolysis of the 5'-acetate esters of the failure sequences. 
The basic solution solvates the released oligonucleotides?? which is washed 
into a separate, gas-tight container with washings of concentrated ammonium 
hydroxide4?,120,143,
To fully deprotect the 5'-acetate esters and cleave the amide 
protecting groups requires the utilisation of the somewhat drastic
conditions of 5 hours, up to overnight, heating at 5 5 - 6 0 in concentrated 
ammonium hydroxide solution4?.?5,77,106,1 is,120, The use of the 
phenoxyacetyl 6-amide protecting groups6 (recently commercialised) limits 
the necessary time period of these harsh conditions to 15 minutes.
If depurination, of principally dA, has occurred at any of the 5'-DMTr 
deprotection reactions during the synthesis, the partially depurinated
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oligomer will cleave at the sites of depurination by double ^ elimination in 
the strongly basic conditions of the deprotection reaction??•loo.108. This 
is reminiscent of Maxim-Gilbert DNA sequencingisi.
2.29 HPLC Purification
The residue from the deprotection reaction consists of a complex 
mixture of compounds*?,106,120.152. Apart from the oligomer of desired 
length and sequence, there are also truncated oligomers representing the 
failure sequences, byproducts such as benzamide (from dA and dC residues), 
isobutyroylamide (from dG resdiues), polymerised acrylonitrile from the 
ys-elimination of the 2-cyanoethyl phosphate ester protecting groups?5 and 
also modifications of oligomers, such as depurinations and DMTr bearing 
5'-terminii from incomplete detritylationsiGZ. This necessitates the use of 
a high resolution purification technique to ensure high purity of the 
desired oligonucleotide*?. For the relatively large quantities of material 
required for physico-chemical studies, the technique of choice is
reversed-phase HPLC (RP-HPLC).
Reversed phase separations are based on the exclusion of a solute 
containing lipophilic components from a polar mobile phase. When the mobile 
phase is made less polar, partition no longer favours the stationary phase 
for the most polar lipophilic molecules^^B. Solutes elute from the column 
in order of decreasing polarity. In order to decrease the retention time and 
limit band-broadening, gradient elution is used to make the mobile phase 
progressively less polarise.
The ammonium acetate /acetonitrileiss or TEAAc/
acetonitrile?5.iio,i20,i54,i55 binary solvent system introduced by Fritz et 
al in 1978155 is used for RP-HPLC of oligonucleotides. Acetonitrile is 
preferred over methanol due to its low vapour pressure which reduces bubble 
formation by cavitation at the high flow rates employed (2-5 ml/min) and the 
comparatively low viscosity of acetonitrile helps to keep the pressure in 
the system to a miniraumi53.
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The gradient elution is shallow, usually covering only a few per cent 
(<5%) increase in the lipophilic acetonitrile component. This gives 
retention times of typically 5-15 minutes which may be altered by changing 
the slope of the gradient. The technique gives acceptable resolution for 
relatively short oligomers up to 20-30 r e s i d u e s i ^ s , 156,
Filtration of the crude sample is essential in order to remove 
insoluble material resulting from acrylonitrile polymerisation before 
application onto the column?^,i22.
The 5'-DMTr group of the 5'-terminus is used as a lipophilic 
handle!06,1 2 0,155 to aid the separation of the desired oligonucleotide as 
only this species in the crude material should bear.this group. However, due 
to the complex nature of the crude product this situation is not always 
clear-cut, sometimes negating the "DMTr lipophilic handle" method. Moreover, 
it is observed that the observed retention time is a direct function of the 
oligomeric length!53. Thus, fully deprotected oligomers can be easily 
purified by R P - HPLC!08 ,1 5 2 . The base elution order is dG, dC, dA with dT 
last.
Problems associated with the RP-HPLC purification of oligonucleotides 
relate to occasional low recovery due to irreversible adsorption on the 
c o l u mn!68, Indeed, 78% recovery for an 11-mer has been recorded in a 
comparative test of purification t e chniques!52, Sequences with greater than 
50% G-C content (the Dickerson 12-mer is 2/3rds. G-C) may elute as 
associated species such as duplexes of sequences of different l ength!52 (eg. 
the desired product may co-elute as a duplex with a failure sequence).
46
3. EXPERIMENTAL
3.1 r8-5HlN6-Benzovl-2*-deoxyadenosine (1): Catalytic Exchange with T2 Gas
On the NTLF gas line, a solution of N^BzdA (Cruachem;50mg, lAljimoles) 
and DIPEA (62^ 1, 360jimoles) in anhydrous DMF (3ml) was prepared in a glass 
reaction vessel containing a magnetic stirrer bar. The catalyst spoon above 
the solution was charged with 30% Pd/C (50mg). The solution was frozen with 
liquid nitrogen and the headspace of the reaction vessel was repeatedly 
flushed with nitrogen gas. The solution was thawed with stirring to degas, 
refrozen and again flushed with nitrogen gas. The freeze-thaw-pump cycle was 
repeated. After evacuation, tritium gas was admitted to the reaction vessel, 
the solution thawed and the catalyst added. The gas pressure was adjusted to 
670mmHg. The uptake of Tz gas was monitored and after three hours was deemed 
to be complete. The suspension was frozen and the tritium gas evacuated from 
the reaction vessel. After flushing with nitrogen gas the suspension was 
thawed. The reaction vessel was brought to atmospheric pressure with 
nitrogen gas and methanol (1ml) was added while stirring. The solvent was 
lyophilized to remove exchangable tritons. Another aliqout of methanol was 
added and lyophilized. After the further addition of methanol (1ml), the 
suspension was passed through a glass-fibre filter to remove the 
heterogeneous catalyst and the reaction vessel and catalyst were rinsed 
with a CH2CI2: MeOH (1:1) solvent mixture in order to recover all the 
tritiated product. The clear solution was lyophilized overnight to leave the 
product (1) as a solid. This was dissolved in da-methanol for specific 
radioactivity determination by liquid scintillation counting and analysis by 
!H and NMR spectroscopy. Yield = 1.29Ci. Liquid scintillation counting, 
assuming complete conversion of the starting material and 100% product 
recovery gave a specific radioactivity of 9.2Ci/mmole. Compound (1) was 
further derivatised for incorporation into DNA oligomer, J.^H NMR (CD3OD) 
H2, 8.69,s; H8,8.64,s; Bz:o,8.08,d(3J=7.6); p,7.65,t(3J=7.3);
m,7.55,t(3J=7.5); HI',6.56,dd(3J=6.68,6.79);H2',2.50,2.85,2m;H3',4.61,m; 
H4',4.07,dd(3J=6.7,3.4); H5',3.76,3.84,2dd (2J=-12.15,3J=3.86,3.32)
3H NMR (CD3OD) T8,8.66,s. Appendix 4A.
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3.2 r2.8-^H1N^~Benzoyl-2*-deoxyadenosine(5) via a Brominated Precursor
The following synthetic scheme was followed to afford the title
compound (5). 8BrdA (compound (2)) was synthesized using the method of
Ikehara^o,82 with the modifications of Guy et al®8. SBrN^BzdA (compound (4))
was synthesized following the route of Singh**.
NH,
(1) NaOAc.pH 5,Br2,3hrs. ^
(2) Na2S2Û4,K0H,pH 7
(1) py, TMSCl
NBz,
6 c>“
(2) BzCl, 2hrs. TMSO~^On^
O T M S
(3)
BzNH
30% Pd/C, DIPEA 
DMF,T2, 3hrs.
OH
NH
H O
O H
(2) HNBz
NH4OH, l/2hr.
(4) OH
3.3 8-Bromo-2'-deoxyadenosine (21
2'-Deoxyadenosine (5g, 20mmoles) in a 500ml round-bottomed flask was 
dissolved in water (100ml) with warming from a hot air-gun, followed by the 
addition of sodium acetate buffer (0.5M, pH5, 100ml). To the clear solution 
at room temperature a saturated aqueous solution of bromine was added 
(150ml, 30mmoles). The flask was stoppered and the dark-red solution was 
stirred at room temperature for three hours. The reaction was monitored 
using TLC (A 9:1:0.05, CHCI3:EtOH:py8*, Rf(A)= 0.3; B 5:10:1:0.05, 
EtOAc:acetone:water:py, Rf(B) = 0.6) coupled with UV (254nm) detection. 
Sodium hydrosulphite (dithionite) was then added until the colour of the 
reaction mixture turned from red to yellow and the pH was adjusted to 7 with 
potassium hydroxide (0.77M). The solution was refrigerated overnight to
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yield red/brown crystals of 8BrdA (2) (3.80g, ll.Smmoles) which were
collected by filtration with sparing washings with water. The collected 
eluant was evaporated to half its volume and again refrigerated overnight to 
yield a second crop of product (1.27g, 3.8mmoles). The purity of the product 
was checked by TLC and NMR spectroscopy. Yield = 5.1g, ISmmoles, 77%,iR 
NMR86.98 (CD3OD) H2,8.12,s; HI',6.48,dd(3J=6.00Hz);H2',2.29,3,11,2m; 
H3',4.63,m; H4',4.09,m; H5',3.73,3.88,2dd(2J=-12.46, 3J=3.30,2.70). Appendix 
2B.
3.4 N^-Benzoyl-8-bromo-2'-^eoxyadenosine (41
8BrdA (2) (1.60g, 4.8mmoles) was dried by lyophilization and placed in 
a septum sealed, oven-dried 100ml round-bottomed flask equipped with a 
magnetic stirrer bar. Anhydrous pyridine (40ml) was syringed in and the 
translucent green/brown solution was cooled to 0®C in a CO2/H2O bath with 
stirring for 30 minutes. Over a five minute period, chlorotrimethylsilane 
(5ml,40mmoles) was added dropwise. A suspension of
3',5'-bis(trimethylsilyl)-8-bromo-2'-deoxyadenosine was formed. After ca. 30 
minutes, TLC monitoring (Rf(A)=0.9) revealed complete conversion to this 
primary reaction intermediate. Benzoyl chloride (3,0ml, 26mmoles) was added 
similarly with vigorous stirring. The mixture was then stirred at room 
temperature for two hours (Rf(A,B)=0.9) to give the secondary reaction 
intermediate,3',5'-bis(trimethylsilyl)-N6-dibenzoybB-bromo-2'-deoxyadenosine
(3). The septum was then removed and water (10ml) was slowly added to give a 
translucent brown solution. Concentrated ammonia solution (30%, 10ml) was
added to effect hydrolysis to the product (4), Rf(A)=0.5, Rf(B)=0.7, over
twenty minutes. Prolonged hydrolysis regenerates the starting material (2). 
Ammonia and pyridine were evaporated under vacuum and after addition of 
water, the resultant oil was extracted with diethyl ether (2x50ml). The 
aqueous phase was cooled in a refrigerator overnight to give light brown 
crystals of (4) which were collected by filtration with sparing washings 
with water. The purity of the product was checked by TLC and iH NMR.
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Yield=0.84g, 1.9nimoles, 40% .
iH NMR (CD3OD), H2,8.66,s;Bz:o,8.06,d;D,7.65,t;B,7.55,t; HI',6.56,t; 
H2',2.38,3.32,2m; H3',4.71,m; H4',4.07,dd(3J=7.50,3.75); H5’,3.75,3.88,2dd
(2js=-i2.16,3J=4.20,3.75). Appendix 2C.
3.5 f2.8-3H1N*-Benzoyl--2'-deoxyadenosine (5)
The title compound was prepared from SBrN^BzdA (4) using the 
experimental procedure detailed in SECTION 3.1. Specific parameters and 
results for this reaction are given in TABLE 7.
iH NMR (CD3OD) H2, 8.69,s; H8,8.64,s; Bz;o,8.08,d(3J=7.6);
p,7.65,t(3J=7.3); m,7.55,t(3J=7.5); HI', 6.56,dd(3J=6.68,6.79); H2',2.50,
2.85,2m; H3*,4.61,m; H4',4.07,dd(3J=6.7,3.4); H5',3.76,3.84,2dd
(2J=-12.15,3J=3.86,3.32)
3H NMR (CD3OD) T2,8.70,s; T8,8.67,s. Appendix 4B.
TAHLK 7: Catalytic Tritlations
Substrate Catalyst Base Solvent Rxn. Tine 
(hrs.)
Pressure
(mmHe)
Radioctaen. 
Yield (nCi)
Sp. Act. 
(Ci/mnole)
N*BzdA 30% Pd/C DIPEA DMF 3 670 1290 9.2
(50mg> (SOmg) (62jil) (3ml)
8BrN*BzdA 30% Pd/C DIPEA DMF 3 688 755 9.11
(36mg) (36mg) (38^1) (3ml) IO.54I
2ClN*BzdA2 30% Pd/C DIPEA DMF 3 680 1480 21.9/24.33
(35mg) (35mg) (40yl) (3ml) 2180 25,7/25.8*
Rxn. Time = Reaction time; Sp. Act. « Specific radioactivity (calculated from liquid 
scintillation results unless ,otherwise stated)
1. NMR determination; 18 = B.76Ci/mmole, T2 = 1.78Ci/mmole
2. Two reactions for this substrate
3. NMR determination; T8 = 16.3Ci/mmole, T2 = S.OCi/mmole
4. %  NMR determination: T8 = 19.2Ci/mmole, T2 = 6.6Ci/mmole
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SCHEME 1: Synthesis of a Tritium-Labelled DNA Synthon
hn■HN
HjN HgN"H,N Et4NCl/CH3CN 
60"C,20 Bins,65»AcO AcOHO
OAc OAc
(6)
NHa
PhCOCl/pyCH2C12 -20"C, 
3.5 hrs,74%
R.T,,2.5 hrs 
54% R.T.,25-30 hrs 68%
AcO AcO
OAc OAc
(8)(7)
HN HN
He0H/H20/K2C03 30% Pd/C/DIPEA/R.T.,45 Bins 
44% DMF/T2 3 hrs 90%
HOAcO' HO
OHOAc OH
(10)(9)
HN
HN NC, O—P—N:
DMTrCl/py/TEA /DIPEA/R.T.,4 hrs 
75%
THF R.T.,45 Bins
DMTrO
DMTrO
OH
(12)
(13)
3 .6  2 .6 -D ic h lo r o ~ 9 - (2 '-d e o x y ~ 3 *  .5 * -d i -0 - -a c e ty l-y » - ’D ~ r ib o f iira n o s y l)T n ir in e  (7 )
2-Amino-6-chloro-9-(2'-deoxy-3',5'-di-O-acetyl-y^-D-ribofuranosyl)purine
(6) (6.85g»18.53mraoles, dried under vacuum over Drierite) was dissolved in 
dichloromethane (180ml) in an oven-dried 500ml round-bottomed flask at room 
temperature to give a yellow solution. The flask was stoppered with a rubber 
septum and cooled (approximately -20 C^) in a CCU/liquid nitrogen bath. In a 
separate septum-sealed, oven-dried 100ml round-bottomed flask, antimony(III) 
chloride (5.26g, 23.Immoles) was dissolved in dichloromethane (60ml).
Dissolution was not complete at room temperature. This solution was added to 
the solution of (6) over 15 minutes by syringe to give an opaque yellow 
mixture. After stirring for 5 minutes, tert-butyl nitrite (14.5ml,
122mmoles) was syringed into the reaction mixture which immediately formed a
dark orange/red suspension that was stirred at -20 ®C and monitored by TLC
(24:1 CHzClziEtOH, Rf(6)«=0.5, Rf(7)=0.7) until the reaction was complete
after 3.5 hours. Crushed ice (40g) was then added to hydrolyse the excess 
reagents and after stirring at room temperature for 15 minutes, an
orange/red precipitate was collected by vacuum filtration. The crude product
(7) was eluted from the precipitate by washing with chloroform (500ml in
total) to give a yellow filtrate. This wet, acidic organic solution (pH=l-2) 
was washed with water (3x50ml) and 5%(w/v) sodium bicarbonate solution
(50ml) to effect neutralisation. The dark yellow chloroform solution of (7) 
was dried over magnesium sulphate and evaporated to yield the crude product 
(7) as a viscous, dark yellow oil (7g). Initial purification by flash
chromatography (260x20mm column of 40-6(^m silica gel, 24:1 CHzClzzEtOH)
separated out the remaining antimony salts. Compound (7) was further
purified by centrifugally-assisted TLC (4mm plate, 7:3 EtOAc:hexane) to give 
pure (7) (5.3g, 13.6mmoles) as a yellow, crystalline solid. The purity was
checked by melting point, TLC and NMR spectroscopy. Yield=74%,
mpt.-106.5-107 *C. IR NMR (CDCI3) H8,8.33,s; Hl',6.46,dd(3J=6.42,7.38);
H2',2.67,2.86,2m; H3',5.39,d(3J=6.06); H4',H5',4.35,2m;CH3C0-,2.10,2.14,2s
52
3.7 2-Chloro-3*.5'-di-O-^cetvl-2'-deoxyaydenosine (8)
2,6-Dichloro-9-(2'-deoxy-3',5'-di-O-acetyl-jB, D-rlbofuranosyl)purine (7) 
(800mg, 2.Immoles) was suspended in propan-2-ol (80ml) in a 250ml
round-bottomed flask equipped with a magnetic stirrer bar. Ammonia gas, at 
approximately 3 lb/in2, was bubbled through the suspension for about 10 
minutes before the reaction flask was stoppered and sealed with parafilm and 
stirred at room temperature. As the ammonolysis proceeded, the dissolution 
of the substrate increased to give a translucent yellow solution. The 
reaction progress was monitored by TLC (1:1 Acetone:hexane, Rf(8)=0.6, 95:5 
CH2Cl2:EtOH, Rf(8)=0.8). After 2.5 hours, the clear solution became cloudy. 
If the reaction was left to continue, side products accumulated. Thus, after 
2.5 hours, ammonia gas in solution was displaced by nitrogen gas and the 
solvent was removed by evaporation. The crude product (8) was purified by 
centrifugally-assisted TLC (2mm plate,95:5 CH2Cl2:EtOH) to give pure (8) 
(410mg, 1.Immoles) as a yellow solid. Purity was checked by melting point, 
TLC and NMR spectroscopy. Yield = 54%, mpt.192 °C; NMR (CDCI3)
H8,7.98,s; HI’,6.40,dd(3J=6.0,8.0); H2',2.63,2.81,2m; H3',5.4G,m;
H4',4.39,m; H5’,4.35,m; CH3C0-,2.11,2.14,2s
3.8 2-Chloro-N^-dibenzoyl-3 *. 5 ' -di-O-acetv 1-2 ' -deoxyadenosine (9)
2-Chloro-3',5'-di-0-acetyl-2'“deoxyadenosine (8) (430mg, 1.2mmoles)
was dissolved in anhydrous pyridine (9ml) with stirring in a CO2/H2O bath at 
0°C. The yellow solution was stirred for 5 minutes to reach thermal 
equilibrium. The head-space of the oven-dried 50ml reaction flask was 
flushed with nitrogen gas. On the dropwise addition of benzoyl chloride 
(5ml, 43mmoles), a suspension was formed whose colour changed to dark brown 
as the acylation reaction proceeded. The reaction mixture was stirred at 
room temperature whilst monitoring by TLC (7:3 EtOAc:hexane, Rf(9)=0.5). 
After 25-30 hours, the suspension was evaporated under vacuum to remove 
pyridine. The residue was dissolved in ethyl acetate (100ml) and washed with 
water (2x30ml). The organic phase was dried over magnesium sulphate,
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evaporated and applied to a 2mm TLC disk. Using centrifugally-assisted TLC, 
the benzoyl chloride contaminant was eluted with hexane followed by a second 
elution, collecting (9), with 7:3 EtOAc:hexane giving pure (9) as a white, 
crystalline solid (460mg, O.Smmoles). Purity was checked by melting point, 
TLC and NMR spectroscopy. Yield = 68%, mpt. 132 "C. NMR (CDGI3)
H8,8.23,s; Bz: p,7.85,d(SJ=7.60); p,7.50,t(3J=7.68); m,7.37,t(SJ=7.52);
HI’,6.46,dd(3j*5.9,8.1); H2', 2.67,2.82,2m; H3’,5.40,m; H4',H5’,4.37,s;
CH3C0-,2.10,2.16,2s
3.9 2-Chloro-N^-benzovl-2'-deoxyadenosine (10)
To a mixture of 2-chloro-N^-dibenzoyl-3’,5’-di-O-acetyl-2’-deoxy­
adenosine (9) (460mg, O.Bmmoles) in 2:1 Me0H:H20 solvent (33ml) was added
potassium carbonate (920mg, 6.7mmoles). After 15-20 minutes, the dissolution
of (9) was complete to a give a translucent brown solution. At 45 minutes,
TLC analysis revealed the reaction had reached completion (17:3 CH2Cl2:Et0H, 
R f(10)“0.52). The crude product was extracted with 9:1 CH2Cl2:EtOH (3x50ml). 
The solution was concentrated by evaporation and the residue was purified by 
centrifugally-assisted TLC (1mm plate, 9:1 CH2Cl2:EtOH) to give pure (10) 
(141mg, 0.35mmoles). If the solvent was evaporated rapidly, a gum resulted, 
yet if the solvent was left to evaporate in air, then a white crystalline
solid resulted. Both forms of (10) were pure as indicated by TLC and NMR
spectroscopy. Yield = 44%, mpt.108-125 ®C. NMR (d?-DMF) H8,8.77,s;
Bz: o,8.19,d(3j=7.55); p,7.69,t(3j=7.12); m,7.59,t(3J=7.44);
Hl’,6.54,t(3j=6.64); H2',2.52,2.85,2m; H3’,4.62,m; H4’,4.04,m; H5’,3.74,m.
IH NMR (CD3OD) H8,8.63,s; Bz:o,8.06,d(3J=7.68); p,7.66,t(3J=7.28);
ffl,7.56,t(3j«7.56); HI’,6.50,t; H2’,2.50,2.81,2m; H3’,4.60,m; H4',4.04,4.07, 
dd(3j=3.60); H5’,3.76,3.84,2dd(2j=-12.03,3J=3.41,4.24)
3.10 2-Bromo-N^-benzoyl-2‘-deoxyadenosine (15)
A sample of 2-bromo-N6-dibenzoyl-3',5’-di-O-acetyl-2'-deoxyadenosine
(14) (81.1mg, 13Cÿimoles), synthesized by Dr. D.K. Jaiswal was partially
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deprotected to give, after flash chromatographic purification (200x20mm 
column, 85:15 CH2Cl2:EtOH) pure (15) (33.1mg, 76jLimoles). Yield = 59%.
(14)iH NMR (CD3OD) H8;8.53.s; Bz:p,7.83,d(3J=7.78);p,7.57,t(3J=7.43), 
l,7.42,t(3j=7.55); Hl',6.46,t(3j=6.8); H2',2.68,3.09,2m; H3',5.48,m; H4',
H5',4.35,s; CH3C0-,2.00,2.12,2s
(15)IH NMR (CD3OD) H8,8.61,s; Bz:p,8.06,d(3j=7.64); p,7.66,t(3J=7.31); 
a,7.56,t(3j=7.53); HI',6.50,t(3j=6.58); H2',2.53,2.81,2m; H3',4.60,ra;
H4‘,4.05,m; H5',3.76,3.85,2dd(2J=-12.09,3J=3.56,4.09)
3.11 r2.8-3H1N^-Benzovl-2'-deoxyadenosine (11)
The title compound was prepared from 2ClN6BzdA (10) using the 
experimental procedure detailed in SECTION 3.1. Specific parameters and 
results for these reactions are given in TABLE 7. The title compound (11) 
was analyzed by reversed-phase HPLC using an Altex 5 ^pm,250x10mm column, 
eluted with 6:4 Me0H:H20 at a flow-rate of 2ml/min (Appendices 3B1,2 and 
4C). Compound (11) was further derivatised for incorporation into DNA 
oligomers, H and I.
IH NMR (CD3OD) H2, 8.69,s; H8,8.64,s; Bz:o,8.08,d(3j=7.6); p,7.65.t(3J=7.3); 
m,7.55,t(3j=7.5); HI', 6.56,dd(3j=6.68,6.79); H2',2.50, 2.85,2m; H3',4.61,m; 
H4',4.07,dd(3j=6.7.3.4); H5',3.76,3.84,2dd (2J=-12.15,3j=3.86,3.32)
3H NMR (CD3OD) T2,8.73,s; T8,8.69,s.Appendix 4C.
3.12 18-3H1 and f 2.8-3HlN^-Benzoyl-5'-0-(4.4*-dimethoxv)trityl-2'-deoxy­
adenosine (12)
This and the following reaction (SECTION 3.13) were initially optimised 
for the experimental conditions necessary when working with compounds of 
high specific radioactivity. The following procedure refers to 
[2,8-3H]N&BzDMTrdA.
4,4'-Dimethoxytrityl chloride (DMTrCl,77mg, 0.23mmoles) and 
4-(dimethylamino)pyridine (DMAP,5mg, 4Idoles) were added to an oven-dried 
20ml side-arm flask equipped with a magnetic stirrer bar. The flask was
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attached to the NTLF gas line and [2,8-3H]N^BzdA (11) (54mg,
0.15mmoles,3.7Ci) was added as a solution in anhydrous pyridine (5ml). The 
solution was lyophilized and the mixture of reactants was kept under high 
vacuum overnight. The reaction flask was flushed twice with dry nitrogen gas 
and brought to 650mmHg pressure with dry nitrogen gas. Anhydrous pyridine 
(1.5ml) and TEA (33^ 1) were added by syringe and the yellow solution was 
stirred at room temperature. After 4 hours, the solvents were lyophilized 
and the reaction flask was flushed with dry nitrogen gas. Diethyl ether
(10ml) was added to the reaction mixture with stirring, followed by
distilled water (2ml). After vigorous stirring, the ethereal layer was 
extracted by syringe and transferred to a 50ml pear-shaped flask via passage 
through a sodium sulphate-filled Pasteur pipette. The ether extraction was 
repeated twice. The purity of the product was checked by TLC (85:15
CH2Clz:EtOH, Rf = 0.5). The resulting dry ethereal solution of (12) (approx.
30ml) was lyophilized before analyses by liquid scintillation counting, 
and 3h NMR spectroscopy and reversed phase-HPLC with a Microsorb Cl8 
250x10mm column, eluting with 85:15:1 Me0H:H20:TEA at a flow-rate of 
2ml/min., ta = 9.0 mins., UV detection at 280nm.
[8-3H]N6BzdA [8-3H]N6BzDMTrdA [2,8-3H]N6BzdA [2,8-3H]N6BzDMTrdA
Yield:
% - 40 - 75
Ci 1.17 0.44 3.66 2.38
Sp.act. 9.2 8.6 24.0 20.8
(Ci/mmole)
Mass(mg) 45 33 54 75
3H NMR (CD3OD), [8-3H]N6BzDMTrdA T8,8.48,s
3H NMR (CD3OD), [2,8-3H]N6BzDMTrdA T8,8.52,s; T2,8.64,s
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3.13 F8-3H1 and F2. B-^HIN^-Benzovl-5*-O-(4.4*-dimethoxvltxity 1-2'-deoxy­
adenosine. 3'-0-f f2-cyanoethyl) . (N.N-diisopropvDlphosphoramidite (13)
The following procedure is illustrated with the preparation of the 
2,8-position tritiated material.
In an oven-dried 15ml side-arm flask with a magnetic stirrer bar was 
placed [2,8-3H]N6BzDMTrdA (12) (75mg, 0.114mmoles, 2.4Ci) as a solution in 
anhydrous THF. The solvent was lyophilized and the resulting solid was 
redissolved in anhydrous THF and lyophilized. The reaction flask was flushed 
with dry nitrogen gas and anhydrous THF (2ml) was added with stirring. Dry 
diisopropylethylamine (DIPEA, 65jil, 0.37mmoles) was syringed into the 
reaction flask, followed by the dropwise addition, at room temperature, of 
2-cyanoethyl-N,N-diisopropylchlorophosphoramidite(40pl, 0.18mmoles) to give 
a translucent grey solution. After stirring at room temperature for 45 
minutes, methanol was added (20pl, O.Smmoles) to quench the excess 
chlorophosphoramidite, stirring for 2-3 minutes to ensure complete 
hydrolysis. To the reaction were added ethyl acetate (5ml) and 10% (w/v) 
sodium carbonate solution (l-2ml) to basify. After vigorous stirring, the 
organic phase was extracted by syringe and dried through a column of sodium 
sulphate in a Pasteur pipette. A second aliqout of ethyl acetate was used to 
ensure complete extraction from the reaction vessel and washing of the 
drying column. TLC of the dry organic solution (9:9:2 EtOAc:CH2Cl2:TEA, 
Rf(13) =0.9, two spots of partially resolved diastereoisomers) showed the
major contaminant as 4,4'-dimethoxytrityl alcohol. The [8-3H]product was 
lyophilized before use at this stage. In the case of the [2,8-3H]product the 
impurities were eliminated by subjecting the crude product to flash 
chromatography (solvent as TLC, 120x10mm column), pooling the appropriate 
fractions and lyophilizing to yield pure (13) which was analysed by liquid 
scintillation counting, H^ and 3H NMR spectroscopy and reversed phase-HPLC 
(Altex 5pi Ultrasphere 250x10mm column, eluted with 99:1 MeOH:TEA at 
flow-rate of 2ml/min. tR(13) = 7 mins., UV detection at 280nm).
3H NMR (CDsCN) T2,8.60,s; T8,8.29,s
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3.14 NOE Difference Spectra
The Bruker frequency selective NOE program, NOENÜLT, was used with a 
Bruker/IBM 300MHz NMR spectrometer.
The following conditions were used:
Dwell time on irradiation frequency,D2 = 0.1 or 0.5s
Aquisition time,AQ = 0.819s
Recovery Delay,Dl = 3.63s
Number of transients,NS = 2048 or 4096
Decoupler Power,S3 = 40L or 45L
(XL where X represents the dB attenuation below 200mW. 40L equals 2mW and
45L is approximately ImW)
The FID'S were subtracted to give the difference spectra. Irradiation 
of the HI' ribofuranosyl proton and the consequent H8 purine ring NOE was 
used to assign the purine ring proton resonances in dA, N^BzdA, ATP and 
confirm the site of halogénation in N6Bz2CldA and N6Bz2BrdA (APPENDIX 1). 
The results were used to assign the 3H NMR spectra of the tritium-labelled 
nucleosides.
TABLE 8; Aromatic H^ NMR Assignments in Adenosine Nucleosides
dA ATP* N^BzdA N6Bz2CldA N6Bz2BrdA
H2 8.17 8.43 8.70 - -
H8 8.31 8.63 8.65 8.77 8.60
Solvent CD3OD D2O CD3OD d7-DMF CD3OD
* This result was used to confirm the tritium labelling pattern reported by 
Jaiswal et al43,52.
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3.15 Description and Use of a Manual MfA Synthesizer
A raap-diagram and key of the manual DNA synthesizer used are shown in 
FIGURE 1.
The chemicals and equipment were contained within an argon gas-filled 
"Atmosbag" (medium, Aldrich). The atmosphere in the bag was dried with two 
lib bottles of Drierite(27)*. The chemicals, including the radioactive 
phosphoraraidite, were placed within the confines of a spill tray(41) to 
enable the safe containment of any spillage if this were to occur.
The essential features of the apparatus were the reaction column(21), 
which contained the solid-phase support, the argon gas line(38/30) used as a 
pressure source to flow solution reagents(1-5,14-17) and solvent(23) through 
the column to effect reactions, the excess being expelled into the waste 
bottle(22). The effuient from the trichloroacetic acid (TCA,1) reaction was 
collected (25) for visible spectrophotometric analysis after the completion 
of the synthesis.
A more detailed diagram of the column configuration is seen in FIGURE
2. The column was modified from a chromatography column. It held the 
solid-phase support material that was secured by a glass-wool plug. The 
mouth of the column was stoppered by a rubber septum with a 
pressure-equalizing needle for use in conjunction with the argon gas line. 
Effuient flow from the column was controlled by a nylon tap.
The elongation of the oligonucleotide involved the repetition of 
reactions. Hence, the synthetic route is cyclic and this is illustrated in 
FIGURE 3. The experimental aspects of each segment of the cycle are detailed 
in the context of the manual synthesizer at the 4^ole reaction scale. 
Reagent volumes and the major deviations for 1 jmole reaction scale are 
bracketed.
* Numbers in brackets refer to the key to FIGURE 1.
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FIGURE 1: Mati-Diagram and Kev of Manual DNA Synthesizer
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1. 3%(w/v) trichloroacetic acid/CH2Cl2 :DEBLOCK
2. 0.5M tetrazole/ CH3CN: COUPLING ACTIVATOR
3. l:l:8(v/v/v) acetic anhydride/2,6-lutidine/THF solution: CAPPING I
4. 6.5%(w/v) 1-methylimidazole/THF solution: CAPPING II
5. O.IM I2 in 10:l:40(v/v/v) pyridine/water/THF: OXIDATION
6. Spare waste bottles
7. Spare natural rubber septa for reaction column
8. Spare tap for reaction column
9. Rubber bung
10. Double-tipped needle, 2 feet, 20G
11. Tissue
12. Work area tissue
13. Box of tissues
14. dA phosphoraraidite solution (250mg/2.5ml CH3CN)
15. dC phospohramidite solution
16. dT phosphoraraidite solution
17. dG phosphoraraidite solution
18. [2-^H]dA phosphoraraidite in Eppendorf vial
19. Cork ring
20. Clarapstand, 11" height
21. Reaction column, modified chromatography column, 8x40 mm
22. Waste reagent/ solvent collection bottle
23. Acetonitrile solvent reservoir, 125ml Sure/seal bottle
24. Spare CH3CN Sure/seal bottles(2)
25. Rack and 15 numbered clean and dry test tubes (hold 15ml)
26. Parafilm squares(8)
27. Bottles of 8-mesh Drierite
28. Drierite bottle screw caps
29. Rubbish bag
30. 1" disposable 22G needle push-fit in argon tube
31. Glass Pasteur pipettes
32. Pointed tip tweezers
33. Spare needles, 3"x22G
34. Needle to pressure equalise phosphoraraidite bottles when dispensing 
solutions
35. 250 ^ 1 syringe/needle assembly
36. Bag of 5ml PP/PE syringes. 35 needed for 4 ^ ole synthesis
37. Bag of 1ml PP/PE syringes. 60 needed for 4 ^ ole synthesis
38. Tygon tubing(for argon gas)
39. Tube crimp
40. 3-way tap. Outlet of tap may be alternated to maintain argon gas 
pressure inside the Atmosbag
41. Plastic spill tray
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FIGURE 2: Reaction Column of DNA Synthesizer
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3.16 Synthesis of Tritium-Labelled DNA Oligonucleotides
The synthetic target was the Dickerson dodecamer tritium-labelled at 
the adenosine residues using a manually operated DNA synthesizer and 
phosphite triester chemistry on a solid-support.
Analysing the course of test oligonucleotide syntheses using the DMTr 
visible absorbance assay technique and the products of these syntheses by 
reverse-phase HPLC, the apparatus was improved by a "result-effect" 
developmental scheme. The aims were to achieve (i) high yield of product; 
(ii)reproducible and reliable use and (iii) experimental expeditiousness. As 
a consequence, the nature of the apparatus was in flux until it had been 
optimised for the intended use. This developmental course followed is 
illustrated below:
S' AAAÂAA 3' Nucleotides A,B
S' CGCGAA 3' Nucleotides C.D
S' CGCGAATTCGCG 3' Nucleotides E,F,G
S' CGCG[3H]AATTCGCG 3' S' CGCGA[3H]ATTCGCG 3'
Nucleotides H,J Nucleotide I
One advantage of solid-support syntheses is the ability to use large 
molar excesses of solution reagents to force each reaction to virtual 
completion. For the tritium-labelled residue the use of fewer molar 
equivalents was prudent and the experimental conditions were altered to 
achieve reasonable yields for these steps, bearing in mind the possibilty of 
side reactions these alterations may induce.
For the purposes of ease of comprehension of the tables of data, the
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numbering of oligonucleotide residues is opposite to convention (ie. goes 
from 3' to 5'), thereby following the course of the syntheses.
This experimental section describes the use of the apparatus first to 
give the reader some fimiliarity with the components and their function.
3.17 Preparation of Equipment
Several items for use in the DNA synthesizer apparatus must be prepared 
before inclusion in the apparatus: 15 stainless steel needles(33), waste 
bottles(22), 10 round-bottomed flasks(25ml), 15 test tubes(25), 3 Sure/seal 
(Aldrich) bottles(125ml,23,24) and a double-ended transfer needle(lO) were 
oven-dried overnight at 150*C.
After capping with Sure/seal (Aldrich) caps, the three Sure/seal 
bottles(23,24) were filled with anhydrous acetonitrile by cannulationi^s 
from a storage bottle (21) with dry nitrogen gas. Only one acetonitrile
bottle was used at the 1 ^ ole scale. The acetonitrile in the storage bottle
(Aldrich,<50 ppm water) was further dried with Trap-pak (Millipore) 
molecular sieves before use. Sequentially, the round-bottomed flasks were 
filled with the solution reagents (1-5) under a blanket of dry nitrogen gas,
stoppered with rubber septa and placed in their glass beaker containing
vessels. The flasks containing the oxidation reagent(5) were covered with 
aluminium foil. Only one flask of each reagent was needed at the 1 jimole 
reaction scale.
The Atmosbag (medium, Aldrich) was modified before use by replacing the 
polythene gloves by latex gloves. These were taped to the remaining 
polythene sleeves of the Atomosbag. The use of latex gloves improved the 
ease with which manipulations could be performed.
The Atmosbag was contained within a fume cupboard and was equipped with 
the following items: spill tray(41), clampstand(20), polythene bags
containing individually packaged syringes (1ml and 5ml capacity, all 
polythene/polypropylene construction(36,37) 1ml syringes only for 1 jimole), 
rubbish bag for solid waste(29), bottles of Drierite(27), small box of
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tissues(13), glass (Pasteur) pipettes(31), pointed tweezers(32), parafilm 
squares(26), rubber bung(9), tube crimp(39), argon gas line(38), test tube 
rack(25) and cork ring(19).
The Atmosbag was flushed with argon gas from the gas-line(38) and under 
a blanket of argon gas (40 psi) the remaining items were transferred (some 
from a desiccator* (Drierite)) to the apparatus. Those items to be placed at 
the rear edge of the spill tray were transferred first to expedite the 
process: Solution reagents(1-5), acetonitrile solvent(23,24), rubber
septa(7)*, column taps(8)*, needles(33)*, test tubes(25)*, transfer 
needle(lO)*, two reaction columns(21)*, glass wool, pressure-equalizing 
needle*(see FIGURE 2), 25(^1 syringe(35)*(100pl syringe for 1 ^ole), waste 
bottles(6,21)*(only one for 1 ^ ole), commercial phosphoraraidites of dA, 
dT(2x0.25g), dC and dG(lx0.25g)(14-17)* (one of each for Ijmole), 
female-to-feraale Luer fitting and dG-CPG solid-support
columns(4xljimole)*(only one for 1 ymole!). The Atmosbag was tape sealed, the 
argon gas pressure reduced to 10-20 psi to inflate the bag and the three way 
tap(40) was adjusted to divert the gas flow through the needle(30). The gas 
pressure was reduced to 3psi at which it remained throughout the experiment. 
The Drierite bottles were opened to the argon atmosphere and the equipment 
was arranged as shown in FIGURE 1.
The phosphoraraidites (14-17) were dissolved in anhydrous acetonitrile 
(2.5ml,23) using a syringe(5ml)/needle assembly and a spare needle to 
displace gas in the phosphoraraidite bottles. All phosphoramidite solutions 
had a concentration of lOOrag/ml, resulting in the following molarities:
Phosphoramidite Concentration (mol/1)
dA 0.117
dC 0.120
dG 0.119
dT 0.136
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3.18 General Procedure I: Washing Column Contents
Washing of the column contents is one of the essential facets of 
solid-support synthesis. It performs numerous functions, amongst which are; 
(i)removing a solution reagent (ii)avoidance of mixing solution reagents on 
the column and (iii)elimination of chemical species deleterious to the 
synthetic reactions.
After opening the column tap, one end of the transfer needle(10) was 
removed from the rubber bung(9) and inserted, via the rubber septum, into 
the reaction column(21) such that the needle tip was at the edge of the 
conical taper of the column (see FIGURE 2). This ensured that the solvent 
flowed into the column and not around the septum. The argon needle(30) 
piercing the solvent reservoir(23), forced argon gas to flow through the 
column materials, effusing through the column tap. The transfer needle was 
pushed below the solvent level in the solvent reservoir(23) causing 
acetonitrile solvent to flow into the column. When the solvent level 
reached the transfer needle tip in the column, the transfer needle(10) was 
placed above the liquid level in the solvent reservoir(23). The 
pressure-equalizing needle was closed with a finger, removing all the liquid 
from the column into the waste bottle(22) and partially drying the column 
contents with the argon gas stream. The washing procedure was repeated as 
necessary. When completed, the argon needle(30) was removed from the solvent 
reservoir(23) and the transfer needle(lO) was removed from the column(21) 
and replaced to the rubber bung(9) simultaneously. The argon needle(30) was 
placed into the septum of the reaction column(21) to further dry its 
contents.
3.19 General Procedure II: Applying Solution Reagents (Non-Tritiated) 
to Column Materials
The efficient application of solution reagents to the solid-support 
material was vital for high-yielding reactions, a crucial factor in 
generating an oligonucleotide. A solution reagent may consist of one
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solution (TCA,(1) and 12(5)) or may necessitate the in situ mixing of two 
reagents (phosphoramidites (14-17) with tetrazole(2) and
1-methylimidazole(4) with acetic anhydride(3)). This procedure is 
illustrated with the more complex dual reagent addition.
The beakers containing the reagents were placed, one on either side of 
the clampstand(20) base. Segregation of the two reagents prevented 
accidental swapping of reagent needles.
New syringes (5ml for TCA(l) and Iz(5) at the 4 n^mole scale, 1ml for 
all others at both scales) were attached to the reagent needles and the 
needle bore was flushed once with the reagent, discharging the reagent onto 
the work area tissue(12). In succession, the required volumes of each 
reagent (stated in the appropriate section) were drawn into the syringes and 
placed, needle down, into their respective reagent beakers.
After removing the argon needle(10) from the column and closing the 
column tap, both reagent syringes were placed into the column septum and 
simultaneously forcefully discharged onto the walls of the reaction column 
avoiding disruption of the solid-support material. The reaction duration was 
timed from this point. The syringes were removed to the waste bag(29) and 
the work area tissue(12) was replaced. The column tap was opened to allow 
percolation of the reagents throughout the length of the solid-support 
material.
Detail differences and addenda apply to some of the reagents and are 
mentioned in the following sections.
3.20 Canning of Glass-Wool
The glass-wool plugs' function was to prevent disruption and loss of 
solid-support material during the synthetic manipulations. However, the 
silanol groups in the glass structure must be protected such that they do 
not participate in the oligonucleotide reactions, possibly denying the 
solid-support material of solution reagents.
The glasswool was placed at the filter bed of the column, washed 4-5
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times with acetonitrile according to General Procedure I and acetyl capped 
with reagents (3) and (4) (0.4ml each) according to General Procedure II, 
this cycle being repeated four times. The reaction time was two minutes.
3.21 Preparing the CPG Column
The dG derivatised 500A pore-size CPG solid-support material was 
obtained from commercial 1 ^ ole columns designed for use with an automatic 
DNA synthesizer.
After thoroughly drying the reaction column(21) and glass-wool therein 
with a stream of argon gas, the septum and tap were removed. The glass-wool 
was placed on a dry tissue using tweezers(32) and the argon needle(30) was 
used to further dry the sides of the reaction column(21) where the septum 
was seated. A new septum was prepared.
The dG-CPG beads were placed onto the filter bed of the reaction 
column(21) while vertically tapping the column to displace any material 
adhering to the walls of the reaction column(21). The dG-CPG was manipulated 
until the top of the material was level, followed by plugging the column top
with the capped glasswool. The new septum and tap were replaced and the
column(21) was returned to the clampstand(20).
3.22 5’-Deblocking: The TCA Reaction
The 5'-deblocking reaction utilises irifihloroacetic acid (TCA) to
cleave the 4,4'-dimethoxytrityl ether thereby exposing the 5'-OH function as 
a nucleophile for chain propagation in the coupling reaction. The acidic 
washings from the reaction were collected for visible spectrophotometric 
analysis (see rxn. I, FIGURE 3).
The freshly prepared column was washed extensively and TCA(l) was
applied according to General Procedure II using 4.2ml at 4jamoles and 3.2ml 
at Ipmoles for one minute and 30 seconds respectively. All spent reagent and 
subsequent solvent washings were collected in numbered test tubes(25), 
washing a further two times into the waste bottle(22).
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3.23 Coupling with Non-Tritiated Phosphoramidites
This reaction adds the nucleophilic 5'-OH to the solution nucleoside 
phosphoramidite, extending the oligonucleotide to form a phosphite triester 
(see Rxn 2,3; FIGURE 3).
The reagent syringes were filled with tetrazole solution(2) (0.2ml at 1 
^ole and 0.4ml or 0.7ml(see TABLE 9) at 4 jumoles) and phosphoramidite 
solution (14-17) (same volumes as tetrazole) in that order and applied to 
the column as described in General Procedure II for, typically, one minute 
at 1 jnnole and 2 minutes at 4 ^ moles. The coupling times varied in order to 
maintain optimum yields. These were:
3' G1-C2-G3-C4-T5-T6-A7-A8-G9-C10-G11-Cl2 5'
2 2 2 2 3 3  2* 2* 5 2  2 3 minutes
* When using non-tritiated reagents
3.24 Coupling with Tritiated Fhosnhoramidite
Before the use of the tritiated phosphoramidite, the Atmosbag was 
cleared of all solid and liquid waste thereby avoiding cross-contamination 
with the radioactive waste, thus minimizing the quantity of radioactive 
waste. It was helpful to clear the work area in the Atmosbag. Also, it was 
advantageous to halt the synthesis one step early so that a large molar 
excess coupling buffered any deleterious effects the Atmosbag opening may 
have had.
The tritiated dA-phosphoramidite in an Eppendorf vial(18) was dissolved 
in anhydrous acetonitrile from the solvent reservoir(23) using a microlitre 
syringe(35) to give a lOOmg/ml concentration (typically 200jil for 4 jimoles).
The column(21) was removed from the clampstand(20), stripped of tap and 
septum and a female-to-female Luer fitting with an attached 1ml syringe was 
placed at the end of the column(21). The [^H]phosphoramidite solution(18) 
was applied to the column followed by an equivolume of tetrazole 
solution(35) (25-5(^l of acetonitrile was also added at 1 jimole as a volume
bulker). The syringe of the reaction column(21) assembly was oscillated to
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flow the solution reagent over the CPG to optimise the coupling efficiency. 
After 40-45 minutes, the tap and (new) septum were returned to the column 
and the excess tritiated solution reagent was washed into a test tube with 
acetonitrile.
3.25 Ga-pping of Failure Sequences
Protection of unreacted 5'-OH groups that failed to couple with the 
phosphoramidite was achieved by acétylation.
The acetic anhydride(3) and 1-methylimidazole(4) reagents were used as 
described in General Procedure II (0.4ml each for 2 minutes at 4^moles and 
0.2ml each for 2 minutes at the 1 ymole scale).
3.26 Oxidation: The I2 Reaction
The phosphite triester formed at the coupling stage is highly reactive 
and the iodine/water reagent(5) was used to oxidise phosphorus to a 
phosphate triester in a very rapid reaction.
The argon needle(30) remained in the column septum at all times. The
quantities of reagent used were 1.5ml at 4yimoles and 0.65ml at 1 ymole for
30-40 seconds. The column was thoroughly washed at the end of the reaction 
to displace all the reagent (water and iodine); to ensure the column 
materials were dry (6-8 washings).
Oxidation is the last stage in the synthetic cycle (FIGURE 3) which
should take approximately 15 minutes to complete and about 50 minutes for
the cycle involving the labelled addition step.
3.27 Concluding the Synthesis
The synthesis was finished with the deblocking of the last base of the 
oligonucleotide. Reagent bottles (14-17, 3,4) were flushed with argon gas
and sealed with parafilm(26). The Drierite bottles(27) had their caps(28) 
replaced. All the needles were washed with methanol and chloroform before 
oven-drying. All glassware were washed before oven-drying.
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3.28 Deprotection of Protecting Groups
The CPG solid-support material from the reaction column(21) was
transferred with the aid of an anti-static instrument (Zerostat 3 from 
Discwasher Inc., IL,USA) to a 20ml screw-cap vial. Concentrated ammonia 
solution (30%, approx. 2ml) was added to cleave the oligonucleotide from the 
CPG solid-support material over a 60-70 minute period. Using a glass Pasteur 
pipette, the ammonia/oligonucleotide solution was transferred, with washings 
of concentrated ammonia solution to a second 20ml screw-cap vial. This vial
had a wrap of PTFE tape around its thread and the cap was sealed with
parafilm. The solution was heated at 55*C for 5-6 hours (can be heated
overnight without noticeable effects for non-labelled oligonucleotides). 
After cooling to room temperature, the solution was freeze-dried overnight 
to give a white residue of the fully deprotected DNA oligonucleotide.
3.29 Purification by HPLC
Stock solutions of the binary solvent system were prepared. These were: 
(A)O.IM triethylammonium acetate (TEAAc) pH6.8 and (B)6:4(v/v); O.IM TEAAc 
pH6.8: acetonitrile.
The lyophilized solid from the ammonolytic deprotection was dissolved 
in buffer (A) (1ml) and filtered through a 0.45pm nylon filter to remove 
residual CPG solid-support and poly(acrylonitrile) particles.
Purification was achieved by elution on a C18 reversed-phase 250x10mm 
60Â pore-size column at a flow rate of 5ml/min using 260nm UV detection. The 
following linear gradient was used:
Time
(mins)
A
(%)
B
(%)
0 75 25
2 75 25
14 69 31
18 75 25
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Following an analytical separation (5( 1^), three preparative purifications, 
each of approximately 32(^ 1, were conducted, collecting the oligonucleotide 
in about 10ml of eluent which were pooled and freeze-dried. The HPLC column 
was washed with acetonitrile at 5ml/min for 30 minutes to remove lipophilic 
contaminants. The HPLC column was stored in acetonitrile.
3.30 Dialysis
The lyophilized white solid from HPLC purification was dissolved in 2mM 
NasPO*/ 2mM NaCl pH7.0 (5ml), transferred to IkDa molecular weight cut-off 
cellulose dialysis tubing and dialysed against 2mM NasPOa/ 2mN NaCl pH7.0 
(11) containing sodium azide (50mg) to prevent bacterial decay of the 
dialysis bag material and ethanol (50ml) as a token radical scavenger. The 
dialysis proceeded at room temperature overnight, then in a refrigerator at 
4 ^C for one day. The sample was further dialysed against water (11) for one 
day. The sample was washed from the dialysis bag and freeze-dried.
3.31 Sample Preparation for NHR Spectroscofpy
The lyophilized solid from dialysis was dissolved in either DzO or 
8:2(v/v) HzOiDzO (200pl) which contained lOmM NasPO*, pH7.0 and 50mM NaCl. 
H^ NMR samples were contained in teflon-lined 5mm NHR tubes. Spectra were 
obtained at 320MHz. Oligonucleotides H,I and J were used to perform NMR 
experiments. Chemical shifts are listed in TABLE 11 and shown in APPENDIX 8. 
The NMR samples of oligonucleotides H and I contained 12mCi and 5raCi 
respectively. This indicates low recoveries caused by the deprotection 
and/or purification procedures, typically 18% (see TABLE 10).
3.32 Visible Absorbance Measurement of DMTr Washings
Visible spectrophotometric analyses of the intense orange trityl 
washings gave yield datai20 and was used as a diagnostic tooli20 in 
pinpointing abnormalities during a synthesis, such that constructive changes 
were made to synthetic procedures.
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The washings collected in test tubes were diluted with O.IOM 
p-tolylsulphonic acid/acetonitrile solution (10ml) and then filtered through 
a glass-wool plug in a glass Pasteur pipette. An aliquot (3^1 for 4jimoles, 
66jil for 1 ymole) was transferred to a 1cm path length cuvette, which was 
diluted with O.IOM p-tolylsulphonic acid/acetonitrile solution (1.21ml). The 
mixture was homogenized before the absorbance was measured at 498nm. A 
Hewlett- Packard HP8452A diode array spectrophotometer was used.
Using the following form of the Beer-Lambert law equation the number of 
moles of DMTr+ at each coupling was calculated:
c = A. D. V.
E. 1.
where c = Amount of DMTr+ (jimoles)
A = Absorbance
D = Dilution factor
V = volume of DMTr solution (ml)
E = Molar extinction coefficient of absorbing species 
(70 jimole”! ml cmri)i2i 
1 = path length (cm)
As D,v,E and 1 are constants for a given synthesis, the amount of 
DMTr*, and by implication, the amount of oligonucleotide, was determined 
from the absorbance readings, A. The equality between the molar quantities 
of DMTr+ measured and those of the corresponding oligonucleotide to which 
this result reflected was validated by comparison of the DMTr* results and 
HPLC peak areas measured at 260nm for the synthesis of oligonucleotide A 
assuming that the extinction coefficient for oligonucleotides of differing 
chain length were identical't^  The above variables were factored into a 
constant, c'; c=A.c' where c'=Dv/El=constant thus simplifying the subsequent 
calculations.
The calibration curve was assumed to be linear over the range of
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absorbance readings recorded (0.1 - 1.0). A typical UV/visible spectrum of 
the above solution composition is shown in FIGURE 4.
FIGURE 4: UV/ Visible Spectrum of DMTr* inp-Tol ylsulnhonic Acid/ Acetonitr_Ll_e
_tfnvEL£ttGin
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TABLE 9: Stepwise Yields for Manually Synthesized 12-Mers
Nucleotide Nucleotide H Nucleotide I Nucleotide J
G.J5 symbol X 0 A P
Base DMTr
(jfiaoles)
DMTr
(|imoles)
DMTr
(jimoles)
DMTr
(^moles)
G1 4.40 4.72 5.34 5.11
C2 5.16* 5.57I 5.84I 5.39I
G3 5.01 5.67 5.81 6.09
C4 5.00 5:60 5.45 6.04
T5 4.74 5.12 5.18 5.63
T6 4.62 4.91 5.18 5.35
A7 4.57 4.77 1.62) 5.37
A8 2.932 3.18) 1.645 0.87*
G9 3.205 3.255 1.56 1.105
CIO 2.90 3.17 1.65 1.03
Gil 2.88 3.16 1.587 1.127
C12 2.90^ 3.017 NR8 NR8
1. DMTr yield increased due to (i) dG-CPG exposed to moisture, causing 
5'-DMTrdGl hydrolysis (ii> phosphitylation of dGl-0^.
2. Four molar equivalents (16 ;imoles) of dA8-phosphoramidite from 
lOOmg/ml anhydrous acetonitrile solution. Reaction time = 40 mins.. 
stepwise yield = 64%,
3. 5.5 molar equivalents (22pmoles) of [2,8-^H]dA7/8-phosphoramidite 
from lOOmg/ml anhydrous acetonitrile solution (approx. 450mCi).
Reaction time = 40 mins. Stepwise yields = 67% (H) and 31% (1). (All 
other couplings, 47 ^ moles (G), 82 ^ moles (H,1,J) for two mins.).
4 . Coupling with [8-3H]dA8-phosphoramidite as an anhydrous acetonitrile 
solution. Reaction time - 45 mins. Stepwise yield = 16.2% (J).
5. Use of three consecutive capping reactions to effectively halt dA7/8 
failure sequences.
6. %  NMR of nucleotide G in APPENDIX 6. HPLC trace, FIGURE
7. Mean stepwise yields = 94% (G); 94% (H); 88% (I); 82% (J).
Chemical yields = 56% (G); 64%(DMTr),75%(HPLC)(H); 28%(DMTr),
33%(HPLC)(I); 20%(DMTr),24%(HPLC)(J); see APPENDIX 7.
8. N R =  Not Recorded.
FIGURE 5; Stepwise Yields for Manually Synthesized 12-Mers
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TABLE 10: Summary of DNA Synthesis Data
Nucleotide Scale
(paoles)
Restricted 
dA Coupling
No. Equivs Mean
Stepwise 
Yields (X)
Chemical 
Yield(%)
Radiochem. 
Yield(mCi)
A 1 n a I _ 76 33 NA
B 1 NA - 97 90 NA
C 1 NA - 76 33 NA
D 1 dA2 2 79 39 NA
E 1 dA8 2 88 29 NA
F 1 dA8 2 90 35 NA
G 4 dA8 4 94 56 NA
H 4 dA8 5.5 94 64 60
I 4 dA7 5.5 88 28 32
J 4 dA8 UN2 82 20 9
1. NA = Not Applicable
2. UN = Unknown
TABLE III )H NMR Chemical Shift Data (320 MHz)
Nucleotide H8
(ppm)
H2
(ppm)
Solvent Temp.
CC)
H 8.15 7.27 D2O 25
8.13 7.25 D20:H20(2:8) 25
7.97 7.00 D2O 10
7.92 6.95 D20:H20(2:8) 10
I 8.13 7.64 D20:H20(2;8) 25
8.23 7.97 D20:H20(2:8) 25
J 8.16 - D2O 25
Duplex
Hairpin loop
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4. DISCUSSION
4. Discussion
2'“Deoxyadenosine has been successfully tritiated at high specific 
radioactivity, derivatized at the N^ , 3' and 5' positions and incorporated 
into a synthetic DNA 12-mer which has been characterized by )H NMR 
spectroscopy. The H2 and H8 NMR signals of a number of derivatized dA's 
have been assigned.
4.1 Syntheses
The ammonolytic 6-dechlorination to yield compound 8 (see SCHEME 1) 
applied much milder reaction conditions using the same synthetic route 
outlined in TABLE 2. The course of the reaction was shadowed by TLC to give 
the 6-aminated heterocyclic purine ring whilst retaining the 3',5'-acetyl 
protecting groups in order to simplify post-reaction purification of the 
product, compound 8 . The completion time of the reaction was a compromise 
between ester hydrolysis of the 3 5 ' -protecting groups and 6-amino 
dechlorination and this was reflected in the modest yield (54%) achieved for 
this reaction.
The reported^o,48 conditions for 6-benzoylation of purines were 
ineffective with compound 8 as the substrate for benzoylation. The use of a 
greater number of equivalents of benzoyl chloride (20-30 equivs.) over a 
much longer time (ca. 25 hours) was necessary. This was seen5i»52 as the 
effect on the 6-NH2 group of the electron-withdrawing 2-chloro substituent.
An alcohol/water solvent system*0 with potassium carbonate as the 
base^i was used for the selective déacylation of compound 9 for a 44% yield 
of compound 10. This was a problematic step in the synthesis of 2ClN^BzdA. 
Incomplete dissolution of substrate (compound 9) in the Me0H/H2Ü solvent is 
believed to be the problem. The "transient" protection route of Jones et 
al55, used in the preparation of N5-benzoyl-8-bromo-2'-deoxyadenosine was 
not applicable here as the 3 5 ' -hydroxyl functions are already protected 
with acetyl groups. The use of the pyridine/alcohol solvent system with 
sodium hydroxide as base may achieve higher and more reliable y i e l d s * o , 4 8 ,
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The three preparations of tritiated nucleosides described here gave 
products of lower than maximum (28.76 Ci/mmole) specific radioactivities: 
Catalytic exchange (9.2 Ci/mmole); 8-debromination (10.5 Ci/mmole) and 
2-dechlorination (24 Ci/mmole) of 2'-deoxyadenosines. A number of factors 
may contribute to this, with two causes predominating.
(11 Isotonic Dilution via Proton Exchange
Apart from the 3'-, 5'-0H's and the 6-NH protium sources common to all 
three starting materials, large differences in specific radioactivity were 
observed. Although both H8 and H2 are capable of catalyzed exchange, H8 is 
known to be about 2000-times more acidicSS. This carbon acidity differential 
between H2 and H8 was demonstrated by the preparation of [B-^HJN^BzdA from 
N^BzdA and is reflected in the appearance of the HTO peak in the )H NMR 
spectrum (APPENDIX 4A); a clear indication of catalytic exchange. Although 
tritium gas of maximum specific radioactivity was used, a product of low 
specific radioactivity resulted (9.2 Ci/mmole). Direct exchange labelling of 
the nucleoside is attractive as it negates the need for synthetic effort 
preceding the synthesis of the oligonucleotide product.
Elimination of H8 by halogénation to give SBrN^BzdA gave a tritiated 
product of similar specific radioactivity (10.5 Ci/mmole), including an 
element of H2 exchange not seen in the simple exchange reaction of N^BzdA. 
This might be due to the increased H2 acidity in BBrN^BzdA upon substitution 
with the electronegative halogen.
The overall labelling mechanism for BBrN^BzdA is probably a
superimposition of two processes: (1) H2 exchange in the halogenated 
precursor and (2) 8-position reductive debromination. Both processes would 
occur at the catalyst surface.
For the 2ClN5BzdA substrate the more electronegative chlorine 
substituent probably increases the acidity of the H8 hydrogen and thus 
increases its propensity to catalytic exchange before the C2-C1 bond is 
cleaved. The C2-C1 bond is more difficult to cleave than the C-Br bond by 
hydrogenolysis making H8 exchange more facile than direct exchange of the
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parent nucleoside. During this "pre-dechlorination-exchange" period, the 
catalyst surface would become contaminated with protium from H8 so that when 
2-dechlorination occurs, a mixture of hydrogen and tritium is incorporated 
at the H2 position. A 3:1 (H8:H2) tritium ratio was observed (APPENDIX 4C). 
Although the specific radioactivity was increased (24 Ci/mmole), it was 
still lower than expected for two labelled sites.
(21 Effect of Catalyst
The catalyst utilised in all experiments was 30% palladized charcoal. 
This constitutes a very high catalyst loading. As the catalyst has a very 
high surface area and functions in its catalytic capacity by adsorption of 
chemical species at the surface, it is to be expected that if left in the 
atmosphere it will adsorb airborne species, including water. Before use, 
these species must be efficiently desorbed so that the catalyst may operate 
effectively in hydrogenolysis reactions.
The catalyst was degassed by placing it under very high vacuum 
immediately before use. Special preparation of the catalyst by heating under 
vacuum for a prolonged period may be an essential prerequisite before use to 
enable the attainment of very high specific radioactivity nucleosides.
Highsmith et al*) have shown that the H2 position can be specifically 
tritiated at high specific radioactivity (23Ci/mmole) with 2BrA as the 
substrate, a halogenated precursor lacking an N^-benzoyl substituent.
There is a need for further investigation to delineate a more 
successful route to tritium labelled 2'-deoxyadenosines suitable for DNA 
oligomeric incorporation. The following scheme is proposed:
2XdA Buffered [2-)H]dA DNTrCl,py [2-)H]DMTrdA ^
X=Br5 2 or 1)7 water, pH 8-9 DMAP, 4hrs 77%55
(l)TMSCl,BzCl,2hrs [2-)H]N6BzDMTrdA as before [2-)H]N& BzDMTrCEDdA   ^ ^
(2)NH40H,30mins,88%55
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All three functional group protection/activation manipulations would 
have to be performed after the labelling reaction. Use of a 2-bromo or
2-iodo precursor may enhance the rapidity and specificity of labelling.
4.2 NMR Data
The NOE-assisted assignments of the H2 and H8 protons in the 
2'-deoxyadenosines studied (TABLE 8, APPENDIX 1) formed a crucial part of 
the experimental data, enabling the characterization of the labelled 
nucleoside and nucleotide products. The swapping in relative chemical shift 
positions upon N^-benzoylation is of note (APPENDIX 1) and this pattern is 
mirrored for the tritiated nucleoside synthon (APPENDIX 4C) and tritiated 
oligonucleotide (APPENDIX 8B). This avoided inaccurate inferences to be 
drawn about the position(s) of the label. The data for dA (TABLE 8) are in 
qualitative agreement with that of compound D^s of TABLE 5.
Most of the tritium label was situated at H8 in the nucleoside 
(Compound 11, APPENDIX 40) and this situation is unchanged for the resultant 
oligonucleotide H (APPENDIX 8B). The )H NMR spectra (APPENDIX 8) provide 
direct assignment of H8 and H2 tritons on both A5 and A6 residues of the 
Dickerson dodecamer. The )R NMR spectrum of nucleotide I (APPENDIX 80) shows 
direct evidence of the loop of the hairpin structure. As the hairpin 
conformer consists of one strand of DNA as opposed to two strands of the 
duplex, its NMR linewidths are about half those of the duplex, as observed. 
This identifies the hairpin loop signals being downfield of those associated 
with the duplex (APPENDIX 80).
Integration of the )H NMR signals of both the tritiated nucleoside 
synthon (Compound 11, APPENDIX 40) and the consequent tritiated 
oligonucleotides H and I (APPENDIX 8B,80) are identical. It could be that no 
back-exchange of the H8 and/or H2 tritium label occurs under the 
deprotection conditions used or that the exchange rates at both positions in 
the oligonucleotide are very similar.
The "no exchange" possibility, although extraordinary considering the
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known lability of the H8 in purines is probable as the production of 
nucleotide J has been demonstrated (APPENDIX 8A) from an H8 
exchange-labelled precursor (APPENDIX 4A). One is left with the case that 
the extent of the base-mediated exchange of H8, if it has occurred, is 
undetectable under the conditions of 3H NMR spectroscopic analysis employed 
here. Reduced rates of exchange-labelling for nucleotides over nucleosides 
has been reported as 0.71 at 50°C for polyadenylates over AMP^^e,
4.3 Purification
The recovery of the oligonucleotide after deprotection and/or HPLC 
purification was low. To isolate the source of this product loss, the 
deprotection and HPLC methods need to be quantitated:
(11 Denrotection
Both "cold" and "hot" steps of the oligonulceotide deprotection need to 
be quantitated to optimize their respective durations. This would ensure 
that all the oligonucleotide is hydrolytically cleaved from the solid-phase 
support in the "cold" step followed by an efficient transfer to another 
vessel and complete cleavage of the remaining protecting groups in the "hot" 
step.
(21 HPLC
Although the HPLC purification method gave good resolution and a 
product of high purity (APPENDICES 6,7 and 8) it can also lead to product 
loss (see SECTION 2.29). The method therefore requires characterization for 
the Dickerson dodecamer and any recovery problems amended, if possible.
Recently, reversed-phase HPLC has been used for the novel application 
of resolution of identical molecules based on isotopy^z. This phenomenon's 
was employed by Kudelin et al^z to increase the specific radioactivity of 
tritium labelled nucleosides. This may explain the peak shape observed in 
the HPLC chromatogram of [2,8-SH]dA (see APPENDIX 3B).
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4.4 Manual DNA Synthesizer
In the manual apparatus described here, the use of a syringe connected 
via a double-ended female Luer adaptor to the reaction column for the 
restricted coupling is similar to that described by Schotti*s. However, in 
Schott's case, commercial CPG columns were used. The IjjM and lOpM column 
sizes available were inconvenient for the quantity of nucleotide required. 
Also, the large internal volumes of the commercial column cavities would 
have been problematic when dealing with the small volumes of solution 
reagents encountered at the restricted coupling. This necessitated the use 
of the novel apparatus described (FIGURES 1 and 2) in order to keep the 
amount of radioactivity necessary to a minimum.
The only problem with the apparatus was the difficulty in transferring 
the support-bound [)H]oligonucleotide from the column for deprotection. The 
use of an anti-static instrument was only partially successful. However, the 
manual apparatus used was able to produce very high coupling efficiencies on 
a par with automated DNA synthesizers. For example, the hexameric 
nucleotide B had an average stepwise coupling yield of 97% and for the 
dodecameric nucleotides G and H (TABLE 9) the couplings either side of the 
restricted coupling averaged between 97-99%. These are some of the highest 
efficiencies reported for a manual apparatus (see TABLE 6).
4.5 raiTr Visible Spectral Data
The first DMTr absorbance readings for all manually synthesized 12-mers 
were low (FIGURE 5) compared to subsequent readings. The possibility that 
0^-dG phosphitylation was the cause, because of an inappropriate coupling 
procedure was unlikely because a similar sharp increase in DMTr absorbance 
reading was not seen in other regions of the oligonucleotide with an 
identical sequence, even though the same coupling procedure has been used 
(see TABLE 9, FIGURE 5). It is probable that spontaneous detritylation of 
the 5'-DMTr group from the support-bound dG nucleoside has occurred on the 
CPG-support used.
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The reaction progress for the non-tritiated nucleotide G was very 
similar to that of its tritiated analogue, nucleotide H (FIGURE 5). This 
validates the synthesis of the nucleoside phosphoramidite monomer and 
illustrates that no unforeseen problems are associated with the synthesis of 
tritiated oligonucloetides. Although the risk of side-products is higher for 
long coupling reaction times, the 40-45 minute reaction time used for the 
restricted coupling did not present structural abnormalities or detectable 
side-product accumulation (APPENDIX 6). As the restricted couplings had low 
yields this resulted in a larger than normal number of failure sequences 
which had to be efficiently capped. After the restricted coupling it was 
necessary to perform multi-capping to achieve this goal.
The synthesis of nucleotide G was an optimisation test for nucleotide H 
and the restricted dA5 coupling. A similar optimisation was not performed 
for the restricted dA6 coupling in nucleotide I for which a much reduced 
efficiency was observed (TABLE 9, FIGURE 5). It is not prudent to increase 
the duration for the coupling reaction so a greater number of molar 
equivalents of phosphoramidite may be necessary for a more efficient dA6 
coupling in the synthesis of nucleotide I.
A major problem was the quality control of the contents of the 
commercial CPG columns used as a source of the solid-phase support. All 
contained more than the purported 1 ^ ole. Indeed, 4 ^oles of CPG were 
analyzed to be up to nearly 6jumoles! (see TABLE 9). In these circumstances 
a reasonably high yield for the restricted coupling reaction where a limited 
quantity of tritiated material was available was uncertain. As the typical 
loading is 27-30 jimoles/g for the type of CPG column used a pre-synthesis 
"DMTr analysis" of a test sample would be necessary to calibrate the 
reaction scale used for the oligonulceotide.
The highly inefficient restricted coupling in the synthesis of 
nucleotide J (FIGURE 5, TABLE 9) may have been due to the (im)purity of the 
phosphoramidite as it was not purified by flash chromatography as had the 
phosphoramidite used for the syntheses of oligonucleotides H and I.
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APPENDICES
APPENDIX 1
(A) NHR of 2'-deoxyadenosine 
in d4-nethanol.Ir-^H NOE 
difference spectrum shown 
immediately below indicates 
H8 assignment. Arrow denotes 
irradiation of HI' ribose 
resonance.
3 0 t.O
(B) Ig NMR of
N^-benzoyl-2'-deoxyadenosine 
in d4-methanoI.As (A) above.
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(C) %  NMR of
N^-benzoyl-2-chloro-2'-deoxy­
adenosine in d7-DMF.^H-^H NOE 
difference spectrum shows NOE 
of H8, suggesting solely 
2-position halogénation. DMF 
was used as the solvent in 
the reductive dechlorination 
reaction.
1 0  R 0 7 0 6 0 S O 4.0 S O  . g o
(D) iR NMR of
N^-benzoyl-2-bromo-2'-deoxy­
adenosine in da-methanol. As 
(C> above. Extraneous 
signals appear for the 
solvents CH2CI2 and BtOH.
g o  l.O
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APPENDIX 2
f '-VA4\^ ^^ rvA^ rVY^ /^ vV^ 4^Wy/MV>^ M0'l
(A) %  NMR of N^-benzoyl-2-chloro-2'- 
deoxyadenosine in d4-methanol. 
Shown as a two-part expanded plot
K
(B) iR NMR of 8-bro»o-2'-deoxyadenosine 
in d4-methanol.
(C) NMR N^-benzoyl-8-bro«o-2'- 
deoxyadenosine in d4-methanol.
Un J I
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APPENDIX 3
A2 .icdGQ 4SBcj g eûQ-l s 400'j
2 E B -|
LC  R 2 E B . 4 3 3  0 .  : 0 0
T t diii { A ; rt .
00"00
EPS X10ÛQQ
B2
B.eo|-00"BO
r
(Cl) UV spectrum of 5*-trityl-N^-benzoyl 
-2'-deoxyadenosine in HPLC solvent.
(C2) Reference RP-HPLC chromatogram of
5'-trityl-N^-benzoyl-2'-deoxyadenosine. 
Same conditions as (A2). Rt = 8.8 mins,
(Al) UV spectrum of N^-benzoyl-2‘- deoxy 
-adenosine in HPLC solvent.
(A2) Reference RP-HPLC chromatogram of 
N^-benzoyl-2'-deoxyadenosine on a 
Nicrosorb CIS 250x10 mm column 
eluted with 85:15:1 HeOH:H20:TEA at 
a flow rate of 2 ml/ min. monitored 
by UV detection at 280 nm. Rt = 6.0 
mins.
(Bi) RP-HPLC chromatogram of
[2,8-3r ]N^-benzoy1-2'-deoxyadenosine 
on an Altex 5 ^ m 250x10 mm column, 
eluted with 6:4, Ne0H:H20 at a flow 
rate of 2 ml/ min. monitored by UV 
detection at 280 nm. Rt = 8.3, 9.0 
mins.
(B2> Corresponding radioactivity 
chromatogram.
r *  U V  Ê . Ê Î i  >rij cr ÛM".- . ûAatQBQ - 3 0 0 -
0-'
2 3  0  3 0 0  2 3 0  4 0 0
Ha v^Blen t! t h Cnml
C2 LC R 230,4 330, : 03UÜ-JEQej4BDi
2BB-j
3-=
• I iiiB £ Ji I n . 5
(Dl) RP-HPLC chromatogram of [2,8-^H]5'-trityl- 
N^-benzoy1-2'-deoxyadenosine. Same 
conditions as (A2). Rt = 9.0 mins.
nv XIQQ
Dl (9
A _o.aot'^ — r'
0O"00 0 2 '00  0 4 '00  BS'00 0 8 '00  i 0 ' GO , ig'OO ' i4 '0 a  16'
(D2) Corresponding radioactivity chromatogram.
CPS X1000
D2e.
B.
2,
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APPENDIX 4
(A) NMR of [8-^H]N^“benzoyl--2'-deoxy 
-adenosine in dA-nethanol. Product 
of exchange reaction. Peak at 4.8 
ppm is HTO.
(B) NMR of [2,8-%] N^-benzoy 1-2 ' -deoxy 
-adenosine in d4-nethanol. Product 
from the reductive debromination of 
8-bromo-N^-benzoyl-2'-deoxyadenosine.
(C) NMR of [2,8-^H]N^-benzoy1-2'-dexoy 
-adenosine in d4-methanol. Product 
from the reductive dechlorination of 
2-chloro-N^-benzoy1-2'-deoxyadenosine
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APPENDIX 5
Variation of W«A synthesis reagent quantities over a reaction 
scale range of 0.2 to lO^noles. shown in graphical form.
Consumption ol Tricliloroacatic add roagent at diflerenl raaction scaios. (DEBLOCK)
Volume of reagent/ ml Réaction Scale/mIcromoies 2.00.2 3.21.0 4.24.0 5.710.0
Consumption of phosphoramidite and tetrazole reagents at dilferent reaction scales (COUPUNG)
Volume of reagent/mi Reaction Scale/ micromoles 0.150.2 0.201.0 0.404.0 1.2010.0
1 0
a
6
4
2
0 0 0.2 0.4 0.6 0.8 1 1.2
Consumption ol acetylating reagents at different reaction scaios 
(CAPPING)
Volume ol reagents/ ml Reaction Scale/ micromoles 0.150.2
0.20
1.0
0.40
4.0
0.70
10.0
Consumplton of Iodine reagent at different reaction scales (OXIDATION)
Volume of reagenis/ ml Reaeüon Scale/ micromoles 0.380.2 0.651.0 1.54.0 4.810.0
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APPENDIX 6
i
3.0 2.5 2.0 1.5
!
p p m
(A) NHR of machine synthesized (10 
^noles) DNA oligomer, CGCGAATTCISCG 
recorded as a duplex in D20 at 600 
MHz.
(B) NMR of manually synthesized (4 
^moles) DNA oligomer, CGCGkKTSCfXG 
recorded as a duplex in DzO at 600 
MHz. Synthetic protocol was 
identical to the radiochemical 
syntheses.
(C) Expanded plot of (A) and (B) above 
showing the aromatic base proton 
and HI' ribose proton chemical 
shift domains.
HQIE;. NMR spectra were not 
plotted on an identical 
chemical shift scale.
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APPENDIX 7
0.00
nv XI eeA1
00-00
XI553 
4.00 A2
h j
8 e _ & ;
(Al) RP-HPLC chromatogram of
[2,8(A^) CGCGA+ATTCGCG obtained on a 250x10 
mm 60 A pore size CIS column, eluted with a 
G.IM TEAAc, pH 6.8 , 6;A(v/v) O.IM TEAAc, pH 
6,8; CH3CN binary solvent system on a linear 
gradient at a flow rate of 5 ml/min. ÜV 
detection at 260 nm. Chemical yield was 64% as 
determined by DMTr* ÜV assay.
^  (A2) Corresponding radioactivity chromatogram.
rtV XI00
eo"00
CPS XI000
(Bl) RP-HPLC chromatogram of
12,8 (A^)CGCGAA+TTCGCG obtained as 
described in (Ai) above. Chemical yield was 
28% as determined by DNTr* UV assay.
(B2) Corresponding radioactivity chromatogram.
Cl
pps X1C0
C2
I
^ (Cl) RP-HPLC chromatogram of
[8(A^) CGCGA*ATTWCG obtained as described 
in (Al) above. Chemical yield was 20% as 
determined by WITr* UV assay.
(C2) Corresponding radioactivity chromatogram.
Peak 1 = 7-mer ATTCGCG in (Al) and (Cl) 
a 6-mer TTCGCG in (Bl)
Peak 2 a Benzamide from amine protecting group
ammonolysis.
Peak 3 = (^H]12-mer
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APPENDIX 8
(A) NMR of [8(A5)-3H]CGCGA+ATTCGCG in D20 at 297K. 
2'-deoxyadenoslne residue was labelled by exchange.
(B) 3h NMR of [2,8(a5)-3h ]CGCGA+ATTCGCG in 2:8, D20:B20 
at 297K. 2'-deoxyadenosine residue was labelled by 
reductive dechlorination of 2-chloro-N^-benzoyl-2'- 
deoxyadenos ine.
(C) 3r NMR of [2,8{A&>-3h ]CGCGAA+TTCGCG in 2:8, D20:H20
at 297K. 2 '-deoxyadenosine residue was prepared as 
in (B). Insert shows expansion of the 3fl signals. 
Both duplex and hairpin loop (+) structures were 
present in solution.
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APPENDIX 9
\J
p(* (A) 1h NIffi of [2,8(A5)-3h ]CGCGA+ATTCGCG in D20 at 297K, recorded at 300 NBz 
Compare with APPHE)I% 6.
(B) Aromatic region of (A) above.
<C) Aromatic region of [2,8(A6)-3h JGGCGAA+TC60G in 
D20 at 297K. recorded at 300 MHz. Comparison 
of (B).(C) of APPENDIX 9 with (B).(C) of 
APPENDIX 8 bigblights tbe difficulty in 
assigning tbe hairpin loop structure resonaces 
by NMR.
-i-- 1-- 1-- 1-- 1-- 1-- 1-- 1-- 1 I ~B b  B 4  8 a 8 P ; «  7.Î 7 C B B B h
93
5. REFERENCES
5. References
1. R.E. Dickerson, H.R. Drew. J. Mol. Biol. 149. 761-786 (1981); H.R. 
Drew, R.M. Wing, T. Tanako, C. Broka, S. Tanako, K. Itakura, R.E. 
Dickerson. Proc. Natl. Acad. Sci. (USA) 78, 2179-2183 (1981)
2. K. Miaskiewicz, R. Osman, H. Weinstein. J. Am. Chem. Soc. 115. 
1526- 1537 (1993)
3. W.-C. Huang, J.Orban, A. Kintanar, B.R. Reid, G.P. Drobny. J. Am. 
Chem. Soc. 112, 9059-9068 (1990)
4. J.G. Pelton, D.E. Weramer Biochem. 2Z, 8088-8096 (1988)
5. R.E. Klevit, D.E. Wemmer, B.R. Reid Biochem. 25, 3296-3303 (1986)
6. M.T. Tomic, D.E. Wemmer, S.-H. Kim Science 238. 1722-1725 (1987)
7. D.R. Hare, D.E. Wemmer, S.-H. Chou, G. Drobny J. Mol. Biol. 171. 
319-336 (1983); M.S. Broido, G. Zon, T.L. James Biochem. Biophys.
Res. Commun. 119. 663-670 (1984); N. Jamin, T.L. James, G. Zon Eur.
J. Biochem. 152. 157-166 (1985)
8. A. Kintanar, W.-C. Huang, D.C. Schindele, D.E. Wemmer, G. Drobny 
Biochem. 28, 282-293 (1989)
9. H.M. Berman Curr. Opin. Struct. Biol. 1, 423-427 (1991)
10. G. Otting, K. Wuthrich J. Am. Chem. Soc. HI, 1871-1875 (1989)
11. R.V. Hosur, G. Govil, H.T. Miles Magn. Reson. Chem. 26, 927-944
(1988)
12. M.G. Kubinec, D.E. Wemmer J. Am. Chem. Soc. 114. 8739-8740 (1992)
13. M.G. Kubinec, Private communication
14. G. Otting, E. Liepinsh, K. Wuthrich Science 254. 974-980 (1991); J. 
Am. Chem. Soc. 113, 4363-4364 (1991)
15. Y.Q. Qian, G. Otting, K. Wuthrich J. Am. Chem. Soc. 115. 1189-1190 
(1993)
16. R. Mathur-de Vre, R. Grimee-Declerck, P. Lejeune, A.J. Bertinchamps 
Radiation Res. 90, 441-454 (1982)
17. M.G. Kubinec, D.E. Wemmer Curr. Opin. Struct. Biol, in the press
18. X. Gao, R.A. Jones J. Am. Chem. Soc. 109. 3169-3171 (1987)
19. B. Goswami, B.L. Gaffney, R.A. Jones J. Am. Chem. Soc. 115. 3832-
3833 (1993)
20. E.A. Evans, D.C. Warrell, J.A. Elvidge, J.R. Jones "Handbook of 
Tritium NMR Spectroscopy and Applications", J. Wiley (1985)
21. S. Libor, J.P. Bloxsidge, J.A. Elvidge, J.R. Jones, L.F.J. Woods,
A. Wiseman Biochem. Soc. Trans. 8, 99-100 (1980)
22. J.P. Bloxsidge, J.A. Elvidge Prog. NMR Spectros. 16, 99-114 (1983)
23. J.N.S. Evans, P.E. Eagerness, N.E. Mackenzie, A.I. Scott J. Am. 
Chem. Soc. 106, 5738-5740 (1984)
24. K. Gehring, P.G. Williams, J.G. Pelton, H. Morimoto, D.E. Wemmer 
Biochem. 30, 5524-5531 (1991); K. Gehring, K. Bao, H. Nikaido FEBS 
Letts. 300, 33-38 (1992)
25. T.M. O'Connell, J.T. Gerig, P.G. Williams J. Am. Chem. Soc. 115. 
3048-3055 (1993)
26. T.M. O'Connell, P.G. Williams, J.T. Gerig J. Label. Compd. 
Radiopharm. 33, 371-380 (1993)
27. T.M. O'Connell, J.T. Gerig, P.G. Williams J. Chem. Soc., Chem. 
Commun. 1502-1503 (1990)
28. Aldrichimica Acta 2Q, 52 (1987)
29. J.A. Montgomery, K. Hewson J. Heterocyclic Chem. 1, 213-214 (1964)
30. W.-C. Huang, K. Hatfield, A.W. Roetker, J.A. Montgomery, R.L.
Blakley Biochem. Pharmaco. 30, 2663-2671 (1981)
31. L.F. Christensen, A.D. Broom, M.J. Robins, A. Bloch J. Med. Chem.
15, 735-739 (1972)
32. M.J. Robins, B. Uznanski Can. J. Chem. M, 2601-2607 (1981)
33. L.L. Bennett, Jr., C.-H. Chang, P.W. Allan, D.J. Adamson, L.M. 
Rose, R.W. Brockman, J.A. Seer1st III, A. Shortnacy, J.A. 
Montgomery Nucleosides and Nucleotides 4, 107-116 (1985)
34. Z. Kazimierczuk, H.B. Cottam, G.R. Revenkar, R.K. Robins J. Am. 
Chem. Soc. 106, 6379-6382 (1984)
94
35. G.E. Wright, C. Hildebrand, S. Freese, L.W. Dudycz, Z. Kazimierczuk 
J. Org. Chem. 4617-4618 (1987)
36. A.G. Beaman, J.F. Gester, R.K. Robins J. Org. Chem. 27, 986-990
(1962)
37. V. Nair, D.A. Young J. Org. Chem. 50, 406-408 (1985)
38. M. Ikehara, H. Tada J. Am. Chem. Soc. 85, 2344-2345 (1963)
39. M. Ikehara, H. Tada J. Am. Chem. Soc. 87, 606-610 (1965)
40. R.A. Jones in "Oligonucletide Synthesis: A Practical Approach" Ed. 
M.J. Gait pg.22-34 (1984) IRL Press, Oxford
41. M.J. Robins, B. Uznanski in "Nucleic Acid Chemistry" Vol.3 Eds. 
L.B. Townsend, R.S. Tipson 3, 144-148 (1986)
42. Y. Hirota, A. Yoshioka, S. Tanaka, K. Watanabe, T. Otani, J. 
Minowada, A. Matsuda, T. Ueda, Y. Wataya Cancer Res. 915-919
(1989)
43. S. Highsmith, M. Kubinec, D.K. Jaiswal, H. Morimoto, P.G. Williams, 
D.E. Wemmer J. Biomolecular NMR 3, 325-334 (1993)
44. G.B. Brown, V.S. Weiiky J. Org. Chem. 23, 125-126 (1958)
45. T. Sato in "Synthetic Procedures in Nucleic Acid Chemistry" Vol.1
Eds. W.W. Zorbach, R.S. Tipson i, 264-268 (1968)
46. Work reported here.
47. T. Brown, D.J.S Brown in "Oligonucleotides and Analogues: A
Practical Approach" Ed. F. Eckstein pg.1-24 (1991) IRL Press,
Oxford
48. H. Shaller, G. Weimann, B. Lerck, H.G. Khorana J. Am. Chem. Soc. 
85, 3821-3827 (1963)
49. E.L. Brown, R. Belagaje, M.J. Ryan, H.G. Khorana Methods Enz. 
109-151 (1979)
50. S.A. Narang, R. Brousseau, H.M. Hsiung, J.J. Michniewicz Methods 
Enz. 610-620 (1980)
51. D.Y. Chi NTLF Quarternary Report, Aug. 1987
52. D.K. Jaiswal NTLF Report, 1991
53. K. Anzai, M. Matsui Bull. Chem. Soc. Jpn. 46, 3228-3232 (1973)
54. P.A. Lyon, C.B. Reese J. Chem. Soc., Perkin Trans. I 2645-2649 
(1974)
55. G.S. Ti, B.L. Gaffney, R.A. Jones J. Am. Chem. Soc. 104. 1316-1319
(1982)
56. E.E. Leutzinger, W.A. Bowles, R.K. Robins, L.B. Townsend J. Am. 
Chem. Soc. 90, 127-136 (1968)
57. E.A. Evans, H.C. Sheppard, J.C. Turner, D.C. Warrell J. Label.
Compd. 10, 569-587 (1974)
58. J.A. Elvidge, J.R. Jones, C. O'Brien J. Chem. Soc., Chem. Commun. 
394-395 (1971)
59. M. Moss, P.A. Frey J. Biol. Chem. 262, 14859-14862 (1982)
60. C.-M. Chen, D.K. Melitz, B. Petschow, R.L. Eckert Eur. J. Biochem.
108. 379-387 (1980)
61. M. Laloue, J.E. Fox Phytochemistry 26, 987-989 (1987)
62. B.K. Kudelin, L.V. Gavrilina, Yu. L. Kaminski J. Label. Compd.
Radiopharm. 31, 723-728 (1992)
63. W.J.S. Lockley in "Isotopes: Essential Chemistry and Applications
II" Ed. J.R. Jones RSC, London pg.56-87 (1988)
64. M. Smith, D.H. Rammler, I.H. Goldberg, H.G. Khorana J. Am. Chem. 
Soc. 84, 430-440 (1962)
65. S.K. Chaudary, 0. Hernandez Tet. Lett. 20, 95-98 (1979)
66. H. Lund J. Am. Chem. Soc. 42, 1346-1360 (1927)
67. A.D. Borane, J.-Y. Tang, M.H. Caruthers Nucleic Acids Res. 12.
4051-4061 (1984)
68. S.L. Beaucage, M.H. Caruthers Tet. Lett. 22, 1859-1862 (1981)
69. M.H. Caruthers, S.L. Beaucage, J.W. Efcavitch, E.F. Fisher, M.D.
Matteucci Nucleic Acids Research Symposium Series No.7, 215-223
(1980)
70. L.J. McBride, M.H. Caruthers Tet. Lett. 24, 245-248 (1983)
95
71. S.P. Adams, K.S. Kavka, E.J. Wykes, S.B. Holder, G.R. Galluppi J. 
Am. Chem. Soc. 105. 661-663 (1983)
72. M.W. Shwarz, W. Pfleiderer Tet. Lett. 25* 5513-5516 (1984)
73. S.L. Beaucage Tet. Lett. 25 375-378 (1984)
74. F. Seela, H. Driller Nucleic Acids Res. 13, 911-926 (1985)
75. N.D. Sinha, J. Biernat, J. McManus, H. Koster Nucleic Acids Res.
12, 4539-4557 (1984)
76. G. Zon, K.A. Gallo, C.J. Samson, K.-L. Shao, M.F. Summers, R.D. 
Byrd Nucleic Acids Res. 13, 8181-8196 (1985)
77. T. Atkinson, M. Smith in "Oligonucleotide Synthesis: A Practical 
Approach." Ed. M.J. Gait pg.35-81 (1984) IRL I^ess, Oxford
78. T. Dorper, E.-L. Winnacker Nucleic Acids Res. 11, 2575-2584 (1983) .
79. R.E. Holmes, R.K. Robins J. Am. Chem. Soc. 86, 1242-1245 (1964)
80. M. Ikehara, M. Kaneko Chem. Pharm. Bull. 18, 2441-2446 (1970)
81. M. Ikehara, S. Uesugi, M. Kaneko J. Chem. Soc., Chem. Commun. 17-18
(1967)
82. M. Ikehara, M. Kaneko Tetrahedron 26, 4251-4259 (1970)
83. S.R. Sarfati, S. Pochet, C. Guerreiro, A. Namane, T. Huynh-Dinh, J. 
Igolen Tetrahedron 42, 3491-3497 (1987)
84. D. Singh, V. Kumar, K.N. Ganesh Nucleic Acids Res. 18, 3339-3345
(1990)
85. P. Mamos, A.A. van Aerschot, N.J. Weyns, P.A. Herdewijn Tet. Lett. 
33, 2413-2416 (1992)
86. A. Guy, A.-M. Duplaa, P. Harel, R. Teoule Helv. Chira. Acta 71.
1566-1572 (1988)
87. K.K. Ogilvie, A.L. Scifman, C.L. Penny Can. J. Chem. 57 2230-2238 
(1979)
88. M. Maeda, M. Saneyoshi, Y. Kawazoe Chem. Pharm. Bull. 19, 1641-1649 
(1971)
89. G.E. Calf, J.L. Garnett J. Phys. Chem. 3887-3889 (1964)
90. D.S. Letham, H. Young Phytochemistry 10, 2077-2081 (1971)
91. R.E. Summons, B. Entsch, D.S. Letham, B.I. Gollnow, J.K. Macleod
Planata 147, 422-434 (1980)
92. M. Maeda, Y. Kawazoe Tet. Lett. 1643-1646 (1975)
93. T. Kinoshita, K.H. Schram, J.A. McCloskey J. Label Compd. 
Radiopharm. 12, 525-534 (1982)
94. K.R. Shelton, J.M. Clark,Jr. Biochem. 6, 2735-2739 (1967)
95. J.A. Elvidge, J.R. Jones, C. O’Brien, E.A. Evans, H.C. Sheppard J.
Chem. Soc., Perkin Trans. 2, 2138-2141 (1973)
96. R.W. Adamiak, M.Z. Barciszewska, E. Biala, K. Grzeskowiak, R. 
Kierzek, A. Kraszewski, W.T. Markiewicz, M. Wiewiorowski Nucleic 
Acids Res. 3, 3397-3408 (1976)
97. H. Takaku, K. Morita, T. Sumiuchi Chem. Lett. 1661-1664 (1983)
98. M.-C. Huang, J.A. Montgomery, M.C. Thorpe, E.L. Stewart, J.A. 
Secrist III, R.L. Blackley Arch. Biochem. Biophys. 222. 133-144
(1983)
99. D.A. Barawkar, R.K. Kumar, K.N. Ganesh Tetrahedron 48, 8505-8514 
(1992)
100. S.A. Narang Tetrahedron 39, 3-22 (1983) and references therein.
101. G. Alvarado-Urbina, G.N. Sathe, W.-C. Liu, M.F. Gillen, P.D. Duck, 
R. Bender, K.K. Ogilvie Science 214. 270-274 (1981)
102. W. Bannwarth Chimia 41, 302-317 (1987)
103. R.B. Merrifield J. Am. Chem. Soc. 85, 2149-2154 (1963)
104. "Solid Phase Biochemistry: Analytical Synthetic Aspects" Ed. W.H. 
Scouten Wiley-Interscience, New York (1983)
105. "Po1ymer-Supported Reactions in Organic Synthesis" Eds. P. Hodge, 
D.C. Sherrington Wiley-Interscience, New York (1980)
106. K. Itakura, J.J. Rossi, R.B. Wallace Ann. Rev. Biochem. 53. 
323-356 (1984)
107. A.M. Michelson, A.R. Todd J. Chem. Soc. 2632-2638 (1955)
108. E. Sonveaux Bioorganic Chem. 14, 274-325 (1986)
96
109. H. Ito, Y. Ike, S. Ikuta, K. Itakura Nucleic Acids Res. 10,
1755-1769 (1982)
110. A.F. Markham, M.D. Edge, T.C. Atkinson, A.R. Greene, G.R. 
Heathcliffe, G.R. Newton, D. Scanlon Nucleic Acids Res. 8, 
5193-5205 (1980)
111. M.H. Caruthers Science 230. 281-285 (1985)
112. W. Parr, K. Grohmann Tet. Lett. 2633-2636 (1971)
113. H. Koster Tet. Lett. 1527-1530 (1972)
114. J.W. Efcavitch, C. Heiner Nucleosides and Nucleotides 4, 267
(1985)
115. J.W. Engels, E. Uhlmann Angew. Chem. Int. Ed. Engl. 28, 716-734
(1989)
116. M.D. Matteucci, M.H. Caruthers Tet. Lett. 21, 719-722 (1980)
117. Millipore seminar, Emeryville,California. Oct., 1992
118. Applied Biosystems 381A DNA Synthesizer User Manual (1984)
119. T. Tanaka, R.L. Letsinger Nucleic Acids Res. 10, 3249-3260 (1982)
120. Applied Biosystems DNA Synthesizer User Bulletin No.13, Nov.9,
(1984)
121. M.D. Matteucci, M.D. Caruthers J. Am. Chem. Soc. 103. 3185-3191
(1981)
122. J. Nielsen, M. Taagard, J. Marugg, J.H. van Boom, 0. Dahl Nucleic 
Acids Res. 14, 7391-7403 (1986)
123. E.F. Fisher, M.H. Caruthers Nucleic Acids Res. H , 1589-1599 
(1983)
124. B.C. Froehler, M.D. Matteucci Nucleic Acids Res. H, 8031-8036
(1983)
125. Millipore (1993)
126. R.L. Letsinger, J.L. Finnan, G.A. Heavner, W.B. Lunsford J. Am.
Chem. Soc. 97, 3278-3279 (1975)
127. R.L. Letsinger, W.B. Lunsford J. Am. Chem. Soc. %, 3655-3661
(1976)
128. N.D. Sinha, J. Biernat, H. Koster Tet. Lett. 24, 5843-5846 (1983)
129. X. Gao, B.L. Gaffney, M. Senior, R.R. Riddle, R.A. Jones Nucleic 
Acids Res. 13, 573-584 (1985)
130. G.M. Tener J. Am. Chem. Soc. 83, 159-168 (1961)
131. A.K. Sood, S.A. Narang Nucleic Acids Res. 4, 2757-2765 (1977)
132. W.J. Stec, G. Zon Tet. Lett. 25, 5279-5282 (1984)
133. S.L. Beaucage, M.H. Caruthers Tet. Lett. 22, 1859-1862 (1981)
134. R.S. Edmundson Chem. Ind. 1828-1829 (1962)
135. H.P. Daskalov, M. Sekine, T. Hata Tet. Lett. 21, 3899-3902 (1980)
136. S.E. Jones, C.B. Reese, S. Sibanda, A. Ubasawa Tet. Lett. 22. 
4755-4758 (1981)
137. H.P. Daskalov, M. Sekine, T. Hata Bull. Chem. Soc. Jpn. 54. 
3076-3083 (1981)
138. B.L. Gaffney, R.A. Jones Tet. Lett. 23, 2257-2260 (1982)
139. T. Trichtinger, R. Charubala, W. Pfleiderer Tet. Lett. 24, 711-714 
(1983)
140. R.T. Pon, M.J. Danha, K.K. Ogilvie Nucleic Acids Res. 13, 
6447-6465 (1985)
141. M.J. Nemer, K.K. Ogilvie Tet. Lett. 21, 4149-4152 (1980)
142. C.B. Reese, A. Ubasawa Tet. Lett. 21, 2265-2268 (1980)
143. M.E. Schott Am. Biotech. Lab. 2, 20-23 (1985)
144. R. Belagaje, K. Brush Nucleic Acids Res. 10, 6295-6303 (1982)
145. P.L. deHaseth, R.A. Goldman, C.L. Cech, M.H. Caruthers Nucleic 
Acids Res. H, 773-787 (1983)
146. N.D. Sinha, V. Grossbruchhaus, H. Koster Tet. Lett. 24, 877-880 
(1983)
147. R.C. Pless, R.L. Letsinger Nucleic Acids Res. 2, 773-786 (1975)
148. H. Seliger, C. Scalfi, F. Eisenbeiss Tet. Lett. 24, 4963-4966
(1983)
149. H.M. Hsiung, W.L. Sung, R. Brousseau, R. Wu, S.A. Narang Nucleic 
Acids Res. 8, 5753-5765 (1980)
97
150. F.H. Westheimer Acc. Chem. Res. 1, 70-78 (1968)
151. A.M. Maxim, W. Gilbert Proc. Natl. Acad. Sci (USA) 74, 560-564
(1977); Methods Enz. 65, 499-560 (1980)
152. G.Zon, J.A. Thompson Biochromatography i, 22-32 (1986)
153. G.D. McFarland, P.N. Borer Nucleic Acids Res. 7, 1067-1080 (1979)
154. C.R. Becker, J.W. Efcavitch, C.R. Heiner, N.F. Kaiser J.
Chromatography 326. 293-299 (1985)
155. H.-J. Fritz, R. Belagaje, E.L. Brown, R.H. Fritz, R.A. Jones, R.G. 
Lee, H.G. Khorana Biochem. 17, 1257-1267 (1978)
156. C.S. Craik Biotechniques 3, 12-19 (1985)
157. R.J. Abraham, J. Fisher, P. Loftus "Introduction to NMR 
Spectroscopy" Wiley (1990) Chapter 6 pg.108-113
158. A.E. Derome "Modern NMR Techniques for Chemistry Research" 
Pergamon Press (1988) Chapter 5, pg.113-121
159. D.H. Williams, I. Fleming "Spectroscopic Methods in Organic
Chemistry" McGraw-Hill (1987) Chapter 3.15 pg.116-118
160. W. Holzer Tetrahedron 5471-5480 (1991)
161. B. Giraud, R. Nouguier, C. Jaime, A. Virgili Magn. Reson. Chem. 
30, 133-136 (1992)
162. D. Neuhaus J. Magn. Reson. 53, 109-114 (1983)
163. M. Kinns, J.K.M. Sanders J. Magn. Reson. 54, 518-520 (1984)
164. G.B. Gill, D.A. Whiting Aldrichimica Acta L9, 31-41 (1986)
165. Aldrich Technical Information Bulletin No. AL-134
166. R.N. Maslova, E.A. Lesnik, Ya.M. Varshavsky Biochem. Biophys. Res. 
Commun. 34, 260-265 (1969)
167. D. Voet, W.B. Gratzer, R.A. Cox, P. Doty Biopolymers 1, 193-208
(1963)
98
CHAPTER 2: A Study of Phospholipase Az Inhibition by
3R NMR Spectroscopy
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1. General Introduction
Phospholipase Az (PLAz) inhibition represents a fortuitous combination 
of circumstances that allow the detailed study of enzyme action by NMR 
spectroscopy. The protein is quite small allowing its ready analysis and 
assignment by present NMR techniques enabling the observation of inhibitor 
complexation. PLAz inhibition is presently of great interest in the 
pharmaceutical sciences. The purpose of this work was to synthesise and 
tritium-label an amide substrate-ana1ogue extracellular PLAz inhibitor in 
order to study complexation using NMR spectroscopy.
The chapter begins with literature reviews of all relevant topics: The 
structure and function of PLAz; the molecules known to inhibit PLAz and 
their modes of action; the synthetic routes to amide phosphocholines and the 
various hydrogen isotope labelling procedures available for alkene 
saturation.
The experimental section describes the deuteriation of a model compound 
by various methods in order to identify the most appropriate procedure; the 
synthesis of the amide inhibitor; its tritium-labelling and analysis and the 
complexation studies by NMR spectroscopy.
The discussion section appraises the results and suggests a likely 
strategy in order to obtain further results using the techniques detailed 
here.
1.1 Abbreviations
The following abbreviations have been used in this chapter. They are 
listed approximately alphabetically;
Ala Alanine
AMP Adenosine 3',5'-monophosphate
Arg Arginine
Asn Asparagine
Asp Aspartate
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Ci Curie
COSY Correlated spectroscopy (MR)
cpm Counts per minute
ID One dimensional
2D Two dimensional
Da Dalton
DCC N,N'-Dicyclohexylcarbodiimide
DMF Dimethylformamide
DMAP 4-(N,N-Dimethyl)aminopyridine
DMSO Dimethylsulphoxide
DQF Double quantum filter
E Entgegen (Trans) - Geometric isomeric description
EDTA Ethylenediaminetetra-acetic acid
Glu Glutamate
Gly Glycine
HBT N-Hydroxybenzotriazole
His Histidine
Hm meta hydrogen (on benzene ring)
HPLC High pressure liquid chromatography
lie Isoleucine
1RS Interfacial recognition site
Leu Leucine
Lys Lysine
Net Methionine
MS Mass spectrometric
NMR Nuclear magnetic resonance
NOE Nuclear Overhauser enhancement
PADA Potassium azodicarboxylate
PAF Platelet activating factor
Phe Phenylalanine
PLAz Phospholipase Az
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TT pi
ppm Parts per million
PTFE Polytetrafluoroethene
QCM Quartz crystal microbalance
R Rectus, right-handed according to
Cahn-Ingold-Prelog sequence rules, 
rds Rate determining step
Rf Relative front
RP Reverse phase
Ser Serine
TEA Triethylamine
THF Tetrahydrofuran
TLC Thin layer chromatography
TMS Trimethylsilyl
TRIS Tris(hydroxymethy1)aminomethane
Tyr Tyrosine
UV Ultraviolet
Val Valine
Z Zusammen (cis) - geometric isomerism description
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2. LITERATURE REVIEWS
2. LITERATURE REVIEWS
2.1 The Enzyme. PLAz
The following sections review the evidence for the architecture and 
function of phospholipase Az (PLAz), with especial emphasis on bovine
pancreatic PLAz as this enzyme was used for the NMR spectra reported in the 
experimental section.
2.2 Introduction
Listed here are the lUPAC recommended definitions of terras which will 
feature prominently throughout the following sections1:
ENZYME - Macromolecules, mostly of protein nature, that function as 
(bio)catalysts by increasing reaction rates. An enzyme 
catalyzes only one reaction type (reaction specificity) and 
operates on only one type of substrate (substrate 
specificity). Substrate molecules are attacked at the same 
site (regiospecificity) and only one or preferentially one of 
the enantiomers of chiral substrates or of racemic mixtures is 
attacked (stereospecificity).
SUBSTRATE - The chemical entity whose conversion to a product or products 
is catalyzed by one or several enzymes.
ACTIVE SITE “ The region of a functional protein where a substrate is
specifically bound and undergoes a reaction.
2.3 Description of PLAz
The phospholipase family of enzymes act upon 3-sn-phosphoglycerides. 
FIGURE 1 shows the regiospecificity of these enzymes2,3 ;
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FIGURE 1: Regiospecificit-V of Phospholipases
phospholipase A-,/phospholipase Ag CH9OOCR,
\  IR 2 C 0 0 " ^ C “^ H  phospholipase d
I î /
CH9O'—P—OR3 y  I ^
/  O"
phospholipase C
Of interest here is the PLAz enzyme. PLAz stereospecifically'^ •5 attacks 
the R-isomers of 3- s n - p h o s p h o g l y c e r i d e s 2-5 with the Az type hydrolyzing the 
acylester bond of the C2 fatty acid^.3.6.
There are basically three types of PLAz^, being divided by molecular 
mass. The secretory, extracellular PLAz's have the lowest molecular mass at 
14kDa. Most information has been collected for these enzymes as they are 
available in large quantities from snake and bee venoms8-1 1, mammalian 
pancreases and synovial fliud^.12-1 6, These have been used for the majority 
of physical and structural studies reported. Much less is known about the 
other two types; Myocardial PLAz (45kUa) and cytosolic, intracellular PLAz 
(85kDa)2. The literature review which follows will concentrate on secretory,
extracellular PLAz's with emphasis on bovine pancreatic PLAz.
PLAz is a single peptide chain^ of 123 r e s i d u e s  ^3,14 of 14kDa molecular 
mass4,6,13.17,18, The structural content is approximately 54% c<-helix 
(three helices), 15% -sheet and 23% ^-turns for pancreatic enzymes 19, The 
N-terminal amino acid residue is alanine while that at the C-terminus is 
c y s t e i n e ^'13, The enzyme’s structure is rigid as it contains seven 
disulphide bridges^.6.13,17-19, This structural feature lends great 
stability to the protein6,17,20 ^ It is difficult to denature, being stable
to heat, acid and detergents.
Forty PLAz enzymes have been sequenced^ and it is observed that, 
irrespective of source, all the secretory, extracellular PLAz enzymes show a 
high degree of sequence homology and three-dimensional structural 
similarity^,1 4.1 7,2 1,zz, Some 32-36 amino acid residues are absolutely
106
conserved!9 .2 1, These include His48 and Asp99 of the active site; the GlySO. 
Gly32, Tyr28 and Asp49 ligands of the calcium ion co-factor and the 
structurally essential c y s t e i n e s 2 1 . Those residues that are changed are very 
similar with respect to size, charge and hydrophobicity!9.
A schematic of the components of PLAz are illustrated by FIGURE 2^ 3; 
FIGURE 2: Schematic of PLAz Structure
Micellar structure
Substrate and Ca2+ bound
u  ■
-y- =
= Monomer binding site.
Ca^* binding site. 
Catalytic region
= Interfacial recognition site.
2.4 ProPLAz
The PLAz enzyme is activated and secreted as needed. It exists as its 
enzymatically inactive zymogen or proPLAz. ProPLAz consists of a single 
peptide chain with an approximate molecular mass of ISkDa^,6,24-26, its 
structure deviates from that of PLAz by the existence of an extra seven 
amino acid residues at the N-terminus:
^Trypsin
Glu-Gly-Glu-IIe-Ser-Ser-Arg-^Ala-
Active PLAz
Although proPLAz is able to bind and hydrolyse substrate in a monomeric 
state, it is unable to act upon substrate aggregates, such as bilayers and
micelles!3.
The N-terminus heptapeptide is cleaved by the enzyme, trypsin, to 
reveal the fully active PLAz. Trypsin is a 24kDa enzyme specific for peptide 
cleavage adjacent to Arg or Lys residues. It is itself activated by the 
enzymatic cleavage of a hexapeptide^^.
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2.5 Interfacial Recognition Site
The highly flexible^ ^ » ^7 N-terminus ,^ 1 3 . 1 7 , 2 3 , 2 7  of PLAz enables the 
enzyme to readily interact with the aggregated phospholipid/water 
interfacial structures 9 , 1 7 , 2 3 . 2 6 , 2 8 - 3 0  of the substrate, thereby 
dramatically increasing the rate of hydrolytic action by the enzymeio,31,32_ 
Functionally and topologically distinct from the active site, this so-called 
Interfacial Recognition Site (1RS)1 3 , 1 7 , 2 3 , 2 6 , 3 2  is composed of amino acid 
residues of hydrophobic and polar side-chain characteristics^^,26,
The ammonium group of Alai interacts with the carboxyl groups of Asn71, 
Gln4, Pro68 and a fully enclosed water molecule. The hydrogen bonding 
network is further extended to the absolutely conserved His48 and Asp99 of 
the active site. This is illustrated by FIGURE 3 from the X-ray crystal 
structure of bovine pancreatic PLAz ^ ^ :
FIGURE 3: Interaction between the N-terminus and Active Site.
Dekker et al 7^ state that Alai, Trp3, Phe63 and Tyr69 are located in
the 1RS and that Phe22, Tyr75, Phel06 and Tyrlll are involved in binding to
micellar phospholipids. Peters et al^7 determined the conformational changes
as depicted in FIGURE 4 from a and ^^ n NMR study:
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FIGURE 4: Conformational Changes at the 1RS.
Ty/52
HjC-
cB
A: Conformation in solution. The N-terminus is not helical.
B: Conformation in a micelle. There are rearrangements in the 
N-terminus.
C: Conformation in a micelle with inhibitor bound. The N-terminus has a 
helical conformation and the hydrogen-bond network is formed. The 
Tyr-69 hydroxyl group is binding to the phosphate group of the 
inhibitor.
2.6 The Substrate
The phospholipid substrate has long chain fatty acid carboxylate esters 
at the sn-1 and sn-2 positions. They are C16-C20 in length being usually 
saturated at sn-1 and unsaturated at sn-2. The sn-3 position can be a 
variety of phosphate derivatives including choline, ethanolamine, serine, 
inositol and a c i d ^ .
A typical natural substrate would be^^;
O 0
c h,(c h4(c h=c h c h,)/c h ,)^--^q o-^C„H3,
\  9, NR,
The structural and functional well-being of biological membranes 
depends on the composition of the lipid matrix^^.^s. One of PLAz's roles is 
to remove phospholipids that have become auto-oxidised^ .34.35, Very fast 
hydrolytic rates for oxidised phospholipids are observed as they
have a greater surface area and are present at the water/lipid 
interface. The hydroperoxy or hydroxy groups on the sn-2 chain alter the 
molecular conformation which facilitates access to the sn-2 ester by PLAz^s, 
It is the first step in the repair mechanism for oxidative damage to
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membrane phospholipids. It is known that several classes of phospholipids 
are involved in signal transduction. This membrane phospholipid turn-over 
by PLAz has been suggested as a transmembrane signalling mechanism^,34,
The elegant work of Okahata et &136-39 demonstrates the use of a quartz 
crystal microbalance (QCM) to determine the course of catalysis by PLAz. A 
QCM is a very sensitive mass measuring device operating at the nanogram 
level. They observed39 that the catalyst's action was highly dependent upon 
the phase of the substrate, although the mode of binding is identical in all
cases2 2.
2.7 Metabolites
PLAz holds an essential, central position in the mediation of
inflammation^0"^2J
FIGURE 5: Metabolism of Phospholipids 
Phospholipids
PLAz (rds)
Arachidonic acid + Lysophospholipid
Cyclo-oxygenase 5-Lipo-oxygenase Acetyl transferase
Prostaglandins Leukotrienes
Thromboxanes
The products of phospholipid hydrolysis by PLAz are arachidonic acid 
and the lysophospholipid^3 ;
 OR^
HO'
 OR, oAcetyl transferase ji
 OPC
Lysophospholipid
-OPC
PAF
110
This and subsequent enzymatic transformations are collectively referred 
to as the arachidonic cascade^ '' » 45.
The lysophospholipid causes changes in the properties of biological 
membranes6,22,46, The sn-2 alcohol is acetylated to yield platelet 
activating factor (PAF) which is known to be a potent lipid inflammatory 
mediator^.io,4 i,4 6 - 4 8,
Arachidonic acid is not found as a free entity in cells2.&. Thus, its 
generation catalyzed by PLAz must precede the production of the metabolites 
and this step is seen to be the rate determining step (rds) of their 
biosynthesis^,6,4 0 ,49 _ Arachidonic acid is a reactive and versatile 
substrat6^ 2 which is enzymatically oxidised to yield a range of powerful 
inflammatory mediators that cause pain and swelling2,6.21,40,50,51,
Disruption of the action of PLAz is envisaged to be a "one step" route 
to the alleviation of the chronic physiological effects of inflammation^.
2.8 The Calcium Co-Factor
A calcium ion in the active site of PLAz is essential for catalytic 
activity by the e n z y m e ^ s,31, Calcium addition to the protein is independent 
of substrate additional and the cation is present in a 1:1 stoichiometric 
rationsJ although a second, non-functional calcium is observed in the X-ray 
crystal structure of porcine pancreatic PLAz^^.
The cation is coordinated by three backbone carbonyls of the amino acid 
residue 28-32 binding loop^,27 ^ the carboxylate of Asp49 and two waters, 
being seven-coordinate in total 13,2 1, This is illustrated by data from the 
X-ray crystal structure of bovine pancreatic PLAz at 1.7 X resolutioni3, 
FIGURE 6:
in
FIGURE 6 : Schematic of Calcium Coordination in Bovine Pancreatic PLA2
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One of the carboxylate oxygens and a water are 0.35% more distant from 
the calcium than the other ligands.
The cation is thought to anchor the substrate on binding by chelating 
one of the phosphate oxygens of the phospholipid headgroup and also the 
carbonyl oxygen of the scissile sn-2 carboxylate esterai*22, The other 
phosphate oxygen is hydrogen bonded to Tyr69 and the substrate carbonyl is 
hydrogen bonded to the backbone amide of GlySO. The two water ligands are 
displaced upon substrate binding.
Acting as an electron sink, the calcium is believed to stabilise the 
developing negative charge on the carbonyl oxygen during the transition 
state of the enzyme h y d r o l y s i s 2 2 .52.
For the extracellular, low molecular mass PLAz's, substitution of Ca^ + 
by Sr2+ or Ba2+ results in complete loss of enzyme activity. This has been 
rationalised on the basis of size and charge density. The increase in ionic 
size displaces the binding of the substrate resulting in the incorrect 
geometry of the substrate and the inability of the reactive 
Asp99-His48-water couple to effect hydrolysis. Also, the decreased charge 
density would affect the binding characteristics of the substrate and 
probably makes the Lewis acid property, essential for the enzyme's function, 
too weak5 2. Similar replacement experiments for human intracellular, 
cytosolic PLAz result in the retention of full enzyme a c t i v i t y 5 3 .
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2.9 The Asp99-His48 Catalytic Diad
His48 and Asp99 as well as Asp49 are the only amino acid residues in 
the active region of the enzyme possessing polar side chains. The remaining 
residues at this site are h y d r o p h o b i c ^ ® >21,27.
Evidence obtained from pH-activity profilessa, pH-titration NMR
studies^s and X-ray c r y s t a l l o g r a p h y 1  ^ suggest that a Asp99-His48-water 
couplers,52,55 is responsible for the nucleophilic attack of water on the 
scissile ester bond of the enzyme-bound substrate*®. The enzyme shows 
maximum activity at around pH 8 2 .®.5 4, suggesting a group (His48) of pKa 
7-7 .552,54 is catalytically active. The p Ka of this residue is lowered by 
over one pKa unit due to its close proximity to the electropositive calcium 
ion2 5.52. N 3 of His48 is hydrogen bonded to the carboxylate of A s p 9 9 2 5 ,46,55 
whilst its non-protonated N152 in conjunction with an adjacent water 
molecule completes the "machinery" of the catalysts®. This is similar to 
serine proteases®?.
The function of Asp99 has been shown to be structuraland stabilises 
the correct tautomer of the imidazole ring of His48 for catalytic 
a c t i v i t y ® ® .  Very recent work has bolstered the evidence for the N1 of His48 
as the general base essential for catalytic activity whilst N3 is prescribed 
a structural role which compliments the structural role presribed to 
A s p 9 9 5 7 .  These data were obtained by comparing PLAz mutants.
Chemical blocking of the N1 His48 position by active site directed 
irreversible inhibitors completely eliminates catalytic activityS2. The 
action of the Asp99-His48-water couple is summarised in FIGURE 7:
FIGURE 7: Catalytic Proton Transfer Action of the Asn99-His48 Diad
O ^ H i s 4 8  .
ASP99— / = <  \
H /
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2.10 Catalytic Mechanism
The active region of the enzyme exists as a depression in the molecular 
surface of the e n z y m e ® .26 and is represented by invariant amino acid 
residues mostly with hydrophobic side-chains. These are Phe5,22,106, Xle9 
and Alal02,1038.l3,i7,26,58,59, The Phe22 and Phel06 side-chains create an 
aromatic sandwich which accommodates the sn-2 alkenyl chain of the 
substrate®®, as shown in FIGURE 8:
FIGURE 8: Part of the Bovine Pancreatic PLA2 Crystal Structure showing 
the Phe22.106 Aromatic Sandwich
4 -4
A kink in the sn-2 chain at the «x-carbon is an absolute requirement of 
the substrate for interaction with the active site. Leu2 and Tyr69 perform a 
similar- function to Phe22,106 by creating a hydrophobic slot for the sn-1 
alkyl chain of the substrate2i. The active site holds between four and six 
carbons of each alkyl chain2®.
The sn-3 phosphate derivative and substrate sn-2 carbonyl are bound® 1 
as described in SECTION 2.8. In this way, the substrate sn-2 carbonyl is 
brought into line with the Asp99-His48-water couple in preparation for 
hydrolysis. See FIGURE 9.
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FIGURE 9: Computer Model of a Fully Saturated Phosphatidylethanolamine 
Substrate (in black') bound at the active site of Bovine 
Pancreatic PLAz
Ô—4PI:
As shown in FIGURE 7, His48 acts as a proton acceptor and there is 
nucleophilic attack by water to yield an anionic tetrahedral intermediate 
which is stabilized by its interaction with GlySO and Ca2+. Collapse of this 
intermediate gives the fatty acid product and the lysophospholipid anion is 
quenched by His48, this time acting as a proton donor. This regenerates the 
catalytically active imidazole tautomer of His4826. The fatty acid is 
reported to leave the active site before the lysophospholipid^^. Kinetic 
models of PLAz action on monomersand also substrate aggregates^2-66 have 
been developed. The rate determining step of enzymatic turnover is the 
chemical step of hydrolysing substrate to product in the enzyme complex^?.
[18Q]Water labelling studies reveal that the released fatty acid 
contains one oxygen-18 atom, thus supporting this catalytic m e c h a n i s m ^ * ,  a 
computational representation of PLA2 hydrolysis is provided by Waszkowycz et 
al5& who report a combined quantum and molecular mechanical model of the 
potential energy surface of the process. However, even this sophisticated 
computational approach is still largely unable to adequately model the full 
environment of a protein/substrate complex.
The function of various critical amino acid residues has been probed by 
the study of PLA2 mutants. These results are presented as TABLE 1:
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TABLE 1: Function of Residues Probed by PLAz Mutants
Ref. No, Wild Type Mutant Position Comments
55
18
20
20
Tyr52
Tyr73
Tyr73
Tyr52
Tyr73
Phe.Val 
Phe,Ser, 
Ala
Ser
Phe.Lys, 
Ala,Ser, 
Val 
 //— ' '
H-bond network 
between 1RS and 
active site
Asp99 is able to perform its catalytic 
function without H-bond to Tyr-52 and 
Tyr73. Aromaticity of both Tyr’s is 
req'd to stabilise tertiary structure 
of the protein.
Mutant is more conformationally 
flexible. Tyr73 plays a critical 
structural role.
H-bonds between Tyr52,73 and Asp99 are 
non-essential. Aromaticity is 
essential. Tyr52 serves a functional 
role. Tyr73 serves a structural role.
15
58
58
61
Lys56 Met
Phe22 
Phe106
lie,Ala, 
Tyr
— — /I—---
Active site. 
Aligns the sn-2 
alkyl chain of 
substrate.
A conformation change forms a new 
hydrophobic pocket of Met56,Tyr52 and 
Tyr69. Choline N+Me3 is readily 
accommodated increasing catalytic 
turnover.
Neither side chain contributes to 
stability or global conformation of 
PLA2. Aromaticity is not important but 
hydrophobic!ty is. F106y 1 mutant shows 
decreased activity, F22Y activity is 
identical to WT^.Rationalised as Phe22 
points towards facing solvents but 
Phel06 points towards the active site.
Tyr69 Lys.Phe Mouth of active 
site. H-bond to 
phosphate oxygen 
of substrate.
£-NH2 of Lys69 is analogous to the -OH 
of Tyr69 - some residual activity 
retained. Y69F mutant able to 
accommodate bulkier substrates. Some 
stereospecificity is lost.
18
57
Asp99
His48
Asn
Asn,Gln,
Ala
His48 catalytic 
diad.
General base of 
catalytic diad.
Mutants more conformâtionally 
flexible. Asp99 plays a critical 
structural role,
N1 of His48 serves a functional role 
as the general base of catalysis.
N3 serves an essential structural 
role.
1. Y=Tyr, F=Phe
2. WT = Wild Type
Crystallographic data continues to be of importance for the structural 
investigation of macromolecules. Johnson^® predicts the use of the Laue 
method of X-ray diffraction to obtain detailed real time structural 
information of enzymatic actions. This technique would use intense
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polychromatic X-rays to record all reflections very quickly. The substrate 
would be derivatised with a photolabile moiety thus enabling the 
enzyme/substrate to be activated immediately before recording the diffracted 
X-rays. If possible, this would be a useful advance.
2.11 NMR Studies of PLA2
The use of NMR, especially NMR spectroscopy, has become a technique 
of increasing importance for the study of PLA2. This is undoubtedly due to 
the large quantity of valuable information that can be gained about the 
structure and action of biomolecules using the range of experiments now 
available to the NMR spectroscopist.
The first step in NMR investigations is that of signal assignments^. 
Most of the iH NMR spectrum of porcine pancreatic has been
assigned and 26 out of 123 residues of bovine pancreatic PLAz, including all 
the aromatic resonances have been reported^?. The procedures used involve 2D 
spectroscopy allowing the linking together of the same spin system (ie. the 
same amino acid residue) and identifying the type of amino acid by COSY. 
Assignments to particular residues are made by throughspace connectivities 
using NOESY. It is observed that X-ray crystal and solution structures 
determined by NMR are very similari?'69. This may be due to the rigidity of 
the enzyme structure. Most of the hydrophobic aromatic residues are 
clustered close to the active region. Hence, these data are helpful in 
understanding substrate and inhibitor binding in solutionis.
The absolute magnitude of the chemical shifts observed are dependent on 
temperature, pH and calcium concentration's. Large relative chemical shift 
changes are observed for some resonances (including Tyrlll Hm, of
Leu41, Ile9) upon binding to a substrate^^,2 2,46. These have been used to 
determine binding characteristics of substrates in terms of exchange on the 
NMR time scale2% under the particular experimental conditions used.
Obtaining spectra at elevated t e m p e r a t u r e s  ^ •6s enables the spectral
line width to be reduced because of more rapid molecular reorientation
allowing the spectroscopist to elude resolution problems which are common
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with NMR spectra of large m o l e c u l e s i s ,  it is fortunate that PLA2 is a highly 
stable protein.
2.12 PLA2 Inhibitors
This section looks at naturally occurring molecules and synthetic 
routes which have been taken to effect PLA2 inhibition.
2.13 Introduction
The use of inhibitors has been and continues to be used to help 
understand and define the role of the PLA2 enzyme^^.34.7 0 .7 1, Also, 
inhibitors have been of assistance in detailing the catalytic mechanism of 
PLA2^6 . PLA2 is of particular interest as its inhibition is seen as a "one 
step" method of alleviating the effects of a range of inflammatory disease 
states6'22, such as rheumatoid arthritis and asthma.
Inhibitors can be divided into two main groups, specific and
non-specific. Specific inhibitors act upon the enzyme in contrast to 
non-specific inhibitors which act upon the enzyme substrate or the 
substrate/enzyme interface. Specific inhibitors are further sub-divided into 
suicide/covalent irreversible, transition-state analogue reversible and 
substrate analogue reversible inhibitors. The division of the following 
sections reflects this classification.
The starting point for all the reversible inhibitors is the recognition 
of the minimum structural frameworks? which will interact with the active 
region of the enzyme. These "rules" of the enzyme have been listed by van 
Deenen et al?? and Bonsen et al??.
FIGURE 10: Minimum Ligand Structure Requirements for PLA2
' O -P-O X
6-1 2  3 5
These early investigations observed that the active site recognized 
only molecules with (R)-stereochemistry (L-isomers) at position (4) and that
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their overall physical characteristic must be lipophilic rather than 
hydrophilic??. Other requirements are:
(I) At least one acyl chain for hydrophobic interaction with the 
enzyme (1)??.
(II) A carboxylate ester linkage vicinal to the phosphate group 
- (2,3)??.
(III)The phosphate moiety (5) must possess a negative charge??. It can 
be replaced by a-phosphonate or sulphonate group??.
Several PLAz inhibition studies have approached the design of 
inhibitors in a rational way by utilising the archive of three-dimensional 
structural information available for PLAz as crystallographic data. Used in 
conjunction with computational calculations and solution data from NMR 
experiments, this approach has proved to be the most powerful and efficient.
2.14 Covalent Inhibitors
This type of inhibitor acts by reacting with an amino acid side chain
in, or close to, the active region of the PLAz enzyme and becoming
covalently bound thereto. Two types of these active-site directed
irreversible inhibitors exist. The first type binds to the E-NHz of lysine 
residues, while the second type binds to the N^ l of histidine residues.
Irreversible inhibition offers little information about substrate
binding in the active region. Only reversible inhibition provides useful 
information about the geometry of the active site^s. It is unlikely that an 
irreversible inhibitor would be useful as a therapeutic agent^.
2.14.1 Histidine Modifiers
These active-site directed irreversible inhibitors act by alkylating 
the N^ l of histidine-48 of the active site, thereby incapacitating the 
catalytic Asp-99-His-48 diad and preventing catalysis by the PLAz enzyme.
The most widely used inhibitor of this type is 
p-bromophenacylbromide6,59,74-76;
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which gives the following adduct with His-48
whose complex has been analyzed by X-ray crystallography to 2.5 A 
resolution?*. The X-ray data found that calcium ions were not found within 
the calcium binding loop of the inhibited enzyme due to loss of hydration 
water molecules.
Other examples of His-48 alkylating agents are methyl 
p-nitrophenylsulphonate52, l-broraooctan-2-one?^ and the molecule of Durley 
et al?? which in its lactone-hydrolyzed form is another l-bromoalkan-2-one;
2.14.2 Lysine Modifiers
These inhibitors alkylate the 6 -NHz group of lysine amino acid 
residues. As some of these residues occur at, or close to, the active region 
of the enzyme, this region is then sterically hindered towards incoming 
substrate molecules.
All synthetic inhibitors are based upon sea-sponge derived 
manoalide&.59,78,79;
The two oxygen-containing rings ring-open to
species ;
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OOH
HO
The C-NHz of the lysine residues form a covalent bond to the alkenes by 
a Michael addition:
H NH—Lys
OOHLys—N
The amino groups of lysine residues have been identified as the
nucleophiles by observing that when G-NHz groups of all lysine residues had
been previously amidinated, manoalide addition had no effect^B. This 
eliminates the N-terminus as the site of addition.
However, manoalide is not specific to PLAz as it also inhibits PLC and
5-lipo-oxygenase2 2.
Synthetic analogues have been presented by Ghomashchi et al^ B;
"Manoalogue'
CHO
and Senderoff et al®0:
C11H23
O^O^OH
2.15 Transition State Analogue Inhibitors
This class of inhibitor has ■ the sn-2 carboxylate ester of the
substrate replaced by a synthetic moiety that is a structural mimic of the
putative high-energy tetrahedral intermediate that forms during the
enzyme-assisted attack of water onto the carbonyl group of the substrate
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sn-2 esteras,81, As such, these molecules are competitive, active 
site-specific inhibitors of PLAz.
Two types of structure have been reported for this class of inhibitor: 
phosponates or phosphates and difluoromethylketonesB.io.
2.15.1 Fluoroketones
The development of fluoroketones as transition-state substrate 
analogues for hydrolytic (not PLAz specific) enzymes by Gelb et al49,83 is 
based on the enhanced electrophilicity of the ketone. In aqueous solution, a 
stable hydrate is formed:
HQ OH
R' HoO
It is this isostere of the tetrahedral transition-state intermediate 
that is thought to act as the inhibitory species. As fluorine is only 
slightly larger than hydrogen no steric problems are introduced^^.
Examples of this approach have been presented by Gelb et al49 and Yuan
et al respectively^3 ;
Ô"
C^eHaa
2.15.2 Phosphonates and Phosphates
The carbonyl group of the carboxylate ester of the substrate is 
replaced, by a -POz'- moiety in phosphonate or phosphate transition-state 
substrate analogues.
Two X-ray crystal structures of bee venom^* and Naja naja atra (cobra) 
venom85 PLAz coraplexed 1:1 with the phosphonate inhibitor, R-1-0-octyl-2- 
heptylphosphonyl-sn-glycero-3-phosphoethanolamine;
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o
P-O-
Ô"
have been solved at. 2.0 Â resolution. Both studies show that the sn-1 
and sn-2 alkyl chains lie parallel in a hydrophobic cleft extending from the 
active site. This parallelism is achieved by a sharp bend at the '^ -^methyle.ne 
to the phosphonate. The alkyl chains end near the N-terrainus. It was 
observed that the sn-1 chain was more mobile than the sn-2 chain and that 
the last two carbons of the sn-2 chain were less ordered than methylenes
closer to the glycerol backbone.
The electrophilic calcium ion interacts electrostatically with one of 
the two non-esterified oxygens of the phosphonate, just as the putative
substrate mechanism where the intermediate oxyanion is stabilized by the
cation which acts as an electron-sink. Two chelating waters are displaced by 
this interaction's. Calcium ion interaction is also reported by Yuan et al^ i 
and, for phosphates, Jain et al88.
That the active site is the locale of phosphonate inhibition, although 
obvious from these X-ray data, is confirmed by Yuan et al^2 who observed 
that the extent of inhibition was dependent on the stereochemistry of the 
inhibitor thus concluding that phosphonate inhibitors bind at the active 
site. Yuan at al32 ; based their study on short alkyl chain, water soluble 
inhibitors. Using this technique they were able to study inhibition without 
the complicating interference of substrate association in solution to form 
micelles, bilayers and other structures.
Using l-hexadecylthio-l-deoxy-2-hexadecylphosphono-sn-glycero-3-
phosphocholine, Yu et al87 determined that phosphonate inhibition was most 
potent under acidic conditions (below pH 6.5). As His-48 of the Naja naja 
naja (cobra) venom PLAz they used has a pKa of 6.1, they reasoned that below 
pH 6.5, His-48 is protonated. The increased inhibition potency was related 
to the need for a bridging hydrogen between the phosphonate group and the 
His-48 N(T1 in the complex. They concluded that His-48 acts as a proton 
acceptor.
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Lin et replaced the esterified oxygen of phosphonates;
l-octylthio-l-deoxy~2-heptylphosphono-sn-glycerophosphoroethanolamine, 
-choline and -glycol by a methylene group to yield the corresponding 
phosphinates. Although this position does not undergo specific interaction 
in the enzyme complex, computer modelling of X-ray data84,85 suggested 
steric hindrance between the methylene group of the phosphinate and the 
protonated NJl of His-48.
Phosphate inhibitors are reported by de Haas et al®8 and Jain et al®&.
2.16 Substrate Analogue Inhibitors
This class of inhibitor has a similar overall structure to the natural 
substrates yet the compounds are modified in the region of the scissile sn-2 
carboxylate ester. This approach assures efficient binding of the molecule 
within the active region of the enzyme yet denying the hydrolytic action of 
the enzyme upon the substrate analogue, thereby inhibiting its action.
At the present time there are three sub-types of substrate analogue 
inhibitor: Amide, ketone and lactone.
2.16.1 Lactones and Ketones
Campbell et al33,89 employed a molecular mechanical computational 
approach to design a lactone inhibitor of bovine pancreatic PLAz:
I , 0 = p — oIO'
They observed a better "fit" for the diastereomer depicted.
Golec et al^o evaluated a similar series of compounds as inhibitors of 
Naja naja naja (cobra) venom PLAz. The best inhibitor was:
X o — 'N(Me)3
6 -
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They observed that the lactone did not inhibit the initial rate of 
hydrolysis but inhibition was seen after a time delay. Using this 
observation, they proposed that the time delay was due to the hydrolysis of 
the lactone to yield a bidentate ligand that inhibits the enzyme by 
chelation of the essential calcium^o.
Golec et a l 42 also used a non-hydrolysable ketomethylene function 
instead of the scissile sn-2 carboxylate ester for cobra venom inhibition:
O
II O P -0
2.16.2 Amides
A secondary amide linkage at sn-2 as opposed to the natural substrates' 
carboxylate ester abolishes catalytic h y d r o l y s i s ^ o . Inhibition is effected 
as the result of a hydrogen b o n d ^ ^ . 4 6 , 8 7 , 9 1 , 9 2  between the N-H hydrogen of 
the amide inhibitor and the n o n - p r o t o n a t e d ®  ^ imidazole ring N <T 1 of the 
catalytically essential His-48 amino acid residue in the active region of 
the enzyme. This displaces the nucleophilic water molecule from the 
Asp-99-His-48 couple. The hydrogen bond contributes to the potency of 
inhibitions^ by lending stability to the enzyme/inhibitor complex. As the 
histidine must be deprotonated. for amide inhibitors to be effective, maximum 
activity is seen at pH 7 or higher®?. The carbonyl of the amide is more 
electron-rich than the carbonyl of the carboxylate ester. This enables a 
stronger electrostatic interaction with the essential calcium ion29 and 
Gly-30 backbone amide.
r
  X
The other components of amide inhibitors are very similar’ to those of
the natural substrate. These include a long sn-2 alkyl or alkenyl chain,
(R)-stereochemistry3 at the sn-2 position and a phosphoglycol, -ethanolamine
or -choline headgroup. The region of most structural variability is the sn-1
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chain as this part of the natural substrate has not been designated as 
essential to PLAz complexation.
2.16.2.1 The sn-1 and sn-2 Chains
Replacement of the acyloxy moietyi9'70'88 by an a l k o x y ^ . 2 7 , 2 9 . 9 3  or 
alkylthioii'75,59,87 function at the sn-1 position is seen to enhance the 
hydrophobic interaction with the binding pocket in the active region of the
enzym e 2 9 ,
O n --O— R
H
Plesnialc et alii used a thioether chain at sn-1 to provide chemical 
shift dispersion of the sn-1 methylenes to enable the sn-1 and sn-2 chains 
to be differentiated for a 2D NMR study.
Short alkyl chains, deleting the oxygen-containing function completely 
have also been successfully applied by Bennion et a l 22,46;
OX
and Thunnissen et ali2,92;
H -OX
There are examples of the sn-1 chain being completely absent. This is 
illustrated by the work of Chandrakumar et api;
R ^
o~p-
and Jain et al9i who found that the primary amide of long chain fatty acids 
were potent inhibitors of a wide range of extracellular PLAz's. The most
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active inhibitor was shown to be synthetic arachidonylamide.
Structural evidence of the interaction of amide substrate analogue 
inhibitors with PLAz enzymes is provided by X-ray and NMR data.
The X-ray crystal structure of (R)-2-dodecanoylaraido-l-hexanolphospho- 
glycol bound to a mutant porcine pancreatic PLAz at 2.4 Â resolution?? shows 
that the chelation of the essential calcium ion by the carbonyl and one of 
the non-esterified phosphate oxygens of the inhibitor displaces two waters 
observed in the native enzyme. The phosphate is also hydrogen-bonded to the 
phenol of Tyr-69. The sn-2 chain has a 9Cf bend at the ex.-methylene to enable 
it to make hydrophobic contacts with the side-chains of amino acid residues; 
Leu-2,-19; Phe-5,-22; Ile-9 and Tyr-52. This sn-2 methylene kink is seen
u n i v e r s a l l y ! 1 , 2 2 , 4 6 , 8 4 , 8 5  and preservation of a methylene group at this
position is thought to be important for successful binding to the enzymeS?.
The short sn-1 alkyl chain had no interaction closer than 4A with the 
enzyme.
2.16.2.2 NMR Studies
Dekker et all? per-deuteriated the sn-2 alkyl chain of the inhibitor
used for the X-ray structure determination for a novel NMR application. They
recorded 2D NOE spectra for both the per-deuteriated and per-hydrogenated 
inhibitor. By comparison of these spectra, intermolecular NOE's between the 
sn-2 fatty acid chain of the inhibitor and the side-chains of a number of 
amino acid residues were identified as illustrated below:
Phê"(M)
IU*(8) Ph**(J,») II
Ça’*
,0H
" \.
I)
Tyr*’o h
Bennion et al??'*6 used an alkenyl sn-2 chain to bring the proton 
resonances of the alkene into a chemical shift "window" of the NMR
spectrum of bovine pancreatic PLAz:
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HA large downfield shift of +0.63 ppm was observed for the C3 proton due 
to the influence of magnetic anisotropy from nearby Phe-5 and Phe-106 
aromatic amino acid side-chains which move apart to accommodate the sn-2 
alkyl chain. This and other interactions are summarised below:
Tyr-69
Phe-3 His-48
1.9
H- '1.85
2.5Phe-106 4.6 2.42.2
Leu-19 Gly-30
Am-23
The movement of Tyr-69 to hydrogen bond to the phosphate seals the 
"mouth" of the active site thereby shielding it from solvent during normal 
catalysis.
Bennion at al22 made use of chemical shift changes for NMR
resonances of the protein to determine the rate of dissociation of the 
enzyme/inhibitor complex, in effect measuring the potency of the inhibitor 
by IH NMR spectroscopy. They used the meta-proton of Tyr-111 and the 
^-methyls of Leu-41 and Ile-9 to classify the exchange rate as slow, medium 
or fast on the NMR time scale.
Plesniak et al il delibrately kept the alkyl chains of their amide 
inhibitor short;
— S
0 -P -O
Ô-
to minimise the binding constant and so ensure fast exchange on the NMR
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tirae-scale enabling the transfer-NOE technique to be used. Using a large 
molar excess of ligand (up to 10 times over cobra venom PLAz), efficient 
dipolar relaxation for the bound ligand dominates and this information is 
transferred to all ligands because of the rapid exchange rate. The NOE 
develops quickly.
Peters et al27 used the amide inhibitor, (R)-T-0-octyl-2-(N-dodecanoyl- 
amido-2-deoxyglycero-3“phosphoglycol to study the conformational changes 
occurring to porcine pancreatic PLAz upon binding by and NMR
spectroscopy. These are shown below:
%
TyfK
Th»70
Tip3,
TWTO.
cA B
A: Conformation in solution. The N-terminus is not helical
B: Conformation in a micelle. There are rearrangements in the 
N-terminus.
C: Conformation in a micelle with inhibitor bound. The N-terminus has a 
helical conformation and the hydrogen-bond network is formed. The 
Tyr-69 hydroxyl group is binding to the phosphate group of the 
inhibitor.
Within the head-group, the substitution of a cationic ethanolamine or 
trimethylamino group by a neutral glycol or propyl chain leads to an 
increase in the effectiveness of the inhibitor22.8 2 ,88,94 ^up to an order of 
magnitude better22,B2. Lin et al®2 explains this difference by noting a 
strong electrostatic intermolecular interaction of the zwitterionic 
head-groups in the substrate's associative structures (micelles, bilayers). 
Getting the zwitterionic ligand to the active site is energetically 
unfavourable compared to the anionic ligands.
2.17 Miscellaneous Inhibitors
Some compounds achieve overall PLAz inhibition by an indirect route by 
modulating the substrate.
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Cyclic-AMP inhibits PLAz by decreasing the levels of "free" cytoplasmic 
calcium. Calcium ions are essential for extracellular PLAz^. Apolipoprotein 
C-1 (6.5 kDa) and lipocortin (36kDa)&'io are proteins that alter the 
structure of the substrate thereby making it unrecognizable by the PLAz 
interfacial recognition site&.10,95,96. Halothane, cholesterol, sodium 
chloride and temperature illicit similar effects&,3l.
Using the X-ray crystal structure of bovine pancreatic PLAz at 1.7Â' 
resolution as the basis of a computer modelling exercise in rational design, 
Ripka et al 21 came up with a series of novel molecules based on the parent 
structure:
380X
R V
They identified the following enzyme interactions and their effects on 
inhibitor potency:
Leu*
Pho®
GH] '(hytJrophobicj-NH,*
4X
fSiric InttnctioRs
His*'
Oinuma et al9? studied heavily subsituted benzenesulphonamides as 
inhibitors of rabbit heart intracellular PLAz. Finally, Wallach et al*4 
synthesized a novel series of inhibitors of hog PLAz. The best one was:
(H*band aoctptor)
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2.18 Synthesis of sn-2 Amide Phosphatidylcholine Phospholipids
This section looks at the methods used to synthesise phospholipids with 
illustrations of typical reactions taken from the literature.
2.19 Synthetic Strategy
The universal route to synthetic sn-2 amide phosphatidylcholines is 
that pioneered by Chandrakumar et al in a series of papers published in the 
early 1980's7o,7i,93. This strategy involves a three-step synthesis:
//° -R— + HjN—R'— O H ----------------^ R^ — OH^ H
(A) (B) (C)X ..V/'P R-cf 9 jP
H Q-
(D) (E)
involving the coupling of an acid or acyl derivative (A) with an amine (B) 
to yield an amidoalcohol (C). Stereochemistry at sn-2 can be introduced by 
the use of amino acid derivatives as the amine reactant (B). (C) is then
condensed with 2-chloro-2-oxo~l,3,2-dioxaphospholane, to give the unstable 
cyclic phosphate triester (D) which is then reacted with an amine to yield 
the product phosphocholine (E),
The synthesis is very short, involving only three steps. The use of 
protecting groups is u n n e c e s s a r y ^ o , 7 i . Intermediate (C) and product (E) are 
purified by column chromatography. However, the overall yields for this 
route are quite low with typical examples ranging from 19% to 36% of (E) 
based on starting material (A) or ( B )2 2.59.70. This low yield stems from the 
unstable nature of intermediate (D) to nucleophiles, particularly 
hydrolysis.
The following sections deal with each of these reactions in more 
detail.
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2.20 Amidoalcohol Synthesis CC)
This reaction involves the condensation of aliphatic carhoxylic acid or 
acyl derivative (A) with the aminol (B) to yield an amidoalcohol (C).
Natural glycerolipids have (R)-stereochemistry at C2 of the glyceryl 
chain. For sn-2 amide analogues, a convenient method of introducing this 
stereochemistry is through the use of carboxylic-acid-reduced non-natural 
(R)-amino acids:
LiAlH4 I Qp,
H . N ^ \ c O O H  ---------^
H H
(R)-Leucine (R)-Leucinol
This efficient approach to reactant (B) has been successfully applied 
to proline, serine and l e u c i n e 2 2 . 4 6 . 7 0.75,93.
Fatty acid (A) is usually prepared as its reactive acyl chloride 
derivative by reaction with thionyl c h l o r i d e ^ ^ -7 0 .7 i ,93. Condensation is 
then facile with moderate to good yields of intermediate amidoalcohol (C). 
The following examples are taken from the work of Chandrakumar et al7i and 
Slaich et al46, respectively:
,0R ~ <   > H^Cl in ether, O'C Yields = 65-88%
R = palmitoyl (C12), lauroyl (Cie) and stearoyl (Cis)
1 hr.
A ---------> " A
CH2CI2 Yield = 90%
R = palmitoyl (C12)
For unsaturated fatty acids, this rigorous approach to the amide 
coupling is unsuitable and risks movement of the position of a double bond
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bring it into conjugation with other unsaturated functionalities such as
other alkenic double bonds in the fatty acid alkyl chain or more especially
conjugation with the carbonyl group of the carboxyl function's,98,
The DCC coupling route to form amide linlcages in peptide syntheses is 
used. Introduced in 195599, this mild amide coupling reaction enables a 
carboxylic acid and an amine to couple directly and rapidly in high 
yield99»ioo upon treatment with a slight stoichiometric excess of 
N,N'-dicyclohexylcarbodiimide (DCC) at room temperature. The co-product of 
the reaction, N,N'-dicyclohexylurea does not introduce separation problems 
for the product (C), as it is highly insoluble in most organic and aqueous
solvents and can be removed by simple filtration99.
As (R)-leucinol is used as reactant (B) in the synthesis detailed in 
the experimental section, it is of interest to note that leucine is the only 
amino acid not prone to deleterious side-reactions under these 
conditionsiOi.
Racemization of the stereochemical centre can happen to a small extent 
(ca. 2%)102 with a DCC coupling. This can be a serious problem as a high 
degree of steric homogeneity is necessary for unequivocal results from 
physical studiesioz such as the proposed NMR spectroscopic approach to 
the study of enzyme:inhibitor complexes. The 1-hydroxybenzotriazole reagent;
o>
O H
was found to be a useful additive for peptide syntheses employing the DCC 
methodioo as racemization is virtually eliminated (<0.1%) yet maintaining 
the very high yieldsioo,1 0 2 , 103  inherent for the DCC coupling. A mechanism 
for the reaction has been presented by Konigioo.
2.21 Cyclic Phosphate CD)
This reaction involves the condensation of amidoalcohol (C) with 
2-chloro-2-oxo-l,3,2-dioxaphospholane to yield the cyclic phosphate 
intermediate (D).
133
2-Chloro-2-oxo-l,3,2-dioxaphospholane is the reagent that makes the 
synthetic strategy outlined here possible. This reagent is difficult to 
obtain in a pure state as it is extremely reactive towards n u c l e o p h i l e si04, 
Its synthesis involves the condensation of phosphorus trichloride with 
ethylene glycol :
PCI3  +  H R  OH  ,  / \\ / Q
followed by oxidation of phosphorus with oxygen gas in a benzene 
solution for an overall 80% yieldios;
Cl ClO  —  o\__/ benzene \ __/
As a solution in organic solvents (benzene is the most popular,
although ether, DMF and THF can also be u s e d ) 46.4 2,70,71,90,104 in the
presence of an HCl acceptor (TEA is universally used), the reagent gives
quantitative yields with alcohols, phenols and a m i n e s  194;
Cl V ° "0 4  RNH,   / \™ V7 " vy
\— /  (I) (II)
Two examples from the literature are from the work of Golec et al^o and
Chandrakumar et al i^. respectively:
Cl
0 4
,0v, / OCwH# /  \
0 = <  A  R f  .benzene, TEA X  OX \  P
 ^ OH  ,  ' '--o-p-0
,benzene, TEA  > n-p-nR - C
5 C, 24hrs.
Yield = 95%
R = palmitoyl (C12), lauroyl (Cio), stearoyl (Cis).
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Cyclic phosphates of type (I) are extremely sensitive to hydrolysis 
whereas those of type (II) are quite stable22.i04. Type (I) cyclic 
phosphates are found in the synthesis of phosphocholines and it is the 
reactivity of the (D) intermediate that prevents its isolation and 
compromises the yields of synthetic phosphocholines when using the 
2-chloro-2-oxo-l,3,2-dioxaphospholane reagent.
The alternative method of Yu et al59 and Kinder et alioG involves the 
condensation of the alcohol intermediate (C) with phosphorus oxychloride to 
yield a dichiorophosphate ester intermediate.
POCI3 m /--OR
OH TEA OOPCI2
2.22 Phosphocholine (E)
The final reaction in the synthesis involves ring-opening the cyclic 
phosphate triester intermediate (D) with a nucleophile to yield the product 
phosphoglycol, phosphoethanolamine or phosphocholine (E).
Reaction conditions have been standardised to a solution of anhydrous 
trimethylamine (for a phosphocholine) in acetonitrile, although acetone has 
been advocated as a s o l v e n t 19 4  ^ heated in a sealed apparatus at 60-65^C for 
17-24 h o u r s 4 2 . 4 6 . 7 0 , 7 i .90. This is illustrated by the work of Golec et al99;
9 ^  MesN, MeCN 0=^
6OT, 17 hrs.
Although yields as high as 8 8 % 4 6 . 7 l , i 0 4  have been reported for this 
reaction, yields of lesser magnitude are more typical (25
58% ) 2 2,4 6 , 7 0 , 7 5 , 9 0  resulting in overall poor yields of the phosphocholine
(7-36%)2 2 ,46.59,70,107.
The alternative method of Yu et al59 and Kinder et al^96 involves the 
condensation of a dichlorophosphate ester with choline tosylate to yield the 
product phosphocholine. This is illustrated by the work of Yu et al59;
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0 -P -
o _ « X p
'S-
'R HO'
-H
-OPCI2  i  'N(Me)^
Yield = 24%
This method also suffers from poor yields.
The zwitterionic phosphocholines are very hygroscopic showing high 
solubilities in water, alcohols and nitromethane. The latter solvent can be
used for recrystallization^94.
2.24 Chromatographic Purification
The final reaction mixture after the formation of product (E) is quite 
complex, with reagents and byproducts that must be separated to yield the 
pure phosphocholine (E). Although a HPLC method would be ideally suited to 
this task, there exists a number of disadvantages which makes this 
experimentally challenging. The major problem is that phospholipids, 
especially those with fully saturated alkyl chains, have little or no UV 
spectrum. This makes them difficult to detect and hence analyse unless the 
molecule possesses another intrinsic physical property such as radioactivity 
(see FIGURE 20).
Most phosphocholines are analyzed by TLC and purified by flash 
chromatography198.109. All the solvent systems reported involve chloroform, 
methanol and an aqueous component with very little variation in their 
relative proportions. See TABLE 2.
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TABT.E 2: Constituents of Silica Gel Chromatographic 
SolventSystems for Phosphocholines
Rf CHCI3 HeOH 
S by \
H20
rolume
Other Ref. No.
78 20 2 0.25 110
AcOH
0.29 69 27 - 4 71
aq. NH3
- 69 27 4 - 90
60 33 - 7 111
10% NH40B
- 62 33 - 5 112
30% NH4OE
- - 31.25 6,25 62.5 106
CH2CI2
- 69 27 4 - 46
- 60 33 7 - 17
- 69 27 4 - 59
- 69 27 4 - 75
0.29 69 27 4 - 70
The per-deuterated sn-2 amide analogue phosphoglycol of Dekker et all?:
11^ 2^3
O - P - O
has been successfully purified using this method without disruption of the 
label. Therefore, this purification method should be suitable for 
tritium-labelled analogues.
For silica gel TLC analyses the developed plates are visualized by 
spraying with an aqueousii®,ii^  or alcohol (usually ethanol)5,59.113,114 
solution of phosphomolybdic acid (ca. 10% (w/v)) followed by heating to give 
the TLC spots of lipid as blue-grey against a green background^i^. The 
heating process is usually at 105-120*C for ten minutes although saturated 
lipids benefit from a slightly higher temperature of 150-180*Cii3.
The process involves a portion of Mo(VI) being reduced by the lipid to 
Mo(IV) to yield the blue-grey mixed oxides observedii^:
2MOÜ3 M0O2 .M0O3
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2.24 Hydrogen Isotope Labelling by Heterogeneous Metal-Catalvzed Double 
Bond Reduction
This section deals with supported group VIIIB metals used for the 
introduction of hydrogen isotopes into unsaturated alkj^ l chain
precursors.
2.25 Heterogeneous Catalysis
What is usually meant by heterogeneous catalysis is the situation where 
the catalytic elemental metal is supported on an inert material, usually 
c h a r c o a l  115, The reactant(s) occur either as gases or in solution. Hence, 
the system is heterogeneous in that the reactant(s) and catalyst are 
separated by phases of state and reactions occur at the phase interface. For 
double bond reduction on a laboratory scale (mmoles or ^ moles) the variables 
in the experiment are the metal, its loading on the support, the solvent, 
the temperature and with more sophisticated apparatus the hydrogen isotope 
gas pressure may be adjustable. The effects of some of these variables are 
briefly reviewed here.
2.26 The Mechanism
As the system is biphasic, the mechanism of action is seen to be 
associative adsorption of hydrogen isotope gas and the double bond of the 
unsaturated substrate onto the catalysts' metal surface at the phase 
interfaceiii'iiG. The TT-bond electron density of the unsaturated substrate 
is the primary, but not exclusive site for adsorption. Also, the pattern of 
substitution about the double bond and/or other steric factors in the 
substrate molecule can influence which face of the double bond is favoured 
during its association with the catalytic metal surface^^^^^.
The association sites on the catalyst are not uniform, as with the 
discrete molecular homogeneous catalysts, leading to a high variability in 
activity, type of reaction and hence product. This difficulty is the prime 
reason why the study of heterogeneous catalysis is fraught with 
problems12 0 ,1 2 1.
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The adsorbed hydrogen isotope and substrate bond together via a cyclic 
intermediate followed by elimination of the reduced molecule from the
catalyst surfaceii&. Overall cis-addition of the hydrogen isotope is 
observed.
2.27 Types of Reaction
A diverse number of reactions are known to occur during catalytic
hydrogention. These include exchange, double bond migration and hydrogen 
isotope dilution by protium sources.
(I) Exchange: Non-specific exchange on alkyl chains can occur, 
particularly at or adjacent to unsaturated functionalities (eg. alkenes, 
-methylenes of ketones). The extent of exchange labelling is dependent on 
the type of metal and experimental conditions usedizz.
(II) Double Bond Migration: The bane of the heterogeneous catalytic 
method is double bond migration. This means that the two carbon atoms bound 
to the metal catalyst can be outside those that originally contained the 
double bond, the initial site of substrate attachment. Subsequent 
elimination of the reduced product reveals hydrogen isotope additions at all 
carbons along the alkyl chainm. A useful illustration of this phenomenon 
is provided by Dinh-Nguyen et all23 for the fatty acid ester substrate, 
methyl oleate (methyl Z-octadec-9-enoate) by mass spectrometric analysis of 
the deuterium labelled product, methyl [2Hn]octadecanoate.
Platinum catalysts are reported to yield little double bond migration 
in the hydrogenation of a l k e n e s i i 2 .i 1 9. indeed, isomérisations are favoured
by low hydrogen isotope gas pressure, poor agitation of the reaction
mixture, high catalyst-to-substrate ratios and high catalyst loadings, 
especially of those metals deemed to have a greater catalytic 
activity119,122.
(III) Hydrogen Isotope Dilution: Where the hydrogen isotope 
incorporation into the product is significantly lower than the source of the 
hydrogen isotope, this dilution is caused by sources of protium in the 
system, sometimes mediated via an isotope effeetlll•l1^.
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Sources of protium in the catalytic system includes :(i) Species 
adsorbed on the catalyst. These can be removed by placing the catalyst under 
high vacuum, with heating in difficult cases, (ii) The substrate. Usually in 
the form of a hydrogen bound to oxygen or nitrogen (eg. ROM, RNH2 , RCO2H). 
These sources are removed by chemical protection (eg. estérification of 
carboxylic acids); (iii) The solvent is usually the main source of protium 
either inherent in the solvent molecular structure or as water 
contamination. Protic solvents such as water and alcohols are best avoided 
if possible - methanol is widely used to back - exchange exchange-labelled 
positions on isotopically labelled molecules! - leaving aprotic solvents the 
preferred choice (eg. THF, dioxane, benzene, alkanes) especially when they 
are dry ^ ^ 2 ,1 1 8,1 2 2.
Overall, heterogeneous catalytic double bond reduction with hydrogen 
isotopes gives uncertain label distribution and stereochemistry. The number 
of differently labelled species is difficult to d e l i n e a t e ^24. However, 
products with a high level of label incorporation results as heterogeneous 
catalysis is an efficient process. Thus, ligand molecules tritium-labelled 
by heterogeneous catalytic multiple-bond reduction can be a poor methodology 
for use in NliR protein-binding studies.
2.28 Lipids and PLA2 Substrates/Inhibitors Labelled with Hydrogen 
Isotopes
This section presents examples of deuterium and tritium-labelled lipids 
and PLA2 substrates or inhibitors that have appeared in the literature. All 
the compounds were prepared by heterogeneous catalysis.
2.28.1 Labelled Lipids
Stewart et all 12 have deuterium-labelled a wide range of glyceryl 
phospholipids for a solid-state 2r NMR application in order to determine 
time-averaged orientations and rates of motion. They used three techniques 
to incorporate deuterium into fatty acid alkyl chains of the phospholipids:
(I) Reduction of terminal carboxylic acid functions to primary
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alcohols with lithium aluminium deuteride, LiAlD*.
(II) Exchange of %-methylene hydrogens in carboxylic acids (-CgzCOzH) 
with sodium deuteroxide in deuterium oxide.
(III) Reduction of alkenes by platinum (IV) oxide. (Adams' catalyst) and 
deuterium gas in [0-2H]methanol.
Yamamoto et al^25 employed deuteriodeiodination of a glyceryl 
phospholipid structurally modified with a 4,4'-dialkoxybenzophenone unit 
for another application of solid state 2h NMR to probe the orientation of 
phospholipids in membranes.
O
X = l /H
O
C13H27
O J 'O -P-O
Turning to tritium-labelled lipids, Myasoedov and co-workeriii reported 
the labelling of a phosphatidylcholine extracted from eg5% pj/BaSO^L specific 
radioactivity of 6.11 Ci/mmole. They used a 1:1 substrate/catalyst ratio of 
5% Pd/BaSO* in dioxane. The product was repeatedly purified by silica gel 
column chromatography.
Kinder et ali06 detailed the alkene reduction and synthesis of a 
phospholipid with anti-tumour properties:
OH 5% Pd/BaS04
H2/T2, CH2CI2 ^  r - A — OHU2/12, on2^i2 T T
'NCMel
1.2 Ci/mmole
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2.28.2 PLA?. Substrates and Inhibitors
Ghomashchi et al&3 used l-palmitoyl-2-[9,lO-^Hjpalmitoyl-sn-glycero-S- 
phosphocholine and its phosphoethanolamine analogue at 58 Ci/mmole specific 
radioactivity to measure PLAz catalytic substrate specificity where the 
substrate is present as vesicles.
O
T 9 r—
T O-P6-
No synthetic details were given as the compound was obtained from a
commercial source.
Two examples of tritium-labelled compounds that act as suicide 
inhibitors of PLAz, whereby the molecule becomes covalently linked to the 
enzyme at, or close to, the active site thus preventing the normal action of
the enzyme to continue, have been reported.
The work of Senderoff et al^o involves the preparation of a synthetic
analogue of a known PLAz inhibitor called manoalide which is a natural,
non-steroidal, sesterterpenoid found in a certain species of sponge. These
workers retained the reactive portion of manoalide to yield a structurally
simplified PLAz inhibitor. The molecule was prepared from an
(X-bromomethylketone precursor by tritiodebromination over a 10% Pd/C 
catalyst using ethyl acetate as solvent and triethylamine as base. A product 
of 18.3 Ci/mmole was obtained.
CiiHga
0^0 '^ OH
The open form of the molecule is an -unsaturated aldehyde and a
cross-conjugated carboxylic acid:
142
that acts by condensing with lysine amino acid residues close to the 
active site^ .
Finally, Durley et al?? prepared an active-site specific intracellular 
Ca2+-independent myocardial PLAz suicide inhibitor by the
tritiodebromination of a bromonaphthalene derivative;
Br
They used 5% Pd/C as catalyst in ethanol and sodium acetate as base to 
give the above product at 24.0 Ci/mmole.
The mode of action was suggested as the enzymatic hydrolysis of the 
alicyclic ring to reveal an electrophilic (X-bromomethylketone that bonds to 
an essential amino acid residue, probably the N^ l of His-48.
2.29 Diimide. N2H2 . as a Tritium-Labelling Reagent
Diimide is a reductant126,127 that is used for the purpose of hydrogen 
isotope labelling.
The transient reagent is usually prepared by the action of a protic 
source on a azodicarboxylate salt (eg. P A D A ) 128-136;
overnight
K+ -02C-N=N-C02“ K+ + 2RCO2H -----------N2H2 + 2CO2 + 2RC02- K+
It is necessary to prepare the reagent in situ because of a competing
disproportionation r e a c t i o n i27.129,137 giving nitrogen gas and hydrazine:
2N2H2 ------ > N2 + N2H4
which are ineffective as reductants. The disproportionation reaction
incorrectly identified hydrazine as the reductant in earlier studiesi^®.
The competing kinetics of reagent formation and disproportionation makes 
for a slow reductive process when compared to other available methods such 
as heterogeneous catalysisi30,i36 and necessitates the in situ preparation
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of the reagent 127 , 133- 1 36 ,
The nature of the solvent used for the mutual preparation of diimide 
and target molecule reduction can significantly affect the reaction. 
Hamersma et al 132 list the solvent effectiveness as: py>dioxane>DMSO>>MeOH, 
Eton. Pyridine is probably able to support the ionic precursors better than 
the solvents dioxane or DMSO. P y r i d i n e l 3 4  and d i o x a n e i 35,i36 have been 
utilised in deuterium and tritium labelling procedures using PADA as the 
diimide precursor.
Diimide is a useful addition in the armoury of hydrogen isotope 
labelling reagents due to its great selectivity. Its advantages over 
heterogeneous catalysis are listed here:
(I) It is able to reduce symmetrical, non-polarised multiple bonds such 
as alkenes, alkynes and azo compounds in the presence of non-symmetrical, 
polarised multiple bonds like ketones or imides. Thus, the radiochemist is 
able to use this selectivity to perform specific reductions in the presence 
of vulnerable functional g r o u p s ^ 27,i36,i39.
(II) The labelling procedure can be the final synthetic step thereby 
eliminating micromolar synthetic manipulations on high specific radioactive
tritiated intermediates^36,
(III) The addition of hydrogen is specific to the carbon or nitrogen 
atoms embracing the multiple bondi34,
(IV) Sulphur-containing moieties in the target molecule do not present 
any difficulties in diiraide-mediated r e d u c t i o n s ^ 27,
The mechanism of reduction has been described as a six-electron, 
symmetry allowed intermolecular dihydrogen transfer reactioni^o. From a 
practical standpoint, this results in a synchronous, cis-addition of 
dihydrogen via a cyclic transition stated27.131,141.
% R-*— Ri H H
- **N=N-* -I
Z-conformer
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iRj + n = n
h/ \
Tame1en et ali30 noted that as highly stable .nitrogen is the 
coproduct of the diimide reduction, the "reducing power" of this reagent 
should be substantial.
Baldwin et al*35 observed that the addition of deuterium occurred 
from the less-hindered side of a double bond. Saljoughian et a l 136 noted an 
uneven addition of deuterium and tritium across an alkene using and 
3H NMR spectroscopy as the analytical technique. This suggests that in 
slightly polarized homoatom double bonds, the addition of hydrogen has a 
stepwise component. The energetic differential between synchronous and
stepwise addition is reported to be small*40.
There are relatively few reported examples of deuterium or tritium 
labelling utilising this reagent. Deuterium labelling is reported by Baldwin 
et al 135 and Saljoughian et al 136. The former group reported a very high 96% 
deuterium incorporation stating that scrupulously dry conditions were
necessary. The latter group gained typically 50-55% deuterium incorporation 
as detected by mass spectrorateric analysis.
Tritium labelling using diimide is reported by Paliokas et al 133, Koch 
et al 134 and Saljoughian et a l l 36. Koch et a l l34 achieved a less than 30% 
radiochemical yield giving products of mCi/mmole scale specific
radioactivities due to the non-availability of high specific radioactivity 
water. Saljoughian et a l 136 achieved much higher specific radioactivities by 
using maximum specific activity water prepared by the tritium gas reduction 
of platinum(IV) oxidei42;
PtOz + 2T2 ----- > 2TzO + Pt
Hydrolytic fission of acetic anhydride then gives [0-3Hi]acetic acid 
used as the protic source for PADA decomposition to yield the tritiated 
diimide reagent:
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(CH3C0)20 + T 20 ------ > 2CH3CO2T
2CH3CO2T + K+ -02C-N=N-C02“ K+ ----- > N 2T 2 + 2CO2 + 2CH3CO2-K +
However, liquid scintillation counting showed that only l-in-6 
molecules contained one tritium atom and 3h NMR spectroscopic analysis 
revealed 82% of the tritiated molecules being monotritiated, the remaining 
8% being ditritiated as shown by the isotope shift to higher field in the 
NMR spectrum and revealed by DQF-3H NMR. Saljoughian et al136 reasoned that 
the disappointing tritium incorporation observed was due to a significant 
primary kinetic isotope effectifs either for the formation of diimide 
and/or the substrate reduction. This inference is validated by Cahill et 
al144 who give a value of 275 to this effect, although values of less than 
20 are more typical. Hence, anhydrous conditions and aprotic solvents are 
essential for hydrogen isotope labelling using diimide.
As the reagent will be used for the tritium labelling of a phospholipid 
in this study, it is reassuring to note that Z-octadec-9-enoic (oleic)
acidi45 ;
and ethyl 0-p-nitrophenyl oct-7-enylphosphinatei36
0 :N — Ph— P — (CHjg 
OEt
have been successfully reduced using diimide without chemical
degradation.
2.30 Hydrogen Isotone Labelling by Homogeneous Catalytic Double Bond 
Reduction: Wilkinson's Catalyst
This section presents a practical review of the use of Wilkinson's 
catalyst in hydrogen isotope labelling, covering the mechanism of 
hydrogenation and effects of reaction variables in order to define a likely 
experimental procedure for tritium labelling, highlighting the likely regio- 
and stereochemical pattern of labelling to be expected when using this
146
homogeneous metal catalyst.
2.31 Structure of Wilkinson's Catalyst
The invention!46 of Wilkinson's catalyst produced a flurry of 
publications in 1965 detailing its synthesis!47  ^ its ability to form hydride 
complexes and the discovery of the complexes' ability to reduce multiple 
carbon-carbon bonds 1 4 8- 1 50 .
The red-violet monomeric complexly1"1S3, molecular formula
RhiCl(PPh3)3 , is square planar with a tetrahedral distortion as shown by 
X-ray c r y s t a l l o g r a p h y i 5 4 .  The existence of two allotropes, one red-violet, 
the other orange was noted in 1 9 6 6 1 5 5 .  The orange form exists as the 
chlorine-bridged dimer.
(PPh3)3Rh ^Rh(PPh3)3
^ C l ^
The dimer has identical catalytic properties as displayed by the 
m o n o m e r 155, an observation supported by recent quantum mechanical 
calculations 156. The dihydride complex, R h H 2 C l ( P P h 3 ) 3 , has recently been 
analyzed by X-ray crystallography and reveals cis-hydrides and meridional 
TT-acid triphenylphosphine ligandsl57;
%
2.32 Mechanism of Hydrogenation
FIGURE 11 , detailing the catalytic alkene hydrogenation by Wilkinson's 
catalyst will be used as the basis of the mechanistic description presented
h e r e i 5 8 - i 6 1 .
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FIGURE 11: Catalysis cycle for RhClL3 catalyzed alkene hydrogenation 
(L = PPh3. S = Solvent molecule)
t + L -S
^ ‘'•Ts- l'
H
/Rh / ' L, 
s s u
(V)t
c-c _(IV)
Entry into the catalytic cycle begins with the red-violet complex I. 
Catalytic hydrogenation can occur either via the outer or inner cycles, 
although significant rate increases are observed for some solvents that are 
able to enter the inner coordination sphere of the c o m p l e x i 52,161 -163. This 
discussion will concentrate on the inner catalytic cycle.
Displacement of a triphenylphosphine ligand by a poorly coordinating 
solvent molecule to give complex II occurs via an associative
p a t h w a y ! 53,i 6 i ;
RhXL3 + S ------> RhXLsS  > RhXLzS + L
The alternative dissociative pathway is not viable due to very little
observed dissociation of complex Ji53 and on simple valence electron
counting g r o u n d s i l l .  Displacement of PPhs can be caused by CO, Hz, O z ,
peroxides, alkenes, pyridine, DMSO, MeCN and alcohols!52.Complextion by
pyridine or MeCN is too strong to enable the catalytic cycle to proceed 
beyond complex 11 and catalytic activity is l o s t ! 55.
Oxidative addition of hydrogen gas yields the pale yellow rhodium(lll) 
complex 111152,155,157,164 in which the hydride ligands are mutually cis and 
also cis to the TT-acid phosphine ligands. The hydride ligand exerts a
substantial t r a n s - e f f e c t ! 53, thereby labilizing the trans-ligand.
Insertion of the alkene s u b s t r a t e ! 55 displaces the labilized solvent 
ligand producing the TT-alkene complex IV. The rate determining initial
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hydride transferees,160,161 occurs via a four-centre transition state when 
the hydride and TT-alkene ligands are mutually cis and coplanar!6i. An 
intermediary complex containing the mutually trans-hydride and f-alkyl 
ligands rearranges by coordination of a poorly coordinating solvent molecule 
to give complex V with the f-alkyl and remaining hydride ligand mutually 
cis. The rearrangement, subsequent hydride transfer and reductive 
elimination of the alkane product is very rapid. Reaction times are 
typically 1-3 hours!46,i52,i58.i59,160,i6i.i64. This completes the catalytic 
cycle. The stepwise addition of hydrides to the alkene substrate has been 
demonstrated for sterically bulky trisubstituted alkenes for which the rate 
of hydrogenation is very low!6S but for all practical purposes hydride 
transfer is simultaneous, displaying exclusive, cis-addition of hydrogen 
across an alkenic bond!52,155,158-I6i,165. Hence, the lifetime of the 
rf'-alkyl complex is minuscule and is less than the time of Rh-C or C-C bond 
rotation in this transitory complex. Also, hydride transfer to the less
sterically hindered face of the alkenic bond is favoured. This has been
illustrated by the deuteriation of bicyclo[2 .2 .l]heptene!6 3 to give
exclusively the exo.cis product.
RhCl(PPh3)3 à h
A kinetic description is provided by H a l p e r n ! 6 0 .
2.33 Reaction Variables
This section deals with experimental variables that have a bearing on 
homogeneous catalytic hydrogenation.
2.34 The Rhodium(I) Complex
The chlorine ligand of Wilkinson's catalyst can be substituted with the 
halogens bromine or iodine!*? or even n i t r o s y l ! 5 2  (NO). The heavier halogen 
complexes are more soluble!55, show rate increases!6l and exhibit greater 
s p e c i f i c i t y i 52 over their chloro analogue. Similar* effects observed with
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triphenylphosphine ligands substituted with electron donating substituents 
(eg. metho.xyl) !6i, 166 are due to electronic and steric modulation of the 
metal centre thereby lending supporting evidence to the mechanism proposed 
and outlined here.
2.35 The Alkene Substrate
The rate of reduction is highly dependent upon the substitution and 
geometric isomerism of the alkene substrate. The rate of hydrogenation 
decreases in the order: Alk-l-enes>Z-alk-2-enes>>E-alk-2-enes
>E-alk-3-enesi52,155.161.167 and also decreases with increasing substitution 
(ie. steric bulk) about the double bond: mono->di->>tri-
>tetrasubstituted!52,165. As an example, cyclohexene is hydrogenated 
fifty-times faster than l-methylcyclohex-l-enei52. Wilkinson's catalyst is 
selective to alkene and alk)me reduction. Conjugated dienes require greater 
than one atmosphere pressure of hydrogen gas for saturation.
Many other functional groups are unaffected, in contrast to 
heterogeneous catalytic h y d r o g e n a t i o n ! 2 2 , i 5 2 , l6 1 . l6 7 . i 68. These include: 
keto, hydroxy, cyano, nitro, chloro, azo, carboxylates, aldehyde and aryl.
2.36 The Solvent
The solubilities, at room temperature, of Wilkinson's catalyst in a 
variety of solvents are: moderately soluble in CHCI 3 , C H 2C I 2 , benzene,
toluene; slightly soluble in acetic acid, ketones, alcohols; insoluble in 
alkanes such as l i g h t  petroleum and c y c l o h e x a n e ! 52 . 155, 1 6 1 , 162, 169 _ a  list 
of solvents that have been used for homogeneous catalytic hydrogenation is 
given by Birch et al!52. Benzene is a popular solvent in this respect. The 
dihydride complex III is more soluble than the initial complex l!68.
Although Wilkinson's catalyst is indefinitely stable in air at room 
temperature!52,153, its solutions are unstable eventually leading to the 
formation of the insoluble orange/pink dimer, [RhCl(PPhz) 2 ] 2 .!^^
In chlorinated solvents (eg, CHCI3 , CH2CI2) under hydrogen, the 
catalytically inactive RhCl2H(PPh3)2 complex is f o r m e d ! 52. 162.
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Rates of hydrogenation show high solvent-based variability!52,i6i-i63.
A good solvent consists of mixtures of benzene and ethanol with a 3:1 (v/v) 
ratio being the most widely usedi22,I6i.163.165, although various ratios up 
to 1:1, have proved equally successful!S2,168,170, The rate of hydrogenation 
is doubled in 3:1 (v/v) benzene: ethanol over benzene as solventd^i. This
observation validates aspects of the mechanism outlined in section 2.32. 
Overall, the optimum solvent system must have a poor coordinating ability in 
order to form intermediary complexes like II which facilitate the rapid 
ligation of alkene, show adequate solvation of all components of the 
reduction reaction and display good hydrogen dissolution!52,l6i,l63,165,
The solvent system must be rigorously deoxygenated before dissolution 
of the catalyst because of the ability of Wilkinson's catalyst to complex 
o x y g e n ! 5 2 .  The oxidation of alk-l-enes by Wilkinson's catalyst and 
oxygen has been reported!?!.
2.37 Reaction Work-up
The experimental problem of using homogeneous catalysis is the 
difficulty of separating the catalyst from the product. For non-polar, 
alkane-type products, filtration of the reaction solution through highly 
polar materials such as a l u m i n a ! 6 8 ,i70, florisil!68 (magnesium silicate) or 
Celite!?2 (SiOz) have been successfully applied. For volatile products, 
distillation is an o p tion!68. However, for more polar and structurally 
complex product molecules, some form of chromatography is necessary. It is 
envisaged that simple silica column chromatography is best suited for a 
tritiated product because of its simplicity and ease of use.
2.38 Use of Hydrogen Isotopes
This section reviews deuterium and tritium labelling mediated by 
Wilkinson's catalyst.
2.39 Kinetic Hydrogen Isotone Effect
As the differential masses are greatest for the family of hydrogen
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isotopes, the make or break of any hydrogen isotope labelling procedure is 
the magnitude of the kinetic hydrogen isotope effect. For deuteriations
using Wilkinson's catalyst, the rate ratio (kH/ku) is reported to be close 
to unityi43,l55,i73. To paraphrase Osborn et ali5S, "where low ICH/ko values 
are found a complete rupture of the Rh-H bond does not occur. The bond is 
bent so that the H atom can attach itself to the alkene carbon atom leading 
to a four-centre transition state in which the lengthening of the Rh-H bond 
occurs synchronously with the formation of a C-H bond.” Thus, high levels of 
hydrogen isotope incorporation can be expected at a comparable rate to
hydrogenation.
2.40 Deuterium Labelling
Ever since the deuterium labelling of steroids by homogeneous catalysis 
was suggested in 1966170, deuterium labelling has been used to probe the
mechanism and to yield compounds for further applications.
Examples of the former are the regioselective and stereospecific 
labelling of a s t e r o i d i 7 4 ;
AcO
the exclusive exo.cis reduction of bicyclo[2.2.1]heptenei&3;
R h C l ( P P h 3 ) 3
and the overall observation by Birch et all52 that specific deuteriations
with little or no scrambling are typical.
Examples of the latter are afforded by Birch et ali^®, Morandi et al 1^ 7
and Rakoff et a l i & 4 , 1 7 5 - 1 7 7 .  Taking these in order, Birch et a l i & 8  reported
the deuteriation of the long chain fatty acids, Z-octadec-9-enoic (oleicl
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and Z,Z-octadec-9,12-dienoic (linoleic) acids and geraniol in benzene/ 
ethanol solvent systems.
D2
RhCl(PPh3)3 ' OH
Morandi et ali&7 used homogeneous catalytic deuteriation of dec-l-ene, 
dec-3-ene and dec-5-ene coupled with mass spectrometric fragmentation 
pattern analysis to determine the position of the double bond in the 
original alkene for an oil industry application.
In a series of publications, Rakoff et ad 164 . 175-177 have demonstrated 
the preparation of deuteriated long chain fatty acids, esters and 
triglycerides from alkenic precursors. In their most recent report 1^ 7 on the 
saturation of alk-2-ynols and alk-3-ynols and their tetrahydropyranyl ethers 
in benzene as solvent, mass spectrometric analysis revealed that only for 
unprotected hex-2-ynol and pent-2-ynoI a significant scrambling was observed 
with the proportion of d/) species being 70-80% and the remaining species 
being predominantly ds at 15-17%. No hypothesis to explain this result was 
presented.
2.41 Tritium Labelling
Reported examples of tritiated molecules produced by Wilkinson's 
catalytic reduction are rare. This may be due to the added difficulty over 
heterogeneous catalysis of post-reduction separation.
Two examples from Pelc et ali78,i79 involve the tritium labelling of 
the steroids, ergosterol, ergocalciferol and cholecalciferol.
T2, 20%(w/w) 
R h C l ( P P h 3 ) 3
C„H
[ 1,2-3H2]Ergosta-4,22-dien-3-one
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ÇoH
AcO'
[1~3H]Ergosterol
Zilm et a l 180 used tritium labelling of cationic iridium trihydride 
complexes to elucidate the hydride structure of the homogeneous catalyst by 
3H NMR spectroscopy,
2.42 Hydrogen Exchange
Although Osborn et all55 observed that with H2/D2 mixtures products of 
only hydrogen and deuterium adducts resulted at room temperature, 
atmospheric pressure and 10-20% (w/w) catalyst-to-substrate r a t i o s l & 8 ,
Williams' q u e s t i o n i 8 i  about the possibility of using Wilkinson's catalyst in 
hydrogen isotope exchange labelling is answered by the tritium exchange 
labelling work of Odell et a l  182, The conditions for exchange were optimal 
at high temperature (60^C), low catalyst concentration (1 ramole%) and low 
tritium gas pressure (lOOramHg).
2.43 Other Homogeneous Catalysts
The isoelectronic ruthenium(II) complex, RuCl2 (PPhs)3 , is selective for 
alk-l-enes showing a 2-10x10% rate differential over "internal" 
alkenes161 ,18 3,
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3. EXPERIMENTAL
3. EXPKRTMENTAL
3.1 Model Compound Work
A method was sought to incorporate tritium into the phosphatidyl­
choline molecule:
0 - P -6-
by saturation of the aliphatic chain of the fatty acid residue. It was 
necessary to fulfil the following requirements:
(I) Maximum label incorporation. This was an essential prerequisite for 
the study of enzyme complexation due to the inherent insensitivity of NMR 
detection and the low concentration of the biological solution (ie. 1 
mmolar) in NMR samples.
(II) Specific addition of tritium across the double bond. It is 
necessary to know unequivocally the total NMR assignment of the labelled 
molecule to make the fullest use of the anticipated NOE data between the
tritons of the phospholipid ligand and the protons on amino acid residues of
the enzyme in a complex of these two components. If labelling were more 
general in character whereby tritons were present at other carbon positions 
in the molecule, especially extraneous tritons of identical or similar 
chemical shift, identifying the various isotopomers by NMR is
p r o b l e m a t i c ! 24 and compromises the quality of the NOE data r e c o r d e d ! 84,l85.
(III) Symmetrical addition of tritium across the double bond. NOE data 
from both labelled carbon positions are likely to be equally useful.
Protium dilution of one site could make the acquisition of these data 
difficult or impossible.
A labelling procedure whose mechanistic route is reliably known is
required so that the stereochemistry of the labelled sites can be known
from this knowledge. Labelling reagents which permit alkene or allylic
proton/triton exchange prior to saturation may lead to unsymraetrical label
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addition and, hence, assignment difficulties when characterizing the
labelled molecule.
As outlined in the literature review sections, there are many methods 
which can be evaluated and if suitably promising, optimised in order to 
fulfil the points just noted. This highlights the need to perform many 
labelling experiments. Bearing in mind that the synthesis of the
phospholipid is non-trivial, it was decided to conduct the initial labelling 
investigation using (E)-dec-3-enoic acid:
oI
as a model of the phospholipid with deuterium gas instead of tritium 
gas as the hydrogen isotope label source. Although this choice of hydrogen 
isotope meant that NMR analysis would be less detailed than possible for 
1=1/2 3h NMR, this was offset by the ability to obtain additional label 
information from mass spectrometry, an analytical technique not normally 
available for tritiated materials. Also, the elimination of the radiation 
hazard allowed for a speedier experimental throughput.
3.2 Fatty Acid NMR Assignment
In order to derive constructive inferences from the NMR data for 
[2H]decanoic acids obtained from double bond reductions, it was necessary to 
analyze and assign the NMR spectra of the decenoic acid model starting 
material and the expected decanoic acid product of these reductions. The 
chemical shift assignments of some of these molecules have been published 
and these data were used in conjunction with that obtained by the author. 
This survey is presented as TABLE 3 with representative NMR spectra in 
FIGURE 12. This strategy was especially important as the starting material 
contained a mixture of two positional isomers with the double bond at the 2- 
and 3-positions, thus complicating the assignment of the starting material 
and the 2H-labelled products as labelling would be present over a minimum of 
three carbon atoms with a common central carbon at the 3-position.
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3.3 Deuteriation of the Model Compound
This section details the preparation of the deuterium-labelled decanoic 
acid model compounds.
3.4 (A1: 10% Pd/C Heterogeneous Catalyzed Reduction
10% Pd/C (Johnson Matthey, 25.2 mg) and (E)-dec-3-enoic acid (Lancaster 
Synthesis, Technical grade, 60yl, 55.7mg, 327.4jimoles) were placed in a 5ml 
glass flask equipped with a magnetic flea as a solution in dry THE (0.5ml). 
THE was dried with sodium wire and distilled onto activated 4A molecular 
sieves!®^.
Using a hydrogenation apparatus similar- to that described by 
L o c k l e y i 8 7 ,  the solution was frozen in liquid nitrogen and the headspace of 
the reaction vessel was repeatedly flushed with helium gas. The solution was 
thawed with stirring to degas, refrozen and again flushed with helium gas. 
After evacuation, deuterium gas was admitted to the reaction vessel and the 
solution was thawed. The reaction proceeded with stirring at room 
temperature and atmospheric pressure for two hours after which time 
deuterium gas uptake had ceased. The reaction flask was removed from the 
apparatus. Dry THE (2-3ml) was added to the flask and the suspension was 
filtered through Celite filter agent (SiOz) contained in a Pasteur pipette 
into a 25ml round-bottomed flask. The reaction flask and Celite were rinsed 
with another aliquot of dry THE (about 1ml) to ensure the complete recovery 
of the deuteriated product as a THE solution. The THE was removed by rotary 
vacuum evaporation to leave a colourless oil of [G-^H]decanoic acid. 
Exchange labelled deuterium at the carboxyl function was removed by repeated 
dissolution and evaporation of methanol.
The product was analyzed by H^ NMR (300MHz in CDCI3 , FIGURE 13B) and
2H NMR (46MHz in CHCI3 , TABLE 4, FIGURE 14B). The unlocked 2h FT-NMR spectra
were accumulated until the 2h NMR signal due to natural abundance deuterium
of the CHCI3 solvent could be detected above background noise. This occurred
usually about between 500 and 1000 scans. The 2h NMR spectra were referenced
to this signal. Electron impact mass spectra of the acid and its TMS ester
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were also recorded (TABLE 5, FIGURE 16B).
3.5 (B1: 5% Pt/C Heterogeneous Catalyzed Reduction
The procedure used was identical to that for 10% Pd/C catalyzed 
reduction except for the following differences: 5% Pt/C (Johnson Matthey, 
17.7mg); Reaction time =2.75 hours.
The product was analyzed by !H NMR (300MHz in CDCI3 , FIGURE 13A), 
2H NMR (46MHz in CHCI3, TABLE 4, FIGURE 14A) and electron impact mass 
spectrometry of the acid and its TMS ester (TABLE 5, FIGURE 16A).
3.6 (C): RuClafPPhals Homogeneous Catalyzed Reduction
(E)-Dec-3~enoic acid (Lancaster Synthesis, Technical grade, 60pl, 
55.7mg, 327.4^oles) was dissolved in a 3:2 (v/v) mixture of benzene
(Aldrich 99.9+% HPLC grade) and dry absolute ethanol (500pl total volume) in 
a 5ml reaction flask equipped with a magnetic flea. The homogeneous catalyst 
(lOmg, lOjimole, 18% (w/w), 3 mole% catalyst/substrate ratio) was placed on a 
spoon above the solution. Dry ethanol was prepared by refluxing with 
magnesium turnings under dry nitrogen gas for 2-3 hours. The dry ethanol was 
then distilled onto activated 4A molecular sieves 1 8 6,188,
The reaction flask was then placed onto the hydrogenation apparatus. 
Using the freeze-pump-thaw cycle previously described, the solution was 
rigorously degassed. The cycle was repeated five times to ensure all the air 
had been eradicated from the solution. After the final evacuation of helium 
gas, the headspace of the reaction flask was flushed with deuterium gas 
whilst stirring. The deuterium gas was evacuated, the solution was thawed 
and the homogeneous catalyst was dissolved in the solution with stirring to 
give a dark red solution. A fresh batch of deuterium gas was introduced into 
the reaction flask whilst stirring. The uptake of deuterium gas (at 
one atmosphere pressure) was very slow. The translucent solution remained 
red in colour. After 20 hours, the solution was applied to a 200x200x1 mm 
silica préparâtive-TLC glass-backed plate. Washings were taken to ensure the 
complete transfer of the product from the reaction flask to the TLC plate.
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The plate was developed in a 9:1 (v/v) CHCl3 :MeOH solvent system for about 
one hour. Silica in the Rf range between 0.6-0.8 was .scraped off the TLC
plate into a sinter glass funnel and the [3,4-2H2]decanoic acid product was
extracted with CHCI3 . The resultant CHCI3 solution was filtered through
glass wool to remove particulate debris and the solution was rotary vacuum
evaporated to yield a colourless oil of [3,4-2H2]decanoic acid.
This material was analyzed by NMR (300MHz in CDCI3 , FIGURE 13C), 
2R NMR (46MHz in CHCI3 , TABLE 4, FIGURE 14C) and electron impact mass 
spectrometry of the acid and its TMS ester (TABLE 5, FIGURE 16C).
3.7 (D): RhCKPPhs) 3 (Wilkinson's) Homogeneous Catalyzed Reduction
The procedure used was identical to that for RuCl2 (PPh3)3 catalyzed 
reduction except for the following differences: Uptake of deuterium gas (at 
one atmosphere pressure) was complete after 10 minutes to give a pale yellow 
transparent solution. The reaction solution was stirred for five hours.
The product of the reduction was analyzed by IR NMR (300MHz in CDCI3 , 
FIGURE 13D, 13E), 2h NMR (46MHz in CHCI3 , TABLE 4, FIGURE 14D) and electron 
impact mass spectrometry of the acid and its TMS ester (TABLE 5,FIGURE 16D).
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NMR of Standard Reference CIO Acids
Numbering sequence used: 
C - C - C - C - C - C - C - C - C - C  
HIO H9 H8 H7 H6 H5 H4 H3 H2 OH
Compound (E)-Dec-2-enoic (E)-Dec-4-enoic (E) -Dec-3-enoic Decanoic
Acid Acid! Acid Acid
Source Sadtler^* Lancaster^ Sadtler^!* Lancaster3 Sadtler^c/Aldrich^
Solvent CCI4S CDCI3 CCI4 CDCI3 CDCI38
iH(ppm) 3j(Hz)7 !H(ppm) 3j (Hz ) iR(ppm) 3j(Ez) In(ppm) 3j(Hz) !R(ppm) 3j(22)
Proton H2 7.04 7.08 m(-) 2.37 3.06 d(6.2) 2.34
H3 5.76 5.81 d(15.0) 5.54 m(-) 1.64
H4 2.20 2.22 q(-) 5.48 -
H5 2.02 q(6.65)
H6 1.99 1.30
H7 1.31 1.3 *(-) 1.00- — 1.27 m(-)
H8 1.70
H9
HID 0.89 0.87 t(6.5) 0.90 0.87 t(6.5) 0.90
C02H 12.35 s - 11.80 s - 11.79 s
1. Model of (E)~dec-3-enoic acid for NMR assignment purposes as Lancaster 
Synthesis source is a mixture of 2-ene and 3-ene isomers.
2. Sadtler Standard Spectra. Sadtler Research Laboratories Ltd.
(a) Spectrum 3828 at 60 MHz <b) Spectrum 17620 at 60 MHz (c) Spectrum 
6723 at 60 WHz
3. Lancaster Synthesis. Source of (E)-dec-3~enoic acid used in the synthesis 
of Phospholipid 3. ^H NMR at 300 MHz. Proportion of (E)-dec~2-enoic acid 
contaminant in {E)-dec-3-enoic acid* calculated from comparison of 
integrals of H4 and H5* and H2,H3 and H3*,H4* in the %  NMR spectrum = 
18mole%. See FIGURE 12.
4. Aldrich NMR Spectrum 15.376-1 at 60MHz. See FIGURE 12.
5. 30mg/0.5ml
6. 60mg/0.5ml
7. Not given
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FIGURE 12: NMR Spectra of Decanoic and (E')-Dec-3-enoic Acids
100 V
C02H
I I CH|CH,(CHt),-C-OH !
H4-H9600 Hz. ShUt
‘IHIOL__:. H2
A: Reference spectrum 15,376-1 of decanoic acid from Aldrich NMR Spectra at
60 MHz, 60me/0.5ml CDC13. Used to assist the assignment of the NMR
spectra of reduced (E)-dec-3-enoîc acid. See TABLES 3 and 4 .
JLd_ i
— I—5PPM
[i Technical grade (E)-dec-3-enoic acid in CDC13 at 300 MHz. Used as a model 
compound in order to identify the appropriate reduction method for tritium 
labelling. Also used as a starting material in the phospholipid 
synthesis-
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TART.E à: 2h NMR Data for F^ HtilDecanoic Acids
Numbering sequence as TABLE 3.
For 2h NMR spectra, see FIGURE 14.
Method of 
Preparation!
Chemical 
Shift(ppm)
Positions
Labelled^
Extent of Labelling(%)3
10% Pd/C, 0.90 HIO 15.0
D2, THF 1.29 H4-H9 66.0
1.64 H3 14.0
2.35 H2 2.8
5.45 H3/H44 2.2
5% Pt/C, 0.87 HIO 1.4
D2, THF 1.29 H4-H9 67.3
1.60 H3 27.3
2.32 H2 4.0
RuCl2(PPh3)3, 1.34 H4 -5
Dz, 3:2 benzene: 1.63 H3 -
ethanol 2.33 H2& —
RhCl(PPh3)3,
D2, 3:2 benzene: 
ethanol
1.33
1.63
2.35
H4
H3
H26
42.5
50.5 
7.0
1. See SECTIONS 3.4 to 3.7 for full details.
2. H3/H4 is the position of the double bond in precursor (E)-dec-3-enoic 
acid (82 mole%) and H2/H3 is the position of the double bond in the 
(E)-dec-2-enoic acid contaminant (18 mole%) of the Lancaster Synthesis 
source.
3. Percentage of the total integral over all signals in the NMR spectra. 
For absolute ^H-labelling results, see the mass spectrometric data, 
TABLE 5.
4. Alkene exchange labelling of (E)-dec-3-enoic acid only.
5. High noise level in NMR spectrum (FIGURE 14C) invalidated integral 
measurements.
6 . Indicates (E)-dec-2-enoic acid labelling only.
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FIGURE 13: 300 MHz IR NMR Spectra of Gas Reduced (E)-Dec-3-enoic Acid
For the corresponding NMR spectra, see FIGURE 14 .
T
2
T5T4TS iT7 PPM
A: [G-2HnlDecanoic acid prepared by 5X Pt/C catalytic reduction with 
one atmosphere pressure ^H2 &&s in THF at room temperature.
~r8 —T-5PPM7 6 4 Z 2
B; As A above, using 10% Pd/C as catalyst.
_UaJ aJU
8 5PPM 1
£: t3,4-2H2]Decanoic acid prepared by RuCl2(PPh3)3 catalytic reduction 
with one atmosphere pressure of E^2 gas in 3:2 benzene:ethanol at rooi 
temperature.
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PPM
J2: As C above, usine RhCl(PPh3)3 (Wilkinson's catalyst) as catalyst.
H4-H9
HIO
11 (12)
H2
H3
(2)2 (2)
JE: Expansion of I) above. The signal integrals reveal two deuterium atoms 
per molecule. Values in brackets are the Integrals expected for 
[3,4-^H23decanoic acid.
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FIGURE 14: 46 MHz NMR Sueetra of ^Ei Gas Reduced 
(E^-Dec-3-enoic Acid in CHCls
For corresponding NMR spectra and mass spectrometric data, see FIGURES 
13, 16 and TABLE 5 respectively.
34 278 G SPPM
A: [G-^HnlDecanoic acid prepared by 5% Pt/C catalytic reduction with 
one atmosphere pressure E^2 gas in THF at room temperature.
37 26 5 46 PPM
B: As A above, using 10% Pd/C as catalyst.
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£: [3.4-2H2]Decanoic acid prepared by RuCl2(PPh3)3 catalytic reduction 
with one atmosphere pressure of gas in 3:2 benzene;ethanol at room 
temperature.
-T I-----1--------1----- 1------- 1------i------i----8 7 6 5 4 3 2 1PPM
D; As C above, using RhCl(PPh3)3 (Wilkinson's catalyst) as catalyst,
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FIGURE 15; CiMnmter Program for the Calculation of Mole X Deuterium in Deuteriated Conmonndsi
1 CLS
2 PRINT "PROGRAM FOR CALCULATION OF %D"
10 DIM P(50), Q(50), N$(30), R(50), A(50)
15 T=0:X=0:M=0
20 INPUT "ENTER SAMPLE DETAILS (NAME, NO.?) ";N$1005 FOR 1=1 TO 17
1010 PRINT "P";I-3;" PEAK";: INPUT"? ";P(I)1015 IF P(I)=666 THEN 1=1-1:G0 TO 1010
1020 IF P(I)=999 THEN GO TO 1040
1030 NEXT I
1040 P(I)=0
1050 INPUT "C?";C
1051 INPUT "H?";H
1052 INPUT "0?";0
1053 INPUT "SI?";SI
1060 F0=1.lE-2*C+4E-4*0+5.1E-2*SI
1070 F3=2E-3*0+3.4E-2&SI
1080 F1=P(2)/P(3)
1090 F2=P(1)/P(3)
1100 I=0:M=0:K=0
1110 1=1+1
1120 Q(1)=0:Q(2)=0
1130 Q(I+2)=P(I+2)*(1+F1+F2)-P(I+3)*F1-P(I+4)«F21140 R(1)=0:R(2)=0
1150 R(1+2)=(Q(1+2)-FO*R(I+l)-F3*R(I))*(1+F0+F3)1160 IF R(I+2)<0 THEN R(I+2)=0
1165 M=M+R(I+2)
1170 IF K=H THEN GO TO 1110
1190 CLS
1200 AT 0,0:PRINT N$
1201 AT 1,0:FOR 1=1 TO 22
1202 PRINT "-":AT 1,1
1203 NEXT I
1204 AT 2,0:PRINT " #D OBS PK %CORR PK"1205 AT 3,0:FOR 1=1 TO 22
1206 PRINT "-":AT 3,1
1207 NEXT I
1210 FOR 1=0 TO H
1215 IF T=1 THEN GO TO 1260
1220 A(I)=100*R(I+3)/M
1230 K=K+(I*A(I))
1231 GO SUB 6000
1250 IF A(I)<0 THEN A(I)=0
1255 IF P(I+3)=0 THEN GO TO 1300
1260 AT 1+4,0:PRINT" ";I;:AT 1+4,6 ;PRINT P(I+3);:AT 1+4,16:PRINT A(I)1290 NEXT I
1300 FOR Z=1 TO 22
1301 PRINT "-":AT 1+4,Z
1302 NEXT Z
1303 A(20)=K/H:IF A(20)<0 THEN A(20)=01310 1=20:GO SUB 6000
1320 PRINT "%D= ”;A(20)
1330 STOP
6000 X=0
6030 IF A(I)<327.67 THEN GO TO 60506040 X=X+l:A(I)=A(I)-300
6050 A%=A(I)*100+0.5:B=(A%/100)+(X&300)
6060 A(I)=B:RETurn
1. A truncated and amended version of the computer program, DEUTCALC_80*89, rewritten in SuperBASlC to run on a Sinclair QL microcomputer.
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TABLE 5: Mass Snectrometric Data for f^HnlDecanoic Acids and TrimethvlsilylF 1decanoates
For mass spectra, see FIGURE 16.
A: Decanoic Acid Molecular Ion Clusters
Decanoic acid C10H20O2 = 172 g mol"i
[2^ 2] Decanoic acid C10H18D2O2 = 174 g mol l
Observed !intensity! Corrected Intensity (X)2»7Method:3 Pt Pd Ru Rh Pt Pd Ru Rh
*D* m/z5
0 172 1904 992 _ 112 50 29 100 9.61 173 1560 1104 - 240 34 28 - 192 174 624 880 - 847 12 22 - 703 175 118 504 - 112 3 12 - 0.84 176 48 267 — 1 6.2 —5 177 120 2.76 178 40 0.8
%D6. 7 3.6 7.5 - 8.1
B: Trimethvlsilyldecanoate Molecular Ion Clusters 
Trimethylsilyldecanoate Ci3H2802Si = 244 g mol"l 
Trimethylsilyl[2H2]decanoate Ci3H26D202Si = 246 g mol“i
Observed Intensity Corrected Intensity CXIMethod: Pt Pd Ru Rh Pt Pd Ru Rh
#D m/z
0 244 605 136 391 112 38 11 77 6.21 245 664 213 192 433 33 14 19 222 246 400 241 60 1336 16 15 3.6 683 247 192 256 360 7 16 2.54 248 96 240 96 3.7 14 1.55 249 56 193 2.3 116 250 32 144 1.3 7.97 251 112 6.38 252 65 3.29 253 46 2.5
%D 4.2 12.2 0.95 6.1
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C: Dimethvlsilvldecanoate cation. M-15 Daughter Ion Clusters 
Dimethylsilyldecanoate cation CizHzsOzSi = 229 g mol"i 
Dimethylsilyl[2H2]decanoate cation CizHzaDzOzSi = 231 g mol"%
Observed Intensity Corrected Intensity (X)
Method: Pt Pd Ru Rh Pt Pd Ru Rh
#D m/z
0 229 19713 3448 12728 33 38 8.4 77 0.07
1 230 21824 6329 5960 9168 34 14 19 17
2 231 12512 7833 1846 46334 15 16 3.4 82
3 232 5920 7695 424 9726 6.5 15 0.94 0.01
4 233 2855 7060 129 2616 3.4 13 0.42 1.0
5 234 1472 6071 320 1.8 11 0.36
6 235 776 4792 48 0.95 8.6 0.01
7 236 396 3448 0.48 6.0
8 237 197 2259 0.24 3.8
9 238 96 1424 0.12 2.4
10 239 44 833 0.05 1.3
11 240 480 0.77
12 241 268 0.43
13 242 149 0.24
XD 4.7 15 1.2 7.5
Footnotes apply to parts A, B and C of this TABLE.
1. Absolute intensity of mass spectrometric peaks at shown m/z values.
2. Mass spectrcMnetric peaks corrected for the natural abundance of isotopes, 
expressed as a percentage of the total molecular ion cluster.
3. Method of deuterium labelling. Pt = 5% Pt/C, Dz, THF; Pd = 10% Pd/C, Dz, 
THF; Ru = RuClz(PPh3)3, Dz, 3:2 benzene:ethanol; Rh = RhCl(PPh3)3, Dz,
3:2 benzene:ethanol.
4. #D = Number of deuterium atoms per molecule.
5. m/z = Mass-to-charge ratio of cations and radical cations recorded in the 
mass spectrometer. For all the species displayed, z = 1.
6 . XD = Mole atom X deuterium. For 2D's, A = lOX, B =* 7.IX, C = 8 .OX
7. Calculated using a truncated and amended version of the computer program, 
DEUTCALC_80i®9^ rewritten in SuperBASlC to run on a Sinclair QL 
microcomputer. See FIGURE 15 for a listing of this program.
169
FIGURE 16: 70eV Electron Impact Mass Spectra of F^HnlDecanoic Acids 
For mass spectrometric data, see TABLE 5 .
108.
A2
5X Pt/C Catalyst
Ai; [G-%n]l)ecanoic acid
A2: Trimethylsilyl[G-^Hnldecanoate
170
173 B1
B2
IDS Pd/C Catalyst
Bl: tG“^Hn]Decanoic acid
B2: Tri»etliylsilyl [G—^HnJdecanoate
171
HuCl2<PPh3)3 Catalyst
Cl: [3,4-%2]Decanoic acid
C2: Trinethyl[3,4-2H2]decanoate
172
len, D1
35.
Ml 203
RhCl(PPh3)3 Catalyst
D1 : (3,4“2H2]DecaTioic acid
Trimethylsilyl[3,4-2H2)decanoate
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SCHEME 1: Synthesis and Tritium-Labelling of an 
Unsaturated Phosphatidylcholine
DCC, HBT
CH2C12, 19hrs.,70%
b&nzene, EtsN
65®C, 19 hrs., 26S
DHAP.ci-p-0 *3-Stirs
(2)
Tritiation Method a.b,c
•N(Me)^
(3)
0-P-i6-
(4a-c)
a = N2T2, dioxane
h = lOS Pd/C, T2, HeOH
c = RhCl(PPh3)3, T2. 3:2 benzene:ethanol
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3.8 Synthesis of an Unsaturated Phosphatidylcholine
The following sections detail the preparation of a triturn-labelled 
amide substrate-analogue PLAz inhibitor for NMR studies.
3.9 (Rl-N~r(l^-Hvdroxymethvl)isoTientvnE-dec-3-enaiDide (1)
Anhydrous dichloromethane and benzene were prepared by refluxing over 
calcium hydride under a continuous stream of dry nitrogen gas. The dry 
solvents were then distilled onto activated 4A molecular sieves^é.i86.
An oven-dried 25ml round-bottomed flask containing a magnetic stirrer 
bar was sealed with a rubber septum and a wrap of parafilm around the neck. 
The flask was flushed with dry nitrogen gas using an oven-dried needle inlet 
and outlet. In the flask were syringed anhydrous dichloromethane (15ml), 
(E)-dec-S-enoic acid (Lancaster Synthesis, Technical grade, 0.74ml, G.69g, 
4.05 mmoles) and (R)-leucinol (Aldrich, 98%, 0,55ml, 0.5g, 4.27mmoles).
After the addition of each reactant, the syringe was rinsed several times in 
the reaction solution to ensure complete transfer of each reagent to the 
flask. The colourless, transparent solution was stirred for a few minutes to 
ensure homogeneity. The septum of the flask was removed and in quick 
succession, DCC (0.90g, 4.4mmoles) and N-hydroxybenzotriazole (0.59g, 
4.4mmoles) . were added. After replacing the septum, the headspace of the 
flask was flushed with dry nitrogen gas and the septum and neck of the flask
were sealed with a wrap of parafilm. A white precipitate of
N,N'-dicyclohexylurea began to form about 2-3 minutes after the start of the
reaction.
The reaction mixture was stirred at room temperature for 19 hours. The 
course of the reaction was monitored by TLC on silica gel plates; 7:3 (v/v) 
ethyl acetate:hexane. The TLC plate was sprayed with ethanolic
phosphomolybdic acid solution (10% (w/v)) and heated at. 120 C for 15 
minutes. Rf(l) = 0.33 (3-ene isomer); Rf = 0.49 (2-ene isomer). After this 
time, the suspension was vacuum filtered through an oven-dried glass sinter 
funnel to give a translucent yellow solution and a flaky white crystalline 
co-product. The yellow dichloromethane solution was rotary vacuum evaporated
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to yield a yellow oil containing the two positional isomers of the title 
compound. The oil was dissolved in ethyl acetate (20ml) and successively 
washed with 2M HCl (to remove unreacted (R)-leucino^L water, saturated sodium 
hydrogen carbonate solution (to remove unreacted decenoic acid) and saturated 
brine solution. The organic phase was dried over magnesium sulphate, 
filtered and evaporated.
The yellow oil was dissolved in 7:3 (v/v) ethyl acetate:hexane (5ml). 
Four equal fractions of this volume were separately purified by "flash" 
chromatography using a 250x20 mm silica column, eluting with 7:3 (v/v) ethyl 
acetate:hexane, collecting 20ml fractions. The fractions containing the pure 
3-ene isomer (typically fraction nos. 14-25) were pooled and rotary vacuum 
evaporated. Fractions containing a mixture of the 2-ene and 3-ene isomers 
(typically fraction nos. 10-12) were pooled, evaporated and subjected to 
flash chromatography for a second time. The resultant yellow oil was 
dissolved in ethyl acetate and filtered through a glass-wool plug to remove 
particulate debris. The solution was lyophilized to yield the pure 3-ene 
isomer (1) as a sticky, yellow oil. Yield = 624mg, 2.32 mmoles, 70% - based 
on the proportion of (E)-dec-3-enoic acid in the limiting starting material.
The product was analyzed by TLC (as above), NMR (FIGURE 17A) and 
IH/IH-COSY (FIGURE 17B).
12 ^ O H
IH NMR (CD3OD, 300MHz, 298K): H4,5.6,m; H3,5.5,m; Eli,3.95,2t
(3J=5.62Hz); H12,3.45,d (3J=5.27Hz); H2,2.90,d (3J=5.71Hz); H5,2.03,q
(3J=6.46Hz); H14,1.63,m; H13,1.36,m; H6-H9,1.30-1.34,m; H15,H16,0.93,d
(3J=7.07Hz); H10,0.89,t (3J=5.0Hz).
Note: The numbering scheme used for NMR assignment bears no relation 
to the numbering scheme used for its nomenclature!
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3.10 (E)-(R')-(2-Dec-3-enainidoisohexvl)phosphocholine (3)
(R)-N~[(1-Hydroxymethyl)isopentyl]E-dec-3-enainide (1) (620njg,2.31minole) 
in an oven-dried 25ml round-bottomed flask with a magnetic stirrer bar and 
stoppered with a rubber septum was dissolved, with stirring, in anhydrous 
benzene (15ml) to give a translucent, yellow solution. The headspace of the
flask was flushed with dry nitrogen gas. The solution was cooled to
approximately in a cyclohexane/liquid nitrogen bath for 10 minutes. Dry
triethylamine (0.40ml, 2.9mmoles) was then syringed into the flask, followed 
by DMAP (3mg, 25uraoles). The headspace of the flask was again flushed with 
dry nitrogen gas. After removing from a freezer and thawing in a desiccator, 
2-chloro-2-oxo-l,3,2-dioxaphospholane (0.28ml, 3.0ramoles) was added dropwise 
to the flask at 6‘’C over a five minute period. The flask was removed from
the cooling bath and stirred at room temperature whilst monitoring the
reaction by TLC (7:3 (v/v) ethyl acetate:hexane, Rf(2) = 0.17).
The reaction was complete after 3.5 hours, giving an opaque, yellow 
suspension of a white precipitate. The suspension was vacuum filtered 
through an oven-dried glass sinter funnel. The benzene solution was then 
rotary vacuum evaporated to leave a residual orange oil of compound (2). 
This was immediately dissolved in anhydrous acetonitrile (Aldrich, <50ppm 
water, further dried over Trap-pak (Millipore) molecular sieves) (5ml) and 
was transferred to an oven-dried thick-wall glass tube by Pasteur pipette. 
The flask was rinsed with an additional aliquot of acetonitrile (l-2ml) to 
ensure total transfer.
In an efficient fume-cupboard, anhydrous triraethylamine was bubbled
through the solution of (2) in the glass tube. Anhydrous triraethylamine was
supplied in an Aldrich Sure/Pac cylinder fitted with a valve, Tygon tubing
and a NMR Pasteur pipette held with zip fasteners. After approximately 2-3
minutes, a volume of about 15ml of trimethylamine had been transferred. The
tube was immediately sealed with a rubber septum and the volatile solution
was promptly frozen in liquid nitrogen. The headspace of the glass tube was
evacuated by connecting a needle inserted through the rubber septum via a
syringe barrel and Tygon tubing to a vacuum pump. Whilst maintaining the
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evacuation, the tube was flame-sealed. The glass tube was allowed to 
equilibrate to room temperature before placing in an oil bath at 60-65°C for 
19 hours. After this time, the glass tube was removed from the oil bath and 
allowed to cool to room temperature. After further cooling in a COz/water 
bath, the neck of the glass tube was cautiously opened inside an efficient 
fume cupboard. The excess trimethylamine was allowed to boil off. The
resultant acetonitrile solution was rotary vacuum evaporated to give an 
orange tacky oil.
The oil was purified by flash chromatography (silica column 225x20mm, 
eluting with 65:25:4 (v/v/v) CHCI3 :Me0H:H2 0, collecting 15 fractions of 
10-20ml each; Rf(3) = 0.2). The appropriate fractions (typically fraction
nos. 7-12) were pooled and evaporated to give a white, waxy, hygroscopic 
solid (3). This was taken up in methanol, filtered through a glass-wool plug 
to remove particulate debris and lyophilized. Yield = 261mg, O.bmmoles, 26%.
Overall yield from (E)-dec-3-enoic acid = 18% (Lit. = 36%2 2, 7%!07),
The product was analyzed by TLC (as above), IR NMR and IH/IH-COSY
(FIGURE 18).
IH NMR (D2O,300MHz,298K): H4,5.67,m; H3,5.56,m; H17,4.3,m; Hll,4.08,m;
HI2,3.86,3.80,2ra; HI8,3.68,m; HI9,3.24,s; H2,2.97,m (resolved as 2m at 
500MHz); H5,2.04,m; H14,1.65,m; H13,1.50,1.40,2m; H6,1.35,m; H7-H9,1.29,m;
H15,H16,0.93,0.89,2d (3j=6.56Hz); H10,0.87,t (3J=6.14Hz).
3.11 (R)-(2-Decanamidoisohexyl)phosphocholine
This molecule was synthesized and its IH NMR spectrum analyzed by 
Fisons Pharmaceuticals personnel. It is the saturated analogue of 
phospholipid (3) and the hydrogen analogue of the tritiated phospholipids 
(4a-c). Its H^ NMR spectral assignment, although incomplete due to some 
signal overlap, is helpful for the assessment of the corresponding
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tritium-labelled phospholipids (4a-c).
15
13/
16
17 19
H 111 18
IH NMR (DzO,500MHz,303K, FIGURE 19): H17,4.30,m; HI 1,4.11,m; H12,3.86, 
3.80,2m; H18,3.68,m; H19,3.24,s; H2,2.26,m; H14,1.66,ra; H3,1.65,1.58,2m:
H13,1.50,1.37,2m; H4-H9,1.27,m; HIS,H16,0.95,0.91,2d (3J=6.5Hz); H10,0.85,t
(3J=6.3H z ) .
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FIGURE 17; 300 MHz NMR and Magnitude-CQSY spectra(R)-N-f (1-HvdroxvmethvlI isoT)entyl1E-dec-3-enamide in dA-methanol
1 X
A: NMR
rr
12 /O H  •
15.16
r-
fT'
B: Haenitude-COSY. Digital resolution = 0.98 Hz/point in both FI and F2.
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FIGURE 18: 300 MHz NMR and Wagnitude-COSY spectra offE)-rR)-^f2-Dec-3-enaipidoisohexyl)phosphocholine in D2O
'S’kA: ‘H NMR
n / T ^  6
T19
B: Magnitude-COSY. Digital resolution = 0.98 Hz/point in both FI and F2.
181
FIGURE 19 : 500 MHz NMR and Magni tude-COSY spectra of
(R)-(2-Decanamidoisohexyl)phosphocholine in D2O
1^1
A: NMR
9 7 5 3
15
•16
18
B: Magnitude-COSY
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3.12 Tritiiim-Labelling of Phospholipid (3)
The following three sections detail the 
[3H]phospholipids, 4a-c.
preparation of
:3.13 r^HIDiimide Reduction of Phospholipid (31
Into an oven-dried 10ml round-bottomed side-arm flask with magnetic 
stirrer bar were placed phospholipid (3) (16.0mg, 37jjmoles) and potassium 
azodicarboxylate (PADA, yellow solid, 50mg, 257praoles). The two solids were 
lyophilized overnight.
Using the apparatus illustrated below;
platinum (IV) oxide (Adams' catalyst, 23.4mg, 95jjmoles) in flask B was 
lyophilized under high vacuum whilst heating with a hot-air gun (X,Y,Z 
open). After approximately 20 minutes, tritium gas at 340mmHg (about 0.5 
atm.) was introduced into flask B (X closed, Y,Z open). A flash was observed 
which heralded the formation of maximum specific radioactivity [SHzjwater 
(190jjmoles, 10.9 Ci). Anhydrous dioxane (SOOpl) was injected into flask B to 
solvate the tritiated water. After stirring to mix, flask B was placed in 
liquid nitrogen enabling the evacuation of tritium gas from flask B, which 
was then thawed.
The [3H2]water/dioxane mixture was transferred to flask A. This was 
achieved by admitting dry nitrogen gas into flask B at 150mmHg pressure. 
Flask A was maintained under high vacuum. Simultaneously, flasks A and B
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were connected by inserting a double-ended stainless steel needle through 
the septa of the side-arm ports of the two flasks. Flask A was held in 
liquid nitrogen and flask B was gently warmed with a hot-air gun to assist 
this process. Flask B was rinsed with dioxane to complete the transfer. 
After removal of the double-ended needle and a return to room temperature, 
acetic anhydride (1^1, 191pmoles) was injected into flask A. The reaction 
mixture was then heated in an oil bath at 65 C with stirring for 30-40 
minutes to form [O-^Hjacetic acid (382pmoles, 10.9 Ci). The 
phospholipid/PADA mixture in a separate flask was suspended in dioxane 
(1.5ml) with warming. Using the needle transfer procedure described above, 
the [0-^H]acetic acid/dioxane mixture was transferred to the flask 
containing the phospholipid substrate and PADA reactant. Flask A was rinsed 
with additional dioxane (250^ 1) to maximise the [O-^H]acetic acid transfer.
The reaction mixture under dry nitrogen gas of 270ramHg pressure was 
stirred at room temperature for 16 hours. After this time the pressure in 
the reaction flask had increased to 300mmHg and the cloudy yellow solution 
was lyophilized and all exchangable tritons were removed by the addition and 
lyophilization of three separate aliquots of methanol (1ml). A suspension of 
the reaction mixture in anhydrous acetonitrile was filtered with washings 
through a glass-wool plug held in a glass Pasteur pipette. The resultant ' 
translucent solution of phospholipid (4a) (SCHEME 1) was lyophilized and 
analyzed by liquid scintillation counting, and NMR (TABLE 6, FIGURE 
21A1-3). Yield = 74 mCi.
3.14 10% Pd/C Catalyzed Reduction of Phospholipid (3)
A solution of phospholipid (3) (B.Omg, 18.5jimoles) in methanol (HPLC 
grade, 2ml) was prepared in a glass flask equipped with a magnetic stirrer 
bar. The catalyst spoon above the solution was charged with 10% Pd/C 
(8.3rag). The solution was frozen with liquid nitrogen and the headspace of 
the flask was repeatedly flushed with nitrogen gas. The solution was thawed 
with stirring to degas, refrozen, evacuated and again flushed with nitrogen 
gas. The freeze-pump-thaw cycle was repeated. After evacuation, tritium gas
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was admitted to the reaction flask, the solution thawed and the catalyst 
dropped into the solution. The tritium gas pressure was 723mmHg. Tritium gas 
uptake was monitored by observing the gas pressure and was complete after 
two hours. After flushing with nitrogen gas, the suspension was thawed. The 
flask was brought to atmospheric pressure with nitrogen gas and methanol 
(1ml) was added with stirring. The solvent was lyophilized to remove 
exchangable tritons. The procedure was repeated. After a further addition of 
methanol (1ml), the suspension was passed through a PTFE filter to remove 
the heterogeneous catalyst and the reaction flask and catalyst were rinsed 
with methanol in order to recover all the tritiated product. The pale yellow 
solution was lyophilized to give phospholipid (4b) which was analyzed by 
liquid scintillation counting, NMR (FIGURE 21B1) and NMR ( TABLE 6, 
FIGURE 21B2-3). Yield = 1.6Ci, approximately 85 Ci/mmole (about 3 tritiums 
per molecule).
3.15 RhCl(PPh3)3 (Wilkinson's) Catalyzed Reduction of Phospholipid (3)
A solution of phospholipid (3) (lO.Omg, 23jLiraoles) in a 3:2 (v/v)
solvent mixture of benzene:ethanol (1ml total volume) was prepared in a
glass flask equipped with a magnetic stirrer bar. The catalyst spoon above
the solution was charged with RhCl(PPh3)3 (Wilkinson's catalyst, 20.5mg,
22.2jimoles). The solution was frozen with liquid nitrogen and the headspace
of the flask was repeatedly flushed with nitrogen gas. The solution was
thawed with stirring to degas, refrozen, evacuated and again flushed with
nitrogen gas. The freeze-pump-thaw cycle was repeated three times. The
soluble catalyst was then added with stirring to the substrate solution.
After a further sweep of nitrogen gas followed by evacuation, tritium gas at
one atmosphere pressure was admitted to the solution with vigorous stirring.
The initially red solution adopted a translucent dark yellow colour after
approximately 20 minutes. The solution was stirred vigorously for 3.5 hours.
The solution was frozen in liquid nitrogen, tritium gas was evacuated and
after flushing with nitrogen gas, the solution was thawed. The flask was
brought to atmospheric pressure with nitrogen gas and methanol (1ml) was
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added via the side-arm of the flask. The mixture was stirred and then 
lyophilized. The lyophilized solid was dissolved in 65:25:4 CHCI3 :Me0H:H20 
(v/v/v) (1ml) and applied to a flash chromatography column (silica,
250x20mm). The homogeneous catalyst and tritiated phospholipid (4c) were 
separated as illustrated in FIGURE 2Qi90 with a 65:25:4 CHCI3 :MeOH:H20 
(v/v/v) solvent system. The fractions containing phospholipid (4c) were 
identified by analysis of the liquid scintillation counting results of all- 
the fractions collected. These were pooled and lyophilized. The resultant
white, waxy, hygroscopic solid was analyzed by IH NMR (FIGURE 21C1), NMR
(TABLE 6, FIGURE 21C2-5) and 3h/3H-COSY191 (FIGURE 21C6). Yield = 1.3 Ci,
approximately 57 Ci/mmole (about 2 tritiums per molecule).
3.16 Radiochromatographic Purification
As the [3,4-3H2]phospholipid (4c) was not used for its intended purpose 
for several weeks after its radiosynthesis, radiolysis of the molecule
necessitated chromatographic purification before it could be used for a 
NMR study of PLA2 complexation.
A reversed-phase HPLC (RP-HPLC) analysis (FIGURE 22) revealed the 
extent of the radiolysis. However, RP-HPLC was not suitable for the 
preparative scale purification of small quantities of a highly radioactive 
material as significant post-column "wet" chemistry is needed to retrieve 
the phospholipid, free of contaminating associated counter ions 192.
Flash chromatography was also incompatible because of the small 
quantities of material involved and the chromatographic similarity of the 
impurities. This would mean poor recovery of tritiated material from the 
column coupled with a poor resolution of the separating bands.
Thus, radio-TLC purification was chosen as a purification technique. 
The method has reasonable resolution, higher than flash chromatography, and 
the overwhelming advantage that developed radio-TLC plates can be 
extensively analyzed by gas scintillation counting enabling an adequate 
separation of the pure radio-ligand to be effected.
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I
3.17 Radio-TLC Purification
Using 0.25mm thickness analytical silica glass-backed TLC plates, three 
solvent systems were compared (FIGURE 23). Solvent system C (65:25:4 (v/v/v) 
CHCI3 ;Me0H:H20) was selected because of its low water content, faster 
elution rate (ie. quicker TLC plate development) and apparently higher 
resolution.
A 200x200x 0.5mm preparative TLC plate was blown with nitrogen gas to 
eject loose silica from the surface of the TLC plate before the application 
of the tritiated crude phospholipid (4c) thus avoiding the radiological 
hazard of airborne silica particles impregnated with high levels of 
radioactivity. Crude phospholipid (4c) (195raCi) was applied to the base line 
in the kieselguhr "concentration zone" of the preparative 200x200x0.5 mm 
glass-backed normal-phase silica TLC plate as a methanol solution. A band of 
the TLC plate approximately 20mm wide on one edge of the plate was not used 
for the development.
The TLC plate was developed in a tank containing 65:25:4 (v/v/v)
CHCI3 :MeOH:H20 over a 75 minute period in a fume cupboard. After drying in a 
fume cupboard, the eluted band profile was determined by gas scintillation 
counting at numerous locations across the width of the plate on a Berthold 
LB2842 Automatic TLC-Linear Analyzer. The strip at the edge of the developed 
plate was spotted with crude tritiated material at known locations close to 
the expected Rf of the pure [3H2]phospholipid (4c) in order to assist in 
accurately defining its Rf-limits which were indicated on the plate by 
pencil.
The stem of a glass sinter funnel was connected to a length of rubber 
tubing attached to a vacuum pump. The neck of the funnel was stoppered with 
a bung pierced by a glass Pasteur pipette. With the vacuum pump on, the
silica strip containing the pure [^H2]phospholipid (4c) was removed from the
TLC plate by scraping the tip of the Pasteur pipette across the TLC plate. 
The phospholipid was extracted from the silica in the funnel using a 
water/ethanol (5:1 (v/v)) solvent mixture. The resultant solution was
filtered through a glass wool plug contained in a glass Pasteur pipette and
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evaporated under a stream of nitrogen gas to yield a white solid. Yield = 
70mCi. See FIGURES 23 and 24 for an illustration of the radio-TLC 
purification.
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TABLE 6: NMRi Chemical Shifts of F3fln1Phospholipids in D2Q
For NMR spectra, see FIGURE 21.
Method of 
Reduction
Positions
Labelled
ChemicalShift2
(ppm)
Coupling 
Constant 
3Jtt (Hz)
Integral % 
(%)
N2T2, H3 1.65 — 18.13dioxane 1.57 -
H4 1.30 - 18.23
1.27 —
10% Pd/C, H2 2.24 — 1.9
T2, MeOH H3 1.62,1.60 7.0 29.71.58,1.56* 6.5
H4 1.30,1.28 7.01 67.0
1.26,1.24* 7.2 f
H5-H9 - -  3
\ HID 0.78 — 1.4
RhCl(PPh3)3 V H3 1.64,1.626 5.4 49.0T2, 3:2 1.58,1.56? 6.1
benzene:EtOH H45 1.31,1.296 6.5 51.0
1.29,1.27? 6.4
1. At 320 MHz and 298K
2 . IH decoupled.
3. A total of 36.4% for the iH-coupled NMR of the diimide reduced 
product. The remainder of the 3H NMR signal is CH2TCO2" at 2.05 ppm 
(63.6%). The integral values show even addition specifically across the 
double bond at C3-C4.
4. These signals are of greater intensity than the corresponding doublet 
(see FIGURE 21B3).
5. The inner arms of the overlapping doublets of H4 were resolved at 533 MHz 
(see FIGURE 21C4).
6 . These signals of the diastereotopic H3 and H4 doublets are J-coupled (see 
FIGURE 21C6) and hence belong to one of the two diastereomers.
7. As footnote 6 above.
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FIGURE 20: Radiochromatograin of Flash Chromatographic Purification _ of
r3H2lPhosTiholipid4c after Homogeneous Catalytic Tritiation.
xlO& cpm
lOi
A = RhClT2(PPh3)3
B = [3H2]Phospholipid 4c
20 40 60 80 100 120 140 160 180 200 220 2400
Volume of Eluant (ml)
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FIGURE 21: 300 MHz and 320 MHz NMR Spectra of r^ H2lPhospholipids
For chemical shift data, see TABLE 6 .
_A
Al; NMR of the product of diimide reduction.
A2T4
1*6
A2: NMR (%-decoupled). Shoulders on the high-field side of the signals
indicates J-coupled doublets which represents the small
percentage of the [3,4-%2]phosphoIipid. Main signals are due to 
[3-3h i ]- and [4-%l]phospholipids.
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T3
IP
Ài; %  NMR (^H-coupled) . This spectrum reveals the extent of the CH2TC02" 
contaminant.
ai: NMR of the product of 10% Pd/C catalytic reduction.
-A_J
B2
NNR <^H-decoupled).
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B3
B3: Expansion of the two major signals of 62 above. Unresolved shoulders and 
unequal signal intensities reveal general labelling of the aliphatic 
chain.
IIL: NMR of the product of RhCl(PPh3)3 (Wilkinson's) catalytic reduction.
Compare with FIGURE 19.
CZ
C2: %  NMR (^H-decoupled).
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C3
T4T3
Ci: Expansion of C2 above.
J V
C4
'^v
C4: Resolution of the T4 doublets at 533 MHz.
05
Ci: ^H NMR after préparâtive-TLC purification approximately 6 weeks after 
radiosyntbesis.
194
C6
T T3
C6: Phase-senstive COSY, Presents the correlation identifying the two
diastereomers.
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FIGURE 22 : Analytical Radio-HPLC of [^HnlPhospholipid^ 
3 Weeks after Synthesis.
On a Waters Radial Pak colusn eluted with a binary solvent system consisting 
of 85:15 (v/v) I:II; I = CH3CN:H3P04 100:1.2 (v/v), II = HeOH:H3P04 100:1.2 
(v/v) at a flow rate of 2 ml/min.
2.00
0.50
0. 00 20' 00
A: 10% Pd/C, T2, HeCH. Rf = 15.4 minutes
CPS X10G0
1.50
1 . 0 0
20'0015'0005‘00
B: RhCl (PPh3)3, T2, 3:2 benzene:ethanol. Rt = 16.5 minutes
196
FIGURE 23: Finding a Solvent System for Normal-Phase Silica TLC 
Purification of r^H2lPhospholipid 4c
Shown here are radio-TLC chromatograms of [%2]Phospholipid 4c eluted on 
10x5 cm analytical silica TLC glass-backed plates detected on a Berthold 
LB2842 Automatic TLC-Linear Analyzer using 10% methane in argon gas as 
scintillant.
cpi A +
i
I \
A: EtOAc; iprOH: H20. 10:7:6 (v/v)
plate length, cm
cpm
i V I
plate length, cm
B: “BuOH: AcOH; H20, 12:5:3 (v/v). Double peak is thought to be due to the 
presence of the acetate double salt of the phosphatidyl choline.
cpm
a plate length, cm
£: CHC13: MeOH: B20, 65:25:4 (v/v). This solvent system was selected due to 
its low water content, high volatility and faster elution rate.
+ = [ % 2]Phospholipid 4c, All other peaks are impurities.
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FIGURE 24 : The Préparât ive-TLC Purification of— [ 1 Phosphpl ipid 4c
cpm
î
• ^i , l\J.
Ô ' ' ' 4 ' ' plate length, cm
A: Typical radio-TLC Cross-section of 195mCi of crude [%2]phospholipid 4c 
developed on a preparative 200x200x0.5 mm glass-backed normal-phase 
silica TLC plate with kieselguhr concentration zone. Elution time = ca. 
75 minutes in CHCl3:MeOH;H20, 65:25:4 solvent system.
cpi
il
Ï
/ V '.
J2 ' ' ' Ë plate length, cm
B: Preparative-TLC plate after the removal of silica within the Rf limits 
(0.5 cm) of the eluted [%2]phospholipid4c.
cpm
/V !
plate length, ci
£: A channel on the side of the TLC plate was used to apply Rf-locating 
spots of crude tritiated material. The plate length shown by the 
scintillation trace is not necessarily linear and the Rf-locating spots 
at known positions near to the expected Rf of the pure [%2]phospholipid 
4chelped to accurately define the Rf limits of the pure material 
especially with close-running impurities present.
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cpm
ô ' ' 2 ' ' ' 4 ' ' ' & ' ' ' B ' 'plate length, cm
E; Analytical radio-TLC of the purified [%2]phospholipid 4c on a 100x50x0.25 
mm glass-backed normal-phase silica TLC plate. Radiochemical yield “ 70mCi.
FIGURE 25: Suggested Correlation of the Structure of the Diastereomeric Pair 
of r^HalPhospholipid4cand NMR Signals
(R,R)-Diastereomer (S, S)-Dias tereomer
c = o
H N M e
Me
C = 0
MeH N
Me
1.8 1.6 1.4 1.2
ppm
1.8 1.6 1.4 1.2ppm
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3.18 PLA2/Amide Substrate-Analogue Inhibitor Complexation 
Studied by NMR Spectroscopy
Purified bovine pancreatic PLA2 enzyme containing various buffers with 
and without calcium ions were supplied by Dr. W.U. Primrose, Department of 
Biochemistry, University of Leicester.
All enzyme and enzyme:[^H]inhibitor mixtures were investigated by 
NMR spectroscopy at 500MHz (FIGURE 26) and NMR spectroscopy at 533MHz 
(FIGURE 28) as solutions in D2O (20C^1). The NMR spectra were recorded at 
330K (57*C) in teflon-lined 5mm NMR tubes. The teflon liners were sonicated
immediately before data acquisition in order to remove dissolved air.
Typically, the solution components were: Bovine pancreatic PLA2 (ImM); 
NaCl (200mM); CaCl2 (50mM), dn-TRIS^^s (lOmM) and d4~succinate (lOmM) with 
or without varying quantities of [3H2]phospholipid (4c) inhibitor 
(10mCi=lmM).
For the solution devoid of calcium ions, typical solution components 
were: Bovine pancreatic PLA2 (ImM); NaCl (300mM) ; EDTA (25(^) ; dn-TRIS 
(lOmM); d4-succinate (lOmM) and [3R2]phopsholipid (4c) (lOmCi, ImM).
In both cases, pH* = 7.3. pH* denotes the measurement of pH uncorrected 
for the deuterium isotope effect. All salts (ie. TRIS, succinate, EDTA) were 
present as the sodium salts. Addition of the appropriate quantities of the 
[3H2]phospholipid inhibitor (4c) was effected by the preparation of a D2O 
solution of known radioactivity per unit volume. The concentrations of 
inhibitor contained in NMR tubes were analyzed by liquid scintillation 
counting to determine the stoichiometry of the enzyme:inhibitor complexes.
3.19 Differentiating "Free" and "Bound" Inhibitor NMR Signals
As calcium ions are essential for specific interaction of the 
[3R2]phospholipid inhibitor (4c) at the active site of the enzyme, an 
enzyme:inhibitor solution devoid of calcium ions was used to determine the 
"free" H^ NMR signals due to the tritium-labelled inhibitoris*. The signals 
in this spectrum (FIGURE 28A) are exchange-broadened due to non-specific 
interactions with the protein (enzyme). The chemical shift data observed,
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therefore, is a time-average of all these interactions. It is these chemical 
shifts that are approximated to the non-complexed, "free" [3H2]phospholipid 
inhibitor (4c) in the presence of the PLA2 enzyme.
In complexes with calcium ions present, chemical shift changes and the 
emergence of new NMR signals could therefore be assigned to the effects 
of specific binding of the inhibitor at the active site of the enzyme.
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FIGURE 26: MHz iH ID-NHR Spectra of Bovine Pancreatic FLA;and PLA2/T3Hz 1 Phospholipid 4c Complexes
A: 1-2 pH Bovine pancreatic PLA2, 200«H NaCl, 50nM CaCl2, 10«M dH-TRIS and 
IObH d4-succinate in 200;il of D20 at pH* 7.3. Temperature = 314K (4l'’C). 
All samples were contained in teflon-lined 5mm NNR tubes.
(ipc. ■'T6 “ I i r n - n - r - i —*—r  i - | -  1 0
h As A above containing lOmCi of [%2]phospbolipid 4c to give a 1:1 complex.
J
£: 1-2 mH Bovine pancreatic PLA2, 300mH NaCl, 250^ EDTA, lOmH dll-TRIS and 
lOmM d4-succinate containing lOmCi of [%2]phospholipid 4C in 200;il of D20 
at pH* 7.3. Temperature = 330K (57°C). This sample was devoid of 
essential calcium ions.
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FIGURE 27: cf-methyl Leu41 Signal in the NMR of Bovine Pancreatic PLA2 andr^EzlPhospholipid 4c •
Stoichiometry of complexes are approximate
(A)
(B)
f (C)
ppm
(A) The isolated, synchronous f -methyl signals of the L41 (L=Leucine) 
residue of bovine pancreatic PLA2. The 500 MHz spectrum was acquired in 
D2O containing 200mH NaCl, 50mM CaCl2, lOmM dll-TRIS, lOmM d4~succinate 
(pH* = 7.31 at 314K (41“O  in a teflon-lined 5mm NMR tube.
(B) As (A) but with a 2:1 molar ratio of PLA2 to tritiated competitive 
inhibitor 4c. The ^-metliyl signals of L41 become non-degenerate upon 
binding of the inhibitor at the catalytic site and are partially 
resolved under these conditions,
(C) Full resolution of "bound" (b) and "free" (f) <f-methyl L41 signals for a 
1:1 molar ratio of PLA2 to tritiated competitive inhibitor 4c. The "free" 
signal is to higher field. This indicates that the tritiated substrate 
has successfully bound at the catalytic site of the enzyme.
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FIGURE 28: 533 MHz 3R ID-NMR Spectra of Bovine Pancreatic PLAz/f 21Phospholipid 4c complexes
_ r —
3.0 —I - 1.1 —I " 1.0 "I0.1
A: 1-2 mM Bovine pancreatic PLA2, 300«M NaCl, 250pM EDTA, IÛbM dU-THIS, 
lOmM d4~succinate and lOmCi [ % 2]p h o s p h o l ip id  4c i n  20G)il of D20 at pH* 
7.3. Temperature = 330K (57*’C). All samples were contained in 
teflon-lined 5mm NMR tubes. The signals labelled "A" = T4 and "C" = T3 
are of the "free" [%2]phospholipid 4c. The sample was devoid of essential 
calcium ions' and the spectrum shows the time-averaged chemical shifts 
which approximate to the non-complexed, "free" tritiated inhibitor in the 
presence of the enzyme.
—I- .1.0
B: 1-2 mM bovine pancreatic PLA2, 200mM NaCl, 50mH CaCl2, lOmH dH-TRIS, 
lOmM d4~succinate and lOmCi [^ H2]phospho1ipid 4c in 200;il of D20 at pH* 
7.3 to form a 1:1 complex. Temperature = 330K <57°C). Signals "B", "D" 
and "E" emerge as the complcxed, "bound" tritiated inhibitor.
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■“ 1“
1. 0
— I -0 1
Qi As B above except 5mCi of [ % 2]phospholipid 4c (2:1 PLA2: inhibitor)
—1— 1.1 1.0
D: As B except a molar, stoichiometric excess of [%2]phosphoiipid 4c 
Number of transients = 128.
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FIGURE 29 : Schematic of ID-NMR Results of f3H2lPhospholipid 4c 
Complexation with Bovine Pancreatic PLA2
For %  ID-NMR spectra, see FIGURE 28.
2
ppm
Signals A and C = "free" tritiated ligand.
Signals B,C?,D and E = "bound" tritiated ligand
A,C = UncoBplexed inhibitor. A = T4, C = T3.
B.C.D,E =1:1 Complex, PLA2 enzyme: t^Hzlphospholipid 4c inhibitor. 
A,B,C.D,E =2:1 Complex. More D than C?.
A,B,C,D,E = 1 :>1 Complex
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4. DISCUSSION
4. DISCUSSION
4.1 Model Conmound Work
The use of (E)-dec-3-enoic acid as a model for the unsaturated 
phospholipid (3) precursor served a useful and informative illustration of 
the propensities of the various hydrogen isotope labelling procedures 
available in order to effect the tritium-labelled phospholipid (4).
The 2h NMR and mass spectrometric (MS) analyses of the model compounds 
were complimentary and, thus, highly informativei95.196. The NMR data 
established which positions were labelled and the relative extent of 
labelling whereas the MS data disclosed the absolute labelling efficiencies 
and pointed to the extent of the various isotopomers. A fairly complete 
picture of the characteristics of a particular labelling procedure can be 
discerned#196.
The absolute intensities of the [2H]decanoic acid molecular ion 
clusters in their mass spectra were low. More reliable data were obtained
for the TMS esters for which the absolute molecular ion and M-15 daughter
ion peak intensities were much greater.
Dealing with the heterogeneous catalyzed examples first, the iH NMR of 
these deuteriated decanoic acids (FIGURE 13A,13B) revealed a remnant of the 
3-ene precursor, the 2-ene contaminant appears to have been preferentially 
saturated in both cases. The extent of the 3-ene precursor was most 
predominant in the Pd/C case. iR NMR signals either side of 4 ppm were also
present in both cases. These signals are not coincident with solvents with
which the acids had been in contact. One must, therefore, tentatively 
suggest that they represent some sort of alkyl chain rearrangement mediated 
by the catalyst, maybe even chain branching.
The 2r NMR data summarised in TABLE 4 and FIGURE 14A, 14B confirmed, 
as expected, that double bond migration is a serious problem with 
heterogeneous metal catalysts. This is illustrated by the high relative 
intensity of the H4-H9 signals which points to the presence of a large
207
number of isotopomers. This is confirmed by the MS data (TABLE 5, FIGURE 
16A,16B). The presence of deuterium at HIO highlights the extent of double 
bond migration. Indeed, the 2h NMR spectrum for the Pd/C case is almost 
identical to the NMR spectrum of decanoic acid such is the overall 
generality of labelling! Compare FIGURES 14B and 12A. Alkene exchange had 
occurred for Pd/C catalyzed reduction. Although lacking in regiospecificity, 
heterogeneous catalytic reduction was very efficient and yielded highly 
deuteriated products (TABLE 5).
For both homogeneous catalyzed reactions, the NMR spectra (FIGURE 
13C,13D,13E) were readily assignable to decanoic acid, employing the data of 
TABLE 3. Comparison of the NMR integrals for the Ru(II) case showed very 
low deuterium incorporation had occurred even though the alkene precursor 
was fully saturated. The low deuterium incorporation was corroborated by the 
MS data (TABLE 5, FIGURE 16C) and was indicated by the poor quality of the 
2H NMR spectrum, FIGURE 14C. However, the NMR spectrum verifies that the 
2H-addition is completely regiospecific. The greater intensity of the D3 
signal over the D4 signal is due to the presence of both [2,3-2Hz]- and 
[3,4-2H2]decanoic acid molecules.
It is known that the RuCl2(PPh3)3 complex is highly selective for 
alk-l-enes (see SECTION 2.43). As the substrate, (E)-dec-3-enoic acid, is an 
"internal" alkene, this explains the slow reaction rate. The very high 
isotopic dilution observed may be due to mechanistic differences from 
Wilkinson's catalyzed reduction that enhance the kinetic hydrogen isotope 
effect(s) for the reductive process. Investigation of this phenomenon would 
be worthwhile.
For the Rh(I) (Wilkinson's) example, the IR NMR spectrum (FIGURE 
13D,13E) revealed the presence of approximately two deuteriums per molecule 
from signal integration comparisons, FIGURE 13E. The 2g NMR spectrum 
mirrored that obtained for the Ru(II) case but reflected very high deuterium 
incorporation. The MS data, however, shows that the dz-species accounts for 
only 70-80%, the remainder being the di-species. Thus, significant isotopic
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dilution had occurred. This result is almost identical to that reported by 
R a k o f f l 7 7 ;  see SECTION 2.40.
Rakoff Culf
Alk-2-ynols Alk-3-ynols Dec-2/3-eno i c 
Acid
d4 70-80% >95% dz 70-82%
d3 15-17% - di 17-22%
This author observed that the (E)-dec-2-enoic acid contaminant 
represented 18 mole% of the decenoic acid starting material (TABLE 3). 
[2,3-2H2]Decanoic acid was shown to represent 14 mole% of the deuteriated 
(TABLE 4). These two determinations of substrate composition by and 2r
NMR are in agreement within the expected experimental error of NMR signal
integration and shows that both the 2-ene and 3-ene reduced products must be 
equally deuteriated. Moreover, in view of Rakoff's results, one concludes
that the (E)-dec-2-enoic acid component is the most probable source of the
proton that leads to isotopic dilution.
I propose that the mechanism of dilution must proceed via the formation 
of hydrogen deuteride gas, HD. Upon complexation at the metal of the 
homogeneous catalyst of a substrate molecule with a multiple bond one carbon 
atom distant from an acidic functionality (eg. -OH, CO2H):
O
the geometry is then such that, in the Brdnsted sense, an acid-base 
neutralisation occurs between the oxygen-bound proton of the substrate and 
the cis-deuteride ligand of the homogeneous catalyst to yield hydrogen 
deuteride gas. The coproduct might be a rhodium(III) carboxylate complex 
(see FIGURE 11):
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l/ Is 2RC00H
RCOO
I /L
very slow'
Rh
l/ 1
+ 2HD + S
*CI
OOCR
The proposed isotope dilution mechanism does not proceed by exchange so 
deuterium at the carboxylic acid is not expected, as observed.
The alcohols employed by Rakoffl?? typically have pKa's of about 16, 
whereas aliphatic carboxylic acids exhibit pKa's of about 5. Hence, there 
exists over 10-orders of magnitude difference in acidity. Assuming that the 
similarity in the proportions of deuteriated species is not coincidental, it 
would appear that the isotope dilution may not be chemically controlled by 
the acidity of the substrate molecule but is probably kinetically controlled 
by the rate of formation of HD.
The HD gas formed may then form mixed-hydrogen isotope dihydride 
complexes which is able to saturate alkene substrate molecules to render a 
proportion of all multiple bond species mono-labelled:
Eg. R-Ç-C-CH2CO2H 
H D
R-Ç-C-CH2CO2H 
D H
The product labelling scheme depends on which hydrogen isotope is cis 
to the TT-alkene substrate ligand in the dihydride Rh(III) complex 
intermediate.
Obviously, a careful and detailed study of this observation will be 
required. The effects of solvent acidity and protection of the functional 
groups of the substrate molecules will need to be investigated. The study 
would have to be conducted solely with deuteriated compounds as MS data 
would be the only viable analytical technique. Both ends of the double bond 
should, on average, be labelled with an equal amount of either hydrogen 
isotope so that no detectable effect would be present by 2r NMR analysis. 
The precision of H^ NMR signal integration would defy observation of this
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effect as was the case here.
Overall, homogeneous catalytic reduction by Wilkinson's catalyst of the 
3-ene precursor yielded a regiospecifically labelled alkyl chain at high
label incorporation with overall cis-addition of the hydrogen isotope. This 
approach fulfilled the requirements outlined in SECTION 3.1.
4.2 Diimide Labelling of Phospholipid (31
The [3H]diimide labelling of phospholipid (3) (SCHEME 1) was evidenced 
by the increase in pressure, from 270 mmHg to 300 mmHg in the closed gas 
line system used at the NTLF, ignoring temperature fluctuations. A pressure 
increase was anticipated for this reaction because of the generation of
nitrogen and carbon dioxide gas co-products of PADA decomposition and 
concurrent diimide disproportionation (SECTION 2.29).
The reaction time of 16 hours (SECTION 3.13), although lengthy compared 
with alternative labelling strategies, was still insufficient to achieve 
full saturation of phospholipid (3). iH NMR analysis of the reduction 
product (4a) (FIGURE 21Al) showed a substantial amount of the alkene 
precursor, phospholipid (3), still present. Observe the alkene proton 
signals centered at 5.6 ppm. However, no chemical degradation of the
molecule had occurred under the reaction conditions.
The labelling efficiency was very low. Starting with 10.9 Ci of 
[0-3H]acetic acid, 74 mCi were incorporated into the phospholipid (4a). The 
radiochemical yield was, therefore, low. This mirrored other workers' 
experiences when using [^HJdiimide as a labelling reagenti36. The iH-coupled 
3R NMR spectrum of the phospholipid (4a) (TABLE 6, FIGURE 21A3) gave an 
intense triplet at 2.05 ppm. This chemical shift does not coincide with
those observed for the [3,4-IH2]analogue (SECTION 3.11, FIGURE 19) nor with 
solvents used for the labelling procedure. I propose that this signal is due 
to auto-acid-catalyzed exchange of [O-^H]acetic acid yielding predominantly 
[methyl-3Hi]acetic acid. The remaining oxygen-bound tritium was exchanged 
with methanol at the conclusion of the synthesis (SECTION 3.13). Exchange is
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effected via the enol tautomer:
RO -P-
This deleterious, isotope diluting side reaction had probably been 
overlooked in a previous studyi36 because the reaction work-up procedure 
involved high vacuum lyophilization to remove residual traces of acetic acid 
from the involatile product molecules. This procedure was similarly applied 
by this author although it is envisaged that acetic acid would exist as a 
double salt with the zwitterionic choline headgroup:
'3 +  ACOH --------------------- > R o lo ^ - \^ * N (M e ^ A c O -
OH
Evidence for the double salt is gleaned from the observed double peak 
for the TLC elution of phospholipid (4c) in an acetic acid containing 
solvent system (FIGURE 23B). A large proportion of the 74 mCi observed for 
the product must have been associated with the [methyl-^Hi]acetate anion.
I would, therefore, suggest the use of an alkyl carboxylic acid of 
similar pKa yet devoid of ^-hydrogens, such as pivalic (2,2-dimethy1- 
propanoic) acid.
The iH-decoupled NMR spectrum of phospholipid (4a) (FIGURE 21Al) had 
four separate signals. The C3 methylene protons are magnetically 
non-equivalent. See SECTION 3.11 and FIGURE 19. The triton analogue, 4a, had 
two well-resolved signals at the same chemical shift values, 1.65 and 1.57 
ppm, ignoring isotope mediated shifts. The NMR spectrum showed that the 
T4 methylene tritons are similarly magnetically non-equivalent although the 
signal dispersion is less, FIGURE 21A2. The main signals in the spectrum are 
singlets and are not J-coupled to the vicinally disposed tritons. This 
indicated that the majority of phospholipid (4a) molecules were 
mono-tritiated. The high-field signals of each diastereotopic pair were more 
intense than the lower-field signals of each pair. Each pair of signals
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(TABLE 6) were of almost equal areas. It was inferred that the diimide 
reduction had occurred with symmetrical addition of tritium giving equal 
amounts of tritium at C3 and C4. However, one face of the alkene may have 
been attacked in slight preference to the alternative face giving rise to 
the non-equivalent signal intensities within each diastereotopic pair.
At the foot of each main signal was a shoulder to higher field, 
especially evident for the T3 signal at 1.57 ppm. This represented the small 
proportion of ditritiated productive.
For hydrogen isotope labelling using the diimide reagent, the choice of 
solvent can have a dramatic effect on the reaction rate and labelling 
efficiency. See SECTION 2.29. The ideal solvent solvates both the ionic PADA 
reagent precursor and the substrate and does not have exchangable or 
potentially exchangable protons. Moreover, for the reaction work-up a 
solvent that will only solvate the reduced product enabling its separation 
from ionic reagents and co-product is necessary.
For the ionic phospholipid these restrictions were only partially 
resolved. Dioxane dissolution of phospholipid (3) was slight and may have 
been responsible for the very slow reaction rate observed.
4.3 Heterogeneous Catalytic Labelling of Phospholipid (31
This method of tritium labelling was experimentally very easy and rapid
showing a very high labelling efficiency. The H^ NMR spectrum shows that the
product, 4b, was not chemically degraded and that the alkene function was 
fully saturated, FIGURE 21B1. With a specific radioactivity of approximately 
85 Ci per mmole, each molecule had about three tritons. As well as full 
saturation (2 tritons), exchange labelling had also occurred. The extent of 
exchange labelling is illustrated by the vy NMR spectrum (FIGURE 21B2) and
integration of the signals therein (TABLE 6):
O29.7%
1 . 9%1 .4% 67.0%
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Labelling at C2 is as a result of allylic interchange whereas that for 
C5-C10 is either due to non-specific exchange or double bond migration. See 
SECTIONS 2.24-2.27. The product, 4b, is a very complex mixture of tritium 
isotopomers which would be very difficult to delineate using vg NMRi 
technique because the chemical shift and coupling constant values of tritons 
along the Cio-alkyl chain are very similar (SECTION 3.11, FIGURE 19). The 
tritium-labelling results compliment those obtained by the 
deuterium-labelling of the decenoic acid model compound (SECTION 3.4, 4.1).
Similar to the diimide case (SECTION 4.2), the high-field 
diastereotopic triton is of greater intensity. This suggests that one face 
of the alkene preferentially interacted with the palladium metal surface and 
cis-addition of Tz is favoured onto this face. This observation may be due 
to differences in the steric accessibility of the two alternate faces of the 
alkene to the metal interface mediated by the isobutyl side-chain projecting 
from the (R)-stereocentre.
Due to the generality of the labelling observed, phospholipid (4b) was 
of no use for vy NMR investigations of PLAz inhibition.
4.4 Homogeneous Catalyzed Labelling of Phospholipid (3)
This procedure yielded a product, 4c, of approximately 57 Ci per mmole 
equating to two tritons per molecule. This is expected for alkene reduction. 
The precursor phospholipid, 3, was fully saturated without chemical 
degradation.
The iH-decoupled Vfl NMR spectrum, FIGURE 21C2 shows that only the C3 
and C4 positions were labelled. This methodology gave site-specific 
tritiation. Integration of the signals for T3 and T4 (TABLE 6) revealed 
symmetrical addition of tritium across the double bond. Both tritiated 
diastereomers are equally populated, FIGURE 21C3. This pointed to the 
conclusion that during the catalytic cycle, FIGURE 11, complex IV is formed 
by equally favourable chelation of the metal centre at either face of the 
double bond to give the TT-complex. I propose that the isobutyl group at the
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(R)-stereocentre is too remote to hinder the attack of the rhodium complex 
resulting in cis-addition of tritium at either face to give the equally 
populated diastereomers observed.
The signal structure observed was confirmed as due to vj-coupling by 
the observation of the COSY spectrum shown as FIGURE 21C6. This showed that 
the two upper-field doublets of each diastereotopic pair of triton signals 
were due to one diastereomer. The same is true for the two lower-field 
doublets of each triton signal. See TABLE 6, FIGURE 21C6. The vj values 
observed (ca. 6 Hz) are typical for a rapidly rotating alkyl chain.
The 3H M R  spectrum, FIGURE 21C3, 21C4, did not reveal signals due to 
mono-tritiated species. I conclude that isotope dilution did not occur for 
this labelling procedure. The maximum tritium incorporation was realised. As 
a cautionary note, a small percentage of the species analyzed may be 
mono-tritiated and the low intensity singlets from these species may be 
hidden by the much greater intensity of the more disperse J-coupled doublets 
of the dominant ditritiated species. As the specific radioactivity of 
phospholipid (4c) cannot be known with any precision due to its lack of UV 
absorbance and also as a result of its hygroscopic property, uncertainity 
about maximum tritium incorporation must remain. Compare FIGURE 21A1 with 
21C3.
Magnetic non-equivalence even under conditions of rapid rotation, as 
illustrated by these data, is acceptedi??. The chemical shift differential 
for tritons bound to the same carbon atoms C3 and C4 may be caused by 
magnetic anisotropy originating from the rapid rotation of the isobutyl 
alkyl chain at the (R)-stereocentre. These possibilities are illustrated 
below.
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Possibility fil : Rapid rotation of methyl group.
C—
Me
C = 0
Me
(B)(A)
Rapid rotation of the C-H bonds sets up the induced magnetic fields 
shown. Bo of lesser magnitude is required to bring the tritons of case (B) 
into resonance than those of case (A) as the isobutyl group is below the 
plane of the molecule due to its association with the chiral centre. Thus, 
tritons of case (B) are deshielded and will resonate to lower field (ie. at 
higher chemical shift) than those of case (A).
Possibility (II): Rapid rotation of the (CH3)2CH branch.
C = 0
Me
Me
Bo :c=o
Me
Me
Be
Inference as possibilty (I) above.
Possibility (III): Anisotropy cone of the carbonyl
HN HN^
The anisotropic cone for the carbonyl is seen to have no overall effect 
at the locations of interest.
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Such magnetic anisotropic effects are distance dependent and this 
agrees with the lesser chemical shift separation of the T4 methylene triton 
compared with the well resolved T3 methyl triton which are closer to the 
proposed cause of the magnetic non-equivalence observed. See FIGURE 25, 
FIGURE 2103.
However, as the 03 and 04 carbons are rendered chiral158-20 3 
(stereogenic) upon tritium labelling, the observed chemical shift, 
differences may be due to the intrinsic diastereoism this engenders as the 
triton at the carbon position experiences different environments which are 
unperturbed by the magnetic anisotropism arguements presented.
The suggested structure/ NMR signal correlation, FIGURE 25, 
compliments the inference drawn for the heterogeneous catalyzed labelled 
phospholipid, 4b.
The absolute configuration may be determined by making a Mosher's 
alcohol derivative. Mosher's alcohol is available as both (R)- and 
(S)-isomers;
Me
F,C'"/ ^OH  ph
The adduct would be analyzed by iR, and i5p NMR
spectrescopy82,204,205,
4.5 3h NMR Complexation Experiments
There were two basic reasons why 2D NMR data could not be obtained 
during this study. The first was due to the NMR appearance of the tritons 
of phospholipid, 4c. Because the tritons at each carbon give rise to two 
signals which are mutually 3J-coupled, the S/N ratio is reduced to a quarter 
of the situation where an isolated triton resonates as a singlet and all the 
signal intensity is present in this signal. Due to this non-synchronous 
appearance, the acquisition of NMR spectra of acceptable quality is made
all the more difficult. Also, a 5mm probe was used for NMR acquisitions.
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As the NMR tubes are lined with teflon for tritiated samples, the effective 
sample column diameter is reduced to 3mm with the protective teflon tube 
further reducing NMR detectability. It is noted that all published examples 
of macromolecule investigations using NMR spectroscopy have used 10 mm 
probes at either 320 MHz206-20 9 or 533 MHz^io, Again, the teflon liner 
reduces the tube diameter by 2 mm. Therefore, instead of the 10 mCi of 
phospholipid (4c) used for the ID data reported here, 75-100 mCi were used. 
I suggest, therefore, that any further NMR investigations of this type 
must make use of a 10mm tritium probe.
The high temperature (57°C) used for the NMR spectra (SECTION 3.18) 
was an attempt to offset these overwhelming disadvantages by increasing the 
S/N ratio by the reduction of linewidth as a result of increased molecular 
reorientation.
The observations of Bennion et al2 2 coupled with the data presented as 
FIGURE 27 suggests that phospholipid (4c) was in medium exchange under the 
experimental (monomeric substrate) conditions employed. Bennion et al%2 
observed that the alkene precursor, phospholipid (3) was in slow exchange 
under their lower temperature conditions. This difference in behaviour may 
be a temperature effect and/or may be due to the more favourable molecular 
interaction of the alkene with the phenyl side-chains of Phe5,22 and 106 of 
the active site. FIGURE 8 shows the close proximity of the Leu41 ^-methyls 
to the sn-2 alkyl chain binding site which uncovers its usefulness as a 
probe of ligand binding.
Chemical shift data for the FIGURE 28 spectra were not presented as 
they would be of low precision and are of little intrinsic value due to 
their variability with temperature, pH and Ca2+ concentration as noted in 
SECTION 2.11. What is of value are chemical shift changes of ligand signals 
upon binding. Correlation of "free" and "bound" signals was not possible 
using ID 3h NMR spectra.
Using the calcium-free sample (SECTION 3.19) "free" and "bound" H^ NMR 
signals were differentiated. These data are shown as the FIGURE 29
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schematic. It was observed that all signals moved to lower field on binding. 
This is consistent with the close proximity of the C3,C4 ligand positions to 
the edge of a benzene ring(s) and its associated magnetic anisotropic 
effect. Bennion et al22 observed a +0.63 ppm shift for the C3 alkene proton 
of phospholipid (3). It may be that signal E (FIGURE 28,29) is due to a C3
triton (C) as A)(E-C) is approximately +0.5 ppm.
4.6 Future Work
A wealth of information is waiting to be unveiled once the full range 
of 2D 3h and iH NOE experiments can be undertaken. These will include a 
3H-EXSY206-210 experiment with a stoichiometric excess of 
[2H]phospholipid to identify the correlations between "free" and "bound" 
ligand and 3H,iH-HOESY207-2io experiments at various mixing times and a 1:1 
enzyme;inhibitor stoichiometric ratio to identify specific interactions 
between the enzyme and the bound ligand.
The pattern of tritium-labelling observed for phospholipid (4c) by 
NMR spectroscopy is potentially extremely valuable. As the diastereotopic
tritons at each carbon are distinguishable in NMR spectra, they provide
for different perspectives of the active site from the same bound ligand at 
this site.
It is envisaged that various positional isomers of phospholipid (3) 
could be synthesized to enable tritium to be incorporated into the Cio-fatty 
acid chain at various positions. This will enable the reporting of active 
site interactions along the length of this alkyl chain.
Several decenoic acids are commercially available. For example, 
dec-9-enoic, dec-2-enoic and dec-3-enoic acids. Alternatively, decenoic 
acids can be synthesized from 1-bromononenes or nonen-l-ols via a Grignard 
intermediate quenched with carbon dioxide.
219
5. REFERENCES
5. References
1. Pure Appl. Chem 64* 144-168 (1992)
2. E.G. Lapetina in Ann. Reports Ned. Chem. 19, 213-221 (1984) Section Ed.
R.W. Egan, Editor-in-Chief, D.M. Bailey. Wiley 1984
3. N.S. Chandrakumar, J. Hajdu, J. Org. Chem. 2144-2147 (1982)
4. G.H. de Haas, N.M. Postema, W. Nieuwenhuizen, L.L.M. van Deenen,
Biochim. Biophys. Acta 159. 103-117 (1968)
5. K.S. Bruzik, A.M. Morocho, D.-Y. Jhon, S.G, Rhee, M.-D. Tsai Biochem.
31, 5183-5193 (1992)
6. J. Chang, J.H. Musser, H. McGregor Biochem. Pharmacol. 2429-2436
(1987)
7. S. Connolly 4 th Symposium on Medicinal Chemistry in Eastern England,
3Qth April, 1992. "Design of Inhibitors of Phospholipase Az"
8. R. Renetseder, S. Brunie, B.W. Dijkstra, J. Drenth, P.B. Sigler J. Biol.
Chem. 2^, 11627-11634 (1985)
9. S. Brunie, J. Bolin, D. Gerwirth, P.B. Sigler J. Biol. Chem. 260.
9742-9749 (1985)
10. D. Mobilio, L.A. Marshall Ann. Reports Med. Chem. 24, 157-166 (1989)
Academic Press
11. L.A. Plesniak, S.C. Boegeman, D.W. Segelke, E.A. Dennis Biochem. 32.
5009-5016 (1993)
12. J. Drenth, C.M. Enzig, K.H. Kalk, J.C.A. Vessies Nature 264. 373-377
(1976)
13. B.W. Dijkstra, K.H. Kalk, W.G.J. Hoi, J. Drenth J. Biol. Chem. 147.
97-123 (1981)
14. B.W. Dijkstra, R. Renetseder, K.H. Kalk, W.G.J. Hoi, J. Drenth J. Biol. 
Chem. 168, 163-179 (1983)
15. J.P. Noel, C.A. Bingman, T. Deng, C.M. Dupureur, K.J. Hamilton, R.-T.
Jiang, J.-G. Kwak, C. Sekharudu, M. Sandaralingam, M.-D. Tsai Biochem. 
30, 11801-11811 (1991)
16. B.C. Finzel, D.H. Ohlendorf, P.C. Weber, F.R. Salemme Acta Cryst. (B)
47, 558-559 (1991)
17. N. Dekker, A.R. Peters, A.J. Slotboom, R. Boelens, R. Kaptein, G.H. de 
Haas Biochem. 30, 3135-3147 (1991)
18. C.M. Dupuruer, Y. Li, M.-D. Tsai J. Am. Chem. Soc. 114. 2748-2749 (1992)
19. D.F. Kennedy, A.J. Slotboom, G.H. de Haas, D. Chapman Biochim. Biophys. 
Acta 1040. 317-326 (1990)
20. C.M. Dupureur, B.-Z. Yu, M.K. Jain, J.P. Noel, T. Dong, Y. Li, I.-J.
Byeon, M.-D. Tsai Biochem. 31, 6402-6413 (1992)
21. W.C. Ripka, W.J. Sipio, J.M, Blaney Lect. Heterocycl. Chem. 2, 
S-95-S-104 (1987)
22. C. Bennion, S. Connolly, N.P. Gensmantel, C. Hallam, C.G. Jackson, W.U. 
Primrose, G.C.K. Roberts, D.H. Robinson, P.K. Slaich J. Med. Chem. 35. 
2939-2951 (1992)
23. W.A. Pieterson, J.C. Vidal, J.J. Volwerk, G.H. de Haas Biochem. 13.
1455-1460 (1974)
24. G.H. de Haas, N.M. Postema, W. Nieuwenhuizenm, L.L.M. van Deenen
Biochim. Biophys. Acta 159. 118-129 (1968)
25. A. Aguiar, G. de Haas, E.H.J.M. Jansen, A.J. Slotboom, R.J.P. Williams
Eur. J. Biochem. 100, 511-518 (1979)
26. B.W. Dijkstra, J. Drenth, K.H. Kalk Nature 2^, 604-606 (1981)
27. A.R. Peters, N. Dekker, L. van den Berg, R. Boelens, R. Kaptein, A.J.
Slotboom, G.H. de Haas Biochem. 31, 10024-10030 (1992)
28. J.D.R. Hille, G.M. Donne-Op den Kelder, P. Sauve, G.H. de Haas, M.R.
Egmond Biochem. 20 4068-4073 (1981)
29. F.F. Davidson, J. Hajdu, E.A. Dennis Biochem. Biophys. Res. Commun. 137.
587-592 (1986)
30. D. Lichtenberg, G. Romero, M. Menashe, R.L. Biltonoen J. Biol. Chem.
261. 5334-5340 (1986)
31. G.H. de Haas, P.P.M. Bonsen, W.A. Pieterson, L.L.M. van Deenen Biochim. 
Biophys. Acta 239, 252-266 (1971)
220
32. W. Yuan, D.M. Quinn, P.B. Sigler, M.H. Gelb Biochem. 29, 6082-6094
(1990)
33. M.M. Campbell, J.L. Fox, M. Sainsbury, Y. Liu Tetrahedron 45, 4551-4556
(1989)
34. S.D. Kohlwein J. Chem. Educ. 3-9 (1992)
35. J.J.M. van den Berg, J.A.F. Op den Kamp, B.H. Lubin, F.A. Kuypers
Biochem. 32, 4962-4967 (1993)
36. Y. Okahata, K. Ariga Thin Solid Films 178. 465-471 (1989)
37. Y. Okahata, K. Kimura, K. Ariga J. Am. Chem. Soc. 111. 9190-9194 (1989)
38. Y. Okahata, K. Ariga Langmuir 5, 1261-1262 (1989)
39. Y. Okahata, Y. Ebara J. Chem. Soc., Chem. Commun. 116-117 (1992)
40. W.G.J. Hol Angew. Chem. Int. Ed. Engl. 25, 767-778 (1986)
41. W. Pruzanski, P. Vadas Immunology Today 12, 143-146 (1981)
42. J.M.C. Golec, C.J.R. Hedgecock, P.D. Kennewell Tet. Lett. 33, 547-550
(1992)
43. W. Yuan, R.J. Berman, M.H. Gelb J. Am. Chem. Soc. 109, 8071-8081 (1987)
44. D.P. Wallach, V.J.R. Brown Biochem. Pharmacol. 30, 1315-1324 (1981)
45. E.G. Lapetina Trends Pharmacol. Sci. 3, 115-118 (1982)
46. P.K. Slaich, W.U. Primrose, D.H. Robinson, C.W. Wharton, A.J. White, K. 
Drabble, G.C.K. Roberts Biochem. J. 288, 167-173 (1992)
47. C.A. Derapoulos, R.N. Pinckard, D.J. Hanahan J. Biol. Chem. 254.
9355-9358 (1979)
48. M.L. Blank, T.-C. Lee, V. Fitzgerald, F. Synder J. Biol. Chem. 256.
175-178 (1981)
49. M.H. Gelb J. Am. Chem. Soc. 108. 3146-3147 (1986)
50. W. Ripka New Scientist 129. 54-58 (1988)
51. W. Vogt Adv. Prost. Thrombox. Res. 3, 89-95 (1978)
52. H.M. Verheij, J.J. Volwerk, E.H.J.M. Jansen, W.C. Puiyk, B.W. Dijkstra,
J. Drenth, G.H. de Haas Biochem. 19, 743-750 (1980)
53. L.J. Reynolds, L.L. Hughes, A.I. Louis, R.M. Kramer, E.A. Dennis
Biochim. Biophys. Acta 1167. 272-280 (1993)
54. M.A. Wells Biochem.U, 1030-1041 (1972)
55. C.M. Dupureur, T. Deng, J.-G. Kwak, J.P. Noel, M.-D. Tsai J. Am. Chem.
Soc. 112, 7074-7076 (1990)
56. B. Waszkowycz, I.H. Hi111er, N. Gensmantel, D.W. Payling J. Chem. Soc., 
Perkin Trans. 2, 225-231 (1991)
57. Y. Li, M.-D. Tsai J. Am. Chem. Soc. 115, 8523-8526 (1993)
58. C.M. Dupureur, B.-Z. Yu, J.A. Mamone, M.K. Jain, M.-D. Tsai Biochem. 31.
10576-10583 (1992)
59. L. Yu, R.A. Deems, J. Hajdu, E.A. Dennis J. Biol. Chem. 265. 2657-2664
(1990)
60. T. Rosario-Jansen, H.J. Pownall, J.P. Noel, M.-D. Tsai Phosphorus and
Sulfur 30, 601-604 (1987)
61. O.P. Kuipers, N. Dekker, H.M. Verheij, G.H. de Haas Biochem. 29.
6094-6102 (1990)
62. O.G. Berg, B.-Z. Yu, J. Rogers, M.K. Jain Biochem. 7283-7297 (1991)
63. F. Ghomashchi, B.-Z. Yu, 0. Berg, M.K. Jain, M.H. Gelb Biochem.
7318-7329 (1991)
64. F. Ghomashchi, T. O'Hare, D. Clary, M.H. Gelb Biochem. 30, 7298-7305
(1991)
65. M.K.Jain, G. Ranadive, B.-Z. Yu, H.M. Verheij Biochem. 7330-7340
(1991)
66. M.K. Jain, J. Rogers, 0. Berg, M.H. Gelb Biochem. 7340-7348 (1991)
67. M.K. Jain, B.-Z. Yu, J. Rogers, M.H. Gelb, M.-D. Tsai, E.K. Hendrickson,
H.S. Hendrickson Biochem. 31, 7841-7847 (1992)
68. L. Johnson New Scientist 132. 30-33 (1991)
69. J. Fisher, W.U. Primrose, G.C.K. Roberts, N. Dekker, R, Boelens, R.
Kaptein, A.J. Slotboom Biochem. 2^ , 5939-5946 (1989)
70. N.S. Chandrakumar, J. Hajdu Tet. Lett. 21* 2949-2952 0981)
71. N.S. Chandrakumar, V.L. Boyd, J. Hajdu Biochim. Biophys. Acta 711.
357-360 (1982)
221
72. L.L.M. van Deenen, G.H. de Haas Biochim. Biophys. Acta 70, 538-553
(1963)73. P.P.M. Bonsen, G.H. de Haas, W.A. Pieterson, L.L.M. van Deenen Biochim. 
Biophys. Acta 2Z0, 364-382 (1972)
74. R. Renetseder, B.W. Dijkstra, K. Huizinga, K.H. Kalk, J. Drenth J. Mol. 
Biol. 200, 181-188 (1988)
75. R.L. Magolda, W. Galbraith J. Cell. Biochem. 40, 371-386 (1989)
76. M.K. Jain, B.-Z. Yu, J. Rogers, G.N. Ranadive, O.G. Berg Biochem 30. 
7306-7317 (1991)
77. R.C. Durley, B.L. Parnas, R.H. Weiss J. Label. Compound. Radiopharm. 31.
685-691 (1992)
78. D. Lombardo, E.A. Dennis J. Biol. Chem. 260. 7234-7240 (1985)
79. F. Ghomashchi, B.-Z. Yu, E.D. Milelich, M.K. Jain, M.H. Gelb Biochem.
30, 9559-9569 (1991)
80. S.G. Senderoff, A.Y.L. Shu, K. Lawrie, J.R. Heys J. Label. Compound.
Radiopharm. 31, 519-538 (1992)
81. W. Yuan, M.H. Gelb J. Am. Chem. Soc. 1.10, 2665-2666 (1988)
82. H.-K. Lin, M.H. Gelb J. Am. Chem. Soc. ÜS, 3932-3942 (1993)
83. M.H. Gelb, J.P. Svaren Biochem. 2A» 1813-1817 (1985)
84. D.L. Scott, Z. Otwinowski, M.H. Gelb, P.B. Sigler Science 250, 1563-1566
(1990)
85. S.P. White, D.L. Scott, Z. Otwinowski, M.H. Gelb, P.B. Sigler Science
250. 1560-1563 (1990)
86. M.K. Jain, W. Tao, J. Rogers, C. Arenson, H. Eibl, B.-Z. Yu Biochem. 30.
10256-10268 (1991)
87. L. Yu, E.A. Dennis Proc. Natl. Acad. Sci. USA 88, 9325-9329 (1991)
88. G.H. de Haas, R. Dijkman, M.G. van Oort, R. Verger Biochim. Biophys. 
Acta 1043. 75-82 (1990)
89. M.M. Campbell, J. Long-Fox, D.J. Osguthorpe, M. Sainsbury, R.B. Sessions
J. Chem. Soc., Chem. Commun. 1560-1562 (1988)
90. J.M.C. Golec, C.J.R. Hedgecock, R. Murdoch, W.R. Tully Tet. Lett. 33.
551-554 (1992)
91. M.K. Jain, F. Ghomashchi, B.-Z. Yu, T. Bayburt, D. Murphy, D. Houk, J.
Brownell, J.C. Reid, J.E. Solowiej, S.-M. Wong, U. Mocek, R. Jarrell, 
M. Sasser, M.H. Gelb J. Med. Chem. 35, 3584-3586 (1992)
92. M.M.G.M. Thunnissen, E. AB, K.H. Kalk, J. Drenth, B.W. Dijkstra, O.P.
Kuipers, R. Dijkman, G.H. de Haas, H.M. Verheij Nature 347. 689-691
(1990)
93. N.S. Chandrakumar, J. Hajdu J. Org. Chem. 1197-1202 (1983)
94. T. Bayburt, B.-Z. Yu, H.-K. Lin, J. Browning, M.K. Jain, M.H. Gelb
Biochem. 32, 573-582 (1993)
95. G.J. Blackwell, R.J. Flower Brit. Med. Bull. 260-264 (1983)
96. J. Poensgen Biochim. Biophys. Acta 1042. 188-192 (1990)
97. H. Oinuma, T. Takamura, T. Hasegawa, K.-I. Nomoto, T. Naitoh, Y. Daiku,
S. Hamano, H. Kakisawa, N. Minami J. Med. Chem. 34. 2260-2267 (1991)
98. S. Connolly, Private communication
99. J.C. Sheehan, G.P. Hess J. Am. Chem. Soc. 77, 1067-1068 (1955)
100. W. Konig, R. Geiger Chem. Ber. 103. 788-798 (1970)
101. M. Bodanszky, J. Martinez Synthesis 333-356 (1981)
102. G.C. Windridge, E.C. Jorgensen J. Am. Chem. Soc. 93, 6318-6319 (1971)
103. H.R. Bosshard, I. Schechter, A. Berger Helv. Chim. Acta %, 717-723 
(1973)
104. N.T. Thuong, P. Chabrier Bull. Soc. Chim. Fr. 667-671 (1974)
105. R.S. Edmundson Chem. Ind. 1828-1829 (1962)
106. F.R. Kinder, Y.S. Tang, U.B. Sunay J. Label. Compound. Radiopharm. 31. 
829-835 (1992)
107. C. Bennion, Private communication
108. B.J. Hunt, W. Rigby Chem. Ind. 1868-1869 (1967)
109. W.C. Still, M. Kahn, A. Mitra J. Org. Chem. 43, 2923-2925 (1978)
110. J.A. Vinson, J.E. Hooyman J. Chromatography 135. 226-228 (1977)
222
111. V.P. Shevchenko, N.F. Myasoedov in "Isotopes in the Physical and 
Biomedical Sciences, Labelled Compounds. Part A" Eds. E. Buncel, J.R. 
Jones i, 239-287 (1987)
112. L.C. Stewart, M. Kates Chem. Phys. Lipids 50, 23-42 (1989)
113. H. Jork, W. Funk, W. Fischer, H. Wimmer in "Thin-Layer Chromatography. 
Reagents and Detection Methods. Vol la" VCH, Weinheim 1990
114. W. Wortmann, J.C. Touchstone in "Quantitative TLC" Ed. J.C. Touchstone. 
Wiley-Interscience 1973
115. J. Hardman Chem. Brit. 28, 711-714 (1992)
116. J.L. Garnett Catalysis Rev. 5, 229-267 (1971)
117. A.P.G. Kieboom, F, van Rantwijk "Hydrogenation and hydrogenolysis in 
synthetic organic chemistry" Delft University Press 1977
118. D.W. Blackburn, S.H. Levison in "Catalysis in organic chemistry" Eds. 
P.M. Rylander, H. Greenfield. Academic Press 1976
119. P.M. Rylander "Catalytic hydrogenation in organic syntheses" Academic 
Press 1979
120. G.C. Bond Chem. Soc. Rev. 440-475 (1991)
121. R. Schlogl Angew. Chem. Int. Ed. Engl. 21» 381-383 (1993)
122. P.N. Rylander "Organic syntheses with noble metal catalysts" Academic
Press 1973
123. N. Dinh-Nguyen, R. Ryhage Acta Chem. Scand. 13, 1032-1034 (1959)
124. P.G. Williams, H. Morimoto, D.E. Wemmer J. Am. Chem. Soc. 110. 
8038-8044 (1988)
125. M. Yamamoto, W.A. Warnock, A. MiIon, Y. Nakatani, G. Ourisson Angew. 
Chem. Int. Ed. Engl. 32, 259-261 (1993)
126. S. Hunig, H.-R. Muller, W. Their Tet. Lett. 353-357 (1961)
127. C.E. Miller J. Chem. Educ. 42. 254-259 (1965)
128. J. Thiele Diese Annalen 271, 127-136 (1892)
129. C.V. King J. Chem. Soc. 379-385 (1940)
130. E.E. van Tamelen, R.S. Dewey, R.J. Timmons J. Am. Chem. Soc. 83. 
3725-3726 (1961)
131. E.J. Corey, D.J. Pasto, W.L. Mock J. Am. Chem. Soc. 33, 2957-2958 
(1961)
132. J.W. Hamersma, E.I. Synder J. Org. Chem. 3985-3988 (1965)
133. A.M. Paliokas, G.J. Schroepfer,Jr. Biochem. Biophys. Res. Commun. 26. 
736-741 (1967)
134. G.K. Koch J. Label. Compound. Radiopharm. 5, 110-121 (1969)
135. J.E. ^Idwin, K.A. Black J. Am. Chem. Soc. 106. 1029-1040 (1984)
136. M. Saljoughian, P.G. Williams, H. Morimoto, D.R. Goodlett, R.B. van 
Breemen J. Chem. Soc., Chem. Commun. 414-416 (1993)
137. E.J. Corey, W.L. Mock, D.J. Pasto Tet. Lett. 347-352 (1961)
138. F. Ay1ward, M. Sawistowska Chem. Ind. 404 (1961)
139. E.E. van Tamelen, R.S. Dewey, M.F. Lease, W.H. Pirkle J. Am. Chem. Soc. 
83, 4302 (1961)
140. D.K. Agrafiotis, H.S. Rzepa J. Chem. Soc., Perkin Trans. 2, 475-488 
(1989)
141. E.E. van Tamelen, R.J. Timmons J. Am. Chem. Soc. M, 1067-1068 (1962)
142. U. Pleib, J. Romer GDR Patent 248 680/8 (8th Feb. 1983)
143. E. Rosenberg Polyhedron 8, 383-405 (1989)
144. R. Cahill, D.H.G. Crout, M.V.M. Gregorio, M.B. Mitchell J. Chem. Soc., 
Perkin Trans. 1, 173-180 (1983)
145. F. Aylward, M. Sawistowska Chem. Ind. 433-434 (1961)
146. ICI Ltd. British Patent 1121642 (1965)
147. M.A. Bennett, P.A. Longstaff Chem. Ind. 846 (1965)
148. F.H. Jardine, J.A. Osborn, G. Wilkinson, J.F. Young Chem. Ind. 560
(1965)
149. M.A. Bennett, P.A. Longstaff J. Chem. Soc., Chem. Commun. 131 (1965)
150. J.F. Young, J,A. Osborn, F.H. Jardine, G. Wilkinson J. Chem. Soc., 
Chem. Commun. 131-132 (1965)
151. R.E. Harmon, S.K. Gupta, D.J. Brown Chem. Rev. 73, 21-52 (1973)
152. A.J. Birch, D.H. Williamson in "Organic Reactions" 24, 1-186 (1976) Ed.
W.G. Dauben. Wiley 1976
223
153. F.A. Cotton, G. Wilkinson "Advanced Inorganic Chemistry" 4 th Edition. 
Wiley 1980
154. M.J. Bennett, P.B. Donaldson Inorg. Chem. 16, 655-660 (1977)
155. J.A. Osborn, F.H. Jardine, J.F. Young, G. Wilkinson J. Chem. Soc. (A) 
1711-1732 (1966)
156. F. Maseras, A. Lledos, M. Duran, J. Bertrain J. Chem. Soc., Faraday 
Trans. 88, 1111-1117 (1992)
157. K. Burgess, W.A. van der Donk, S.A. Westcott, T.B. Harder, R.T. Baker, 
J.C. Calabrese J. Am. Chem. Soc. 114, 9350-9359 (1992)
158. C.A. Tolman, P.Z. Meakin, D.L. Lindner, J.P. Jesson J. Am. Chem. Soc. 
26, 2762-2774 (1974)
159. B.R. James Adv. Organometal. Chem. 17, 319-405 (1979)
160. J. Halpern Inorg. Chim. Acta 50, 11-19 (1981)
161. C. Masters "Homogeneous Transition-Metal Catalysis" Chapman and Hall, 
1981
162. F.H. Jardine, J.A. Osborn, G. Wilkinson J. Chem. Soc. (A) 1574-1578 
(1967)
163. A.S. Hussey, Y. Takeuchi J. Org. Chem. 35, 643-647 (1970)
164. H. Rakoff, E.A. Emken J. Label. Compound. Radiopharm. 15, 233-252
(1978)
165. A.S. Hussey, Y. Takeuchi J. Am. Chem. Soc. 91, 672-675 (1969)
166. S. Montelatici, A. van der Ent, J.A. Osborn, G. Wilkinson J. Chem. Soc.
(A) 1054-1058 (1968)
167. J.R. Morandi, H.B. Jensen J. Org. Chem. 34, 1889-1891 (1969)
168. A.J. Birch, K.A.M. Walker J. Chem. Soc. (C) 1894-1896 (1966)
169. B.R. James "Homogeneous Hydrogenation" Wiley 1973
170. C. Djerassi, J. Gutzwiller J. Am. Chem. Soc. 4537-4538 (1966)
171. R. Tang, F. Mares, N. Neary, D.E. Smith J. Chem. Soc., Chem. Commun. 
274-275 (1979)
172. R.E. Harmon, J.L. Parsons, D.W. Cooke, S.K. Gupta, J. Schoolenberg J. 
Org. Chem. 34, 3684-3685 (1969)
173. S. Siegel, D.W. Ohrt J. Chem. Soc., Chem. Commun. 1529-1530 (1971)
174. A.J. Birch, K.A.M. Walker Tet. Lett. 4939-4940 (1966)
175. H. Rakoff, E.A. Emken J. Label. Compound. Radiopharm. 19, 19-33 (1982)
176. H. Rakoff J. Label. Compound. Radiopharm. 23, 699-713 (1986)
177. H. Rakoff, W.K. Rohwedder Lipids 27, 567-569 (1992)
178. B. Pelc, E. Kodicek J. Chem. Soc. (C) 3415-3418 (1971)
179. D.E.M. Lawson, B. Pelc, P.A. Bell, R.W. Wilson, E. Kodicek Biochem. J.
121. 673-682 (1971)
180. K.W. Zilm, D.M. Heinekey, J.M. Millar, N.G. Payne, P. Demou J. Am.
Chem. Soc. HI, 3088-3089 (1989)
181. P.G. Williams in "Isotopes in the Physical and Biomedical Sciences,
Isotopic Applications in NMR Studies" 2, 55-98 (1991) Eds. E. Buncel,
J.R. Jones. Elsevier, 1991
182. A.L. Odell, J.B. Richardson, W.R. Roper J. Catalysis 8, 393-394 (1967)
183. P.S. Hallman, B.R. McGarvey, G. Wilkinson J. Chem. Soc. (A) 3143-3150
(1969)
184. T.M. O'Connell, J.T. Gerig, P.G. Williams J. Am. Chem. Soc. 115.
3048-3055 (1993)
185. T.M. O'Connell, P.G. Williams, J.T. Gerig J. Label. Compound.
Radiopharm. 33, 371-380 (1993)
186. M. Casey, J. Leonard, B. Lygo, G. Procter "Advanced Practical Organic 
Chemistry" Blackie, 1990
187. W.J.S. Lockley J. Label. Compound. Radiopharm. 24, 1509-1515 (1987)
188. Vogel's Textbook of Practical Organic Chemistry, A.I. Vogel. Longman 
1984
189. P.G. Williams, Ph.D. Thesis, University New South Wales (1983) pg. 
243-248
190. C.C. Geilen, A. Samson, Th. Weider, H. Wild, W. Reutter J. Label. 
Compound. Radiopharm. 21» 1071-1076 (1992)
191. G. Bodenhausen, H. Kogler, R.R. Ernst J. Magn. Reson. 58, 370-388 
(1984)
224
192. W.J. Hurst, R.A. Martin,Jr., R.M. Sheeley J. Liq. Chromatog. 9,
2969-2976 (1986)
193. R.A. Durst, B.R. Staples Clin. Chem. 18, 206-208 (1972)
194. W.U. Primrose, Private communication
195. "Isotopes; Essential Chemistry and Applications" Eds. J.A. Elvidge, 
J.R. Jones. R.S.C., Special Publication 35, London, 1980
196. "Isotopes: Essential Chemistry and Applications II" Ed. J.R. Jones.
R.S.C., London, 1988
197. M. Raban Tet. Lett. 3105-3108 (1966)
198. H.G. Floss, S. Lee Acc. Chem. Res. 26, 116-122 (1993)
199. N.D. Priestly, H.G. Floss, W.A. Froland, J.D. Lipscomb, P.G. Williams,
H. Morimoto J. Am. Chem. Soc. 114. 7561-7562 (1992)
200. F.A.L. Anet, D.J. O'Leary, J.M. Beale, H.G. Floss J. Am. Chem. Soc. U.* 
8935-8936 (1989)
201. Y. Ann, J.A. Kryck, H.G. Floss J. Am. Chem. Soc. 113. 4700-4701 (1991)
202. T. Frenzel, J.M. Beale, M. Kobayashi, M.H. Zenk, H.G. Floss J. Am.
Chem. Soc. HQ, 7878-7880 (1988)
203. M. Kobayashi, T. Frenzel, J.P. Lee, M.H. Zenk, H.G. Floss J. Am. Chem. 
Soc. 109, 6184-6185 (1987)
204. J.A. Dale, D.L. Dull, H.S. Mosher J. Org. Chem. 34, 2543-2549 (1969)
205. B.M. Trost, D.P. Curran Tet. Lett. 22, 4929-4932 (1981)
206. T.M. O'Connell, J.T. Gerig, P.G. Williams J. Chem. Soc., Chem. Commun. 
1502-1503 (1990)
207. K. Gehring, P.G. Williams, J.G. Pelton, H. Morimoto, D.E. Wemmer 
Biochem. 30, 5524-5531 (1991)
208. T.M. O'Connell, P.G. Williams, J.T. Gerig J. Label. Compound.
Radiopharm. 33, 371-380 (1993)
209. T.M. O'Connell, J.T. Gerig, P.G. Williams J. Am. Chem. Soc. 115.
3048-3055 (1993)
210. S. Highsmith, M. Kubinec, D.K. Jaiswal, H. Morimoto, P.G. Williams,
D.E. Wemmer J. Biomolecular NMR 3, 325-334 (1993)
225
CHAPTER 3: The Structure of Chromone-2—carboxylates
Studied by IR, and NMR Spectroscopy
CONTENTS Page No.
1. General Introduction 229
1.1 Abbreviations 231
LITERATURE REVIEW
2. Oxygen 233
2.1 Nuclear Properties of Oxygen-17 233
TABLE 1: Physical Properties of Oxygen-17 233
2.2 170 NMR 234
2.2.1 Pulse Power Distribution 234 
FIGURE 1: Relative Intensity Distribution of the 17Q NMR
Spectrum of D2O. Simple 90® Pulses 234
2.2.2 Baseline Distortion in Frequency Domain Spectra 234
FIGURE 2: 170 NMR Spectrum of Aspyrone 236
FIGURE 3: 17Q NMR Spectrum of Vinylene Carbonate, k = 1 236
FIGURE 4: 170 NMR Spectra of Neat Ethylene Glycol 238
2.3 Reference Signal 238
2.4 170 NMR Chemical Shifts 239
2.5 Chemical Shift Range and Coupling Constants 240
FIGURE 5: Data Illustrating the Chemical Shift Ranges
for Various Functional Groups 241
FIGURE 6: 170 NMR Spectrum of 2-Hydroxy-6-methoxy-
acetophenone Showing iJoH for the Phenol Signal 241
2.6 Factors Dictating Solution Composition 242
FIGURE 7: 170 NMR Spectrum of Neat Glycerol 244
2.7 170 NMR Data 245
2.8 The Carbonyl Function 246
TABLE 2: 17Q NMR Chemical Shift of Acetone 246
TABLE 3; 170 NMR Chemical Shift of Acetophenone 246
TABLE 4: Substituent Effects in Acetophenones 247
TABLE 5: Torsional Displacement in Acetophenones 248
TABLE 6: Hydrogen Bonding in Acetophenones 249
TABLE 7*. In-Plane Distortion in Indanones 250
2.8 Ethers, Alcohols and Phenol Derivatives 251
TABLE 8: o(-Alkyl Effect in Alkyl Ethers and Alcohols 251
TABLE 9: -Unsaturation in Ethers 252
TABLE 10: Substituent Effects in Phenols and Anisoles 253
TABLE 11: Torsional Displacement in Anisoles 254
TABLE 12: Hydrogen Bonding in Phenols 254
2.9 Carboxylates 255
TABLE 13A: Alkyl Esters 255
TABLE 13B: Alkyl Esters 255
TABLE 14: Substituent Effects in Methyl Benzoates 256
TABLE 15: Torsional Displacement in Benzoates 257
2.10 Compounds Related to Those Studied 258
2.11 Aryl Carbonyl Compounds 258
TABLE 16: 2'-Hydroxyacetophenones 258
TABLE 17: Substituent Effects in Benzaldehydes 259
2.12 Oxygen Heterocycles 260
TABLE 18: Aryl Ethers 261
2.13 Oxygen-17 Enrichment 265
2.14 Oxygen-17 Enrichment of Carboxylates 265
TABLE 19: Oxygen-17 Enrichment by Acid-Catalysed Exchange
of Carboxylates 266
TABLE 20: Oxygen-17 Enrichment by Saponification of
Carboxylates 267
2.15 Routes to Acyl Chlorides of Chromone-2-carboxylic Acids 268
2.16 Diazomethane 270
2.17 Oxygen-17 Enrichment of Phenols 270
TABLE 21: Oxygen-17 Enrichment of Phenols 271
2.18 Oxygen-17 Enrichment of Ketones 272
226
Page No.
2.19 Mechanism of Brominatlon of Phenols and Phenol Ethers in
Acetic Acid 273
SCHEME 1: Robertson Mechanism: Equation Form 274
SCHEME 2: Robertson Mechanism: Structure Form 274
SCHEME 3: Mechanism of Bromination of Phenols and Phenol
Ethers in Acetic Acid 279
2.20 Synthetic Routes to 3*-Bromo-2'-hydroxy-6'-methoxy-
acetophenone 281
2.21 Saponification of Chromone-2-carboxylate Esters 283
SCHEME 4: Kaye Mechanism 284
SCHEME 5: Zsuga Mechanism 284
2.22 Heterogeneous Catalytic Dehalogenation 284
2.23 Methods for NMR Spectral Assignment 285
2.24 DEPT 135 286
2.25 One-Bond i^C/lH Heteronuclear Shift Correlation 2D NMR
Spectroscopy 286
2.26 Three-Bond 13C/1H Heteronuclear Shift Correlation 2D NMR
Spectroscopy 287
2.27 13C NMR of Chromones 288
TABLE 22: Chemical Shift Ranges for Ethyl Chromone-2-
carboxylates 288
TABLE 23: Chemical Shift Ranges for Chromones 288
2.28 Quantum Mechanics 288
TABLE 24: Calculated TT-Excess Charges of
2'-Hydroxy-6'-methoxyacetophenone 289
3. EXPERIMENTAL 290
SCHEME 6: Compounds Described in the EXPERIMENTAL Sections 291
SCHEME 6: Compound Name Index 293
3.1 Compound Bl: Méthylation 294
3.2 Syntheses of Compounds A2, A3, B2 and D2: Bromination 294
3.3 Syntheses of Compounds Cl, C2, C3, El and E2: Claisen
Condensation 295
3.4 Syntheses of Compounds C4, C5, E3 and E4: Saponification 297
3.5 Syntheses of Compounds C6, C7, E5 and E6: Neutralisation 298
3.6 Synthesis of Compound D3: Catalytic Dehalogenation 298
3.7 Syntheses of Compounds E8a/b: Catalytic Tritiodehalogenation 299
TABLE 32: Dehalogenation of Compound E6 300
TABLE 33: Dehalogenation of Compound E2 300
3.8 Syntheses of Compounds C8, C9 and E7: Butyl Esters 301
3.9 Syntheses of Compounds ClOa/b and Cl2: Exchange Labelling
for Oxygen-17 and Oxygen-18 Enrichment 301
TABLE 34: Compounds Cl2 Molecular Ion Clusters 302
3.10 Syntheses of Compounds ElOa/b: Oxygen-17 Enrichment by
Synthesis 303
3.11 Diazomethane Generation 303
TABLE 35: Compounds ElOa/b Molecular Ion Clusters 305
3.12 Adjusting the NMR Spectrometer for NMR Spectroscopy 305
TABLE 36: Survey of NMR Spectral Aquisition Data 307
3.13 X-Ray Crystal Structures of Compounds C3 and D2 308
TABLE 37: Unit Cell Parameters of Compound C3 and D2 Crystals 309
TABLE 38: Bond Lengths in Compound C3 309
TABLE 39: Bond Angles in Compound C3 309
TABLE 40: Torsion Angles in Compound C3 310
TABLE 41: Bond Lengths in Compound D2 310
TABLE 42: Bond Angles in Compound D2 311
TABLE 43: Torsion Angles in Compound D2 311
FIGURE 27: ORTEP Drawing of Compound C3 312
FIGURE 28: ORTEP Drawing of Compound D2 312
FIGURE 29: Partial Unit Cell Structure of Compound D2
Looking Down the Triad Axis 313
3.14 Compound Bl: Quantum Mechanical Calculations 314
227
TABLE 44: 
SCHEME 7: 
TABLE 25:
TABLE 26: 
TABLE 27:
SCHEME 8: 
TABLE 28:
TABLE 29: 
SCHEME 9: 
TABLE 30: 
TABLE 31:
FIGURE 8: 
FIGURE 9: 
FIGURE 10 
FIGURE 11 
FIGURE 12 
FIGURE 13 
FIGURE 14 
FIGURE 15 
FIGURE 16 
FIGURE 17
FIGURE 18 
FIGURE 19 
FIGURE 20 
FIGURE 21 
FIGURE 22 
FIGURE 23
FIGURE 24
FIGURE 25 
FIGURE 26
Page No,
314
315
Quantum Mechanical Calculations on Compound Bl 
Numbering Schemes Used for IH NMR Assignments 
iH NMR Assignments for Compounds A1-A3, Bl, B2,
D1 and D2
iH NMR Assignments for Compounds C1-C5, C8 and C9 
iH NMR Assignments for Compounds E1-E3, E5-E7 
and ElOa
Numbering Schemes Used for NMR Assignments 
13C NMR Assignments for Compounds Al, Bl, B2,
D1 and D213C NMR Assignments for Compounds C2, C3, El and E5 321
Numbering Schemes Used for 17Q NMR Assignments 322
170 NMR Assignments for Compounds Al, Bl, B2 and D1 323
170 NMR Assignments for Compounds C2, C4-C10a/b,
El, E5 and ElOb
iH NMR Spectra of Compounds Al and Bl at 300MHz 
IH NMR Spectra of Compounds A2, A3, B2, D1 and D2 
iH NMR Spectra of Compounds C1-C3, El and E2
iH NMR Spectra of Compounds C4, E4 and E6
iH NMR Spectra of Compounds C8, C9 and E7
IH NMR Spectra of Compounds Ell, ElOa and ElOb
13c NMR Spectra of Compounds Al and Bl at 75MHz
13C NMR Spectra of Compounds B2, D1 and D2
13C NMR Spectra of Compounds C2, C3 and El
170 NMR Spectra of Compounds Al, Bl, B2 and
D1 at 40MHz
170 NMR Spectra of Compounds C2 and El
170 NMR Spectra of Compounds C6 and E5
170 NMR Spectra of Compounds C8 and C9
170 NMR Spectra of Compounds ClOa, ClOb and ElOb 
3H NMR Spectrum of Compound D3 at 320MHz 
iH NMR Spectra of Deuterodebrominated 
Compound E6 342
IH, 3r and 3h NMR Spectra of Compounds E8a/b at
300MHz, 46MHz and 320MHz, Respectively 343
Mass Spectra of Compounds D2, E2, E4, E6,C8 and C9 346
Mass Spectra of Compounds Cl2 and ElO 348
316
317
318
319
320
324
326
327 
329
331
332
333
334
335
336
337
338
339
340
341
342
5.
DISCUSSION
4. Selectivity of Bromination: Determining the Position of the 
Bromine Substituent in Compounds B2, C3, D2 and E2
4.1 Mechanism and Kinetics
4.2 X-Ray Crystal Data
4.3 Quantum Mechanical Calculations
4.4 iH NMR Spectroscopy
4.5 Tritium Labelling: Dehalogenation of Compounds E6 and E2
4.6 Oxygen-17 Enrichment of Chromone-2-carboxylates
4.7 Oxygen-17 Enrichment by Exchange
4.8 Future Work
4.9 Oxygen-17 Enrichment by Synthesis
4.10 170 NMR Spectroscopy; A Feasibility Study for Chromone-2- 
carboxylate Derivatives and Precursors
4.11 Acetophenones
4.12 Chromone-2-carboxylate Esters
4.13 Chromone-2-carboxylic Acids
4.14 Sodium Chromone-2-carboxylates
4.15 General Remarks
4.16 Future Work
4.17 Miscellaneous 
REFERENCES
349
349
349
351
351
352 
355 
359 
359 
362 
362
364
365 
367
370
371
372 
372 
374
228
1. General Introduction
This final chapter is concerned with the structure of disodium 
cromoglycate (DSCG) and other chromone-2-carboxylic acid analogues as 
studied by iH, 3R and 17q NMR spectroscopy.
Developed from a natural product called khellini*^ as an anti-asthma 
drug3-i3, the mode of action of DSCG in biological systems continues to be a 
contentious issue. There are many suggestions, opinions and differing 
approaches to this elusive problem with representative examples in the 
chemical, biochemical and medical literature^"2l.
Labelling the drug molecule with radioactive atoms is a convenient way 
of tracing DSCG in highly complex biological fluids and the syntheses of 
both carbon-1422-24 and tritium2S,26 labelled analogues has been 
demonstrated. As tritium has a relatively high specific radioactivity, 
synthesis of the DSCG molecule with high tritium incorporation is a 
desirable approach for a radiolabelled analogue. The reported procedures 
suffered from problems of chemical impurity25 and low specific radioactivity 
and hence low tritium incorporation^^.
The unsuccessful reductive dehalogenation work of Wyrick and Ranga25 is 
evaluated here in order to identify the problems they encountered so that a 
modified procedure could be defined for the synthesis of [3H]DSCG at very 
high tritium incorporation. Such a molecule would serve as an excellent 
substrate for detailed structural studies of protein interactions using 
NMR spectroscopy in 2D heteronuclear NOE experiments.
In this chapter, another indirect approach to assist in answering the 
question of the mode of action of DSCG, namely NMR spectroscopy,27 is
introduced.
Chromone-2-carboxylates can be classified as heterocyclic molecules of 
both high unsaturation and oxygen content. Therefore, the NMR spectra of 
these molecules are relatively free of signals whilst NMR spectra suffer 
from overlapping signals and serious assignment difficulties. Moreover, the 
oxygen sites are likely to be important interaction points with the
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biological receptor(s). 17Q NMR spectroscopy allows one to study these sites 
directly.
High resolution NMR spectroscopy enjoys a large chemical shift 
range and has been shown to be a highly sensitive probe of molecular 
structure, electronic character and molecular conformâtion27 in solution. 
These attributes are not as apparent for other heteronuclei. Furthermore, 
the nucleus can be studied at natural abundance or may be isotopically 
enriched thus providing ^^ 0 NMR spectra of higher quality. An appreciation 
of this approach as applied to chromone-2-carboxylates is presented here.
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1.1 AbbreviationsThe following abbreviations have been used in this chapter. They are 
listed approximately alphabetically;
AcOH
Asp
tBOC
ButBu
Ci
D
Dadc
DEPT
DIPEA
DMF
DMSO
2D
DSCG
e
t
AE
El
Et
EtOAc
FAB
FID
FT
G
Glu
Gly
h
HMPA
HPLC
Hz1
Intal
JXLeu
LW
m
M
M
Me
MS
NaOAc
NMR
NOE
NS
o-
P-Ph
Phe
TT
Pr
Acetic acid 
Aspartate
Tertiary butyloxycarbonyl 
Butyl
Tertiary butyl
Speed of light in vacuum
Degrees centigrade
Curie
Debye
Dalton
Crystal density
Distortionless enhancement by polarization transfer
Diisopropylethylamine
Chemical shift
Dimethylformamide
Dimethylsulphoxide
Two-dimensional
Disodium cromoglycate (see Intal)
Electronic charge
Molar absorptivity (extinction coefficient)
First electronic excitation energy of longest wavelength
Electron impact
Ethyl
Ethyl acetate
Fast atom bombardment
Free induction decay
Fourier transform
General labelling
Glutamate
Glycine
Planck's constant 
Hexamethylphosphortriamide 
High pressure liquid chromatography 
Hertz (s-i)
Electronic inductive effect 
Disodium cromoglycate (see DSCG)
Coupling constant
Wavelength
Leucine
Linewidth
atomic mass unit
Molar
Electronic mesomeric effect 
Methyl
Mass spectrometry
Sodium acetate
Nuclear magnetic resonance
Nuclear Overhauser enhancement
Number of scans
Ortho
Para
Phenyl, C&H5
Phenylalanine
Pi
Propyl
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iPr Isopropyl
Pro Proline
ppm Parts per million
Q (Qoo, Qox) Charge density/ Bond order matrix 
R Residual value of refinement
rds Rate determining step
RF Radiofrequency
RP Reverse phase
RT Room temperature
s Second
sat'd Saturated
o-d Diamagnetic screening constant
ffp Paramagnetic screening constant
S/N Signal-to-noise ratio
t Time delay
Tc Rotational correlation time for molecular
reorientation 
THF Tetrahydrofuran
TLC Thin layer chromatography ■
TMS Tetramethylsilane i
Tyr Tyrosine !
UV Ultraviolet
V Unit cell volume
v/v Volume/volume
z Number of molecules per unit cell
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2. LITERATURE REVIEWS
2 ■ Oxygen
O x y g e n 2 8 , 2 9  is the most abundant chemical element in the Earth's crust, 
which contains approximately 50% by mass of oxygen^o and is probably, both 
chemically and biologically, an atom of chief importance on Earth. Oxygen 
forms compounds with all the elements except helium, neon and possibly 
argon. It combines directly with all the other elements, except the 
halogens, a few noble metals and the noble gases either at room or at 
elevated temperatures^o. The oxygen in these compounds exists at various 
oxidation states as well as in various functional situations. For example, 
with carbon, oxygen in the same oxidation state can functionally be an 
alcohol, ether, ester, epoxide, acid, anhydride, peracid etc. The structure 
of oxygen-containing compounds in its widest sense is consequently a subject 
of widespread significance. Despite the ubiquity and importance of the 
oxygen atom, relatively few chemical or biological studies based on the 
physical or chemical properties of the oxygen atom have appeared.
2.1 Nuclear Properties of Oxygen-17
The properties of the nuclide are listed in TABLE 1: 
TABLE 1: Physical Properties of OxvKen-l?
Property Magnitude Ref. No.
Natural Abundance 
Nuclear Spin, I 
Magnetogyric Ratio
NMR Larmor Frequency
Quadrupole Moment,Q
0.0374% (374 ppm)1 
5/2
-3 626.4 rad s”i G’l 
-3 628x107 rad T~i s“i 
13.557 MHz at 23 488 G 
(100 MHz for IH)-2.578x10-30 m2
28,30
31,32
33
34
35,36
l.The isotopic composition as found in air. The isotopic 
composition differs in other sources of oxygen^o.
Of the three stable oxygen isotopes, (99.759%) and ISQ (0.204%) are 
both more abundant at natural isotopic distribution and are magnetically 
inert (1=0). This leaves (1=5/2) as the only practical nucleus for NMR
study37. As NMR spectroscopy is a technique characterized by its relative
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insensitivity to signal detection, the observation of oxygen-17 resonances 
is distinguished by several technical difficulties arising from the large 
magnitude of the electric quadrupole moment, Q, and the onerously low 
natural abundance of oxygen-17 which makes it one of the more difficult 
nuclei to observe by NMR spectroscopy and accounts for the paucity of NMR 
studies until recent times. Since the oxygen-18 isotope is cheaper than 
oxygen-17 it has been utilised to a greater extent to study chemical 
mechanisms and bio-organic problems^*. As oxygen-18 is separated from 
oxygen-16 by two mass units analysis by mass spectrometry is simple thereby 
making it the primary analytical technique. The exact location in a molecule 
is fraught with assignment problems. More recently, the oxygen-18 isotope 
has been employed due to the isotope shift effect on the NMR signal of 
various NMR-active nuclei39.
2.2 170 NMR
The following sections detail the various difficulties and solutions to 
the NMR of quadrupolar nuclei, emphasising the oxygen-17 case.
2.2.1 Pulse Power Distribution
Finite pulse power limits the width of the spectral window in which 
signals can be effectively observed^o. There is a substantial reduction of 
the spectral signal amplitude with an increase in frequency offset. This is 
a serious disadvantage when recording multiline spectra with large chemical 
shift separations^! *^ 2. This is illustrated with the data of Laue et al4%:
FIGURE 1: Relative Intensity Distribution of the RMR Snectrum of
D2O. Simple 90^ Pulses.
J
2.2.2 Baseline Distortion in Frequency Dcxnain Spectra
FT-NMR spectra are notoriously prone to baseline distortions especially
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when FID's of very short duration are recorded^!.43, This is particularly 
apparent in the study of quadrupolar nuclei, that resonate at relatively low 
frequencies44, such as oxygen-17,
The true resonance position(s) may be obscured by these distortions 
which arise when the RF receiver is not protected from the effects of the 
trailing edge of the high power RF pulse4i. The most severe origin of 
baseline "roll" is the transient response of the NMR probe often referred to 
as acoustic ringing4 5. The primary cause of acoustic ringing is the 
electromagnetic generation of ultrasonic waves in metallic components of the 
NMR probe following an RF pulse42.44, fn the static magnetic field, the 
acoustic energy sets up a RF field, which consists of a broad envelope of 
frequencies centred around the carrier frequency and in phase with the RF 
excitation pulse. The resultant extraneous signal is superimposed upon the 
recorded FID,
The following sections look at spectrometer software-based acoustic 
ringing elimination methods.
(II Zero Point Method
As long as the acoustic ringing signal decays significantly faster than 
the FID due to the species of interest, only the early points of the FID 
will be corrupted by the acoustic ringing signal, the remainder of the FID 
being essentially pure NMR signal.
The earliest points of the FID are set to zero in this simple 
procedure42. This reduces the baseline "roll" but the method is compromised 
as new baseline artifacts can be introduced. The experimenter has to decide 
on the number of zero points required in each individual case. This 
judgement is complicated by the need to distinguish between the baseline 
"roll" (which decreases) and the truncation artifacts (which increase) as 
the number of points set to zero are increased.
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FIGURE 2: NMR Spectrum of Aspyrone. (a) Conventional Fourier
Transformation fbl Ten Data Points of FID Set to Zero before 
Fourier Transformation
(Til Delaying the Data Acguishiion
As the acoustic signal decays faster than the "real" signals in the 
FID, a time delay can be inserted between the end of the high power 9CP RF 
pulse and the beginning of the data acquisition to avoid baseline 
distortion^!.43. This method was not popular in the earlier endeavours of 
!7Q NMR spectroscopy because of the resultant loss of NMR signal due to the 
rapid relaxation of the quadrupolar nucleus and concomitant loss of 
sensitivity for an already difficult experiment.
The elegant method of Goulon-Ginet et al43 is applicable to spectra 
that involve only two signals that must be closely spaced or even partially 
overlapping. In these special cases, the acquisition delay, 6t, is set to a 
value according to the relation:
^v.^t = k
where Av is the frequency difference between the two lines and k is an 
integer. Av must be reasonably small so that At is not unduly large such 
that the pulse rate is not decreased to an extent that little signal is 
being accumulated.
FIGURE 3: !?0 NMR Snectrum of Vinvlene Carbonate. k=l.
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(III) Maximum Entropy Method
Although reported in the literatures^, this method is not operated on a 
widespread basis because of the heavy demand required of the spectrometer 
soft- and hard-ware and the limited applicability of the technique.
(IV) Difference Method
This method is the most widely used enabling spectra of satisfactory 
quality to be obtained^1 .46,47.
There are two basic types of difference method. The first involves 
phase cycling. Only the true signals remain in-phase with the pulses 
applied. Although effective, this approach suffers from some disadvantages. 
These include severe pulse power drop with increasing frequency offset and a 
reduction in the S/N ratio. These effects are due to the presence of a 180* 
pulse in the sequence*1.46,48.
The much simpler and more successful "reference baseline subtraction- 
90*" pulse sequence of G e r o t h a n a s s i s * ^ , so overcomes these difficulties. 
Although possessing the same three-pulse format of the phase-cycling 
approach;
(1) 90x - FID+
(2) 90x - (t + tp) - FID+
(3) 90x - t - 9ÜX - FID-
the sequence consists of two consecutive FID acquisitions (lines 1 and 2) 
followed by the acquisition of baseline distortion of double amplitude. 
Subtraction of the (1) and (2) from (3) effectively eliminates baseline 
distortion. The time delay in the second pulse, t+tp, is equal to t+90x of 
the third which ensures that the phase of the acoustic signal is similar**.
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FIGURE 4; NMR Spectra of Neat Ethvlene Glycol (a)Normal Acquisition
fblUse of "Reference Baseline Subtraction-90 " sequence
(b)
2.3 Reference Signal
The common chemical shift reference for NMR spectroscopy is
naturally abundant oxygen-17 in water, although other references such as 
1,4-dioxane5i.52 and nitromethane5 2 have been used. Water is not an ideal 
chemical shift reference because of its relatively large linewidth but it is 
acceptable on the basis of the similarly large linewidths for typical 
NMR resonances. Because of the sensitivity of the "water" absolute chemical 
shift to solvents, solutes, concentration effects, temperature and pH, the 
reference must be external.
It is interesting to note that there is an approximately even balance 
between referencing signals to the resonances of HzO and D2O for 17Q NMR 
studies even though, in the large majority of cases, no field frequency 
locking was employed. Moreover, a secondary isotope effect on the chemical 
shift of the D2O reference signal has been reported5 3-5 5. Although the 
magnitude of this shift (-3ppm53, -1.55ppm per 2^54,55) ig close to the 
uncertainity in the reported NMR signals, it is an added complication in
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the comparison of published NMR work. Most organic compounds have
positive shifts on this scale.
2.4 170 NMR Chemical Shifts
Heteronuclear NMR chemical shifts ( ,  including those for oxygen-17, 
are dependent upon two parameters: The paramagnetic (deshielding,<Tp) and 
diamagnetic (shielding,Oj) screening constants^^,56;
For an oxygen atom bound to another atom (X), the chemical s h i f t , o f  
oxygen is considered to depend predominantly upon the paramagnetic term, 
the diamagnetic term making very little or no contribution®?; = 0,ôo = Gp
Changes in may be small, but itself is not small
The paramagnetic term is defined by the Karplus-Pople equation®®: 
o-p =. -e&i (AE)-l (r-3)2p (Qoo + Qox)
2m2c? \ I
- V ------Term No. 1 2  3
The first term is a constant. In the second term,AE is the electronic 
excitation energy^^.58,59 characterizing the electronic ground state and the 
various excited states of increasing energy. The first excitation of longest 
wavelength serves as a reasonable approximation of AE (ie. AEi = AE) since 
it is unlikely that contributions from higher energy electronic states are 
significant. Only symmetry-forbidden (eg. n TT*) transitions (which are 
magnetically active) can influence the observed chemical shift. As these 
transitions have small extinction coefficients, studies correlating AEi and 
are uncommon®2 . .  In the third term, (r"3)2p is the inverse cube 
radius for the 2p orbitals on oxygen and Qoo + Qox is the charge density 
bond order matrix. Qoo refers to the local charge density on the oxygen atom 
and Qox is the bond order between oxygen and an adjacent atom, X34.
In many studies, the Q term for TT-electron systems is approximated to 
the TT-bond order. In unsaturated systems, the (r"3)2p and Q terms can be 
related to the TT-electron density and its distribution®*». The TT-bond order
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has been established as the dominant factor in influencing the i?0 chemical 
shift values of aryl carbonyl compounds®^ *®2. Heteronuclear NMR chemical 
shifts and the electron distribution defined by quantum mechanical 
calculations have been successfully correlated for indane-1,3-diones®3. 
These correlations provide the basis for useful discussions on bonding, 
complexation and applications in solution structure molecular and 
conformational analyses.
However, enough information is still not available to utilise the full 
predictive potential of this equation®4.
2.5 Chemical Shift Range and Coupling Constants
The first NMR signals were observed by Alder and Yu in 195131.
Since that time many classes of compound have had their i?0 NMR data 
reported28.5 2,62,64,65, Oxygen-17 present in numerous functional groups 
cover a chemical shift range of 700-800 ppm for carbon-bound oxygen 
containing organic molecules and up to 1500 ppm for transition metal 
complexes^®. This helps to compensate for the quadrupole broadened signals 
by aiding signal resolutions*. FIGURE 5 shows the chemical shift ranges 
covered by typical oxygen functional groups.
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Functional Groups
Type Functional Group
Typical Kanf’c 
(PPM )
- 0 - Alcohols ^  to +100
Uihcrs -52 to +140
Esters +90 to+210
Anhydrides + 250 to 4.110
c=o Aldehydes* + 500 to +605
Ketones* + 470 to +615
Esters* + 290 to +380
Amides" 4 2KO to 4 370
Anhydrides undumides i37() to 4 «MO
Isocyanates + 80 10 + 150
Quinones* +520 to +635
X=0, X -Q - //-Oxides* +300 to +400
Nitro + 550 to +700
Nitroso + 620 to+700
Sulfoxides -40 to + 15
Sul Tones + 120 to +180
Phosphoryl +40 to +100
Misc Carboxylic acids + 250 to +290
Carbonyl Functional Groups
R -C O j*H
o*Esters R-C OR
CirboivM c
tslers R C O "  R
Amides R C N H ]
Anhydrideso y
R-C-0*-C-R
Acid li il ld c s  RCO*X
Anh|rdrldM 
R C O f  R l
IsocraMla
R-N CIl*
K c lone  R f  K
Aldehyde R-C IIO *
7ÎÔ 660 560 4ÎÔ 350 Ï5Ô Ï5Ô 5"
1^0 NMR Chemical Shift
"llyd ro g cu  bonded exam ples w ould extend Ihc range upHcId.
Values of U gh are very small (a few Hz, typically <100Hz) in
comparison with the linewidth of the NMR signal such that solvent
choice, temperature and high concentration can conspire to obscure the
coupling quite easily^^.es. The reporting of Joh values is rare. An example
is shown in FIGURE 6.
FIGURE 6: *^0 NMR Spectrum of 2-‘Hydroxy-6-iiiethoxyacetophenone Showing
iJoH for the Phenol Signal (bl
The continued growth in the understanding of NMR chemical shifts
will provide the potential for new insights into the molecular structure of 
organic molecules. Being more sensitive to structural variation than 
comparable i n^ or NMR spectroscopy has enabled NMR spectroscopy to
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become a valued tool for use in structural and conformational analyses&&, 
the investigation of dynamic exchange p r o c e s s e s ^ s .67 and the elucidation of 
reaction mechanisms28,29,
2.6 Factors Dictating Solution Composition
For diamagnetic species in the absence of rapid oxygen site exchange 
processes, the NMR signal linewidth observed for solution spectra is
usually limited by the quadrupolar relaxation rate. Quadrupolar relaxation 
is almost always the most effective pathway for the oxygen-17 nucleus. It is 
independent of magnetic field strength's.29,34.
The quadrupole relaxation time, Ti, in the extreme motional narrowing 
condition is described by the following relation^*:
Linewidth, LW = 1 = 1 = 3 (1 + n%/3)
Ti T2 125
e^ Oa
■fi
2 Tr
where Ti = Spin-lattice relaxation time 
Tz = Spin-spin relaxation timers
n = Assymmetry parameter of the electric field gradient at the 
nuclear site (0 4 1)
= Quadrupole coupling constant 
eq = Field gradient due to the electrons 
eQ = Nuclear electric quadrupole moment
Tc = Rotational correlation time for molecular reorientation 
This equation holds under conditions where isotropic molecular tumbling 
is rapid on the NMR time scale (ie. Tc << W o " ^ ,  where Wo is the nuclear
Larmor frequency). Since n ,q and Q are constants at a specific oxygen 
environment within a molecule, Ti must be increased to afford linewidth 
reduction thus enhancing the S/N ratio and the rapidity of the NMR
experiment. Fiat et aiss state that a 10:1 ratio should be aimed for in 
natural abundance work.
In the above equation, 1/Ti, the rate of quadrupolar relaxation 
decreases with a decrease in the molecular reorientation time.
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Xc28,29.34,47. This parameter is accessible to variation by the 
spectroscopist.
The factors governing Tc for a sphere (molecule) in a continuous medium
(solvent) are given by the Stokes-Einstein-Debye equation:
Tc = 4TTna3 
3kT
where n = Solution or solvent viscosity
a = Radius of the molecular species under investigation 
T = Temperature 
k = Boltzmann's constant 
As the signal linewidth is directly proportional to Tc, a reduction in 
the magnitude of Tc signifies a decrease in linewidth^?. This may be 
achieved in the following ways;
I. Decrease in the molecular size of the species of interest
II. Increase in temperature at which the FID is accumulated
III. Decrease in solution viscosity
(I) Molecular Dimensions
As Tc is directly proportional to the cube power of the molecular 
radius of the NMR species (assuming that it is a sphere), the linewidth will 
be sensitive to the size of the molecule under study implying that smaller 
molecules will yield better resolved spectra^7-69. The work of Duddeck et 
al70 illustrates this point admirably:
o
LW=55Hz LW=180Hz
LW=280Hz
O'LW=310Hz OCH
LW denotes the full peak width at half peak height. Measurement of LW 
at half peak height is necessitated by the inherently high level of noise
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and baseline distortions.
(Ill Temperature and Viscosity
As Tc is inversely proportional to temperature, an increase in 
temperature should help reduce the NMR signal linewidth. This is illustrated 
by the work of Gerothanassis and co-worker^
FIGURE 7: NMR Spectrum of Neat Glycerol. (A1331K (B)313K (C)305K
(D1297K
Solvent viscosity is a function of temperature, so it seems likely that 
a concomitant reduction in solvent viscosity with increasing temperature is 
a factor in this effect?i.
(Ill) Solvents
For solution spectra, utilization of solvents of low inherent viscosity 
is imperative, NMR studies have been executed in acetonitrile, carbon
tetrachloride, chloroform, 1,4-dioxane, toluene, acetone and 
1,2-dibromoethane (See TABLE 36). It is of interest to note that solvents of 
high viscosity (eg. DMSO, DMF) or hydrogen bonding ability (eg. water, 
alcohols) are little used. The use of recently published pulse sequences and 
high field NMR spectrometers has resulted in successful studies in these
solvents72,73.
As the molecules studied by NMR spectroscopy are polar and may act 
as hydrogen bond donors (eg. carbonyl functions) or acceptors (eg. alcohols, 
carboxylic acids) association of the solute and solvent in this or indeed 
any significant manner will, apart from the viscosity problem, enhance the
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molecular size of the species being detected in the NMR experiment resulting 
in poor quality spectra. Even a solvent such as chloroform can form weak 
hydrogen bonds to oxygen donor functional groups?*.
Due to the low natural abundance and the relative insensitivity of 
oxygen-17 to NMR detection, solution composition is usually limited to 
relatively high molar concentrations (0.5 - l.OM) or pure liquids. When
dealing with such conditions, especially with larger molecules, the low 
viscosity ideal is compromised.
Oxygen-containing solvents, such as acetone and 1,4-dioxane, are also 
best avoided, unless they are i?0-depleted as the disparity between the 
molar concentrations of the solute and solvent can prove to be problematic 
in recording the NMR data of the solute.
It has been established, particularly from the work of Boykin et al, 
that acetonitrile is the best all-round solvent for use in recording NMR 
data on a routine b a s i s ^ 2 , 6 5 .  Although dipolar in character, this property 
is a requirement for the relatively high molar solution concentrations 
needed for the moderately polar compounds studied. It is non-protic, unable 
to associate significantly with the solute and lacks oxygen in its molecular 
constitution.
2.7 17Q NMR Data
The quantity of NMR data for chromones and heterocyclic molecules 
in general is limited, there being less than half a dozen sources containing 
at least one example.
Chromone-2-carboxylates have various structural oxygen-containing 
elements, the steric and electronic NMR spectroscopic description of
which is complicated and with inadequate data, is compounded by the ability 
of all these elements to communicate via a common TT-network, such that some 
effects are easily overlooked. To critically evaluate and apply the 
experimental data it is necessary to employ NMR data of sub-structural 
elements in order to describe the more complex molecules of interest here.
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The ?^0 NMR chemical shift values can be influenced by various factors
which include the following:
(I) Electronic perturbation
(II) Torsional displacement 
(III) Hydrogen-Bonding interactions
(IV) In-plane distortions 
Each of these phenomena will be illustrated for the carbonyl, ether and 
carboxylate functional groups.
2.8 The Carbonyl Function: (I) Electronic Perturbation
The NMR chemical shift of acetone has been reported as follows:
TART.E 2: NMR Chemical Shift of Acetone
Chemical Solvent Temp. Ref.
Shift (ppc1) Cc) No.
569 Neat liquid - 75
571 CHbCN 75 76
while that of acetophenone shows a chemical shift difference of -19ppm when 
recorded under identical conditions:
TABLE 3: NMR Chemical Shift of Acetophenone
Chemical Solvent Temp. Ref.
Shift (ppm) (*C) No.
552 Neat liquid 30 53
552 CHaCN 75 77
548.6 CHsCN 60 60
550 1,4-Dioxane 30 53
554 Acetone R.T.l 53
1. R.T. = Room temperature
This was rationalised on the basis of TT-conjugation between the 
carbonyl function and the phenyl ring. The resulting delocalisation of 
electron density imparts greater negative charge at the carbonyl oxygen and 
a reduction in carbonyl bond order consistent with the following resonance 
structures53:
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Changes in the magnitude of the (r"3)2p charge density and/or Q bond 
order terms of the Karplus-Pople equation have been implicated. A similar 
effect was noted for indane-1,3-diones&3:
0534.0 ppm 0 507.0 ppm
0 o
Substituents at the ortho- and/or para-positions of the phenyl ring 
lead to the greatest perturbation of chemical shift in acetophenones as 
expected from inspection of the above resonance structures. This is 
illustrated from the work of Brownlee et al^o and Fiat et al5 3:
TABT.E 4: Substituent Effects in Acetophenones
Substituent Chemical Shift 
(ppm)
— 548.6
4-OH 513.01
4-NHz 513.94-OMe 534.5
4-Me 543.5
4-Br 551.01
4-Cl 551.1
4-CHO 559.0
4-CN 562.8
4-NO 2 564.3
1. In 1,4-dioxane at 30°C. All other values in acetonitrile at 60 C.
Electron-donating substituents result in upfield shifts (shielding) 
whilst electron-withdrawing substituents result in downfield shifts 
(deshielding). Some substituents possess both properties giving chemical 
shift values little changed from the base value (eg. the halogens).
(II) Torsional Displacement
Angular deflection of the carbonyl function from a co-planar situation 
will influence the effectiveness of TT-orbital conjugation. As the carbonyl 
group is rotated out of conjugation with the aromatic ring, greater double
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bond character is predicted for the carbonyl bond. This increases the Q term 
and/or the (r“3)2p term of the Karplus-Pople equation resulting in an 
observed deshielding for acetophenones^^.66. The effect is illustrated from 
the work of Boykin and co-worker^G and Fiat et aiss;
TABUS 5: Torsional Displacement in Acetophenones
Substituent Chemical Shift 
(ppm)
2-Me 582
4”Me 546
2,4-diMe 576
2,4,6-triMe 601
4-OMe 535
3—OMe 551
2-OMe 561
4-Br 551
3-Br 556
2-Br 589
Linear correlations between molecular mechanical calculated torsion 
angles and NMR chemical shifts have been established for aryl methyl
k e t o n e s ^ 2 , 6 6 , 7 6 ,
(III) Hydrogen Bond Interactions
Shielding of the hydrogen bond acceptor (carbonyl) NMR chemical
shift is observed for C=0....H-0 interactions^^.7 9 - s i, This is illustrated
with data for the electronically equivalent o- and p-hydroxybenzaldehyde^s:
540.4 ppm H 509.1 ppm
(260 Hz) 1 1 (142 Hz)
lO]
O H
The average shielding was observed to be -30 ppm for benzaldehydes and 
-50 ppm for acetophenones^z,
The average distance between the oxygen nucleus and its 2p electrons 
increases through hydrogen bonding thereby decreasing the (r-3)2p term. 
Also, since the nonbonding oxygen orbitals in the ground state will be 
stabilized by hydrogen bonding the energy of the n->TT* transition will 
increase, decreasing the^E”i term. The Q term may also be affected due to 
carbonyl bond order reduction.
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It is difficult to pin-point a single cause for the observed shielding 
as the terms of the Karplus-Pople equation are, to an extent, 
inter-related® 3.
For hydrogen bonded aryl carbonyls, the two substituents must be 
mutually ortho to one another. The contribution of the hydrogen bond to the 
chemical shift will be complicated by concurrent electronic and torsion 
effects. Using molecular mechanical calculations, Baumstark et al estimated 
the torsion angle, negating hydrogen bond formation, to be 33® for 
2-aminoacetophenone yet a torsion angle of -13° was calculated when the 
hydrogen bonding contribution was considered?*.
A significant reduction in the observed linewidth is another 
characteristic of intramolecular hydrogen b o n d i n g ? *» 2. The case for 
hydroxyacetophenones is presented by Boykin et al®o and Fiat et a l5 3*.
TABLE 6: Hydrogen Bonding in Acetophenones
Substituent Chemical 
Shift (ppm)
LWl
(Hz)
4-OH 513 1409
3-OH 546 1293
2-OH 488 6002
(QH=90)
2,6-OH 476* 10133
1. LW = Linewidth
2. Linewidth is approximately halved for the 2-OH intramolecularly hydrogen 
bonded example as intermolecular hydrogen bonding is less likely. Thus, 
no aggregates are formed in solution, the NMR species detected is smaller 
resulting in the smaller linewidth.
3. Only one OH available for intramolecular hydrogen bonding at any one 
time. The second OH forms intermolecular hydrogen bonds so that the 
reported linewith is similiar to the 4-/3-0H examples.
4. Second electron-donating ortho-substituent gives additional shielding 
over 2-OH case.
Multiple hydrogen bonding to the same carbonyl results in an additive 
effect®};
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440.3 ppm 
OH O
fIVl In-Plane Distortion
Deshielding of 17q NMR chemical shifts has been observed for aryl 
ketones located near sterically hindering groups in rigid, planar molecular 
systems for which torsional displacement is not p o s s i b l e ® ^“86, A study of 
anthraquinones*4'87 illustrates this;
AO 524 ppm 572 ppm Qo
:oi lo] [^ lo :
O 524 ppm 522 ppm ®
Molecular mechanical calculations predicted bond angle deformation 
which reduces, but does not eliminate, van der Waals interactions. Angle ABC
= 120.5° while angle DEF = 125°. The latter angle was confirmed from the
X-ray crystal structure of this molecule®*.
Chesnut and Li®®'®9 have proposed a theory that states that repulsive 
van der Waals interactions could explain deshielding trends in and 3ip 
NMR data. This is probably mediated via orbital compression, which for 
oxygen, would result in a diminution of the p-orbital volume. This would 
directly influence the (r"^)2p term of the Karplus-Pople equation resulting 
in the observed deshielding.
Boykin et al have presented data for a series of 1-tetralones®®, aryl
cyclic anhydrides90 and indanones®^. Some examples of indanone data are
presented here;
TABLE 7: In-Plane Distortion in Indanones
Position Substituent Chemical Shift 
(ppm)
— — 505.3
3 Me 499.0
4 Me 504.8
2 Me 504.1
1 Me 520.3
250
Methyl substituents at positions 2 and 4 have no steric and little 
electronic influence at the carbonyl function such that the chemical shift 
value is unchanged. At position 3 the methyl substituent , as expected, 
shields the carbonyl resonance. The electronically equivalent position 1 
methyl substituent shows a large deshielding interpreted as an in-plane 
distortion and/or orbital compression of the carbonyl oxygen®^.
2.8 Ethers. Alcohols and Hienol Derivatives
The dicoordinate oxygen atom can appear in many different structural 
environments. The large NMR chemical shift range observed is a sensitive 
structural and conformational measure of this.
(II Electronic Perturbation
For alkvl ethers and alcohols a large deshielding effect is observed on 
going from primary to secondary and tertiary alkyl groups attached to the 
oxygen?!,52,92-94,
TABTJK 8: o<-Alkvl Effect in Alkvl Ethers and Alcohols
R-OH R-O-R'
Class R Chemical 
Shift (ppm)
Me -32.4
r Pr‘ 1.7
2" 2-Pr 40.3
2° 2-Bu 35.0
2" Cyclopentyl 33.1
T Cyclohexyl 35.7
3" tBu 70.0
3" 2—Me—2—Bu 57.4
Class R R' Chemical 
Shift (ppm)
Ÿ Me Me -52.5r Me Et -22.5
r Et Et 6.5
2" Cyclotiexyl 5.0
2^ 2-Pr 2-Pr 52.5
Deshielding of greatest magnitude occurs where the carbon atom adjacent 
to oxygen is substituted with further carbons. It has been established?^,95 
that the chemical shift of alkvl alcohols and ethers is governed by changes 
in theAE"! term of the Karplus-Pople equation.
Introduction of « -unsaturation?2.96 further increases the deshielding 
observed.
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TABTB 9: o( ^ -Unsaturation in Ethers 
R-O-R'
R R' Chemical Shift (ppm)
Et Vinyl 77.5
Ph Me 47.6
Ph Et 68.0
Ph Vinyl 125.0
Ph Ph 101.5
Cyclisation of tx ,/j-unsaturated ethers leads to greater chemical shift 
values but this is ameliorated by annélation of benzene r i n g s ? ? , 9 7 - 9 9 ;
o o240 ppm 158 p3m
A major contributor to the large deshielding effect is thought to be 
due to the influence of the following resonance structures:
C==C-0-C <--- > c-c=g-c
Obviously, the polarized form will affect the (r~3)2p and Q terms 
leading to chemical shifts of greater magnitude.
For aryl ethers and phenols, electron-withdrawing substituents at the 
para- and ortho-positions results in further deshielding:
R = H or CHs
This electronic effect is illustrated with the data of Iwamura et al?®, 
Duddeck et al?o, Boykin et al®? and Facelli et all®®. The oxygen acts in an 
analogous fashion to the carbonyl case.
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TARTJR 10: Substituent Effects in Phenols and Anisoles
R X Chemical 
Shift (ppm)
H 77.33 (71)1
NH2 65.5OMe 68.3 (64)!
Me 73.2
Cl 76.6
Br 77.6
CN 90.7
NO2 93.7 (88)!
CH3 - 48* (47.6)?
NH2 36OH 37!OMe 38
Me 44
Cl 48
Br 51
CN 60
NO2 67
1. Values taken from reference 100
2. Values taken from reference 101
3. Values taken from reference 82
4. Values taken from reference 95
The relative shielding of the aryl ether oxygen is seen?! as the +I 
effect of the methyl group.
(ID Torsional Displacement
Displacement of the CH3-O bond, in aryl methyl ethers, from 
co-planarity leads to shielding of the oxygen resonance. This effect is 
opposite to that observed for carbonyls. With two ortho substituents, the 
CH3-O bond can no longer be co-planar, conjugation of the oxygen lone pairs 
to the aryl TT-system is reduced or lost and the ipso aromatic C-0 bond 
becomes more single bond in character. These factors influence the Q bond 
order and (r~®)2p orbital size terms of the Karplus-Pople equation and 
explains the observed shielding.
The data of Boykin et al!®? for anisoles illustrates this point:
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TABLE 11: Torsional Displacement in Anisoles
Substituent Chemical Shift (ppm)
_ 48
2-OMe 46.2
2-tBu 48.8
2,6-Me 16.5
2,6—Et 16.7
2,6-iPr 13.5
(Till Hydrogen Bonding Interactions
The result of hydrogen bonding is much the same as with carbonyls: 
TABLE 12: Hydrogen Bonding in Phenols 
R = H or CH3
R Substituent Chemical 
Shift (ppm) ! J o h  (Hz)
H 4-OH 91.0!
2-OH 81.0! 92
4-OH 85? -
2-OH 80? -
CH3 2-OH 85.53 862-OH 86.0* -
2-OH 90® -
1. Values taken from reference 82
2. Values taken from reference 100
3. Values taken from reference 80
4. Values taken from reference 83
5. Values taken from reference 53
Shieldings of approximately 10 ppm for the hydrogen bond donor (phenol
OH) are observed which are relatively invariant to further benzene ring
substitutions®!» ®?.
Facelli et al!®® concluded that the hydrogen bond donor shieldings were 
due to molecular orbital stabilization.
As the phenol proton exchange is slower when involved in an
intramolecular hydrogen bond, one-bond oxygen-proton couplings are observed.
These range from 58 to 92 Hz®?.
Baumstark et al?* and Lauterwein et al!®! have shown that increasing 
the acidity of the hydrogen bond donor proton yields a larger hydrogen bond
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contribution (shielding) to the observed !?0 NMR chemical shift.
2.9 Carboxvlates: (I) Electronic Perturbation
The chemical shift value for the carboxylic acid function, RCO2H, is
the mean of the carbonyl and hydroxyl oxygen constituent v a l u e s ! ® 3 .104^
being in the approximate range of 250 - 300ppm. The observation of a single 
signal is due to rapid proton exchange between the two oxygen sites®?. With 
carboxylate esters, there is a distinct resonance for each oxygen?!, a rough 
guide would be!®3; -0-, 130-160 ppm and 0=0, 340-400 ppm for aryl esters.
For alkyl esters of the type: R— COO*Bu ;addition of alkyl groups at the
«-carbon results in shielding of the carbonyl resonance, leaving the ethereal 
oxygen little affected!®®:
TABLE 13A: Alkvl Esters
R Chemical Shift (ppm)
C=0 —0—
Me 368.7 204.4
Et 356.8 200.0ipr 325.5 198.9
Conversely, for: CH3COO— R' ;deshielding is observed, analogous with 
■ the ether case!®®:
TABLE 13B: Alkvl Esters
R' Chanical
C=0
Shift (ppm) 
-0-
Me 355.0 148.0
Et 363.0 169.0iPr 363.0 196.0
tBu 368.7 204.4
For the carbonyl oxygen of the carboxylate group the +I effect of the R 
group must be predominant leading to changes in the Q bond order and/or 
(r“3)2p charge density terms of the Karplus-Pople equation. For the ethereal 
oxygen, the AE"! term is known!®® to be most important and this agrees with 
ether and alcohol data already presented.
, 1^ -Unsaturation to the carbonyl is responsible for a marked
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shielding105; 3^3 _q ppm
169.0 ppm
327.2 ppm O
'O'
129.5 ppm
due to the contribution of the polarized resonance structure.
Methyl benzoates display substituent effects as the result of 
influences from the following resonance structures!®®"!®®:
. X  X
TABT.K 14: Substituent Effects in Methvl Benzoates
Substituent Chemical Shift (ppm) Other Groups
C=0 -0-
337.3 127.2
4-NH2 322.8 122.3
4—OH 330.0 125.3 85.3
4-OMe 330.6 124.8 60.1
4—Me 334.7 126.3
4-Cl 338.3 127.9
4-Br 338.6 128.1
4-CN 344.6 130.5
4-NO 2 345.8 131.2
The relatively large chemical shift value for the methoxyl and hydroxyl 
groups in the above table is due to the carboxyl group acting as an electron 
sink thereby enhancing the contribution of the following resonance 
structure:
OCH,
The carbonyl oxygen is much more sensitive to substituent 
effects!®®•!®®.
The heterocyclic nitrogen of pyridinecarboxylates causes deshielding of 
both oxygen resonances as electron density is drawn to the electronegative 
heteroatom:
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337.3 PP»^^oCH3 34* 4 xOCH.
127.2 ppm 1 131.8 ppm
fll) Torsional Displacement
Carboxylic acids and esters respond in a similar fashion to 
carbonyls.109;
TARÏ.K 1 5 : Torsional Displacement in Benzoates
R Substituent Chemical Shift (ppm)
0 0 -0-
H
Me
4-Me
2-Me
2.6-diMe
4-Me
2-Me
2.6-diMe
21
2i
2i
2f
340
339
359
377
)0
K9
)5
10
128
127
138.5
150
OR
The carbonyl oxygen is more sensitive than the ethereal oxygen&6 to 
torsional displacement.
(Ill) Hydrogen Bonding Interactions
Boykin and K u m a r 0^7 reasoned that, compared to methyl benzoates, the 
charge density at the carboxyl group was less in pyridinecarboxylates, 
suggesting that the carbonyl oxygen was less basic and that the hydrogen 
bond contribution to the observed chemical shift was reduced. However, for 
pyridine-2-carboxylates this situation was reversed:
CH3O.
OAÇhb = -10 ppm
CH3O ,0 .
= -4 ppm
<ûi^ B = -13.4 ppm 
ÔCH 3
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The anomalous result was explained by invoking van der Waals repulsive 
interactions between the nitrogen and alkoxy electron lone pairs. This 
increases the charge density on the carbonyl oxygen, increasing its apparent 
basicity and hence its effectiveness as a hydrogen bond acceptor. The 
torsional displacement of the carboxyl functions were f as indicated by 
molecular mechanical calculationsio?.
2.10 Crngpounds Related to Those Studied
The following few sections describe compounds which are structurally 
related to those detailed in the experimental sections.
2.11 Arvl Carbonyl Compounds
Compounds of interest here are multiply substituted benzene rings 
containing carbonyl, hydroxyl, halogen and methoxyl substituents.
Fiat et al5 3 and Boykin et al*o report data for compounds used as 
spectroscopic test samples in this study:
TABT.F 16: 2 ' -Hvdroxvacetonhenones
Solvent Chemical Shift IJOH
C=0 OMe OH (Hz)
CHaCN 484 62.5 89 87
Toluene 488 — 91 —
CH,0
Solvent Chemical Shift
0=0 OH
Dioxane 476 -
CH3CN 481 91
Granzhan et aliio presented a study of the solution structure of these 
compounds in benzene and dioxane solvents by comparison of experimentally 
derived and calculated dipole moments. They showed the structure to be the 
same for both compounds:
R = H or CH3
Only one hydroxyl group participates in the intramolecular hydrogen
258
bond at a given time, the other OH (or OMe) substituent remains co-planar to 
the benzene ring but is disposed away from the acetyl group because of 
steric constraints. The acetyl function is displaced from co-planarity 
because of the steric effect of the two ortho-substituents.
Kolehmainen et al^^.iii have reported extensive data for multiply 
substituted benzaldehydes:
TABLE 17: Substituent Effects in Benzaldehvdes
Compd.
No.
Substituent Chemical Shift (ppm)C=0 OH m e
1 560
2 2-Cl 573
3 3-Cl 567
4 4-Cl 564
5 2-OH 506 87
6 3-OH 551 80
7 4-OH 527 98
8 2-0H,3-Cl 509 84
9 3-0Me.4-0H 539.1 77.2 37.2
10 2-Br,3-OMe,4-OH 559.0 85.7 10.0
11 3-0Me,4-0H,5-Br 549.2 83.8 45.4
12 3-OMe,4-OH,6-Br 555.8 78.7 38.9
Compound 4 reveals the electronic effect of the chlorine substituent 
whereas compound 2 shows that torsional displacement causes additional 
deshielding to the carbonyl resonance. Compound 7 shows the electronic 
mesomeric effect of the hydroxyl substituent leading to a substantial 
shielding of the carbonyl resonance whereas the phenolic function is 
deshielded. These effects are reconciled in the following resonance
structure:
+OH
Although compound 5 has an ortho-substituent, the carbonyl resonance is 
shielded due to the formation of an intramolecular hydrogen bond. Compound 8 
shows that the chlorine substituent is of little overall electronic 
consequence when attached meta to the aldehyde. Compare with compound 5.
For compound 9, the introduction of the 3-methoxyl function has a
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marked effect when compared with compound 7. The hydroxyl oxygen is shielded 
as is the methoxyl oxygen when compared to typical phenols and anisoles. 
This is due to the formation of an intramolecular hydrogen bond between 
these two functions. Both functions remain essentially co-planar to the 
benzene ring. The electronic implications of the hydrogen bond lead to less 
charge density at the carbonyl resulting in its observed move to lower 
field. Compounds 10 and 12 are similar in that torsional displacement of the 
aldehyde caused by the bulky ortho-bromine substituent results in the 
observed deshielding of the carbonyl oxygen. Note that their chemical shifts 
are very similar. In compound 10, the methoxyl function is flanked by two 
ortho-substituents and is displaced from co-planarity. The hydroxyl group 
can no longer hydrogen bond effectively causing deshielding of this hydroxyl 
oxygen. The hydroxyl and methoxyl groups in compound 12 are identical to 
those of compound 9 discussed above.
With the use of NMR data, structural and conformational states of 
molecules may be discussed.
2.12 Oxygen Heterocycles. (I) Electronic Effects
Annélation of benzene rings leads to shielding as a result of 
conjugative TT-network e x t e n s i o n ^ o ,97j
^454.8 ppm
g
137.2 ppm
463.6 ppm 460.8 ppmO O
174.2 ppm 158.2 ppm
The effect may be seen with the use of resonance structures:
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The extended aromatic TT-network délocalisés the positive charge. The 
top row of resonance structures have greater significance than those of the 
lower row. This is reflected in the proportionately larger shielding of the 
ethereal oxygen which reveals that the importance of the lower row of 
resonance structures is diminished as the benzene ring takes over from the 
ethereal oxygen in supplying the electron demand of the carbonyl oxygen.
The alkene bond between carbons 2 and 3 is essential in "connecting" 
the two oxygens 112,113;
446 ppm515 ppm
CK70 ppm 162 ppm
The ethereal oxygen's chemical shift should be dependent on the 
functionality at the 4-position from the above arguments. The work of Boykin 
et all 1^illustrates this;
TABLE 18: Arvl Ethers
X Chemical Shift 
-0- (ppm)
0 88.0
NH 93.0
CH2 112.0CH. OH 119.0
S=0 129.7
0 0 137.2
As expected, electron-donating groups (ie. -0- and NH) result in 
shielding whereas electron-withdrawing groups (ie. S=0 and C=0) result in 
deshielding of the ethereal oxygen chemical shift value.
From the above resonance structures it is evident that substituents at 
the 5- and/or .7-positions of such ring systems should display the largest 
electronic effects. This is illustrated by data for 7-methoxyl substituted 
chromone, 2,2-dimethylchromanone, flavanone and coumarin
respectively?0 ,113,115;
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446 ppm
162 ppm
Q 518 ppm
O 419 ppm
CH3O'65 ppm 163 ppm 
Q 500 ppm
CH3O O
117 ppm
q 518 ppm
93 ppm
'CH j
71 ppm 118 ppm
499 ppm
T O65 ppm 99 ppm
CH3O219 ppm 351 ppm 52 ppm
"O 347 ppm 
225 ppm
The following resonance structure has been implicated^o:
O'
CH 3 0 C H 3 0 CH,0
The shielding of the carbonyl is thus produced by electron donation 
from the 7-methoxyl oxygen shifting the carbonyl resonance upfield whereas 
the electronic situation of the heterocyclic ethereal oxygen is hardly 
affected when compared to the unsubstituted case. The lower charge density 
and increase in bond order at the methoxyl oxygen gives it a downfield shift 
as observed.
Substitution with benzene rings at the C2 and C3 positions also results 
in shielding of the carbonyl oxygen r e s o n a n c e 113 , 115 by extending the 
delocalisation of positive charge. The long range TT-acidity of the chlorine 
substituents is evident:
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o 446 ppm
162 ppm
Q Cl
The conclusion must be that the carbonyl oxygen in chromones acts as an 
electron sink.
Shielding of the heterocyclic ethereal oxygen resonance is possible by 
substitution at the 6- and/or 8-positions by electron-donating groups. This 
is illustrated by 7-methoxy-2,2,8-trimethylchromanoneii3 where a non-bulky 
methyl group is substituted at the 8-position:
O 499 ppmo500 ppm
O CH, CHjO^ ^
71 ppm 118 ppm 70 ppm CHj 108 ppm
(III) Hydrogen Bonding Interactions
The single example of a hydrogen bonding interaction identified by 
NMR spectroscopy in aromatic oxygen heterocycles is provided by Duddeck et 
all 13:
q500 ppm 93 ppm 0^^' o 443 ppm
CHP O CH3
71 ppm 118 ppm
CH3O
CH3
•''70 ppm 120 ppm
Only the carbonyl resonance is significantly affected. The relatively 
high chemical shift value for the hydrogen bonding hydroxyl oxygen is due to 
the contribution from the following resonance structure;
o-
CHj<r ^  u 'CH,
which reduces the charge density and increases the bond order at the
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hydroxyl oxygen leading to the observed deshielding in accordance with the 
Karplus-Pople equation.
The more observant reader will have noticed the disparity in the 
reported chemical shift values for chromone:
460.8 ppm (216 Hz) 446 ppm (350 Hz)O 0
158.2 ppm (154 Hz) 162 ppm (370 Hz)
Boykin et al Duddeck et al
Boykin et al*? reported their data as solutions in toluene whereas the 
data of Duddeck et alH3 were obtained in chloroform, a solvent known to be 
a hydrogen bond donor^4. Thus, the data of Duddeck et al is only
self-consistent and comparisons with other data is not appropriate. As
expected, hydrogen bonding to the carbonyl leads to a shift to high field
for this resonance. The ethereal oxygen is shifted to lower field because of
the greater electrophilicity of the carbonyl oxygen due to hydrogen bond 
formation. The following resonance structure therefore makes a greater 
contribution when the carbonyl oxygen is involved in intermolecular hydrogen 
bonding:
Moreover, as the viscosity of chloroform and toluene are almost 
identical (at 25*C), the increased linewidths for the data recorded as a 
chloroform solution reflects the increased effective molecular size of the 
chromone molecule due to associated solvent molecules.
(IV) In-Plane Distortion
As chromones are rigid, planar molecules, the carbonyl group will be 
subject to in-plane bond deformation and/or orbital compressional effects 
due to the steric constraints of adjacent groups.
This effect is illustrated from data for f l a v o n e s ^ B.84 and
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2,2-dimethylchromanones86.115 :
158 ppm
525 ppmO SOOppm
CHCH)
531 ppm493 ppm CH3O
CH,CH,
Torsional displacement for the chromanones is minimal at only 3^  8^ , All 
the examples are explained by repulsive van der Waals interactions.
2.13 Oxygen-17 Enrichment
Sodium cromoglycate (DSCG) and its analogues possess large molecular 
dimensions and limited molar solubilities in non-viscous, non-associating 
solvents, thus, seriously curtailing the ability to obtain NMR spectra 
of any consequence at natural abundance. There exists two strategies for the 
approach of this challenge. The first involves oxygen-17 enrichment of DSCG 
itself, while the second strategy involves the synthesis of compounds of 
reduced size that faithfully model Intal yet enabling high quality, moderate 
resolution NMR spectra to be obtained at natural abundance. This is the
best approach for conducting a substituent effect study.
The following sections review routes to i^O-enriched compounds 
considered as substructures of chromones and acetophenones.
2.14 1 ^0-Enrichment of Carboxvlates
I have likened the carboxyl group in chromone-2-carboxylates to the 
carboxyl group in amino acids for which several l70-enrichment studies have 
been reported.
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-COOH
The amino acid carboxyl group has an electron-withdrawing function at 
the 2-position analogous to the endocyclic oxygen of the % -pyrone 
heterocycle of chromones.
Routes to i7o-enriched carboxyl groups involve [I70]water as the label 
source and may be either acid or base-induced. The carboxyl function is an 
attractive focus for oxygen-17 enrichment via hydrate formation at the 
carbonyl site and subsequent elimination of water.
There are three procedures by which i70-enrichment at the carboxyl 
function can be obtained: (I) Acid catalyzed exchange; (II) Saponification 
and (III) Acyl chloride hydrolysis.
(I) Acid Catalyzed
As with most procedures for isotopic incorporation it is necessary to 
work with small amounts of material, due to the high cost of the 
label^5,ii6. For oxygen-17, the most convenient label source is [i?0]water 
as it is then possible to recover the diluted label source for subsequent
use. However, this may limit labelling reaction and purification choices^?.
TART.F. IQ; >7o-T^jchiaent bv Acid-Catalyzed' Exchange of Carboxylates
Ref.
No.
Substrate Mass
(g)
Acid [170]water Temp.(*C)
Time
(hrs.;
Work-Up
117 L-o*-Aminoadipi c 
acid
- 3M HCl 50atom% 20 48 NazCOs
118 L-ot-Aminoadipi c 
acid
0.027 ION HCl 
(1 drop)
400pl water
+10Qul
20atom%
R.T.2 48 pH6,Evaporate
119 AcOH, Glyi, Glu, 
Asp
3 5M HCl 
(3ml)
300mg
20atom%
80 5 ION NaOH 
(l%enriched)
69 Glyl, Glu Ig/ml HCl gas 52atom% 105 0.N.2 Water wash, Lyophilize
1. Conditions shown for this substrate.
2. R.T.* Room Temperature. O.N.= Overnight.
It will be noted that all the amino acids labelled by acid catalyzed 
exchange consist entirely of acidic (eg. Asp) or neutral (eg. Gly) amino 
acids. It should also be observed that acid catalysis is a reversible 
process. An advantage is that both oxygens of a given carboxyl group become
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labelled but the level of incorporation is limited by the equilibrium of the 
reaction, requiring an excess of [17q ]water and rather harsh conditions to 
overcome this. The method is further restricted to the more water soluble 
amino acids.
Acid catalysis is an appealing approach for use with chromone-2- 
carboxylates as these compounds are stable under acidic conditions. However, 
this must be qualified by stating that the label incorporated in the 
carboxyl group will be sensitive to the work-up procedure (basification) due 
to the high acidity of this carboxylic acid (pKa =2 .6-3 .0 1 2 0.121) leading to 
extensive back-exchange.
fin Saponification
Hydrolysis of a 2-amino-protected carboxylic ester is an attractive 
method of enrichment. The reaction is non-reversible , quick and requires 
only one equivalent of label source that is consumed entirely during the 
reaction resulting in a product of high e n r i c h m e n t s ^•122.
TAHl.K 20: ^ O-Bnrichaent bv Saponification of Carboxvlates
Ref.
No.
Substrate Mass Solvent Base [170]water Time^
(hrs.)
Work-Up Bnricha»nt
(X)
118
123
69
Amino acid methyl 
ester.HCl 
tHOC-Amino acid 
methyl ester (Leu 
Pro, Phe, Tyr) 
tROC-Glycine 
methyl ester
1 equiv. 
1 equiv.
le
MeOH
1,4-Diox 
(4 ml)
NaOH
(25% excess) 
m e  50atom% 
(0.5ml,
52atom% 1.2M 
(6 ml)
20atom%
(5 equivs.) 
OH Na[17o]OH 
3 equivs.)2
Na[l?0]0H2
12
2
2
PH6,
Evaporate 
HCl to pH2 
BtOAc extract
HCl to pH2 
EtOAc extract
10
(by MS)3 
37
13.9 
(by NMR)3
1. All at room temperature.
2. Prepared by reacting sodium metal with [l^O]water.
3. MS = Mass spectrometry. NMR = Nuclear magnetic resonance.
Baltzer et al124 report the [17Q]hydroxide hydrolysis of methyl 
benzoate in acetone.
Without a large excess of [i^O]hydroxide present it is unlikely that 
both oxygens of a particular carboxyl group are labelled yet there should be 
an equal distribution of enrichment.
Saponification of chromone-2-carboxylate esters is the standard route 
to the acid and salts26.125. However, the ^-pyrone heterocycle of the
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chromone-2-carboxylate is sensitive to base mediated ring-opening which can 
degrade the molecule if an excess of base is u s e d ^ •126-129, As an enrichment 
reaction would be on a small scale, addition of exactly one equivalent of 
base would be fraught with experimental uncertain!ties. Work-up to the 
isolable acid by the addition of concentrated mineral acid would exchange 
out the oxygen-17 placed into the functional group at the initial synthetic 
step. In conclusion, saponification appears of little value to the compounds 
under study.
fill) Acvl Chloride Hydrolysis
Boykin et aliso prepared i^o-enriched benzoic acids and cinnamic acids 
by hydrolysis, by 10atom% [i?0]water, of the corresponding acyl chlorides. 
The oxygen-17 present in the carboxylic acid was made resistant to 
back-exchange by formation of the methyl ester using diazoraethane. In their
synthetic scheme, the acyl chloride (Smmoles) was added to 1Oatom%
[170]water (3mmoles) in dry acetonitrile (10ml) and refluxed for 4 hours.
The resultant [17q]carboxylic acid was obtained by solvent lyophilization 
and recrystallization from ethanol. The compounds revealed a 5-8% 
170-enrichment by mass spectrometry. The methyl esters (Immole) were 
synthesized in quantitative yield from the acid with excess diazoraethane in 
diethyl ether without label-loss.
This strategy is probably the most appropriate as it gives the labelled 
acid directly, without the need for work-up which could dilute the label, 
for facile derivatisation and subsequent investigation by 17Q NMR 
spectroscopy.
2.15 Routes to Acyl Chlorides of Chromone-2-carboxylic Acids
These compounds have been synthesized using either: (I)Thionyl chloride
or (II)Phosphorus acid chlorides.
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fl) The Thionvl Chloride Route 
O
© X o o .
soci.
0^ ^ COCl
The transformation has been accomplished by heating with a large excess 
of thionyl chloride^^i* 132 in 1,2-dichloroethane or 1,4-dioxane as 
s o l v e n t 133. A  large excess of thionyl chloride was required to limit the 
formation of the trichloride which is a chlorinating agent that readily 
reacts with protic sources, such as water, alcohols and carboxylic acids to 
yield 4-chlorocoumarln along with a chlorinated co-product and carbon 
monoxidei31 :
ROM
COCl -ST COCl
R = H,R,RCO
-t- RCl + CO
The trichloride thus represents a highly reactive contaminant in the 
thionyl chloride mediated synthetic routei3i.
The formation of the trichloride may be avoided by heating with a 
slight excess of thionyl chloride with a catalytic quantity of DMF134 or 
hexamethylphosphortriamidel3i (HMPA) in 1,2-dichloroethane. This synthetic 
procedure is popular with experimentalists, giving an 80-90% 
y i e l d 2 4 ,127.128,135.
In stark contrast, the acyl chloride of chromone-3-carboxylic acid is 
formed with ease with thionyl chloride after five minutes 132.
(Ill The Phosphorus Chloride Route
The trichloride contaminant is formed upon heating for 16 hours with 
phosphorus oxychloride or a mixture of P C I 5/P O C I 3 I 3 i .136.
A successful procedure reported by Payardi37 involves heating the acid 
in cyclohexane with phosphorus pentachloride for 45 minutes to give the pure
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product in high yield (82%). The simple method of Payard was utilised for 
this study.
As a matter of note, an 17q NMR study of aryl acyl chlorides has been
conductedi3 8.
2.16 Diazomethane
Although diazomethane is a valuable reagent in synthetic chemistry, 
there are hazards associated with its use as it is an explosive, 
carcinogenic gas. These are thoroughly detailed by various au t h o r s i 3 9-14i .
A precursor used for the preparation of diazomethane is N-methyl- 
N-nitroso-p-toluenesulphonamide (Diazald):
CH 3- ^ ^ ^ ~ S 02-N-CH 3 
N = 0
Diazoraethane is generated by the decomposition of Diazald in basic 
conditions, the mechanism being:
CH r»H
W  K*ÔH
c h ,=n = n"
to give potassium tosyiate as the byproduct.
Diazald was chosen as the precursor as, although possessing a shorter 
shelf life (1-2 years) it is more commonly used for reaction scales of 
greater than one millimole and its basic decomposition proceeds in a 
smoother manner than for the alternative N-methyl-N'-nitro-N-nitroso- 
guanidine diazomethane precursor, which is also a powerful mutagen^39;
NHI /NONO-NH-C-N^^^^
2.17 ^70-Enrichment of Phenols
The acetophenone precursors of Intal® possess phenolic functions from
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which the chromone endocyclic oxygen and phenoxy functions are derived. 
Moreover, [i^o]acetophenones and [i^o]chromones synthesized from these 
oxygen-17 enriched precursors may be prepared for NMR analysis.
The route to i7Q-enriched phenols may be either via
(I)ExchangeiiG'i42,i43 or (II) Synthesisi44.
(I) Exchange
The first report of oxygen exchange in phenols came from F e s e n k o ^ 4  2 in 
1955. This work was expanded upon by Oae et al143.
TATOJï 211 17o_EnriCiment of Phénols
Ref.
No.
Substrate Mass
(■e)
Exchange
Medium
Tew.
(°C)
Time
(hrs.)
Nork-Up
143
116
Phenol
4-Nitrophenol
1000
7-14
(0.25-
HCl gas in [1®0]water 
(ION, 5ml)
13H NaOH in 33 atom% 
0.5M) [18o]water 
(0.55M, 20()pl)
180
100
24
10
Recrystallise
Acidify, Ether 
extraction ■
The following mechanism was proposed:
O H
t  & -
“bHj
fî N. [ T h '— 2:^J '  V
H H W  '
of pHî
H H H H
For base-mediated exchange, one equivalent of base is consumed in the 
deprotonation of the phenol. This shows that 0H~, not H2O , is the reactive 
species. Enrichment was only observed for 2- or 4-nitrophenols.
*0“
no; n o ;
Exchange at the phenol function of p-hydroxyacetophenone was
ineffective under these conditions.
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fll) Enrichment of Phenols via Synthesis
Fiat and c o - w o r k e r 144 have reported the enrichment of the phenol 
function in (S)-tyrosine by the nitration, reduction and diazotisation of
(S)-phenylalanine. The diazonium salt was hydrolyzed with 45atom% [1^ 0]water 
at 80° C. The acidic conditions in the last step were manipulated to effect 
exchange labelling at the carboxyl group. It was determined that the phenol 
had been labelled to the extent of 100% and the carboxyl function 80-90% 
relative to the label source. The compound was used for the investigation of
chemical shift pH dependence -measuring pKa values by i^ O NMR spectroscopy-
and for an investigation of the structure and dynamics of the amino-acid 
side-chains in short p e p t i d e s i 45.
2.18 170-Enrichment of Ketones
Both the 2-hydroxyacetophenones and chromones in this study contain 
carbonyl moieties which are susceptible to exchange labelling via hydrate
formation and water elimination.
Byrn and c o - w o r k e ri46  ^Gorodetsky et ali47 and Crandall et ali48 report 
similar labelling conditions for alkyl ketones. These involve the 
dissolution of the ketone in an inert solvent, such as THF or 1,4-dioxane, 
at quite low concentrations (3% (w/v)) with a low concentration of mineral 
acid (1-50 mM) either at room temperature for up to one hour or refluxing 
under a nitrogen atmosphere.
Boykin et al*? used almost identical conditions to enrich quinones.
Dahn et ali49 studied the rates of exchange for various heterocyclic 
ketones:
o
eg. 
n = 2-4
X =0,S,CHz,NR
Acid-catalyzed exchange of the oxygen heterocycle shown was very slow.
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Thus, it appears that the ^-pyrone ketone of chromone may be difficult to 
exchange label due to the presence of its endocyclic oxygen, although 
enrichment of this site should be possible under acidic conditions.
2.19 Mechanism of Brcmination of Phenols and Phenol Ethers in Acetic 
Acid
This review of the chemical literature focuses on the mechanisms of 
electrophilic aromatic substitution by molecular bromine, Brz, upon phenols 
and phenol ethers in an acetic acid medium, highlighting the differences 
observed in reactivity between phenols and their respective ethers.
Bromination of aromatic compounds (in this case, phenols and their 
ethers) by molecular bromine exhibits complex kinetics, the overall order of 
reaction being dependent on the relative concentrations of substrate and
bromine^50.
Although activating substituents, such as -OH and -OR direct secondary 
substituent electrophiles into the 2- (ortho-) or 4- (para-) positions, it 
is observed that the main product of bromination of phenols and their ethers 
in acetic acid or carbon tetrachloride as solvent is almost exclusively the 
4-bromoisomeris*.
The general mechanism for aromatic bromination in acetic acid solution 
was first proposed by R o b e r t s o n l 5  2 and subsequently utilised by other 
workers to illustrate their resultsl53.
The mechanism involves a direct electrophilic attack by an electrically 
neutral bromine molecule on the aromatic nucleus forming a bimolecular 
intermediate, ArH.Brz, in which the bromine molecule is polarised. This is 
followed by the rate determining step (rds)- the removal of the bromide 
anion from the bimolecular intermediate complex leading to a transient 
intermediate, ArHBr+. The final, fast step of the mechanism is elimination 
of a proton from this intermediate to form the arylbromide. The mechanism is 
set out in equation form below in which Ar represents a notional aromatic 
nucleus.
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Scheme 1 : Robertson Mechanism: Equation Form 
ArH + Brz < ^ ArH.Brz
ArH.Brz slow, rds., ArHBr+ + Br“
ArHBr+  fast ArBr + H+
H+ + Br“ . HBr
Placing the Robertson mechanism in a structural context employing 
phenol to represent ArH, we obtain;
Scheme 2 : Robertson Mechanism: Structure Form
H
+ OH+ OH+ OH
H
H
+ OH
+ Brz
+ OH+ OH
A 7
H
+ OH OH
rds 4- Br'
-H+
fast
Br
Comparing the mechanisms as laid out in schanes 1 and 2 we interpret 
ArH.Brz as representing;
+ 0H
Br— Br
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+  OH + OH
and not or
A
X ,
as Robertsoniss suggested, as
these latter two structures correspond to ArH and ArHBr+ respectively. 
Hence, the mechanism involves a bimolecular reaction in its slowest step;
CeHsOH + Brz slow _ [C6H5OH+ Br"-Br]-CeHAOHBr + HBr
activated complex
and, as expected, follows second order kinetics where the rate of 
reaction =-d[Br2]/dt = d[C6H40HBr]/dt = k[C6H50H].[Br2] where k is the 
observed rate coefficient (1 mol"* g r * ) *50,151,153-155.
It should be made clear that in dealing with the reactions of phenols 
it is imperative that one is dealing with reaction of the neutral phenol 
molecule and not its more reactive phenoxide anion, especially when 
comparing kinetic data with phenol ethers. Only literature in which this 
prerequisite was clearly operative were handled by this author.
Second order kinetics is not a universal description of the mechanism 
as Rajaram and Kariacose^si noted and de la Marei54,l55 developed. In the 
case of phenol ethers, ArOR, the mechanism relates to a third order process 
in which a second molecule of bromine acts as an electrophile towards the
ArH.Br2 intermediate to form the brominated product. This highlights the 
inadequacy of the above m e c h a n i s m i 5  2,153 as it brings to the fore the fact 
that substitution at the phenol oxygen alters the mechanistic pathway. No 
scope for this is given within the Robertson treatment.
It now seems timely to scan through some examples of work that display 
the differences in reactivity of phenols and phenol ethers outside the 
context of this review, the bromination in acetic acid as solvent.
The first example comes from a study of proto-desilylation of a series
of para-substituted phenyltrimethylsilanes by Eaborn and c o - w o r k e r s 1 ^ 6 , 157.
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Eabom had established that the reaction is kinetically promoted to a 
greater extent by the hydroxyl than by the methoxyl group:
X
SiMe, Q
+ SiM63
X H p-OH p-OMe
Relative
Rate
1 10 700 1 510
The second example comes from the use of equilibria data to obtain 
estimates of the relative electron-releasing ability of hydroxyl and 
methoxyl aryl substituents. The work of Deno et ali58,i59 dealing with the 
following equilibrium:
ArsC.OH + H+ ' ArsC* + H2O
expresses the electron-releasing ability in terms of electrophilic 
substitution constants, denoted
Substituent
-0.82
-0.64
—OH
-OMe
The results indicate that the hydroxyl group is the more electron 
releasing.
The final example turns up from the compilations of Brown et ali^o. 
Their data were derived from the thermodynamic dissociation constants of 
para-substituted benzoic acids and are expressed in terms of Hammett 
values ;
<Sf Substituent
-0.37
-0.27
-OH
-(Me
Once again, these results indicate the greater conjugative 
electron-releasing ability of the hydroxyl group over the methoxyl group.
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This disparity in reactivity between the neutral phenol molecule and 
its homologue, anisole, extends into the study of kinetics of electrophilic 
substitution.
The rates of para-bromination at low concentrations in acetic acid 
(ensuring second order kinetics) were reported by Baddeley et
R Substituent Relative
Rate
CH3 - 1
2-Me 6.3
2,6-diMe 0.39
H - 90
2-Me 450
2,6-diMe 550
The introduction of a single methyl group at the 2-position does not 
prevent the approach towards coplanarity of -OMe or -OH groups and hence 
maximum conjugative overlap of the oxygen lone pairs of electrons with the 
extended TT-system of the phenyl ring. It is seen that 2-methylanisole 
reacts with bromine about six times faster than anisole. This rate 
enhancement is reflected when comparing the relative rates of 2-methylphenol 
(o-cresol) and phenol. The addition of a second o-methyl substituent should, 
if the rate increase is linear, enhance the reactivity by a further factor 
of five for the phenol series to 2300.In fact, with 2,6-dimethylphenol the 
rate is only slightly higher than its predecessor. There is a 2300/550 = 
fourfold reduction in the observed rate which may be explained by steric 
inhibition by the two ortho-methyl substituents upon the ability of the 0-H 
bond to become co-planar with the aromatic ring which curtails the effective 
conjugative ability of the lone pairs of electrons on the oxygen atom. As 
the steric inhibition of 2,6-dimethylphenol is similar to that of anisole, 
it has been proposed that the true rate differential between anisole and
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phenol is 90/4 = 23154,155. Hence, the conclusion from this must be that the 
hydroxyl group is more electron releasing by a conjugative mechanism than the 
methoxyl group by this factor.
With phenol ethers, the nature of the R group (PhOR) influences the 
rate of halogénation in acetic acidi^S;
R iPr Et Me p-MePhCHz PhCHa p-ClPhCH2 p-N02PhCH2
Relative
Rate
4.40 1.99 1.00 0.95 0.68 0.41 0.14
These results were seen as a reflection of the relative inductive 
effects of the R-group.
In a suitable cyclic ether the rate of electrophilic bromination in 
acetic acid can be enhanced by holding the alkoxyl group oxygen in a 
conformationally rigid state. In this way the oxygen lone pairs of electrons 
achieve their most effective conjugative o v e r l a p l ^ l ,162;
Compound OCH3
Ô
0 CH3
c?
CH3CH2O
"0
Relative
Rate
1 6 . 3 76 1 2 .6155
The site of bromination is the 4-position in all the above examples.
In a definitve explanation of the mechanism, de la Marei54 proposed the 
"no-bond canonical form";
cr H+
as the limiting structure involved in the rate determining step. De la 
Mare stated that such a structure with a polarized OH bond helped to
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transfer positve charge from oxygen to hydrogen and so reduce the energy 
restriction imposed by the positive charge on oxygen. The more positive the 
oxygen atom is required to become, the more charge will be transferred to 
hydrogen to allow further lone-pair electron release. It is only when 
electron demand is very high (eg. in the bromination transition state 
complex) that the augmenting effect ascribable to this type of electron 
release manifests itself. This ionic state can easily be solvated in acetic 
acid as the reaction medium. Thus, electrophilic bromination of phenols and 
phenol ethers may be described by the following mechanism;
Scheme 3: Mechanism of Bromination of Phenols and Phenol Ethers in
Acetic Acid
OR + OR + 0R
H
+ OR
+ 0R
+  BT2
+ 0R + 0R
»
r ~ ^ r — Br
(1) R = H
OH
-HBr rds
-Vfast
Br"dienone"
(2) R = CHa
+  OCH. +  OCH
Slow rds
Br-^Br ^ B r-^ B r
-H+
OCHa
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Hence, the bromination of phenol is a second order process.
d[PhOHBr]/dt= -d[Br2]/dt= k[PhOH][Brz]
whereas the bromination of anisole is a third order process.
d[PhOMeBr]/dt= -d[Brz]/dt= k[PhOMe][Br2]^
Evidence for this comes from the work of Robertsoni64 ^ Yeddenapal1i ^ ^  ^
and JoshiiGS. Taking a closer look at the mechanism in the vicinity of the 
rate determining step shows us that a proton is involved and a dienone 
structure is formed. Both points are open to investigation.
The phenolic 0-H normally exchanges rapidly in protic solvents so it 
comes as no surprise that fission of this bond is involved in the rate 
determining step of the reaction. Indeed, de la Harems4 found that the 
bromination of phenol in deuterioacetic acid is slower than that of phenol 
in acetic acid;
Rate,k 
(1 mole-1 min-i)
Phenol in AcOH 
Phenol in AcOD
1100
750
This result suggests that there may be a significant 0-H bond 
polarization in the rate determining step of the bromination of phenols.
Evidence for the view that proton-loss from the hydroxyl group is 
important is demonstrated by the ability to trap the intermediary dienone in 
the bromination of suitably sterically hindered phenols. For 
2,6-di-t-butylphenol, this intermediate was isolated and characterised by UV 
and IR spectroscopic meansi54 and so elucidating the reaction pathway.
O
k=300 1 mole"! min"*
The ability to isolate this intermediate and the relatively low overall
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rate of bromination for 2,6-di-t-butylphenol is due to two primary factors;
(I) Proton loss from the OH function occurs when the 0-H bond is 
co-planar with the benzene ring. The steric effect of the two bulky 
ortho-groups inhibits this proton loss.
(II) The electron-donating characteristic of the two alkyl substituents 
creates a higher electron density over the benzene ring than for the parent 
phenol. This retards proton loss from the dienone intermediate and so 
contributes to its stabilisation.
The dienone intermediate ultimately decomposes to the product of the 
substitution.
The conclusions from the proceeding review may be summarized as a list 
of salient points:
(I) Phenols brominate appreciably quicker than alkoxyphenols under 
the same reaction conditions.
(II) Bromination of alkoxyphenols (eg. anisole) will be favoured at 
higher concentrations of substrate and/or bromine in the reaction medium, 
acetic acid.
(III) The apparent preferential positional substitution point is para- 
to the oxygen function in the absence of any complicating factors from 
additional substituents on the phenyl ring.
2.20 Synthetic Routes to 3'-Bromo-2'-hydroxy-6'-methoxyacetonhenone
The synthesis of this compound has been reported. There appears to be 
two general synthetic routes.
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Route I: Sandmever Reaction 
McCusker et used this route:
CH 3O
OH
OH NO2
CH,< O
CuBr OH
Br
CH,Q
S11CI2/ HCl
This approach is long and suffers from a poor overall yield of about
0.6%166. This route has been used by Kolehmainen et to synthesise
2-bromovani11in: 
>H
CHjO^
>H
Hz
Pd/C, EtOH CuBr
CHO CHO CHO
Route II: Direct Bromination
Direct brominationiG&'iGG has been used for regioselective bromination. 
McCusker et ali6& utilise the following conditions for a 68% yield:
CHoO O:o:'
CH,0
Brz/ CHCI3
OH 3 hrs., RT
Kolehraaninen et a i m  employed a different reaction medium:
OH OH
CHgOsy.^ !^:^  Brz/ AcOH/ NaOAc CH3O'
0.5 hr. ^
CHO
An investigation of halodeacylation of aryl ketones by Bierne et ali&9 
revealed that 2 '-hydroxy-6 '-methoxyacetophenone was one of the few aryl 
ketones resistant to déacylation upon direct bromination. Again, the 
3'-bromoisomer is reported as the product.
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2.21 Saponification of Chromone-2-carboxvlate Esters 
Saponification of cromoglycate diethyl ester;
COOC2H.CoHcOOC
is easily effected using the "standard" conditions of aqueous sodium 
hydroxide26.120.125. However, it transpires that such reaction conditions 
are too harsh for 8-halogenated analogues. Clearly, a modified procedure 
using the same reagents would be unproductivel^o and a different procedure 
is necessary.
The synthetic procedure of Fitzmaurice and Lee^^i is outlined below;
(i) NaHCÛ3(aq)
:00c,H
COOHHOOD
(i) Rextal.
(ii) 2 equivs. NaHCOs
COO"(iii) Lyophilize Nd "OOC
Note the much milder reagent used for the saponification - sodium 
hydrogencarbonate substituting for sodium hydroxide. This procedure formed 
the basis for the saponification of bromocromoglycate diethyl ester 
presented here.
At first sight it seems bizarre that the necessary chemical conditions 
for saponification of cromoglycate diethyl ester and its 8-halogenated 
analogues are so disparate. However, this has been rationalised in a 
recent publicationi27. with the earlier work of Zsuga et ali%9, there now 
exists two mechanisms for pyrone ring fission.
The tendency of the pyrone ring to open is enhanced by the 
presence,on the phenyl ring, of substituents which have electron withdrawing
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characteristics. Bromine is such a substituent. This enhances pyrone ring 
fission which occurs between the endocyclic oxygen and C2 of the pyrone 
ring. The oxygen heteroatom in this case is acting as a leaving group. Any 
factor which increases the capacity of the heteroatom to act as a leaving 
group will make the pyrone ring more susceptible to ring fission.
Listed below are the two possible mechanistic routes;
Scheme 4: Kave Mechanism^
O"
s.
LcOOCgH;:OOCzH
OH
O
rds Q-
K2
OOC2H5
Rate = KiK2k3[substrate][0H‘]2 
Overall third order kinetics 
Scheme 5: Zsuga M e c h a n i s m ^ 29
K i
R = H, Ph
k2
Rate= Kik 2 [substrate][0H‘]
Overall second order kinetics.
2.22 Heterogeneous Catalytic Dehalogenation
Specific hydrogen isotope labelling can be achieved by the 
dehalogenation of aryl halidesi7 2-l7 6. The halogen in these molecules can be 
specifically replaced by the required hydrogen isotope in a heterogeneous 
catalyzed reaction.
The facility of hydrogenolysis is in the order I>Br>Cl>>Fi72,i74 being 
inversely proportional to the carbon-halogen bond strengthi72. Aryl bound 
fluorine does not dehalogenate under normal experimental conditions^75.
The catalyst is usually palladized carbon, barium sulphate or calcium
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carbonatei73. xhe maximum radiochemical yield (using tritium gas) for this 
reaction is 50% as the co-product is the corresponding hydrogen halide. This 
can deactivate the catalyst by associating with the catalytic sites 176, to 
avoid a decrease of catalytic rate as the reaction proceeds a base is added 
to the reaction mixture to neutralize the hydrogen halide. Typical examples 
are tertiary alkylaraines such as triethylamine and diisopropylethylamine or 
alkali metal hydroxides and acetatesi74,
A mechanism of catalytic dehalogenation was presented by Kieboom and
van Rantwijki76,
2.23 Methods for NMR Spectral Assignment
Although carbon-13 at natural abundance is a low isotopic abundance 
nuclide requiring much longer spectral accumulations than for iR M R  
spectroscopy, the general features of M R  spectra are in many respects 
identical to those of IR MIR spectroscopy. With a chemical shift range of 
about 200 ppm for most organic molecules, the spectral dispersion is good, 
resulting in most signals being resolved. The chemical shift range positions 
within the NMR spectrum are, for carbon attached first row atoms (eg. 
0,N,F) qualitatively analogous to those for iR M R  (ie. the M R  chemical 
shifts correlate with the electronegativity of the atom). However, for 
second and subsequent row halogens shielding of the carbon-13 nucleus occurs 
(ie. for Cl, Br and I). M R  spectra acquired with broadband IR
decoupling have their S/N ratio enhanced by the attendant nOe effect (nOemax 
= 1.987, Maximum signal enhancement=2 .987177) yielding a single peak for 
each nuclide in a distinct magnetic environment.
Spin-lattice (Ti) relaxation is a dominant relaxation mechanism for 
carbon-13 nuclei. Ti values for organic molecules of molecular mass of less 
than 1 kDa are typically 0.1 - 10s for protonated carbons and 10 - 300s for 
non-protonated (quaternary) c a r b o n s 177. Consequently, typical acquisition 
times and recovery delays give signals due to protonated carbons of greater 
intensity than those for non-protonated carbons. The intensity of the i^ C
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NMR signal is usually inversely proportional to its Ti value.
2.24 DEPT 135
This pulse sequence - Distortionless Enhancement by Polarization 
Transferees _ is used as an editing technique to distinguish between carbons 
on the basis of the number of directly attached protons; ie. methine (CH), 
methylene (CH2) and methyl (CH3).
The pulse sequence is;
iH (TT/2)x - 1/2J - TT - 1/2J - 6 y - 1/2J - Decouple
13C (TT/2)x Acquire
where J = iJcH is the mean benzenoid coupling constant. iJcH for benzene is 
159 H z 177. 9 y is the proton pulse of variable length which is independent of 
J.
For DEPT 135, 6 y = 3TT/4 (135^ ) such that the relative intensities of
signal are: CH (0.71), CH2 (-1.00) and CH3 (1.06). This results in normal 
"up right" signals for methines and methyls whilst methylene groups appear 
inverted in the DEPT 135 spectrum. As quaternary carbons do not have
directly attached protons, signals due to these carbons are eliminated from 
the DEPT spectrum.
2.25 One-Bond i^C/iH Heteronuclear Shift Correlation 2D NMR 
Spectroscopy
This experiment correlates proton and carbon-13 nuclei using iR-i^C 
one-bond couplings for the transfer of magnetizationi77,179-I82.
The Bruker pulse sequence XHCORRD.AU is;
Preparation Evolution Mixing time Detection
IR DO PI DO PI D3 P2 D3 PI DO D3 PI BB
51 51 51 SI 51 52
13C D1 P4 P3 D4 Acquire FID
The symbols represent the following meanings (and values):
DO = Preset delay time which is automatically incremented during the
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experiment.
D1 = Relaxation, preparation for decoupler pulsing (1.5s).
51 = Maximum decoupler pulse for pulse.
DO = Evolution period (3jis).
D3 = Wait for optimum polarization (1/(2J(1Jch))= 3.5ms)
D4 = Mixing time (=l/(3J(*JcH))= 2.1ms)
PI = IR 90° pulse (19jjs) ;P2 = IR 180° pulse (38jus)
P3 = 13c 9oT pulse (7.Bps) ;P4 = 3^c 180° pulse (15.^s)
52 = Broadband iR decoupling.
2.26 Three-Bond I3ç/1H Heteronuclear Shift Correlation 2D NMR 
Spectroscopy
This pulse sequence - Correlation spectroscopy via LOng range Couplings 
(COLOC)178.183 - is an adaptation of the pulse sequence detailed above. The
differences derive from the observation that when correlating carbons and 
protons through long range couplings (eg. 3jcg) the magnitude of the 
coupling constant can be quite small. For instance, in benzenoid compounds, 
iJcH = 150 Hz and 3Jch = 7 Hz. There is magnetization loss due to relaxation 
prior to detection.
The Bruker pulse sequence, COLOC.AU, is:
Preparation Evolution Mixing time Detection
iR D1 PI DO P2 D2-D0 PI BB
SI SI SI S2
13C P4 P3 D3 Acquire FID
The variables are identical to the XHCORRD.AU case except;
D2 = 1/(2J(3Jch)(= 71ms)
D3 = l/(4J(3JcH)(= 36ms)
Note that in oxygen aromatic heterocycles (such as furan and chromones) 
values for %JcH vary in the range 7-14 Hz for the O.CH:CH fragmenti77.184. 
Similarly, for CRsÇOzMe, 2jcg is 6,9 Hz. Coupling systems such as these may 
complicate assignments.
287
2.27 13Ç NMR of Chromones
The carbon numbering system for chromones isiBS;
 ^ O-"^0OCH jCH 38 1 2a
From 13C NMR analyses of 29 substituted chromones, Ellis and 
W i l l i a m s i 8 5  arrived at the following chemical shift ranges:
TABLE 22: Chemical Shift Ranges for Ethvl Chromone-2-carboxylates
Carbon Chem. shift range/ppm
2a 158.9-160.7
2 151.3-152.9
3 112.2-115.3
4 176.1-178.1
CH2 62.4—63.4CH3 14.0-14.1
TABLE 23: Chemical Shift Ranges for C h r o m o n e s * 86
Carbon Chem. shift
range/ppm
4a 121.5-125.4
8a 154.9-156.4
As can be seen, the chemical shift ranges are narrow enough to be 
useful in assigning the spectra of compounds of related structure.
2.28 Quantum mechanics
Quantum mechanical calculations^87 provide insights into the electronic 
properties of moleculesi88-i90. Molecular energies are calculated by using 
the Schroedinger equation with the Molecular Orbital formalismi88.i89. 
Energy is the most important property of a computer model and quantum 
mechanics can be used to calculate orbital energies, electron densities, 
dipole moments and atomic chargesi^i,192. These properties illustrate those 
regions to which charged and polarised or polarisable species can or cannot 
approach. Such information can throw light on the preferred positions of
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electrophilic or nucleophilic attack on a molecule.
In practice, only molecules containing less than about 50 atoms can be 
studied by the quantum mechanical approach at present as the computational 
effort is a quadratic function of the number of electrons involvedi88,l89.
Forsen and co-w o r k e r si94,195 have used semi-empirical Huckel Molelcular 
Orbital (HMO) calculations to evaluate the TT-excess partial electronic 
charges of 2'-hydroxy-6'-methoxyacetophenone. Their results are listed in 
TABLE 24194:
TABLE 24: Calculated TT-Excess Charges of 
2 ' -Hvdroxv-6 ' -methoxyacetophenone
Carbon HMO TT-Excess Charges
Cl -0.0748
C2 +0.1012
C3 -0.0562 (-0.0718)1
C4 +0.0577 (+0.0577)
C5 -0.0564 (-0.0720)
C6 +0.1016
1. Values in brackets taken from reference 195
5 CH
4
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3. EXPERIMENTAL
3. EXPERIMENTAL
The experimental sections detail the syntheses of the compounds listed 
in the following SCHEME 6. Each compound is identified by a letter and 
number code for the convenience of the reader so that the synthetic details 
are not cluttered with nomenclature.
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SCETOE 6: Compounds Described in the EXPERIMENTAL Sections
OH O
" 6 c ! : -‘OH 
OH O
CH
A2
OH
Br
OH O
CH;A3
‘OH
Br
CH;B1
CH.B2
OH
Br
O^COOCjHj
O'^ ^'COOCjHs
C3 [ O
' O^COOC;H;
Br
CH^p O
O^^COOH
C7
Q ^ C O O "  Na 
C W  9
COO" Na
Br
C H P  O
ClOa/b
O^COOC^Hg
C OO^ Na
C O O H
C O O " N a
C12
OH
CH.
OHHO'
OH
CH.
D2
OHHO'
OH
CH.H,C
D3
OHHO'
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C.H;OOC"^0
COOC2H5C,H,OOC
HOOC^^O
O^COOCjHj ElOa ElOb °
CH,OOC^O O^^OOCHj
C&OH
QX^COOH
COOHHOOC
Q/^COO- Na"Na “OOC^^O
E6
COO' Na
0Q OHE7
COOC.H,
£8a £8b
COOCgH
D/T D/T
CIOC'-^O COCI
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SCHEME 6: Copmoimd Name Index
A1 2',6'-Dihydroxyacetophenone
A2 3'-Bromo-2',6'-dihydroxyacetophenone
A3 3',5'-Dibromo-2',6'-dihydroxyacetophenone
B1 2'-Hydroxy-6'-methoxyacetophenone
B2 3'-Bromo-2'-hydroxy-6'-methoxyacetophenone
Cl Ethyl 5-Hydroxy-4-oxo-4H-1-benzopyran-2-carboxylate 
C2 Ethyl 5-Methoxy-4-oxo-4H-l-benzopyran-2-carboxylate
03 Ethyl 8-Bromo-5-methoxy-4-oxo-4H-1-benzopyran-2-carboxylate
04 5-Methoxy-4-oxo-4H-l-benzopyran-2-carboxylic acid
05 8-Bromo-5-methoxy-4-oxo-4H-l-benzopyran-2-carboxylic acid
06 Sodium 5-Methoxy-4-oxo-4H-l-benzopyran-2-carboxylate
07 Sodium 8-Bromo-5-methoxy-4-oxo-4H-l-benzopyran-2-carboxylate
08 Butyl 5-Methoxy-4-oxo-4H-l-benzopyran-2-carboxylate
09 Butyl 8-Bromo-5-methoxy-4-oxo-4H-l-benzopyran-2-carboxylate 
ClOa/b Sodium [l-i7o/i80]5-Methoxy-4-oxo-4H-l-benzopyran-2-carboxylate
(010a and 010b differ in their method of preparation)
011 Sodium 6,8-di-t-butyl-4-oxo-4H-l-benzopyran-2-carboxylate
012 [1,4,carboxyl-i8O4]6 ,8-di-t-butyl-4-oxo-4H-l-benzopyran-2-carboxylic 
acid
D1 1,1'-[(2-Hydroxy-l,3-propanediyl)]bis[oxy(6-hydroxy-2,1-phenylene)]- 
bisethanone
D2 1,1'-[(2-Hydroxy-l,3-propanediyl)]bis[oxy(5-bromo-6-hydroxy-2,1- 
phenylene)]bisethanone 
D3 [5,5'-^H]1,1'-[(2-Hydroxy-l,3-propanediyl)]bis[oxy(6-hydroxy-2,1- 
phenylene)]bisethanone
El Diethyl 5,5'-[(2-0xo-l,3-propanediyl)bis(oxy)]bis[4-oxo-4H-l-benzopyran 
-2-carboxylate]
E2 Diethyl 5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[8-bromo-4-oxo-4H-l- 
benzopyran-2-carboxyiate]
E3 5,5’-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[4-oxo-4H-l-benzopyran-2- 
carboxylic acid]
E4 5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[8-bromo-4-oxo-4H-l-benzopyran- 
2-carboxylic acid]
E5 Disodium 5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[4-oxo-4H-l- 
benzopyran-2-carboxylate]
E6 Disodium 5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[8-bromo-4-oxo-4H-l- 
ben z opyran-2-carboxylate]
E7 Dibutyl 5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[4-oxo-4H-l-benzopyran- 
2-carboxylate]
E8a Diethyl [8,8'-%H]5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[4-oxo-4H-l- 
benzopyran-2-carboxylate]
E8b Diethyl [8,8'-^H]5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[4-oxo-4H-l- 
benzopyran-2-carboxylate]
E9 5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[4-oxo-4H-l-benzopyran-2- 
carboxylic acid chloride]
ElOa Dimethyl 5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[4-oxo-4H-l-benzo- 
pyran-2-carboxylate]
ElOb Dimethyl [Carboxyl-^?0/iSq]5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis- 
[4-0X0-4H-1-benzopyran-2-carboxylate]
El1 [Carboxyl-170/18Q]5,5'-[(2-Oxo-l,3-propanediyl)bis(oxy)]bis[4-oxo-4H-l- 
benzopyran-2-carboxylic acid]
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3.1 Compound Bl: Methvlation
To compound A1 (Aldrich, 2.7395g, 18.00mmoles, mpt. 156-158 C^) 
dissolved in acetone (50ml) in a 100ml round-bottomed flask was added 
potassium carbonate (2.737g, 19.8mmoles). The suspension was stirred,
lodomethane (3.075g, 1,35ml, 21.7mmoles) was added in one portion from a 
pipette. The flask was immediately stoppered, sealed with parafilm and 
stirred overnight at room temperature in an efficient fume hood. The 
suspension was transferred to a separatory funnel with acetone washings.
Water and chloroform were added. The aqueous layer was discarded and the
organic layer further washed with water before drying over magnesium
sulphate. The solvent was evaporated to yield pure compound Bl as yellow 
crystals (3.750g, 15.3mmoles, mpt. 58-60*C). Analytical TLC on silica plates 
using a 1:1, CHClsiEtOAc solvent system showed one eluted spot. iR, and 
170 NMR spectra of compounds A1 and Bl were recorded, see FIGURES 8,14,17. 
Assignments are listed in TABLES 25,28,30.
The alternative sodium hydroxide/dimethyl sulphate routei9& lacked 
sufficient selectivity for this reaction to be of synthetic use.
3.2 Syntheses of Compounds A2. A3. B2 and D2: Bromination
The generalised synthetic procedure presented was successfully applied 
over a reaction scale range of 0.28 to 16.9 mmoles.
Compound A1, Bl or D1 (0.28-16.9mmoles, mpt. D1 = 167-168^0, lit. mpt. 
= 166-168*025 and 165-166°Ci^7; Compound D1 (kindly supplied by Fisons 
Pharmaceuticals) was suspended in glacial acetic acid (2-20ml) at room 
temperature with stirring. Bromine in glacial acetic acid solution 
(2.1-2.3M, 1.05-2.05 equivalents) was added dropwise. The flask was
stoppered and the reaction mixture was stirred at room temperture for 30 
minutes. Reaction monitoring was by silica plate TLC developed in acetone.
For compounds A2, A3 and B2, the reaction mixture was transferred to a 
separatory funnel and extracted with two aliquots of diethyl ether. The 
ethereal extracts were pooled, washed with dilute sodium bicarbonate
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solution and water before drying over magnesium sulphate. Evaporation of the 
solvent yielded a crystalline yellow solid of compound A2, A3 or B2.
The precipitated compound D2 was isolated on a sinter glass funnel, 
washed with cold diethyl ether and the yellow solid was dried in air.
Yield = 75 - 92% (lit. D2 = 62%25). Melting points; A2: 166-167°C, B2: 
99-100°C, D2: 170°C (lit. D2: 168-170°C25). IH NMR spectra were recorded for
compounds A2, A3, B2 and D2, see FIGURE 9. Assignments are listed in TABLE
25. 13C NMR spectra were recorded and assigned for compounds B2 and D2
(FIGURE 15 and TABLE 28). An NMR spectrum was recorded and assigned for 
compound B2 (see FIGURE 17, TABLE 30). Compound D2 was subjected to mass 
spectrometric (FIGURE 25), elemental and X-ray crystallographic analyses 
(see SECTION 3.13). CigHisOyBrz.HzO Theory: 42.56%C, 3.75%H, 29.80%Br Found: 
42.77%C, 3.50%H, 29.59% Br. Water content was determined by Karl-Fischer
titration. Positive ion FAB-MS198 (M++Na+)539/541/543 (relative peak height 
= 100%), (M+1++Na+) 540/542/544 (21.8%)
3.3 Syntheses of Compounds Cl. C2. C3. El and E2: Claisen Condensation
Anhydrous ethanol was prepared by refluxing absolute ethanol with 
magnesium turnings under dry nitrogen gas for 2-3 hours before distilling
onto activated 4A molecular sievesi40'i4i. Anhydrous toluene and diethyl
oxalate were prepared by fractional distillation. Diethyl oxalate was 
collected on activated 4A molecular sieves. Toluene was collected on calcium 
hydride from which it was fractionally distilled onto 4A molecular 
sievesi40. The synthetic procedure for compound E2 is shown here.
Compound D2 (1.6g, 3.Immoles, yellow solid) was suspended in a solvent 
mixture of ethanol (15ml) and toluene (20-30ml) in oven-dried apparatus 
consisting of a two-necked 250ml round-bottomed flask in reflux
configuration under a dry nitrogen gas atmosphere. Diethyl oxalate (1.0ml, 
7.Immoles) was syringed into the reaction flask. A previously prepared 
solution of sodium metal (0.70g, 30mmoles) in anhydrous ethanol (15ml) was
syringed into the reaction flask and the opaque, red mixture formed was
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refluxed under dry nitrogen gas for 3 hours. After cooling to room 
temperature the reaction mixture was poured into dry diethyl ether (100ml).
The poly-keto intermediate;
OH COOC,H
OHHO'
Br Br
was isolated as a brown solid by filtration through a glass sinter 
funnel. The solid was dried overnight in a desiccator.
The dry solid was suspended in water (50ml) in a 250ml round-bottomed 
flask. Concentrated hydrochloric acid (12M, 10ml) was added to give a brown 
coagulant. Ethanol was added (120ml) and the yellow solution was refluxed 
for 30 minutes. The flask was cooled in an ice bath to yield a gelatinous 
orange/yellow precipitate of crude compound E2 which was isolated by 
filtration on a Buchner funnel, washed with water and dried in air. This 
solid was recrystallized from a 1:2 (v/v) toluene:ethanol solvent mixture to 
yield pure compound E2 as a flaky, pale yellow solid.
Compound Appearance Yield(X) Mpt.C^C) Lit.Mpt.rc)
Ref.
01 White 40 148 148 131,199
02 Yellow 76 129 130-131 131,134
03 Yellow 85 N.R. -
El White 60 182 180-182 26,120
E2 Yellow 40 203-205 —
N.R. = Not Recorded 
IH NMR spectra were recorded for compounds C1-C3, El and E2, see FIGURE 
10. Assignments are listed in TABLES 26,27. NMR spectra were recorded 
and assigned for compounds 02, 03 and El (FIGURE 16, TABLE 29). NMR
spectra were recorded and assigned for compounds 02 and El (FIGURE 18, TABLE 
31). Compound E2 was subjected to mass spectrometric (FIGURE 25) and 
elemental analyses. O27H22O1iBr2.2H2Ü Theory: 45.15%0, 3.64%H, 22.24%Br
Found: 44.99%0, 3.21%H, 21.76%Br. Water content was determined by
Karl-Fischer titration. Positive ion FAB-MS (M+) 681/683/685 (Relative peak 
height = 100%), (M+1+) 682/684/686 (33.6%). Compound 03 was analysed by
X-ray crystallography, see SECTION 3.13.
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3.4 Syntheses of Compounds C4. C5. E3 and E4: Saponification
Compounds C4 and E3 were synthesized according to the method of Lockley 
and co -worker26 and Cairns et al120. The syntheses of compounds C5 and E4 
are illustrated by the procedure for the latter.
Anhydrous DMF was prepared by vacuum fractional distillation from 
barium oxide, collecting the distillate onto activated 4A molecular sieves.
In a 10ml round-bottomed flask were placed compound E2 (62.2mg, 
91.2pmoles) and an aliquot of sodium bicarbonate solution (57.7mM, 3.16ml, 
182pmoles). The suspension was stirred whilst heating in an oil bath at 
65-70 ‘'C for one hour giving a translucent yellow solution of compound E6. 
The hot solution was filtered through an oven-warmed Hirsch funnel to remove 
residual particulates. The collected filtrate was cooled to room 
temperature, then further cooled in an ice bath before adding a 
stoichiometric excess of concentrated hydrochloric acid such that a pH of 
less than 1 was attained. The resultant flocculent precipitate of compound 
E4 was centrifuged for 5 minutes at 2000 rpm to conveniently isolate the 
product. The supernatant acidic solution was discarded and the precipitate 
was lyophilized to yield crude compound E4 which was recrystallized from the 
minimum volume of boiling DMF to yield pure compound E4 as a yellow solid. 
Yield = 91% (58.1mg, 83. Ijnmoles).
Compound Appearance Yield (X) Mpt.(*C) Lit. Mpt. (*C)
Ref.
C4 White N.R. 251 252-253 ■■ 131,200“
C5 Brown 60 N.R. -
E3 White, N.R. N.R. -
E4 Yellow 91 N.R.
N.R. = Not Recorded
NMR spectra were recorded and assigned for compounds C4, C5, E3 and 
E4 (FIGURE 11, TABLE 26). i^ O NMR spectra were recorded and assigned for 
compounds C4 and C5 (TABLE 31). Compound E4 was subjected to mass 
spectrometric (FIGURE 25) and elemental analyses. C23H14O1iBr2.5H20 Theory: 
38.57%C, 3.36%H, 22.31%Br Found: 38.67%C, 2.99%H, 20.84%Br. Water content
was determined by Karl-Fischer titration. Positive ion FAB-MS (M+)
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625/627/629 (Relative peak height * 100%) (M+1+) 626/628/630 (27.5%).
3.5 Syntheses of Contpoimds C6. C7. E5 and E6: Neutralisation
The synthetic procedure was identical for all compounds and is 
illustrated here for compound E6 .
Compound E4 (58.1mg, 83.IjLunoles) was added to a sodium bicarbonate 
solution (135mM, 1.11ml, 149pmoles) and vigorously stirred for one hour at 
room temperature. Use of a sub-stoichiometric quantity of base was necessary 
to avoid the production of pink/purple degradation side-products. Acetone 
(8ml) was added with stirring to precipitate compound E6 . The acetone/water 
solvent had a yellow colouration due to the small quantity of compound E4 
that had not been neutralised. Compound E6 was collected on a glass sinter 
funnel and was washed with a small aliquot of acetone to give pure compound 
E6 as a pale brown solid. Yield = 76% (42.3mg, 63 ^ moles).
NMR spectra were recorded and assigned for compounds E5 and E6 
(FIGURE 11, TABLE 27). The i^ C NMR spectrum of compound E5 was recorded and 
assigned (TABLE 29). NMR spectra of compounds E5, C6 and C7 were 
recorded and assigned (FIGURE 19, TABLE 31). Compound E6 was subjected to 
mass spectrometric (FIGURE 25) and elemental analyses. C23H12O1iBr2Na2.6H2O 
Theory: 35.49%C, 3.09%H, 20.54%Br Found: 35.32%C, 2.70%H, 19.78%Br. Water
content was determined by Karl-Fischer titration. Positive ion FAB-MS (M+) 
669/671/673 (Relative peak height = 100%) (M+l)+ 670/672/674 (27.1%).
3.6 Synthesis of Compound D3: Catalytic Tritiodebromination
Using a hydrogenation apparatus similar to that described by LockleyZOi 
and an experimental procedure identical to that described in SECTION 3.1 of 
chapter 1 of this thesis, compound D2 (20mg, 38.6jimoles) was dissolved in 
dry THF (400^ 1) to which was added 5% palladized charcoal (40mg) and dry 
triethylamine (20jnl, 143^moles). The reaction mixture was vigorously stirred 
under an atmosphere of 12:1 (v/v) H2:T2 gases for 3.5 hours. After work-up, 
the product -compound D3- was analyzed by UV spectroscopy and liquid
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scintillation counting in order to calculate the specific radioactivity. 
(E =: 5153 (A=338.5nm in CH2CI2), 2.98 Ci mmole-1, llSmCi). NMR spectra 
(FIGURE 22) were obtained in de-acetone at 320 MHz: (^H-decoupling) 6.56, s; 
(iH-coupling) 6.56, d, 3J=8.99 Hz.
3.7 Syntheses of Compounds E8a/b: Catalytic Tritodebromination
Various reaction conditions were tested to try and obtain compounds E8a 
and E8b and also [8,8 '-^ H] compound E5 direct from compound E6. These 
experiments were only partially successful because of concurrent 
side-reactions, mostly unidentified, such as saturation of the C2-C3 bond of 
the pyrone ring20%. A selection of the experimental conditions used are 
listed in TABLES 32 and 33. Analytical HPLC analyses used a C18 reverse 
phase colummn and 75:25%(v/v) Me0H:H20 solvent system at a flow rate of 1 
ml/min. using UV detection at 268 nm and radiochemical scintillation 
detection.
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TABI.E 32: Dehalogenation of rnmonwnd Kfi
Substrate Catalyst Base Solvent Hydrogen Rxn. %Dehal. NMR PIG.
(ms) (ms) (pl/ms) (;il) Isotope Time(tart) Number
E6 5% Pt/CaC03 TEA H20 D2 24 -
(8.4) (27.1) (3.8)
E6 5% Pt/CaC03 TEA H20 D2 24 100 23a
(7.2) (24.8) (20) (200)
E6 5% Pt/CaC03 Proton Sponge^ D20 D2 24 100 23b
(9.7) (27) (31.1) (200)
E6 5% Pt/CaC03 Proton Sponge MeOH D2 - none
(7.2) (17.2) (8.9) (300)
E6 10% Pd/C Proton Sponge D20 D2 24 none
(7) (22.2) (11.9) (300)
E6 10% Pd/C Proton Sponge THF H2 44 -
(8.3) (20.9) (12.9) (300)
E6 5% Pt/CaC03 Proton Sponge THF H2 24 -
(6.1) (19) (11.1) (200)
E6 10% Pd/C Proton Sponge Phosphat i D2 24 -
(8.1) (20) (10) buffered pH7 
H20 (200)
E6 5% Pt/C Proton Sponge Phosphate D2 23 100 23c
(7.9) (28.5) (7.2) buffered pH7 
H20 (200)
1, Proton sponge = 1,8-Bis(dimethylamino)naphthalene
TABLE 33.: PelialQKeM tiqn of Compound B2
Substrate
(mg)
Catalyst
(ms)
Base
(^1/mg)
Solvent
(;il)
Hydrogen
Isotope
Rxn. 
Time(tan
XDetaal. NMR FIG. 
Number.) 0 1 2Br’s
E4 5% Pt/CaC03 Proton sponge DMF H2 40 -
(7.3) (23.1) (23.5) (200)
E2 5% Pt/CaC03 TEA CHC13 D2 24 100 24a
(10.4) (22.2) (20) (250)
E2 5% Pd/C TEA CHC13 H2 48 90 24b
(25) (50) (30) (1500)
E2 5% Pd/C TEA CHC13 H2/T2 40 641 24c/d
(25) (50) (30) (1500) 12:1(v/v)
E22 5% Pd/C TEA CHC13 T2 3 3 20 77
(10) (20.3) (6.3) (1500) (1 atm) 19 27 66 7
E22 10% Pd/C DIPEA THF T2 3 -
(7.5) (7.4) (17) (4000) (3/4 atm)
E22 10% Pd/C TEA DMF T2 3 34 59 7
(7.2) (15) (5.5) (1250) (1 atm)
E22 5% Pd/C TEA THF T2 7 28^ 32 40 24e-j
(7.2) (3.8) (9) (4000) (1/2 atm)
1. 1 Ci/mmole, 37«Ci
2. These products were analyzed by reverse-phase HPLC.
3. HPLC purified E8b. 52.1 Ci/mmole, 553mCi
TEA = Triethylamine; DIPEA = Diisopropylethylamine
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3.8 Syntheses of Compounds C8. C9 and E7: Butyl Esters
The synthetic procedure is illustrated with compound C8. The starting 
material for this estérification reaction may be the acid, carboxylate salt 
or another ester.
Compound C4 (SOOmg, 1.36mmoles) was refluxed in butan-l-ol (50ml) 
containing a catalytic amount of concentrated sulphuric acid (18M) for 2.5 
hours. After cooling to room temperature, the reaction mixture was 
transferred to a separatory funnel. Water and chloroform were added in order 
to partition the mineral acid and excess butan-l-ol from the butyl ester 
product. The organic layer was repeatedly washed with water until the 
aqueous layer had a neutral pH. The chloroform layer was dried over 
magnesium sulphate and evaporated to yield pure compound C8 as a yellow 
solid. Yield = 95% (357mg, 1.29mmoles).
iH NMR spectra were recorded and assigned for compounds C8, C9 and E7 
(FIGURE 12, TABLES 26,27). 17q NMR spectra were recorded and assigned for 
compounds C8 and C9 (FIGURE 20, TABLE 31). Mass spectra were recorded for 
compounds C8 and C9 (FIGURE 25). EI-MS, C8: (M+) 276 (Relative peak height = 
100%), (M+D+ 277 (16.7%). EI-MS, C9: (M)+ 354/356, (M+l)+ 355/357 (17%).
3.9 Syntheses of Compounds ClOa/b and 012: Exchange Labelling for
Oxygen-17 and 0xygen-18 Enrichment
Two procedures were used to prepare compound CIO:
ClOa: Compound C4 (210mg, 0.95mmoles) was mixed with concentrated
hydrochloric acid (18M, 0.21ml) and [i^Ojwater (Aldrich, 10.1atom% i?0,
22.9atom% 4(^ 1, 2.21mmoles) and heated in a sealed, thick-walled glass
tube at 120°C for 15 hours. The tube was cooled to room temperature before
opening. A neutral pH was achieved by the dropwise addition of sodium 
hydroxide solution (7.5M). The resultant solution of compound ClOa was 
lyophilized to give a white solid. This was analyzed by NMR spectroscopy 
(FIGURE 21) as a D2O solution (TABLE 31).
ClOb: Compound C4 (77mg, 0.35mmoles) was mixed with concentrated
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hydrochloric acid (IBM, ISjul), [I70]water (Aldrich, 10.1atom% i^ O, 22.9atom% 
180, 30pl, 1.66ramoles) and 1,4-dioxane (SOOjal). The mixture was heated in a
sealed, thick-walled glass tube at 90 “C for 16 hours. The reaction mixture 
was worked up in an identical fashion yielding compound ClOb which was 
analyzed by l?0 NMR spectroscopy (FIGURE 21) as a DzO solution (TABLE 31), 
Compound Cll (200mg, 0.66mmoles) was mixed with [i8Q]water (BOC Ltd., 
100atom% 18Q, 0.3ml, 16.7mmoles) and concentrated sulphuric acid (12M, 5ml) 
in a thick-walled, screw cap glass tube equipped with a magnetic stirrer 
bar. The tube was heated with stirring at 80-90*C in a metal block for five 
days to yield compound Cl2. An aliquot of the reaction mixture was analyzed 
directly by mass spectrometry. A further aliquot was neutralized by the 
dropwise addition of potassium hydroxide solution (5M) before mass
spectrometric analysis. These data are presented as FIGURE 26 and TABLE 34.
TABIÆ 34: Compound Cl2 Molecular Ion Clusters
C18H22O4 = 302
Work-Up Basified None
#1801 m/z 2 Observed^ Corrected* Observed Corrected
Intensity Intensity (X) Intensity Intensity(X)
0 303 1037 3.4 800 6.9
304 413 0.5 250 0.5
1 305 5025 16 2303 20
306 1714 1.6 646 0.8
2 307 11326 36 3144 27
308 3426 2.3 904 1.2
3 309 11694 37 3879 33
310 3027 0.7 931 0.01
4 311 527 1.5 1290 11
312 61 0.01 —
1. #180 = Number of oxygen-18 atoms per molecule
2. m/z - Mass-to-charge ratio of cations and radical cations recorded. For
all the species displayed, z = 1
3. Absolute intensity of mass spectrometric peaks at shown m/z values
4. Mass spectrometric peak intensities corrected for the natural abundance 
of 13c and 2h isotopes expressed as a percentage of the total molecular 
ion cluster. The computer program shown as FIGURE 15 of chapter 2 was
used with the following modifications: lines 1053, 1231 and 1250-6060
inclusive were deleted. The following lines were amended:
1060 FO = 1.1E-2*C+1.5E-4*H
1070 F3 = 0
1210 FOR I = 0 TO 16
1301 PRINT AT 1+5,Z
1302 NEXT Z: STOP
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3.10 Syntheses of Compounds ElOa/b: Oxvgen-17 Enrichment bv Synthesis
Compound ElOa was an isotopically normal reference material whereas
compound ElOb was enriched in oxygen-17. The method of Payard^^? was 
followed for the synthesis of compound E9.
Compound E3 was dried in a calcium sulphate desiccator under high 
vacuum for five hours. All glassware was oven-dried overnight. Anhydrous 
cyclohexane was prepared by stirring over activated 4A molecular sieves and 
calcium hydride, in turn, before fractional distillation onto activated 4A 
molecular sieves. Anhydrous acetonitrile was prepared by stirring over 
potassium carbonate for 24 hours. The filtrate was then stirred over calcium 
hydride overnight before fractional distillation onto activated 4A molecular 
sieves.
Compound E3 (185mg, 0.39mmoles) was placed with phosphorus 
pentachloride (163mg, 0.79mmoles) and dry cyclohexane (5ml) in a 25ml 
round-bottomed flask in reflux configuration under an atmosphere of dry 
nitrogen gas. The suspension was refluxed for two hours. The reaction 
mixture remained yellow. The reaction mixture was cooled to room temperature 
under nitrogen gas and compound E9 was isolated by vacuum filtration as a 
yellow solid. Yield = 50% (106mg, 0.198mmoles).
Compound E9 (lOOmg, 0.186mmoles) was suspended in dry acetonitrile 
(6ml) and [i^o]water (Aldrich, 10,latom% i^ O, 22.9atora% ISQ, 15jil, 
0.83mmoles) was added. The suspension was refluxed under a dry nitrogen gas 
atmosphere until the white solid of compound Ell was observed. The reflux 
was continued for a further hour. The white solid was isolated by 
evaporation of the solvent.
3.11 Diazomethane Generation
Excessive artificial and strong daylight were excluded from the 
laboratory. The generation of diazomethane gas was conducted in an efficient 
fume hood behind a blast screen.
Potassium hydroxide (Ig, 17.8ramoles) was dissolved in water (2ml) and
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diluted with ethanol (8ml) before adding the solution to the following 
apparatus and cooling in an ice bath for ten minutes:
tiopper
8cm
N-Methyl-N-nitroso-p-toluenesulphonamide (Aldrich (Diazald) lOg, 
4.7mmoles) was dissolved in diethyl ether (25ml). The yellow solution was 
added to the cooled reaction flask using a Pasteur pipette. A flow of water 
to the condenser of the apparatus was commenced and the reaction flask was 
stoppered with a rubber bung. The ice bath was replaced by a water bath 
maintained at 60°C. A scratch-free conical flask was placed such that it was 
contained in an ice bath and the receiver from the apparartus was at the 
bottom of the flask. A yellow distillate of diazomethane in diethyl ether 
was collected until the reaction mixture had become colourless (10-15 
minutes). The distillate contained approximately 3.3 mmoles of
diazomethanei40.
Compound Ell (87mg, 0.186mmoles) was suspended in absolute ethanol 
(10ml) and cooled in an ice bath. The ethereal diazomethane solution (20ml, 
3.3mmoles) was added in one portion and the mixture was stirred for five 
minutes. Excess diazomethane was displaced by a stream of nitrogen gas 
bubbling through the reaction mixture. The solvents were evaporated to give 
crude compound ElOa/b as a creamy-white solid in quantitative yield. 
Compound ElOa/b was purified by preparative TLC on a 1mm silica plate in a 
1:1 CHCl3:EtOAc solvent system. A band eluting with an Rf of 0.1 was 
extracted with acetone to give pure compound ElOa/b.
iH NMR spectra were recorded and assigned for compounds ElOa and ElOb 
(FIGURE 13, TABLE 27). An NMR spectrum was recorded and assigned for 
compound ElOb (FIGURE 21, TABLE 31). No signals could be discerned in the
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170 NMR spectrum of compound ElOa. Positive ion FAB-mass spectra were 
recorded for compounds ElOa and ElOb (FIGURE 26, TABLE 35).
TARI.F. 35: CcMBPOunds ElOa/b Molecular Ion Clusters 
C25H20O11 = 496
*170 #180 m/z
Compound ElOa Compound ElOb
Observed
Intensity
Corrected 
Intensity (X)
Observed
Intensity
Corrected
Intensity(X)
0 0 497 20287 94 3018 871 498 5904 0.01 952 0.012 1 499 1332 6.2 353 103 500 243 0.01 108 0.014 2 501 51 0.24 75 2.25 502 — 38 0.33
Footnotes as TABLE 34.
3.12 Adjusting the NMR Spectrometer for ^MR Spectroscopy
The 17q NMR experiments reported here were performed on a Bruker AC-300 
instrument operating at a nominal 40.688 MHz for oxygen-17. A spectral width 
of just over 30kHz (about 800ppm) was used, enabling a single experiment to 
encompass all the possible resonance positions anticipated in the 
investigations, overcoming any "power drop" problems while not unduly 
burdening the analogue-to-digital converter.
A test sample of 10.1atom% [17q]water was used to determine the pulse 
width such that a high quality spectrum could be observed from just one 
pulse. The spectrometer is equipped with a multinuclear, broadband probe of 
10mm bore. The gross tuning and matching values were supplied by the 
manufacturer. A survey of the literature (TABLE 36) revealed the likely 
parameter values for the acquisition of NMR spectra. Those for the pulse 
width suggested a value of between 25-30jis was necessary for a 90° flip 
angle. The procedure used was to optimise the pulse length to primarily 
achieve a 360° flip angle. This procedure was chosen as the pulse length is 
"easier" to optimise in relatively large steps of Ijis. However, this 
approach assumes that the length and area of the pulse are directly 
proportional. This is strictly not the case although the errors imposed are
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not significant for longer RF pulses as here203. a 90° flip angle of 2^s 
agrees well with similar experimental reports (TABLE 36).
The NMR probe was tuned and matched with a reflectance meter178 with 
each sample in the working configuration of the spectrometer. In TABLE 36 
the spectrometric parameters used are shown alongside selected examples from 
other workers.
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3.13 X-Ray Crystal Structures of Compounds C3 and D2
Crystals of compound C3 were obtained by the evaporation, at room 
temperature, of a 1:1 water: ethanol solvent mixture. A crystal of size 
0.ISmmxO.Immx0.55mm was used to determine the unit cell and for data 
collection of intensities. The unit cell was determined from 25 accurately 
centred reflections on an Enraf-Nonius CAD4 diffractometer at a wavelength 
of 0.71073 K (Mo-K%) in the angular range of if -15" . Intensity data were 
collected for ==1“ -27° , covering the index range, cT<h<9° , 0<k<23° and
-13°<K13'’ . In all, 3083 reflections were measured of which 1732 had I>3(5'. 
Inspection of the hOl and OkO data proved the space group to be uniquely 
P2i/n.
The position of the bromine atom was determined from an inspection of 
the Patterson peaks and the heavy atom method was used to locate the 
remaining atoms of the molecule. Isotropic refinement of all non-hydrogen 
atoms converged at B=0.13. Anisotropic refinement of all non-hydrogen atoms 
converged at R=0.041. Unit cell parameters, bond lengths, bond angles and 
torsion angles are presented as TABLES 37-40.
Crystals of compound D2 were obtained by the evaporation, at room 
temperature, of a 1:1 acetone:water solvent mixture. Crystal data were 
collected in a similar fashion to that described for compound C3, above. 
Unit cell parameters, bond lengths, bond angles and torsion angles are 
presented as TABLES 37,41-43. FIGURES 27 and 28,29 show ORTEP drawings of 
the compounds C3 and D2, respectively, with the thermal ellipsoids drawn at 
50% probability. These FIGURES also give the numbering systems used in the 
TABLES of crystal data.
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TABLE 37: Unit Cell Parameters of Contpound C3 and D2 Crystals
CcHnpound C3 Cwopound D2
'Crystal sySTSm Ronoclinic Hexagonal
Space Group P2i/n R3
a(A) 7.113(2) 31.703(3)
b 18.740(6) 31.703(3)
c 10.203(3) 10.196(9)90* 90"
110.26‘*(2) 90“
Y 90“ 120'
z 4 18
V(&3) 1275.9(1.6) 8874(2)
dc(g cm-3) 1.703 1.742
R 0.041 0.056
Interplane 1.6° -
Dihedral Angle
Numbers in parentheses are estimated standard deviations in the least 
significant digits.
TABLE 38: Bond Lengths in Compound C3 (X)
Atoml Atom2 Length Atoml Atom2 Length
Br Cl 1.881(5) Cl C9 1.390(6)
01 C8 1.355(5) C2 C3 1.382(7)
01 C9 1.383(5) C3 C4 1.380(6)
02 C4 1.343(6) C4 C5 1.419(6)
02 C13 1.444(6) C5 C6 1.488(6)
03 C6 1.211(6) C5 C9 1.388(6)
04 CIO 1.322(6) 04 Cll 1.468(6)
C6 C7 1.468(6) C7 C8 1.313(7)
05 CIO 1.197(5) C8 CIO 1.513(6)
Cl C2 1.378(6) Cll C12 1.476(8)
Numbers in parentheses are estimated standard deviations in the least 
significant digits.
TART.E 39: Bond Angles in Compound C3 in Degrees
Atoml Atom2 Atoms Angle Atoml Atom2 Atoms Angle
C8 01 C9 117.6(3) 03 C6 C5 125.1(4)
C4 02 C13 117.0(4) 03 C6 C7 120.8(4)
CIO 04 Cll 115.3(3) C5 C6 C7 114.1(4)
Br Cl C2 120.4(3) C6 C7 C8 121.9(4)
Br Cl C9 120.6(3) 01 C8 C7 124.7(4)
C2 Cl C9 119.0(4) 01 C8 CIO 113.3(4)
Cl C2 C3 120.3(4) C7 C8 CIO 122.0(4)
C2 C3 C4 121.0(4) 01 C9 Cl 114.6(4)
02 C4 C3 123.4(4) 01 C9 C5 123.2(4)
02 C4 C5 116.7(4) Cl C9 C5 122.2(4)
C3 C4 C5 119.9(4) 04 CIO 05 126.5(4)
C4 C5 C6 124.0(4) 04 CIO C8 112.7(4)
C4 C5 C9 117.6(4) 05 CIO C8 120.7(5)
C6 C5 C9 118.4(4) 04 Cll C12 107.7(4)
Numbers in parentheses are estimated standard deviations in the least 
significant digits.
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TARTE 60: Torsion Angles in Coomound C3 in Degrees
Atcnal Atom2 Atoms AtcHoA Angle Atoml Atom2 Atoms Atom4 Angle
C9 01 CB C7 3.3 02 C4 C5 C9 -178.5
C9 01 C8 CIO -177.2 C3 C4 C5 C6 -177.1
C8 01 C9 Cl 179.3 C3 C4 C5 C9 1.9
C8 01 C9 C5 -0.8 C4 C5 C6 03 2.7
C13 02 C4 C3 2.1 C4 C5 C6 C7 -177.9
C13 02 C4 C5 -177.7 C9 C5 C6 03 -176.1
Cll 04 CIO 05 -1.7 C9 C5 C6 C7 3.3
Cll 04 CIO C8 175.6 C4 C5 C9 01 178.7
CIO 04 CIO C12 177.9 C4 C5 C9 Cl -1.4
Br Cl C2 C3 179.6 C6 C5 C9 01 -2.5
C9 Cl C2 CS 0.6 C6 C5 C9 Cl 177.5
Br Cl C9 01 1.2 03 C6 C7 C8 178.3
Br Cl C9 C5 -178.7 C5 C6 C7 C8 -1.1
C2 Cl C9 01 -179.8 C6 C7 C8 01 -2.2
C2 Cl C9 C5 0.3 C6 C7 C8 CIO 178.3
Cl C2 C3 C4 -0.3 01 C8 CIO 04 3.1
C2 C3 C4 02 179.3 02 C8 CIO 05 -179.4
C2 C3 C4 C5 -0.9 C7 C8 CIO 04 -177.4
02 C4 C5 C6 2.7 C7 C8 CIO 05 0.1
TABLE 41 : Bond Lengths in Compound D2
Atoml Atom2 Length Atoml Atom2 Length
Brl Cll 1.882(7) Cll C12 1.361(10)Br2 C21 1.902(10) Cll C16 1.378(9)01 Cl 1.421(7) C12 C13 1.362(9)Oil C16 1.342(9) C13 C14 1.384(9)Oil Hll 0.90(5) C14 C15 1.423(10)012 C17 1.234(10) C15 C16 1.422(9)012 Hll 1.58(5) CIS C17 1.478(9)013 C14 1.354(8) C17 C18 1.461(10)013 C19 1.429(9) C21 C22 1.357(12)021 C26 1.341(9) C21 C26 1.357(14)021 H21 0.95(7) C22 C23 1.388(14)022 C27 1.233(9) C23 C24 1.366(12)022 H21 1.52(7) C24 C25 1.403(10)023 C24 1.320(10) C25 C26 1.402(12)023 C29 1.414(9) C25 C27 1.497(13)Cl C19 1.503(10) C27 C28 1.480(13)Cl C29 1.501(11)
Numbers in parentheses are estimated standard deviations significant digits. in the least
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TABLE 42: Bond Angles in Compound D2 in Degrees
Atoml Atom2 Atoms Angle Atoml Atom2 Atoms Angle
C16 Oil Hll 96(4) 012 C17 CIS 119.6(6)
C17 012 Hll 99(2) 012 C17 C18 117.5(6)
C14 013 C19 117.7(5) C15 C17 C18 122.9(7)
C26 021 H21 88(3) 013 C19 Cl 106.8(6)
C27 022 H21 94(2) C22 C21 C26 121.7(9)
C24 023 C29 121.6(6) C21 C22 C23 119.5(9)
01 Cl C19 111.6(6) C22 C23 C24 120.9(7)
01 Cl C29 105.7(6) 023 C24 C23 122.8(7)
C19 Cl C29 110.7(6) 023 C24 C25 118.2(7)
C12 Cll C16 120.3(6) C23 C24 C25 119.0(8)
Cll C12 C13 122.3(6) C24 C25 C26 119.4(8)
C12 C13 C14 119.2(7) C24 C25 C27 123.5(7)
013 C14 C13 123.5(7) C26 C25 C27 117.1(7)
013 C14 CIS 115.7(5) 021 C25 C21 117.8(8)
C13 C14 CIS 120.8(6) 021 C26 C25 122.8(9)
C14 C15 C16 117.3(5) C21 C26 C25 119.4(7)
C14 CIS C17 125.4(6) 022 C27 C25 119.8(8)
C16 CIS C17 117.3(6) 022 C27 C28 118.6(8)
Oil C16 Cll 117.5(6) C25 C27 C28 121.6(7)
Oil C16 CIS 122.5(6) 023 C29 Cl 107.1(6)
Cll C16 CIS 120.0(7) Oil Hll 012 165(6)
021 H21 022 175(5)
Numbers in parentheses are estimated standard deviations in the least 
significant digits.
TABLE 43: Torsion Angles in CcMiPound D2 in Degrees
Atoml Atom2 AtomS Atom4 Angle Atoml Atom2 Atoms Atom4 Angle
Hll Oil C16 Cll -174.2 C14 CIS C17 012 —178.6
Hll Oil C16 C15 3.8 C14 CIS C17 C18 3.2C19 013 C14 CIS -1.3 C16 CIS C17 012 2.2
C19 013 C14 CIS 177.4 C16 CIS C17 C18 -176.0
C14 013 C19 Cl -177.4 Br2 C21 C22 C23 “175.6
H21 021 C26 C21 -174.3 C26 C21 C22 C23 1.6
H21 021 C26 C25 4.6 Br2 C21 C26 021 -5.4
C29 023 C24 C23 —8.3 Br2 C21 C26 C25 175.6
C29 023 C24 C25 172.4 C22 C21 C26 021 177.4
C24 023 C29 Cl -169.5 C22 C21 C26 C25 -1.5
01 Cl C19 013 -69.0 C21 C22 C23 C24 1.3
C29 Cl C19 013 173.6 C22 C23 C24 023 176.6
01 Cl C29 023 68.6 C22 C23 C24 C25 -4.1
C19 Cl C29 023 -170.4 023 C24 C25 C26 -176.6
Brl Cll C12 C13 178.9 023 C24 C25 C27 4.9
C16 Cll C12 CIS —1.6 C23 C24 C25 C26 4.1
Brl Cll C16 Oil 1.2 C23 C24 C25 C27 -174.5
Brl Cll C16 CIS -176.8 C24 C25 C26 021 179.8C12 Cll C16 Oil -178.2 C24 C25 C26 C21 -1.3C12 Cll C16 CIS 3.8 C27 C25 C26 021 -1.5
Cll C12 CIS C14 -1.1 C27 C25 C26 C21 177.3CIS C14 CIS C16 0.5 C24 C25 C27 022 177.6C13 C14 C15 C17 -178.7 013 C14 CIS C16 -178.2
C14 CIS C16 Oil 178.9 013 C14 CIS C17 2.6
C14 CIS C16 Cll -3.2 C24 C25 C27 C28 —3.4
C17 CIS C16 Oil -1.8 C26 C25 C27 022 -1.0
C17 CIS C16 Cll 176.1 C26 C25 C27 C28 178.1
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FIGURE 27: ORTEP Drawing of Compound C3 with Thermal Ellipsoids at 50X
Probability Showing Atomic Numbering
FIGURE 28: ORTEF Rrawing of Compound D2 with Thermal Ellipsoids at 50% 
Probability Showing Atomic Numbering
C22
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FIGURE 29: Partial Unit Cell Structure of Compound D2 Looking Down The Triad 
Axis
313
3.14 Compound Bl: Quantum Mechanical Calculations
Atomic charges were calculated for compound Bl using two techniques: 
CNDO (Complete Neglect of Differential Overlap) and the more involved 
AMPAC.ANl, a derivative of the more fimiliar MOPAC program. AMPAC.AMI 
calculations were performed on the phenoxide. The 03-09 bond length was set 
to a mean value taken from X-ray crystallographic data2ii-2i3. Ab initio 
quantum mechanical calculations gave atomic charge densities. These results 
are given below.
TART.E 44: Quantum Mechanical Calculations on Compound Bl
Method ’ CNDO AMPAC.AMI Ah Initio
ktam Atom Net Atomic Net Atomic Total ChargeType No. Charge Charge Density
C 1 0.0618 -0.04070 3.9612
C 2 -0.0999 -0.32850 4.0265
C 3 0.2257 0.31390 3.8520
c 4 -0.1412 -0.38440 4.0257
c 5 0.2400 0.16530 3.8390
c 6 -0.1037 -0.38520 4.0303
H 7 -0.0060 0.07960 1.0204
H 8 0.0066 0.10610 1.0250
0 9 -0.2638 -0.48830 6.1859
C 10 0.2564 0.34250 3.7792
0 11 -0.2006 -0.24440 6.1670
H 12 0.0061 0.09940 1.0231
C 13 0.1205 -0.05780 3.8469
H 14 0.0094 0.06860 1.0085
H 15 0.0002 0.06610 1.0097
H 16 -0.0001 0.04870 1.0057
C 17 —0.0668 -0.26570 3.9332
0 18 -0.2751 -0.34660 6.3264
H 19 0.0299 0.09360 1.0067
H 20 0.0190 0.06380 1.0156
H 21 0.0172 0.09380 1.0126
H 22 0.1644 — 0.8995
The CNDO data was used to calculate the dipole moment:
Calculated = 3.943 D. Literature experimental dipole moment = 4.50D in
benzene and 4.78D in 1,4-dioxanelio.
14-i6
19-2112 H
8
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SCHEME 7: Numbering Schemes Used For NflR Assignments
Compounds A1-A3, Bl and B2 (TABLE 25)
5
OH 2
X
R - H or CH3 
X, X' = H or Br
Compounds D1 and D2 (TABLE 25)
HO
Compounds C1-C5, C8 and C9 (TABLE 26)
6
COOR'7 9-12
8
X = H or Br
R = H or CH3 
R ' = Et, Bu, H or Na+ 
X = H or Br
Compounds E1-E3, E5-E7 and ElO (TABLE 27)
5
OH
ROOC COOR9-12
8
R = Me, Et, Bu, H or Na+ 
X = H or Br
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SCHEME 8: Numbering Schemes Used For NMR Assignments
Compounds A1, Bl and B2 (TABLE 28)
9
R = H or CHa 
X = H or Br
Compounds D1 and D2 (TABLE 28)
1
HO
X = H or Br
Compounds C2 and C3 (TABLE 29)
9
6
7
X  = H or Br 
R = Et
Compounds El and E5 (TABLE 29)
OH
11-12 COOR
R Et
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SHHIMF 9: Numbering Schones Used For ^^0 NMR Assignments
Compounds Al, Bl and B2 (TABLE 30)
R\ 3
OH
X
R = H or CH3 
X = H or Br
Compound D1 (TABLE 30)
HO
Compounds 02, C4-C10 (TABLE 31)
COOR
R = Et, Bu, H or Nà+ 
X = H or Br
Compounds El, E5 and ElOb (TABLE 31)
ROOC COOR
R = Et, Me or Na+
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FIGURE 8: NfR Spectra of Compounds Al and Bl at annMR?
FIGURE 8a: Compound Al in ds-acetone
T9 T6 "T58 T"24 ~S 1PPM
FIGURE 8b: Ccwipound Bl in de-acetone
B 5 4 5PPM
FIGURE 8c: iR-iH NOE Difference spectra of compound Bl in de-acetone
PPM
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FIGURE 9: IH NMR Spectra of Cnnrnnimds A2. A3, B2. D1 and D2 at 300Mgz
FIGURE 9a: Compound A2 in de-acetone
Ajil L
— I------ rS 4PPM
FIGURE 9b: Ccxnpound A3 in de-acetone
9 8 1 1 ■ - 1------ r7 6 5 4 5 -- 1--- ---T-----2 ]PPM
FIGURE 9c: C(Hnpound B2 in CDCI3
1 I _ 1 ....... 1
“I----- 1—6 5PPM
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FIGURE 9d: IH-IH NOE Difference spectra of compound B2 in de-acetone
T
1
+i
Y
|— 1— 1— L I -T~1 I I I I ! ' I I |- I I I I "I I I I I I I I I 1 I 1 I I I I I I I I
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FIGURE 9e: CcMDpound D1 in de-acetone
 iU J
-|------- r
jj Cl
-------
9 8 7 6
FIGURE 9f: Compound D2 in de-acetone
5 4PPM
1
~i----— 1--- — —r-6 5 4PPM
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fIGURE in: IH NMR Spectra of Compounds C1-C3, El and E2 at 3Q0m^ 
FIGURE 10a: Compound Cl in de-acetone
i 'ikjL
—r- 1 1 —r- 10 7 6PPM12   9 8
FIGURE 10b: Compound C2 in de-acetone
A 1 I
7i5 7^0 GL5 gT0 s’s 5 ’ 0 4L 5 4^0 s! S s! 0 " 2.! 5 ' ' 2 ' 0 1YPPM
FIGURE 10c: Compound C2 in CDCI3
ill 1
5PPM
FIGURE lOe: Compound C3 in de-acetone
JN 1
-1—5PPM
.A..
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FIGURE lOd: iH-iQ NOE Difference spectra in compound C2 in CDCI3
PPM
FIGURE lOf: Compound El in CDCI3
PPM
FIGURE lOg: Compound E2 in CDCI 3
Î . 0  3.5 3.0 7,5 7.1
i ~ '  I 1 • I I  : ■  I  '  I !  I  I  I  I I i ~ ' '  I ~ i ~ r  I  t - i  - r - i  I  I  I t - f  1 I  I  r  ■ < ’ ! I [ r  I ' '
6.5 6.0 5.5 5.0 fl.5 4.0 i . 5  i 0 2.5PPM
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FIGURE 11: NMR Spectra of Compounds C4. £4 and E6 at 300WHz
FIGURE 11a: Compound C4 in da-DMSO
“ra T8 “T6T7 T5 T T4PPM
FIGURE lib: Compound E4 in de-DMSO
PPM
FIGURE 11c: Compound E6 in DzO
3 2 15 47 689 PPM
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FTfîlIRE 12: IH NWR Spectra of Coppounds C8. C9 and E7 at 300MHz 
FIGURE 12a: Compound 08 in CDCI3
au
5PPM
FIGURE 12b: Compound C9 in CDCI3
jU
1-------- r5 4PPM
FIGURE 12c: Compound E7 in CDCI3
PPM
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FIGURE 13: iH NMR Spectra of CoBiPounds Ell. ElOa and ElOb at 300MHz 
FIGURE 13a: Compound Ell in de-acetone
6 5 34?9 8 PPM
FIGURE 13b: Compound ElOa in CDCI3
iL 1
— y —
SPPM
FIGURE 13c: Compound ElOb in CDCI3
jLIl jUaJ u
— I—
5PPM
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FIGURE 14: NMR Spectra of Cocrpoiinds Al and B1 at 75flHz
FIGURE 14a: Compound A1 in de-acetone
1 ■ I J L
180 160 140 120 100PPM 80 60 40 20
FIGURE 14b; DEPT 135 Spectrum of compound A1 in de-acetone
T---
180 160 140 120 1 00PPM 80 80 40 20
FIGURE 14c: Compound B1 in de-acetone
200 180 160 140 120 100 80 60 40 20PPM
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FIGURE 15: NMR Spectra of Compounds B2. D1 and D2 at 75MHz
FIGURE 15a: Conipound B2 in de-acetone
JU-J*
 ;-----------:-1 -------- 1-i--------- :-!--------- '-!--------- '-1----- ^200 160 160 140 120 100PPM
FIGURE 15b: Compound D1 in de-acetone
60 40 20
200 180 160 140 120 100 80 60 40 20
PPM
FIGURE 15c: Compound D2 in de-acetone
I’M''
180 160 140 120 100PPM 80 60 40 20
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FIGURE 16; ^MR Spectra of Compovmds C2. C3 and El at 75MHz
FIGURE 16a: Compound C2 in de-acetone
— I—  100 PPM
-~r—40180 160 140 120 80 60 20
FIGURE 16b: Ccanpound C3 in de-acetone
"20"160 160 140 120 100PPM 7 7
FIGURE 16c: Compound El in CDCI3
180 160 140 120 100
PPM 77 77 —I—40 77
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FTGUBE 17: 17Q NMR Spectra of Compounds Al. B1, B2 and D1 at 40MHz
FIGURE 17a: Compound Al in  d.6—a c e to n e  a t  328K
450 400 350 300 250PPM 200 150 100 50FIGURE 17b: Compound BÎ in de-acetone at 328K. Note the intense solvent
signal and baseline roll
B00
PPM
FIGURE 17c: Compound B2 in de-acetone at 328K
500 300 200 100
450 350 250PPM 200 150 100 50
FIGURE 17d: Cwopound D1 in acetone at 323K
500 450 400 350 300 250PPM 200 150 100 50
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FIGURE 18: ^^ 0 NMR Spectra of Conpounds C2 and El at 40MHz
AFIGURE 18a: Compound C2 in CECI3 at 320K
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FIGURE 18b: Ccmtpound C2 in methanol at 333K
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FIGURE 18c: Compound C2 in acetone at 328K
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FIGURE 18d: Compound El in acetone at 323K
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FIGURE 19: 17Q NMR Spectra of Compounds 06 and E5 at 40MHz
FIGURE 19a: Compound C6 in [1&0]water at 363K
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FIGURE 19b: Compound E5 in [^^ 0]water at 363K
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FIGURE 20: NMR Spectra of Coppounds C8 and C9 at 40MHz
FIGURE 20a: Compound C8 in GH3CN at 348K j
FIGURE 20b: Compound C9 in CH3CN at 348K
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FIGURE 21: ^^0 NMR Spectra of Compounds ClOa. Cl Ob and ElOb at 40MHz 
FIGURE 21a: Compound ClOa in D2O at 353K
12030160 150PPM180 170190
FIGURE 21b: Compound ClOb in D2O at 323K
140150PPM160160 170190
FIGURE 21c: Compound ElOb in CHCI3 at 320K
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FIGURE 22: 3H NMR Spectrum of Compound D3 at 320MHz
Compound D3 in ds'-acetone.
Insert shows 'H-coupled ffliR spectrum
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FIGURE 23: NMR Snectra of Deuterodebrominated Conpound E6
FIGURE 23a
J
See TABLE 32 for details
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—T— 7.5 PPM
I8. 5 s.'s
FIGURE 23c
PPM
342
FIGURE 24: H^. and NWR Spectra of Compounds E8a/b at 300MH%.
320 MHz. Respectively
FIGURE 24a: zg RMR Spectrum of compound E8a in CECI3.
See TABLE 33 for details
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FIGURE 24b: IR NMR Spectrum of compound El in CDCI3
FIGURE 24c: IH NMR Spectrum of compound E8b in CDCI3.
FIGURE 24d: NMR Spectrum of compound £8b in CDCls*
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FIGURE 24e: Reference RP-HPLC traces for compounds El and E2 using a 75:251
(v/v) Me0fl:H20 solvent system at a flow-rate of 1 ml/min. using 
UV detection at 268nm
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FIGURE 24f: Typical comparative UV and radio-scintillation traces for
mixtures of compounds E2 and E8b. Peak A is compound E2. Peak B 
is compound E8b and peak C represents the mono-debrominated 
intermediate
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FIGURE 24g: NMR Spectrum of the crude reaction mixture in CDCI3
U
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FIGURE 24h: NMR Spectrum of the crude reaction mixture in CDCI3
5.0 B.O 7.0 B.O 5^0 4.0 3.0 2.0 1.0
FIGURE 24i: NMR Spectrum of the RP-HPLC purified compound E8b in CD3OD
FIGURE 24j: NMR Spectrum of the RP-HPLC purified compound E8b in CD3OD
7.0 B.O _ 5I0 4.0 3,0 2.0 1.0
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FIGURE 25: Mass Spectra of C M BPO unds D2. E2. E4. E6. C8 and C9
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FIGURE 25aÎ Positive ion FAB—mass spectrum of compound D2
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FIGURE 25b: Positive ion FAB-mass spectrum of compound E2
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FIGURE 25c; Positive ion FAB-mass spectrum of compound E4
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FIGURE 25d: Positive ion FAB-mass spectrum of compound E6
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FIGURE 25e: El-Mass spectrum of compound CB
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FIGURE 25f: El-Mass spectrum of compound C9
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FIGURE 26: Mass Spectra of Compounds Cl2 and ElO 
26a: Positive ion FAB-mass spectrum of compound Cl2 after no work up
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FIGURE 26b: Positive ion FAB-^ oass spectrum of compound C12 after 
basification
FIGURE 26c: Positive ion FAB-mass spectrum of compound ElOa
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FIGURE 26d: Positive ion FAB-mass spectrum of compound ElOb
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4. DISCUSSION
4. Selectivity of Bromination: Determining the Position of the Bromine 
Substituent in Compounds B2. C3. D2 and E2
The first aspect of the evaluation of Wyrick and Ranga's^s route to 
high specific radioactivity tritiated sodium cromoglycate (DSCG) was to 
conclusively determine the position of bromination in the molecule, D2. This 
information was of the utmost importance because, upon dehalogenation with 
tritium gas, the position which was previously brominated would become the 
site of the radiolabel. As this radiolabelled site may, in future work, be 
used in NMR spectroscopic experiments to report details of the
interaction between DSCG and its protein receptor(s), its NMR assignment was 
a necessary requirement. A combination of information sources, including NMR 
spectroscopy, quantum mechanical calculations, X-ray crystallographic
analyses and analogy with known mechanistic and kinetic examples, were used 
as evidence. The positional assignment differs from that reported by Wyrick 
and R a n g a 2  5.
4.1 Mechanism and Kinetics
The experimental conditions used by the author mirrored those of Wyrick 
and Ranga2 5. Using the data found in the literature review presented as 
SECTION 2.19, pg. 273, it is seen that there is a kinetic advantage for 
bromination mediated by the phenol OH substituent. Bromination controlled by 
the phenol ether substituent would be slower. Therefore, it is likely that 
the phenol mediated route dominates the electrophilic substitution pathway. 
Because of the size of the bromine electrophile, approach to the position 
para- to the phenol is favoured for steric reasons. However, flanking this 
favoured para-position is the phenol ether substituent. As shown by the 
dipole moment data of Granzhan et allio and X-ray crystallographic and 17Q 
NMR data presented here, the phenol ether substituent adopts a conformation 
in which the C-OPh bond is co-planar with the plane of the aromatic ring 
system (-1.3^  and 8.3° in compound D2 (TABLE 43, pg. 312); 2.1° in compound
C3 (TABLE 40, pg. 310) and points towards the favoured para-position. This
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conformation provides steric hindrance effectively prohibiting bromination 
at the activated position para- to the phenol OH substituent. The only other 
activated position is ortho to the phenol. Obviously, the H of the phenol 
has considerably less steric bulk than the phenol ether CH3 of compound B2 
or the extended alkyl chain of compound D2. Also, the PhO-H bond points away 
from the activated ortho-position as it participates in an intramolecular 
hydrogen bond with the carbonyl of the acetyl substituent. Approach of the 
bromine electrophile to this position would be energetically favoured. Due 
to the 1,3-substitution relationship between the phenol and the phenol 
ether, both substituents activate the same positions towards electrophilic 
substitution.
The strong -I effect of the phenol ether and the weaker -I and -M 
effects of the acetyl substituent enhances the likelihood of the dienone 
intermediate (shown here for B2) of SCHEME 3 (pg.279);
H Br
thus lending additional favour to the "phenol mechanism".
So, in conclusion, it appears that a combination of electronically- 
based kinetic and steric effects ensure that mono-bromination occurs 
exclusively in the 5-position, ortho- to the phenol OH for 1,3-alkoxyphenols 
in acetic acid.
Compound Al is a symmetrical molecule such that H3 and H5 are identical 
and both positions are equally reactive in all respects. Electrophilic 
substitution would follow the same mechanistic and kinetic routes. Using one 
equivalent of bromine, it was not possible to synthesise the mono-brominated 
product, A2, free of the di-brominated contaminant, A3. A yield of about 70% 
for A2 was the maximum obtained under these conditions; see FIGURE 9a,9b, 
pg.327. This result verified the arguements presented here whilst also 
presenting a synthetic problem!
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Kinetic studies could not be conducted for the bromination of D1 as the 
product, D2, is insoluble in the glacial acetic acid solvent. A 
spectrophotometric study, following the concentration of molecular bromine 
would be untenable. However, compounds A2, A3 and B2 are soluble under these 
conditions and so would provide a useful starting point for a study of the 
kinetics of bromination of alkoxyphenols.
4.2 X-Ray Crystal Data
X-Ray crystallography provides the most detailed structural information 
of any technique. The analyses of compounds D2 and C3 (SECTION 3.13, 
pg.308), obtained as the sole products from their respective syntheses with 
their purity validated by NMR spectroscopy (FIGURE 9e, lOe, pg.328-329), 
mass spectroraetric and elemental analyses (SECTION 3.2, pg.295) prior to 
crystallisation show that the bromine substituent is present at the 
5-position and not the 3-position as reported by Wyrick and R a n g a ^ s .  The 
position of the bromine substituent is unchanged upon formation of the 
chromone-2-carboxylate product as shown by the X-ray crystal structure of 
compound C3 (FIGURE 27, pg.312).
4.3 Quantum Mechanical Calculations
Atomic charge and charge density calculations were performed on 
compound B1 in an attempt to identify if one of the two positions activated 
towards electrophilic substitution favoured the approach of an electrophile 
(SECTION 3.14, pg.314). These data, together with the results of Forsen et
all94 , 195^  are shown below:
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OCHo O
Method Ref. 194 Ref. 195 CNDO AMPAC.AMl Ab Initio
C6 -0.0564 -0.0720 -0.1037 -0.3852 4.0303
C2 -0.0562 -0.0718 -0.0999 -0.3285 4.0265
Values taken from the literature and the results obtained using more 
recent methodologies agree that the two positions of the benzene ring are 
almost equally activated towards electrophilic substitution. The data 
alone would suggest that both positions should undergo electrophilic 
substitution to an almost equal extent if there were no other factors 
controlling the substitution pathway.
4.4 NMR Spectroscopy
The first step was to fully assign the NMR spectrum of B1 and D1. 
Although a partial assignment has been reportedzs (see TABLE 25, pg. 316) 
for compound D1, the H3 and H5 chemical shifts were not assigned. They are 
almost identical.
The close proximity of the phenol ether methyl H6 of compound B1 or the 
methylene group H6 of compound D1 to the H5 proton (see SCHEME 7, pg. 315) 
was used to identify the H5 proton by the signal enhancement of H5 upon 
irradiation of the H6 protons using the nOe effect (FIGURE 8c, pg. 326). The 
same technique was used for the brominated analogues, B2 and D2 (FIGURE 9d, 
pg.328), where a signal enhancement for H5 meant that the H3 proton and not 
the H5 proton as Wyrick and R a n g a ^ s  had reported, had been substituted upon 
bromination. Moreover, tritiodebromination of compound D2 (SECTION 3.6, pg. 
298-299) swopped the bromine for a tritium atom. Analysis of the NMR 
spectrum of compound D3 lent further weight to the proposal that the H3 
position is solely brominated. These results are summarised in the following 
schematic:
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iH NMR spectrum of D1
H4 H5 H3
nOe difference spectrum of D1
3Q NMR spectrum of D3
s
The iH NMR spectrum of compound D2 was complicated by the fact that the 
H5 chemical shift value was solvent dependent. In CDCI 3 , it had a value of 
6.36ppm, yet in de-acetone its chemical shift was 6.70ppm (TABLE 25, pg 316). 
All other chemical shift values were unchanged. This observation is thought 
to be an effect of the solvation of the D2 molecule such that an induced 
anisotropic magnetic field set up by the carbonyl TT-electrons of the
de-acetone molecule(s) influences the chemical shift of the H5 proton in 
compound D2. Solvent dependent chemical shifts were also observed for
compound C2 (TABLE 26, pg. 318; FIGURE lOb/c. pg.329). D2 has a low
solubility in CDCI 3 thus making its use for NMR work on this molecule 
inappropriate. Furthermore, Wyrick and Ranga^G reported their IR NMR data as 
de-acetone solutions which made its use for this study necessary for
comparative purposes.
A further complication was the observation of signal splitting of the 
H5 proton signal for some de-acetone solutions of the D2 molecule :
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H5
 1------- 1------- 1------- T------- 1-------T--------i------- 1--------1------- 1------- T------ -r-----— I------- 1—7.9 7.8 7. 7 7.6 7.5 7.4 7.3 7,2 7. 1 7.0 6.9 6.8 6.7 6.5
PPM
H5
7. 8 7,6 7.4 7.2 7,0 6. 6 8.6PPM
Initially it was thought to be due to the presence of some of the
5-brominated product as Wyrick and Ranga^s had reported. However, the 
nOe difference experiment did not give any preferential signal enhancement
and the iR NMR spectrum of a CDCI3 solution did not show this signal
splitting. A possibility is that some of the phenol OH substituent becomes 
acetylated during the bromination synthesis as the reaction medium is
glacial acetic acid.
CH,Q O CH3O
BT2
AcOH
This proposal is not supported by the observation of a sharp melting 
point nor the mass spectroraetric and elemental analyses of the D2 product. 
The answer must lie in an extension of the anisotropy arguement. As the D2 
molecule has two benzene rings connected by a flexible alkyl chain, it may 
be that there is a slight variation in the solvation of the H5 protons. The
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x-ray crystal data reveals a slight difference in conformational preference 
between the two benzene rings. Torsion angle C19-013-C14-C13 is -1.3° and 
C29-023-C24-C23 is -8.3° . It is proposed that a differential influence of 
the induced anisotropic magnetic field created by the acetone carbonyl 
explains the observed split H5 signal.
4.5 Tritium Labelling: Dehalogenation of Compounds E6 and E2
This section is divided into two parts. The first analyses the results 
of Wyrick and Ranga^s in the light of experimental investigations carried 
out by the author. The second part discusses the synthetic route adopted by 
the author and the results obtained thereby.
Wyrick and R a n g a ^ s  followed the synthetic route outlined by the 
schematic:
D1----- ^D2------î^ D3  >E8b  V  >"[6,6'-3H2]E5"
= Transformation did not work.
They gave the structure of D2 as the 3,3'-dibromo positional isomer. 
The author found this compound to be the 5,5'-dibromo isomer using the same 
D1 to D2 synthetic procedure as Wyrick and Ranga. Subsequently, they 
incorrectly identified D3 as the [ 3 , 3 isomer and E8b as the 
[6,6'-3H2]isomer. Note that the radiolabel was introduced at an early stage 
of the synthesis with the formation of "[3,3'-3Hz]D3" at a purported 
71Ci/mmole. As the maximum specific radioactivity per site is 
28.76Ci/mmole2i6 the absolute maximum for the two labelled sites shown is 
57.52Ci/mmole. Moreover, it is extremely difficult to exclude all 
tritium-diluting sources of protium from heterogeneous catalytic systems 
such that the absolute maximum specific radioactivity cannot be readily 
a c h i e v e d 2 i 7 .  One concludes that either Wyrick and Ranga^s miscalculated the 
specific radioactivity for "[3,3'-3Hz]D3" or that the labelling pattern was 
more general in character with sites other than those shown being occupied 
by tritium atoms.
After optimisation of the conversion of D2 to "[3,3'-2H2]D3" using
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deuterium gas, Wyrick and Ranga2 5 used the same conditions for 
tritiodebromination. These conditions are listed with those of the author 
(SECTION 3.6) below. Both used hydrogen gas at one atmosphere pressure.
Source Mass of 
D2(mg)
5% Pd/C 
cat.(mg)
Gas EtsN
(;ii)
THF
(jil)
Rxn. Time 
(hrs.)
XDehal. Sp. Act. 
(Ci/mmole)
Wyrick 19.4 10 Tz 100 500 3 <1001 71
Gulf 20 40 12:l(v/v)
Hz:Tz
20 400 3.5 90 2.98
1. Estimated
Differences in the bond dissociation energy of the hydrogen gas 
isotopes (436 and 443kJ/mole for Hz and Tz r e s p e c t i v e l y 2 i 6 ,218) and other 
processes give rise to the commonly observed phenomenon (kinetic isotope 
effect) of tritiation reactions being slightly slower than the corresponding 
hydrogenations and deuteriations. Even though the hydrogen isotope gas
mixture used by the author was mostly hydrogen, it was only possible to 
dehalogenate 90% of the D2 substrate even though a longer reaction time than 
Wyrick and Ranga2s was used. Percentage dehalogenation was determined by 
comparison of the integral traces of D2 and D3 from the NMR spectrum of 
D3. It seems likely that Wyrick and Ranga25 did not fully debrominate 
compound D2. Indeed, they did not employ an analytical technique, such as 
NMR spectroscopy, to check this. The D3 to E8b conversion was, therefore, a
combination of two reactions; D3 to E8b and D2 to E2. Again, the chemical
integrity of the product of this reaction (Claisen condensation, SECTION 
3.3, pg.295-296) was not checked, Wyrick and Ranga25 failed in their 
attempts to saponify this product.
The reaction conditions for the D3 to E8b conversion are harsh,
requiring the reflux of a highly basic medium, followed by the reflux of an
acidic medium to form the ethyl ester; see SECTION 3.3, pg.295-296. As the
radiolabel is located at a benzene ring position activated to electrophilic
substitution, it is probable that scrambling of the label at this position
leading to a dilution of the label and a diminution of specific
radioactivity would occur. Wyrick and Ranga25 report a specific
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radioactivity for "[6,6'-3H2]EBb" as 71Ci/mmole, unchanged from that 
determined for "[3,3'-3Hz]D3".
From information presented in the literature review (SECTION 2.21, 
pg.283-284) and the experiences of the authorise (SECTION 3.4, pg.297) a
sodium hydroxide mediated saponification is inappropriate for E2 as only 
decomposition products result. Milder saponification reaction conditions 
were required to saponify E2. The presence of E2 in the E8b product would 
have made the conversion of E8b to "[6,6'-3H2]E5" impossible, as Wyrick and 
Ranga25 observed. The synthetic schemes used by the author are shown below:
(I) D1------^D2----- >E2---- >E4----- ^E6----- »E5
(II) D1----- kD2----- ^E2---- »E8b
In scheme I, E6 is the brorainated precursor. Results for this approach 
are presented as TABLE 32, pg.300 and FIGURE 23, pg.342. For scheme II, E2
is the brominated precursor. Results for this approach are presented as
TABLE 33, pg. 300 and FIGURE 24, pg.343-345. Dealing with overall comments 
on the two reaction schemes, the syntheses of the E2, E4 and E6 series of 
compounds was undertaken (SECTION 3.3-3.5, pg.295-298) so that the required 
product, [8,8'-^H2]E5 could be obtained with the absolute minimum 
requirement for post-labelling chemical manipulations. Most success was
obtained with the use of a low percentage loading metal catalyst (typically 
5%). Use of higher loadings increased the proportion of chemical degradation 
products as the reaction proceeded. Most dehalogenation reactions require 
reaction times of less than four hours for completion. Full dehalogenation 
of E6 required about 20 hours, whereas E2 required 50 hours or more.
Obviously, the longer the necessary reaction time, the greater the
opportunity there will be for isotopic dilution of the label site yielding a 
product of low specific radioactivity or conversely the greater the
opportunity for non-specific labelling of slowly exchanging sites.
Dehalogenation of E6 was the most attractive route as it would, if
successful, have provided the required product, [8,8'-3H2]E5 directly. No
post-labelling chemical manipulation would have been necessary and the
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extent of dehalogenation would have been immaterial as RP-HPLC could be used 
to isolate the pure product directly. Although, from a chemical standpoint, 
successful dehalogenation reaction conditions were identified (TABLE 32, 
pg.300; FIGURE 23, pg.342), the necessity of an aqueous solvent and a long 
reaction time precluded any hydrogen isotope incorporation.
Heading back up the synthetic pathway, the next likely dehalogenation 
substrate was compound E2. This substrate would require preferably complete 
dehalogenation to give crude E8b followed by a preparative RP-HPLC 
purification, micromolar scale saponification and a further preparative 
RP-HPLC purification. Isolation of E8b free of the E2 substrate would be 
paramount so that the saponification step to yield the [8,8'-^H2]E5 product 
is successful. As E2 is an ethyl ester, aprotic solvents were used although 
the reaction time for dehalogenation increased (TABLE 33, pg. 300). E2 was 
successfully partially dehalogenated, analyzed by H^ and H^ NMR spectroscopy 
(FIGURE 24g/h, pg.345-346) and RP-HPLC (FIGURE 24e, pg.344), purified by 
RP-HPLC on a preparative scale (FIGURE 24i/j, pg.345) at a specific
radioactivity of 52.1Ci/mraole or 90% tritium incorporation. Saponification 
of E8b was not attempted.
As in the case for D1, the H^ NMR spectrum of El was assigned by the 
use of iH-iR nOe difference spectroscopy. The site of the tritium label in 
E8b and, therefore, the site of the bromine substituent was determined from 
a comparison of the IH NMR spectrum of El and the H^ NMR spectrum of E8b. 
The results are presented in the schematic below:
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IH NMR spectrum of El
H7
H3
H8
H6
ifl-iH nOe difference spectrum of El
NMR spectrum of E8b
4.6 Oxygen-17 Enrichment of Chromone-2-carboxylates
The large molecular dimensions and low solubilities of DSCG and its 
carboxylate derivatised analogues meant that their NMR spectra were
either impossible to obtain (eg. the methyl and butyl esters, ElOa and E7) 
or where signals could be detected (eg. the ethyl ester and sodium salt; 
FIGURES 18d and 19b, pg. 339) the low S/N ratio denoted inconclusive and 
incomplete data of poor quality at natural oxygen-17 abundance. Oxygen-17 
enrichment of these compounds provides a route by which high quality NMR 
data were obtained.
4.7 Oxygen-17 Enrichment by Exchange
Compound Cl2 was obtained by the acid catalysed exchange of compound 
Cll with highly enriched [i^ojwater; see SECTION 3.9, pg. 302. Mass 
spectrometric analysis of compound Cl2 showed that all four oxygens were 
enriched, including the endocyclic 01 oxygen (SCHEME 9, pg. 322). 
Approximately 60% of the molecules had either two or three enriched 
positions with only 11% having all four positions enriched with oxygen-18. 
One of the four oxygen positions is extensively back-exchanged upon
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neutralisation (TABLE 34, pg.302) with potassium hydroxide solution. From
the data of Dahn et all49 (SECTION 2.18, pg.272) it would appear that the 04 
position should be the least enriched. This suggests that it also the
position most prone to back-exchange. Furthermore, NMR data for 04 shows 
it to be extensively shielded, denoting a large element of enol structural 
character for this ketone (SECTION 2.12) which would retard exchange.
Compound C4 was similarly oxygen-17 enriched by acid catalysed exchange 
to give compound ClOa or ClOb depending on the nuances of the experimental 
procedure (SECTION 3.9, pg.301). Analysis by NMR spectroscopy (TABLE 31, 
pg.325; FIGURE 21a/b, pg.341) indicated that the 01 position only was 
enriched to an extent that it could be observed in the NMR spectrum (NS 
= 5.1x104). In comparison with compound C12, it would appear that either the
02,03 and 04 positions were not significantly enriched over the time period 
of the exchange reaction (15 hours against 5 days) or that enrichment at 
these sites was back-exchanged during the basic work-up procedure. A
combination of these two factors may have prevailed.
The acid-catalysed exchange conditions used were similar to those 
reported by Baldwin et aliis and Gerothanassis et alll? (SECTION 2.14, 
pg.266) for carboxylates and by Oae et al^43 for phenols (SECTION 2.17, 
pg.271). Enrichment of the endocyclic 01 was an unexpected result, as upon 
inspection of the chromone structure it is not apparent that the 01 position 
is susceptible to facile exchange. The proposed exchange mechanism to
explain this observation is ^-pyrone ring hydration and ring opening
followed by keto-enol tautmerism at the free phenol function released upon 
ring opening. The enone (STRUCTURE III) formed is stabilised by 
delocalisation of negative charge on the benzene ring and the adjacent 04 of 
ketone (IV). Nucleophilic attack at this enone by [I70]water, elimination of 
water, intramolecular nucleophilic attack of the(X-ketone on the alkyl chain 
by the phenol/phenoxide enol tautomer to ring-close the ^-pyrone and 
acid-catalysed dehydration regains the starting material enriched at the 01 
position (VI):
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H;0
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V
O'  \ ; o o H
COOH
II
C"'-0 0 o* ‘'”^ 0
III
COOH
OH
COOH
O ' COOH
COOH
0 0 ( 0
COOH
b ^ C O O H
That the 04 position exists primarily as an enol (STRUCTURE IV) during 
the exchange would explain its resistance to enrichment.
Pcirtial support for this proposed mechanism is provided by Kaye et 
al2i9. They prepared [3-2H]chromone-2-carboxylic acid by the acid-catalysed 
exchange of the disodium salt of ethyl 4-(2-hydroxyphenyl)-
2,4-dioxobutanoate in [0-2H]acetic acid containing 20% H^Cl.
AcOD/ DCl
COOC2H5
O- Na*
- LOI JLBoil, 0.5 hr \ X ^ 0' ^ O O H
A
COOH
A IH NMR spectroscopic analysis showed that the product contained 80% A 
and 20% B. Exchange could occur upon the ring-opened /3-diketone (STRUCTURE 
III) or after ring-closing, directly upon the chromone-2-carboxylie acid 
(STRUCTURE I). Which proton (or deuteron) is eliminated from the 3-position 
of STRUCTURE V would be dependent upon the elimination mechanism (V-^VI).
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4.8 Future Work
Oxygen-17 enrichment by exchange could be extended to compound Cl to 
yield compounds such as C and D with two labelled positions:
OH O ^O H O owater CH2N2
HCl.A
C O O R  r ^ ^ C % > ^ ^ ^ ^ C O O H  ''^s::x^^Q/^COOCH 3C D
These would be useful for extended physico-chemical studies of chromone ‘ 
molecules using i?0 NMR spectroscopy, such as pKa evaluations, temperature 
and solvent chemical shift dependence and hydrogen bonding studies. This 
work would not be restricted by the choice of solvent.
4.9 Oxygen-17 Enrichment by Synthesis
The carboxyl 02 position of compound ElOb (SCHEME 9, pg. 322) was 
enriched by hydrolysis of the acid chloride, E9, with [i^o]water to give the 
oxygen-17 enriched diacid, Ell. The corresponding methyl ester, ElOb, was 
prepared using diazomethane (SECTIONS 3.10-3.11, pg. 303-304).
The mechanism of acyl chloride hydrolysis is k n o w n ^ z o. it should be 
possible for both carbonyl (02) and hydroxyl (03) oxygens of the carboxylate 
function to be enriched upon hydrolysis with an excess of [I70]water. 2.2 
Molar equivalents of water per carboxylate were used in this work.
The 170 NMR spectrum (TABLE 31, pg. 325; FIGURE 21c, pg.341, NS =
7.4x104) shows three signals at 338ppm, 75-79ppm and at 20-28ppm. The signal 
at lowest field was assigned to 02. If 03 had been enriched, its signal 
should have been present at approximately 130-160ppm; see SECTION 2.9, 
pg.255-258. No signal was observed within this region. The remaining 
signals at high field do not belong to compound ElOb. I have assigned these 
to [G-170]trimethylphosphate. This contaminant was formed from the 
phosphorus pentachloride reactant and/or phosphoric(V) acid byproduct of the 
chromone-2-acyl chloride synthesis (SECTION 3.10, pg. 303). Acid-catalysed 
exchange and méthylation by diazomethane yielded [G-170]trimethylphosphate 
which was not resolved and eliminated during the preparative TLC
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purification of ElOb.
H O -P —OHR-CO2H
CH2N2
4  CH,0— P—OCH,I*OCH,* H *[1 7 0 ] w a te r  ^  HO—p—OH
* 0 H
Comparison of the iH NMR spectra of ElOa and ElOb (FIGURES 13b/c, 
pg.333) reveals that the H9 methyl signal is much more intense in the ElOb 
case. This is probably due to the presence of [G-i^O]trimethylphosphate. 
Gerlt et al?i have reported 17q NMR chemical shift values for phosphate 
esters and Dahn et al22i have reported 17q NMR chemical shifts for a number 
of different classes of phosphorus compounds.
Ref.
No.
71
221
Compound
CHP-P-OCH3 3 I
OCH,
P h -P -O C H a
H
P h -P -O C H ,
OCH,
CH3-P-OCH3
OCH,
1 ? X ^ P - O C H ,
OCH,
CH3O-P-OCH3
OCH,
Chemical Shift(ppm) Solvent Temp
P=0 P-0 (°C)
76.6 20% D2O 95
34.3 0.5M in 
CCI4
45
33.7
36.3
26.2
44.1
It can be seen that these data correlate well with the chemical shift 
values observed here. The signals are broadened by phosphorus-oxygen
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coupling, as observed (FIGURE 21c, pg.341).
It is intriguing to observe that only the 02 oxygen of the methyl ester 
is enriched. It is envisaged that the two oxygens of the carboxylic acid 
intermediate. Ell, are equivalent due to rapid proton transfer between the 
two oxygens.
Hence, if only one oxygen of the carboxylate group were enriched, as 
appears to be the case here, there should be every reason to expect the 
NMR signal intensity to be equally distributed between 02 and 03 of the 
methyl ester. As the level of enrichment is low (TABLE 35, pg.305; FIGURE 
26c/d, pg.348), it is unlikely that a kinetic isotope effect is responsible. 
The mechanism of O-methylation by diazomethanei39 does not provide any 
clues.
4.10 170 NMR Spectroscopy: A Feasibility Study for
Chromone-2-carboxylate Derivatives and Precursors
This study presents an appreciation of the applicability of studying 
various chromone-2-carboxylates and their precursors by ^^ 0 NMR 
spectroscopy, and as such is hopefully the first step in an extended 
investigation. This is the first report of any i?0 NMR spectroscopic study 
of chromone-2-carboxylates.
A wide range of solvents, temperatures and molecular analogues were 
used. Some combinations of experimental conditions gave spectra with high 
S/N ratio signals and point the way forward to a more in-depth and 
systematic study of these molecules by NMR spectroscopy. Other
conditions led to poor quality spectra usually coupled with the observation 
of only some of the expected signals. Only a small number of molecules were 
used for these purposes and a complete and unreserved solution structural 
analyses are inappropriate here, although a number of interesting points are
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profitably discussed.
The zero point method, described in SECTION 2.2.2, pg.235-236, was used 
in this study to ameliorate baseline distortions. The number of zero points 
used varied between 4 and 16. Although the difference method (SECTION 2.2.2, 
pg.237-238) has advantages, only a phase cycling method^® was available to 
the author. As this possesses a primary disadvantage of a severe restriction 
of spectral width, this method was not used. To date, the difference method 
of Gerothanassis^9 is not available as an encoded program for Bruker 
instruments.
A number of molecules were represented by models of reduced molecular 
size. Thus, B1 and B2 were models for Dl and D2, respectively. Compounds C2 
and C8 were models for compound El and C9 similarly modelled E2. C4 and C5 
were models for E3 and E5. Finally, C6, ClOa/b and C7 were models for E5 and 
E6.
4.11 Acetophenones
For all compounds (A1, B1, B2 and Dl) the acetophenone carbonyl oxygen 
(01) is heavily shielded at approximately 480ppm. For comparison purposes, 
acetophenone has a chemical shift of 552ppm (TABLE 3, pg.246),
4-hydroxyacetophenone is 513ppm (TABLE 4, pg.247) and 2-hydroxyacetophenone 
is 488ppm (TABLE 6, pg.249). For all the compounds studied, there are two 
ortho-substituents. As detailed in SECTION 2.8, pg.247-248, this arrangement 
of substituents normally promotes torsional displacement of the acetyl 
function from the plane of the aromatic ring leading to loss of conjugation 
with a subsequent displacement of the carbonyl chemical shift to low field. 
X-Ray crystal data for compound D2 (SECTION 3.13, TABLE 43, pg.311) shows 
that torsional displacement is remarkably low at 2.0° and -1.0°. It seems 
likely that the repulsive van der Waals interactions between the acetyl 
function and its flanking substituents are more than compensated by the 
formation of an intramolecular hydrogen bond between 01 and 02. Oxygen 01 is 
further shielded by the +M effect of the two other oxygen substituents.
365
Evidence for the intramolecular hydrogen bond are shown by the high M R  
chemical shift value for H2 in these compounds (TABLE 25, pg.316) which is 
invariant to solute concentration, the dipole moment data of Granzhan et 
all 10, long-range ifl-iH coupling constants of Forsen et ali9S'2i4 and the 
conformation and bond lengths of the phenol OH and acetyl functions in the 
X-ray crystal structure of D2 (SECTION 3.13, pg. 308-313). The torsional 
displacement of the acetyl group is a balance between hydrogen bonding, 
conjugative delocalisation and van der Waals repulsion. A similar example is 
provided by Baumstark et al?*, see SECTION 2.8, pg.249.
R>.
enol/enone
R = H or CH3
C v
Even though the acetyl group is only weakly electron withdrawing, the 
l?0 NMR chemical shift of 02 is heavily deshielded at 89-95ppra (TABLE 30,
pg. 323). Phenol has a chemical shift of 77ppm and 4-nitrophenol is 94ppm
(TABLE 10, pg.253). The +M donation, principally to the carbonyl, thus 
assuring its unexpectedly high field chemical shift and van der Waals 
repulsion must contribute to the low field 02 chemical shift values 
observed.
For compounds B1 and B2, the high chemical shift values of 63-64ppm 
(TABLE 30, pg.323) observed for 03 are due to the same factors. Referring to 
TABLE 10, pg.253, anisole has a chemical shift of 48ppm and 4-nitroanisole 
is 67ppm. These data suggest that the methoxyl group is co-planar to the 
benzene ring (see TABLE 11, pg.254). X-Ray crystal data for D2 shows the
C13-C14-013-C19 and C23-C24-023-C29 torsion angles to be -1.3* and 8.3° in 
the solid state (FIGURE 28, pg.312; TABLE 43, pg. 311). The short bond
lengths for C14-013 at 1.354Â, C24-023 at 1.320Â in D2 and C4-02 in C3 at
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1.343A reflect the +M effect of the 5-alkoxy function. The short C-0 bond 
lengths were highlighted by Hamodrakas et a l 222 for the X-ray crystal 
structure of E5.
On going from compound A1 to B1 (FIGURE 17a/b. pg.337) the 01 chemical 
shift c h a n g e , ,is +5ppm. The reasons for this may be due to differences in 
the OH and OMe groups' electron donating and/or hydrogen bonding abilites. 
Note the stabilising effect of the enol/enone resonance structure above.
The chemical shifts observed for compound B2 are further perturbed by a 
bromine substituent. The electronic consequences are slight (see 
Kolehmainen's data in SECTION 2.11, TABLE 17, pg.259-260) for 01 and 03. The 
greatest deshielding of 5ppm is seen for the adjacent ortho-01. This is seen 
as the -I effect of bromine.
The limited, poor quality data for compound Dl (FIGURE 17d, pg.337) 
were due to its large molecular dimensions and poor solubility. The use of 
compound B1 as its model for i?0 NMR data collection is vindicated by the 
near coincidence of these data (TABLE 30, pg.323).
4.12 Chromone-2-carboxylate Esters
The molecules studied which come under this title are 02, C8, C9, El 
and ElOb. See TABLE 31, pg.324-325. Methyl, ethyl and butyl esters were used 
to obtain NMR data in acetone, methanol, chloroform and acetonitrile as 
solvents over a temperature range of 320-348K. The short alkyl chain esters 
are not very soluble. Solubility increases markedly on extension of the 
alkyl chain; the butyl esters being adequately soluble in the solvent of 
choice, acetonitrile (SECTION 2.6, pg.244-245). However, lengthening of the 
alkyl chain increases the molecular dimensions (SECTION 2.6, pg.243-244) 
which, to an extent, curtails the advantages of higher solubility (SECTION 
2.6, pg.242-245). The use of propyl or isopropyl esters should be tested to 
analyse any advantages in comparative tests with butyl esters. The use of 
isopropyl or sec-butyl esters may be useful in resolving the 01 and 03 
signals which are severely overlapped in the 1?0 NMR spectra of straight
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chain esters.
The data obtained for C8 and C9 in acetonitrile will be used as the 
base values for the chemical shifts recorded and chemical shift values 
obtained in other solvents will be compared and referred to these values.
The chemical shifts observed are consistent with data reported by other 
workers which were reviewed in SECTION 2.12, pg.260-265. The only related 
molecule is 7-methoxychromone (pg.262) reported by Duddeck et all 13.
O 419 ppm
65ppm ^ 500ppm
352ppffl
65 ppm 163 ppm 156ppm
152ppm
C8
The high chemical shift for 04 of C8 is due to in-plane bond 
deformation of the carbonyl. This is consistent with the data of other 
workers (see SECTION 2.12, pg.264-265). X-Ray data for C3 (SECTION 3.13, 
pg.308-313) shows the C5-C6-03 bond angle (FIGURE 27,pg. 312; TABLE 39, 
pg.309) to be 125.1° . The same angles in the X-ray crystal structure of 
E5222 are reported as 124.5° and 125.2°. These data are consistent with the 
work of Boykin et al84,87 on anthraquinones; SECTION 2.8, pg. 250. Even 
though the 5-methoxyl 05 substituent is electron donating to the 04 
position, its presence at the 5-position results in an, as yet unmeasured, 
deshielding effect.
The chemical shifts for the carboxylate oxygens, 02 and 03, are at 
a relatively low field being 352ppm and 152ppm, respectively. This is not 
explained by torsional displacement (SECTION 2.9, TABLE 15, pg.257). X-Ray 
crystal data for C3 reveals the torsion angles C7-C8-C10-04 at -177.4? 
01-C8-C10-04 at 3.1° and C7-C8-C10-05 at O.l" (FIGURE 27. pg.312; TABLE 40, 
pg. 310). Equivalent torsion angles, to the latter, are reported as -4.7° and 
-8.9° in E5222. The carboxylate function is essentially co-planar. Moreover, 
the solid-state carboxylate conformer seen for C3 is the same as that 
identified as the preferred solution conformer by Kaye et al^is using an IR
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spectroscopy technique.
It seems likely that the -I effect of the 01 oxygen is responsible for 
the low field chemical shifts observed for 02 and 03. Below is a comparison 
with methyl benzoate and methyl pyridine-2-carboxylate (SECTION 2.9, 
pg. 255-258).
337.3 ppm cH3 346.4 PPO i'cJST127.2 ppm 1 131.8 ppm
?'CHj
The high value for the ethereal 03 oxygen is, in part, due to the 
longer alkyl chain; see SECTIONS 2.8, pg. 251 and 2.9, pg.255).
The effects of 8-bromination in C9 can be seen as the overall -I effect 
of bromine upon 01. Because of this withdrawal of electron density from the 
01 site, less electron density is available for 01 to 04 delocalisation. 
This results in the 8ppm downfield shift of 04. The very slight deshielding 
for 02 and 03 can be seen as the increased electronic demand of 01 (TABLE 
31, pg. 324-325). The very small effect upon the carboxyl oxygens is 
consistent with the data of Kaye et al^^i who found that the acidity of 
chroraone-2-carboxylic acids was not greatly perturbed by benzene ring 
substituents at opposite ends of the electronic scale (eg. MeO- and -NO2), 
falling within a narrow pKa range of about 0.3 units.
For compound C2, the 04 site is most affected by solvents with hydrogen 
bonding ability. Having a chemical shift value of about SOOppm in acetone, 
this is shielded to 486ppra in chloroform and 468ppm in methanol (TABLE 31, 
pg.324). This compares well with data presented in SECTION 2.12, pg. 263-264. 
There may be evidence for a hydrogen bond to 05 in methanol due to the 
concurrent 60ppm shielding of the 05 oxygen.
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CH,O'
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Methanol has a chemical shift of -32ppm (TABLE 8, pg.251) so the 4ppm 
signal is unlikely to be due to solvent. There is the possibility that 
solvent-borne water may resonate at this chemical shift.
170 NMR data from El was of poor quality and incomplete (see FIGURE 
18d, pg.339) due, again, to the large molecular dimensions and its low 
solubility. Indeed, although E7, the butyl ester, was very soluble in 
acetonitrile, no 17q mMR data were observed. This was probably due to its 
extreme size. High quality spectra of the cromoglycate molecule can be 
obtained by oxygen-17 enrichment as seen for ElOb, the methyl ester with 02 
enriched. Here we see 02 shielded by about 14ppm due to a combination of the 
one carbon methyl alkyl chain of the ester (TABLE 13B, pg. 255) obtained in a 
hydrogen bond donor solvent, chloroform.
4.13 Chromone-2-carboxvlic Acids
The compounds studied were C4 and C5. These data were obtained as DMSO 
solutions at 393K (TABLE 31, pg.324). These were not a wholly practicable
set of experimental conditions and the data recorded were incomplete. For 
the esters, the small chemical shift difference between 01 and 03 led to 
signal overlap and possible assignment errors. The convergence of the 02 and 
03 chemical shifts to one value for carboxylic acids and salts overcomes 
this problem and the 01 resonance is clearly resolved.
02/03 resonate at a low field position of 263ppm for 04. Benzoic acid 
has a chemical shift of 250ppm (TABLE 15, pg.257). 01 is deshielded by
14ppm. This may be the result of the loss of the alkyl group of the ester 
and its associated +I effect. The chemical shift of 05 remains the same. For 
05, slight deshielding is observed as expected of the 8-bromo substituent.
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4.14 Sodium Chromone--2-carboxylates
Compounds C6, C7, ClOa/b and E5 were subjected to NMR spectroscopy. 
The compounds at natural isotopic abundance were studied as saturated 
solutions in 99.99atom% [i^O]water at 363K. This solvent was used to
eliminate the dynamic range problems encountered when using isotopically 
normal water. However, oxygen-17 depletion can occur when compounds are 
heated for long periods in [i^O]water such that signal can be lost to the 
solvent7 2. Compounds ClOa/b enriched at 01 had their spectra recorded as D2O 
solutions at 323K and 353K.
As 02 and 03 are equivalent, this signal is the most intense in the 
spectrum (FIGURE 19b, pg.339) and was the only signal observed for E5 
(FIGURE 19b, pg.339). The 01 chemical shift appears to be relatively 
unchanged at about 170-175ppm whilst the 02/03 chemical shift is deshielded 
by 9ppm to 272ppm (TABLE 31, pg.324). The chemical shift of 02/03 in E5 is
275ppm, in good agreement with the C6 model. The deshielding observed may be
due to a conformation change of the carboxyl group. Comparison of the X-ray 
crystal data for C3 and E5 shows an increase in the torsional displacement 
of the carboxyl group of up to 9° going from an ethyl ester to the salt
which would lead to deshielding as demonstrated by Baumstark et al for
benzoates66 (TABLE 15, pg.257).
Comparing C6 with C8, the butyl ester derivative in acetonitrile, 04
is shielded by 82ppm. This is probably due to multiple hydrogen bonding with
the solvent. The 05 chemical shift is unchanged at 65ppm. This may be seen
as a measure of the importance of the following resonance structure;
which makes hydrogen bonding to the methoxyl oxygen unlikely.
The data for ClOa/b shows that 01 chemical shift has a temperature 
dependence. Comparison of the linewidth at the two temperatures is another 
illustration of the temperature effect reviewed as SECTION 2.6, pg. 244.
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4.15 General Remarks
Oxygens 04 and 01 are the most important atoms which define the 
solution structure of the chromone molecule. 04 is further influenced by 
substituents at the 5- and/or 7-positions and can be indirectly modulated by 
the effect upon 01 of an 8- and/or 6-substituent.
The 02 and 03 oxygens of the carboxylate group possess a low electron 
density when compared to benzoates and pyridinecarboxylates. This is 
probably due to the -I effect of 01. The alkoxy 05 peri to 04 is strongly 
electron donating (+M) yet 04 is still deshielded relative to chromones 
lacking 5-position substituents. This is seen as being due to van der Waals 
repulsion partly relieved by in-plane bond deformation. 01, 02, 03 and 05
did not appear to be greatly perturbed by associations with a range of 
solvents. 02/03 in the acid or salt may undergo a torsional displacement in 
DMSO and water. 04 has the greatest interaction with these solvents 
primarily due to hydrogen bonding.
4.16 Future Work
These preliminary data present methods for obtaining NMR spectra of 
chromone-2-carboxylates. These methods can be used for two types of 
investigation. The first could be a substituent effect study using esters 
(eg. butyl) at natural oxygen-17 abundance. The second type of investigation 
could use various oxygen-17 enriched molecules to study the effects of 
temperature and solvent on hydrogen-bonding and solution structure and other 
parameters such as pH.
4.17 Miscellaneous
The reported X-ray data for 2-methylthiochromone2 2 3 are very similar to 
that reported here for C3:
O
CH,
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C3 Thiochromone
Crystal system Monoclinic Monoclinic
Space group P2i/n P2i
z 4 4
Interplane dihedral 
angle (degrees)
1.6 1.44
The 1 NMR data for compounds C2 and C3 (TABLE 29, pg. 321) may provide 
evidence for the difference in esterolytic reactivity for the 8-brominated 
C3 (SECTION 2.21,pg. 283-284; SECTION 3.4, pg.297). Most chemical shifts are 
similar except for carbon8 and carbon2. The 8.7ppm shielding of carbonB is 
due to the heavy halogen effect as the bromine substituent is at this 
position. Carbon2 is deshielded by 9.2ppm. It will be noted that the carbon2 
and carbon2a chemical shifts are very similar in compound C3. It may be that 
the hydroxide nucleophile is equally likely to attack both carbon2 and 
carbon2a during esterolysis, although carbon2a, the carboxyl carbon, is the 
preferred site of nucleophilic attack in compound C2.
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